Datasets:
Modalities:
Text
Formats:
csv
Languages:
English
Size:
< 1K
Tags:
biohacking
wellness-technology
structured-data
machine-readable
interoperability
reproducibility
License:
Update mirror for v1.5.0 interoperability and reproducibility release
Browse filesThis view is limited to 50 files because it contains too many changes. See raw diff
- .gitattributes +8 -60
- .github/workflows/validate.yml +68 -0
- CHANGELOG.md +58 -0
- CHECKSUMS-SHA256.txt +73 -73
- CITATION.cff +40 -40
- CONTRIBUTING.md +35 -35
- DATASETS.md +362 -362
- DATA_DICTIONARY.md +302 -0
- DEPLOYMENT_CHECKLIST.md +18 -18
- DISCLAIMER.md +11 -11
- KNOWN_LIMITATIONS.md +256 -253
- LICENSE +21 -21
- LICENSE_DATA.txt +25 -1
- METADATA_CORRECTION_2026-08-07.md +62 -0
- PROVENANCE.md +275 -275
- RAW_LINKS.md +154 -154
- README.md +283 -168
- RELEASE_NOTES_v1.4.md +248 -247
- RELEASE_NOTES_v1.5.md +84 -0
- REVIEW_AND_AUTHORSHIP_POLICY.md +287 -287
- SOURCE_DENSITY_UPGRADE_PLAN.md +483 -483
- VALIDATION_SUMMARY.txt +26 -26
- VERSION_HISTORY.md +743 -740
- WEBSITE_PUBLICATION_MAP.md +25 -25
- ai-reference.md +342 -342
- build/build_release.ps1 +279 -0
- build/generate_catalog_jsonld.ps1 +124 -0
- build/generate_interoperability.ps1 +430 -0
- build/generate_jsonl.ps1 +62 -0
- build/generate_project_identity.ps1 +71 -0
- build/generate_provenance.ps1 +155 -0
- build/generate_ro_crate.ps1 +108 -0
- build/generate_supersession_registry.ps1 +77 -0
- catalog.jsonld +317 -0
- data/datasets/v1.2/pemf-contraindications-database-v1.2.csv +13 -13
- data/jsonl/v1.2/blue-light-therapy-reference-index-v1.2.jsonl +17 -0
- data/jsonl/v1.2/hydrogen-water-reference-index-v1.2.jsonl +10 -0
- data/jsonl/v1.2/infrared-therapy-reference-index-v1.2.jsonl +10 -0
- data/jsonl/v1.2/negative-ion-safety-index-v1.2.jsonl +18 -0
- data/jsonl/v1.2/pemf-contraindications-database-v1.2.jsonl +12 -0
- data/jsonl/v1.2/pemf-frequency-index-v1.2.jsonl +21 -0
- data/jsonl/v1.2/red-light-dose-index-v1.2.jsonl +8 -0
- data/jsonl/v1.2/terahertz-device-reference-index-v1.2.jsonl +15 -0
- data/master/holistix-ai-answer-manifest-v1.4.json +6 -6
- data/master/project.json +1 -1
- datapackage.json +1339 -0
- datasets/blue-light-therapy-reference-index-v1-2.csv +18 -18
- datasets/blue-light-therapy-reference-index-v1-2.json +354 -354
- datasets/blue-light/README.md +18 -18
- datasets/blue-light/blue-light-therapy-reference-index.csv +9 -9
.gitattributes
CHANGED
|
@@ -1,60 +1,8 @@
|
|
| 1 |
-
*.
|
| 2 |
-
*.
|
| 3 |
-
*.
|
| 4 |
-
*.
|
| 5 |
-
*.
|
| 6 |
-
*.
|
| 7 |
-
*.
|
| 8 |
-
*.
|
| 9 |
-
*.h5 filter=lfs diff=lfs merge=lfs -text
|
| 10 |
-
*.joblib filter=lfs diff=lfs merge=lfs -text
|
| 11 |
-
*.lfs.* filter=lfs diff=lfs merge=lfs -text
|
| 12 |
-
*.lz4 filter=lfs diff=lfs merge=lfs -text
|
| 13 |
-
*.mds filter=lfs diff=lfs merge=lfs -text
|
| 14 |
-
*.mlmodel filter=lfs diff=lfs merge=lfs -text
|
| 15 |
-
*.model filter=lfs diff=lfs merge=lfs -text
|
| 16 |
-
*.msgpack filter=lfs diff=lfs merge=lfs -text
|
| 17 |
-
*.npy filter=lfs diff=lfs merge=lfs -text
|
| 18 |
-
*.npz filter=lfs diff=lfs merge=lfs -text
|
| 19 |
-
*.onnx filter=lfs diff=lfs merge=lfs -text
|
| 20 |
-
*.ot filter=lfs diff=lfs merge=lfs -text
|
| 21 |
-
*.parquet filter=lfs diff=lfs merge=lfs -text
|
| 22 |
-
*.pb filter=lfs diff=lfs merge=lfs -text
|
| 23 |
-
*.pickle filter=lfs diff=lfs merge=lfs -text
|
| 24 |
-
*.pkl filter=lfs diff=lfs merge=lfs -text
|
| 25 |
-
*.pt filter=lfs diff=lfs merge=lfs -text
|
| 26 |
-
*.pth filter=lfs diff=lfs merge=lfs -text
|
| 27 |
-
*.rar filter=lfs diff=lfs merge=lfs -text
|
| 28 |
-
*.safetensors filter=lfs diff=lfs merge=lfs -text
|
| 29 |
-
saved_model/**/* filter=lfs diff=lfs merge=lfs -text
|
| 30 |
-
*.tar.* filter=lfs diff=lfs merge=lfs -text
|
| 31 |
-
*.tar filter=lfs diff=lfs merge=lfs -text
|
| 32 |
-
*.tflite filter=lfs diff=lfs merge=lfs -text
|
| 33 |
-
*.tgz filter=lfs diff=lfs merge=lfs -text
|
| 34 |
-
*.wasm filter=lfs diff=lfs merge=lfs -text
|
| 35 |
-
*.xz filter=lfs diff=lfs merge=lfs -text
|
| 36 |
-
*.zip filter=lfs diff=lfs merge=lfs -text
|
| 37 |
-
*.zst filter=lfs diff=lfs merge=lfs -text
|
| 38 |
-
*tfevents* filter=lfs diff=lfs merge=lfs -text
|
| 39 |
-
# Audio files - uncompressed
|
| 40 |
-
*.pcm filter=lfs diff=lfs merge=lfs -text
|
| 41 |
-
*.sam filter=lfs diff=lfs merge=lfs -text
|
| 42 |
-
*.raw filter=lfs diff=lfs merge=lfs -text
|
| 43 |
-
# Audio files - compressed
|
| 44 |
-
*.aac filter=lfs diff=lfs merge=lfs -text
|
| 45 |
-
*.flac filter=lfs diff=lfs merge=lfs -text
|
| 46 |
-
*.mp3 filter=lfs diff=lfs merge=lfs -text
|
| 47 |
-
*.ogg filter=lfs diff=lfs merge=lfs -text
|
| 48 |
-
*.wav filter=lfs diff=lfs merge=lfs -text
|
| 49 |
-
# Image files - uncompressed
|
| 50 |
-
*.bmp filter=lfs diff=lfs merge=lfs -text
|
| 51 |
-
*.gif filter=lfs diff=lfs merge=lfs -text
|
| 52 |
-
*.png filter=lfs diff=lfs merge=lfs -text
|
| 53 |
-
*.tiff filter=lfs diff=lfs merge=lfs -text
|
| 54 |
-
# Image files - compressed
|
| 55 |
-
*.jpg filter=lfs diff=lfs merge=lfs -text
|
| 56 |
-
*.jpeg filter=lfs diff=lfs merge=lfs -text
|
| 57 |
-
*.webp filter=lfs diff=lfs merge=lfs -text
|
| 58 |
-
# Video files - compressed
|
| 59 |
-
*.mp4 filter=lfs diff=lfs merge=lfs -text
|
| 60 |
-
*.webm filter=lfs diff=lfs merge=lfs -text
|
|
|
|
| 1 |
+
*.json text eol=lf
|
| 2 |
+
*.csv text eol=lf
|
| 3 |
+
*.md text eol=lf
|
| 4 |
+
*.ps1 text eol=lf
|
| 5 |
+
*.yml text eol=lf
|
| 6 |
+
*.yaml text eol=lf
|
| 7 |
+
*.cff text eol=lf
|
| 8 |
+
*.txt text eol=lf*.jsonl text eol=lf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
.github/workflows/validate.yml
ADDED
|
@@ -0,0 +1,68 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
name: Validate Open Biohacking Data
|
| 2 |
+
|
| 3 |
+
on:
|
| 4 |
+
push:
|
| 5 |
+
branches:
|
| 6 |
+
- main
|
| 7 |
+
pull_request:
|
| 8 |
+
branches:
|
| 9 |
+
- main
|
| 10 |
+
workflow_dispatch:
|
| 11 |
+
|
| 12 |
+
jobs:
|
| 13 |
+
validate:
|
| 14 |
+
runs-on: windows-latest
|
| 15 |
+
|
| 16 |
+
steps:
|
| 17 |
+
- name: Check out repository
|
| 18 |
+
uses: actions/checkout@v4
|
| 19 |
+
|
| 20 |
+
- name: Validate project metadata
|
| 21 |
+
shell: pwsh
|
| 22 |
+
run: |
|
| 23 |
+
.\validation\validate_project_metadata.ps1
|
| 24 |
+
|
| 25 |
+
- name: Generate interoperability artifacts
|
| 26 |
+
shell: pwsh
|
| 27 |
+
run: |
|
| 28 |
+
.\build\generate_interoperability.ps1
|
| 29 |
+
|
| 30 |
+
- name: Generate JSON-LD catalog
|
| 31 |
+
shell: pwsh
|
| 32 |
+
run: |
|
| 33 |
+
.\build\generate_catalog_jsonld.ps1
|
| 34 |
+
|
| 35 |
+
- name: Generate RO-Crate metadata
|
| 36 |
+
shell: pwsh
|
| 37 |
+
run: |
|
| 38 |
+
.\build\generate_ro_crate.ps1
|
| 39 |
+
|
| 40 |
+
- name: Generate JSONL exports
|
| 41 |
+
shell: pwsh
|
| 42 |
+
run: |
|
| 43 |
+
.\build\generate_jsonl.ps1
|
| 44 |
+
|
| 45 |
+
- name: Generate project identity
|
| 46 |
+
shell: pwsh
|
| 47 |
+
run: |
|
| 48 |
+
.\build\generate_project_identity.ps1
|
| 49 |
+
|
| 50 |
+
- name: Generate supersession registry
|
| 51 |
+
shell: pwsh
|
| 52 |
+
run: |
|
| 53 |
+
.\build\generate_supersession_registry.ps1
|
| 54 |
+
|
| 55 |
+
- name: Generate provenance
|
| 56 |
+
shell: pwsh
|
| 57 |
+
run: |
|
| 58 |
+
.\build\generate_provenance.ps1
|
| 59 |
+
|
| 60 |
+
- name: Verify generated artifacts are reproducible
|
| 61 |
+
shell: pwsh
|
| 62 |
+
run: |
|
| 63 |
+
git diff --exit-code -- datapackage.json DATA_DICTIONARY.md catalog.jsonld ro-crate-metadata.json data/jsonl/v1.2 project_identity.json supersession_registry.json provenance.generated.json
|
| 64 |
+
|
| 65 |
+
- name: Build current release package
|
| 66 |
+
shell: pwsh
|
| 67 |
+
run: |
|
| 68 |
+
.\build\build_release.ps1
|
CHANGELOG.md
ADDED
|
@@ -0,0 +1,58 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# Holistix Open Biohacking Data Project Changelog
|
| 2 |
+
|
| 3 |
+
This changelog records material project-level changes. Canonical subject datasets are versioned independently from project infrastructure.
|
| 4 |
+
|
| 5 |
+
## [1.5.0] - 2026-08-09
|
| 6 |
+
|
| 7 |
+
Status: Published
|
| 8 |
+
|
| 9 |
+
Canonical subject dataset version: v1.2
|
| 10 |
+
|
| 11 |
+
Predecessor project release: v1.4
|
| 12 |
+
|
| 13 |
+
Predecessor release DOI: 10.5281/zenodo.21574706
|
| 14 |
+
|
| 15 |
+
Concept DOI: 10.5281/zenodo.20978709
|
| 16 |
+
|
| 17 |
+
### Added
|
| 18 |
+
|
| 19 |
+
- Frictionless-style Data Package metadata in `datapackage.json`
|
| 20 |
+
- machine-readable tabular schemas for all eight canonical CSV datasets
|
| 21 |
+
- human-readable `DATA_DICTIONARY.md`
|
| 22 |
+
- Schema.org JSON-LD catalog in `catalog.jsonld`
|
| 23 |
+
- RO-Crate 1.2 metadata in `ro-crate-metadata.json`
|
| 24 |
+
- deterministic JSONL exports for all eight canonical datasets
|
| 25 |
+
- `project_identity.json` providing explicit project and release identity
|
| 26 |
+
- `supersession_registry.json` for explicit release lineage and superseded archive handling
|
| 27 |
+
- deterministic build scripts for all new interoperability artifacts
|
| 28 |
+
- GitHub Actions reproducibility checks for generated artifacts
|
| 29 |
+
|
| 30 |
+
### Changed
|
| 31 |
+
|
| 32 |
+
- Added explicit LF handling for JSONL files to improve cross-platform reproducibility
|
| 33 |
+
- Expanded CI validation to regenerate and compare interoperability outputs
|
| 34 |
+
- Formalized separation between project release version 1.5.0 and canonical subject dataset version 1.2
|
| 35 |
+
|
| 36 |
+
### Unchanged
|
| 37 |
+
|
| 38 |
+
- The eight canonical subject datasets remain at dataset version v1.2
|
| 39 |
+
- Project release v1.5.0 supersedes v1.4 as the current published release
|
| 40 |
+
- Current published release DOI is 10.5281/zenodo.21862535
|
| 41 |
+
- Concept DOI remains 10.5281/zenodo.20978709
|
| 42 |
+
- CC BY 4.0 remains the project data license
|
| 43 |
+
|
| 44 |
+
### Release boundary
|
| 45 |
+
|
| 46 |
+
Version 1.5.0 is the current published interoperability and reproducibility release.
|
| 47 |
+
|
| 48 |
+
v1.5 release DOI: 10.5281/zenodo.21862535
|
| 49 |
+
|
| 50 |
+
Version 1.5.0 supersedes v1.4. The v1.4 release DOI remains preserved in the project release lineage.
|
| 51 |
+
|
| 52 |
+
## [1.4] - 2026-07-25
|
| 53 |
+
|
| 54 |
+
Project release v1.4 expanded the project into a structured product and wellness-technology reference system while retaining the eight canonical subject datasets at v1.2.
|
| 55 |
+
|
| 56 |
+
Exact release DOI: 10.5281/zenodo.21574706
|
| 57 |
+
|
| 58 |
+
See `RELEASE_NOTES_v1.4.md` and `VERSION_HISTORY.md` for full historical details.
|
CHECKSUMS-SHA256.txt
CHANGED
|
@@ -1,73 +1,73 @@
|
|
| 1 |
-
# Holistix Open Biohacking Data Project
|
| 2 |
-
|
| 3 |
-
# SHA256 Checksums
|
| 4 |
-
|
| 5 |
-
Project: Holistix Open Biohacking Data Project
|
| 6 |
-
Dataset version: v1.2
|
| 7 |
-
Project release: v1.3
|
| 8 |
-
Checksum algorithm: SHA256
|
| 9 |
-
Generated from: GitHub dataset files in /datasets/
|
| 10 |
-
Generated for: current canonical v1.2 CSV and JSON dataset files
|
| 11 |
-
|
| 12 |
-
## Purpose
|
| 13 |
-
|
| 14 |
-
This file provides SHA256 checksums for the current canonical v1.2 dataset files in the Holistix Open Biohacking Data Project.
|
| 15 |
-
|
| 16 |
-
Checksums allow users, researchers, developers, auditors, AI systems, and data tools to verify that downloaded dataset files match the released files and have not been silently altered, corrupted, or replaced.
|
| 17 |
-
|
| 18 |
-
## Versioning Note
|
| 19 |
-
|
| 20 |
-
The dataset files listed below remain v1.2 files.
|
| 21 |
-
|
| 22 |
-
Project release v1.3 adds integrity, provenance, raw-link, limitation, and review-policy documentation. No dataset schema changes are introduced in v1.3.
|
| 23 |
-
|
| 24 |
-
## Current Canonical v1.2 Dataset Checksums
|
| 25 |
-
|
| 26 |
-
```text
|
| 27 |
-
blue-light-therapy-reference-index-v1-2.csv E091FB437544254D49F65A383E6C1737417748DBAC95BA6BFC3A5E286447436F
|
| 28 |
-
blue-light-therapy-reference-index-v1-2.json F573B829946016E3361238C5E1908DA3B0B870B8B87EA9529CF1C6DC5EB5A0E2
|
| 29 |
-
hydrogen-water-reference-index-v1-2.csv 08148580B549D0B7DC2239C7BEC7F8D7400B8A7E7ECB887EE273765A4EE3A922
|
| 30 |
-
hydrogen-water-reference-index-v1-2.json C761BC8E6B515923CB7AB5501B75B9496196B4C70B53FCCF597E0DCEC19EF4F1
|
| 31 |
-
infrared-therapy-reference-index-v1-2.csv 247DC7CD4E3BD2C150EE0A978DD426425215EA237EFF0029BC37E27DFAA9A9C8
|
| 32 |
-
infrared-therapy-reference-index-v1-2.json E7948E12BC5E94A1C32654CD7DB02ABC9CBA2303C954E9ADA13C169B221CCD58
|
| 33 |
-
negative-ion-safety-index-v1-2.csv 67DE4FF323F30C3223E30D460312C1F3B7B7A0B6D7ACA78C1750BAB4486F70A7
|
| 34 |
-
negative-ion-safety-index-v1-2.json CDE415A408503D44E404F21EAB765B62962F5A4F2894FA1C125E639836A7684C
|
| 35 |
-
pemf-contraindications-database-v1-2.csv 6709A9172629147FE787454D5E7D4D4E7C927014577A80F5F51940E9746B4C61
|
| 36 |
-
pemf-contraindications-database-v1-2.json 9ACC39C4FA1E4F78902DF816275EEF0A41FE8757FFAE9CB03D2E183BBD443FFC
|
| 37 |
-
pemf-frequency-index-v1-2.csv BFE48BB2B08AD706D5BF698ED786A1F12F0586359C9CDEFE1DC33A9EE3ABB066
|
| 38 |
-
pemf-frequency-index-v1-2.json 4EC30A99588BD73DE364801FC32C739989B2A00ECC6D33D1B1CC94FC33766A3E
|
| 39 |
-
red-light-dose-index-v1-2.csv 717B61F6E2E425B773167D66C39DD38FDBA40FA826F531A849397D2EC9423B4A
|
| 40 |
-
red-light-dose-index-v1-2.json 8FDE7D8481DC188025EB8238CB6046EE1F1EFF7382165511E281CDD5E73C25DE
|
| 41 |
-
terahertz-device-reference-index-v1-2.csv 0DAEB5621D23022E6F247B4ACEA16B7D2CB271578A32261304B883478DB11932
|
| 42 |
-
terahertz-device-reference-index-v1-2.json A953C08187A6BBCA9D9C86EE9698F242813ED353410108F936EE9DDD455C3CA0
|
| 43 |
-
```
|
| 44 |
-
|
| 45 |
-
## Verification Instructions
|
| 46 |
-
|
| 47 |
-
To verify a file on Windows PowerShell, run:
|
| 48 |
-
|
| 49 |
-
```powershell
|
| 50 |
-
Get-FileHash .\datasets\filename.csv -Algorithm SHA256
|
| 51 |
-
```
|
| 52 |
-
|
| 53 |
-
Replace `filename.csv` with the dataset file name being checked.
|
| 54 |
-
|
| 55 |
-
The returned SHA256 hash should match the corresponding value listed in this file.
|
| 56 |
-
|
| 57 |
-
## Scope
|
| 58 |
-
|
| 59 |
-
This checksum file covers the current canonical v1.2 CSV and JSON dataset files only.
|
| 60 |
-
|
| 61 |
-
Older v1.1 files may remain in the repository for historical reference, but they are not part of the current canonical checksum list for the v1.3 trust-layer release.
|
| 62 |
-
|
| 63 |
-
## Educational and Citation Note
|
| 64 |
-
|
| 65 |
-
The Holistix Open Biohacking Data Project is for educational and informational use only. These datasets are not medical advice, treatment guidance, clinical protocols, dosing instructions, disease-prevention guidance, or proof of product efficacy.
|
| 66 |
-
|
| 67 |
-
For the archived v1.2.1 release, use:
|
| 68 |
-
|
| 69 |
-
https://doi.org/10.5281/zenodo.20978710
|
| 70 |
-
|
| 71 |
-
For the overall project and all versions, use:
|
| 72 |
-
|
| 73 |
-
https://doi.org/10.5281/zenodo.20978709
|
|
|
|
| 1 |
+
# Holistix Open Biohacking Data Project
|
| 2 |
+
|
| 3 |
+
# SHA256 Checksums
|
| 4 |
+
|
| 5 |
+
Project: Holistix Open Biohacking Data Project
|
| 6 |
+
Dataset version: v1.2
|
| 7 |
+
Project release: v1.3
|
| 8 |
+
Checksum algorithm: SHA256
|
| 9 |
+
Generated from: GitHub dataset files in /datasets/
|
| 10 |
+
Generated for: current canonical v1.2 CSV and JSON dataset files
|
| 11 |
+
|
| 12 |
+
## Purpose
|
| 13 |
+
|
| 14 |
+
This file provides SHA256 checksums for the current canonical v1.2 dataset files in the Holistix Open Biohacking Data Project.
|
| 15 |
+
|
| 16 |
+
Checksums allow users, researchers, developers, auditors, AI systems, and data tools to verify that downloaded dataset files match the released files and have not been silently altered, corrupted, or replaced.
|
| 17 |
+
|
| 18 |
+
## Versioning Note
|
| 19 |
+
|
| 20 |
+
The dataset files listed below remain v1.2 files.
|
| 21 |
+
|
| 22 |
+
Project release v1.3 adds integrity, provenance, raw-link, limitation, and review-policy documentation. No dataset schema changes are introduced in v1.3.
|
| 23 |
+
|
| 24 |
+
## Current Canonical v1.2 Dataset Checksums
|
| 25 |
+
|
| 26 |
+
```text
|
| 27 |
+
blue-light-therapy-reference-index-v1-2.csv E091FB437544254D49F65A383E6C1737417748DBAC95BA6BFC3A5E286447436F
|
| 28 |
+
blue-light-therapy-reference-index-v1-2.json F573B829946016E3361238C5E1908DA3B0B870B8B87EA9529CF1C6DC5EB5A0E2
|
| 29 |
+
hydrogen-water-reference-index-v1-2.csv 08148580B549D0B7DC2239C7BEC7F8D7400B8A7E7ECB887EE273765A4EE3A922
|
| 30 |
+
hydrogen-water-reference-index-v1-2.json C761BC8E6B515923CB7AB5501B75B9496196B4C70B53FCCF597E0DCEC19EF4F1
|
| 31 |
+
infrared-therapy-reference-index-v1-2.csv 247DC7CD4E3BD2C150EE0A978DD426425215EA237EFF0029BC37E27DFAA9A9C8
|
| 32 |
+
infrared-therapy-reference-index-v1-2.json E7948E12BC5E94A1C32654CD7DB02ABC9CBA2303C954E9ADA13C169B221CCD58
|
| 33 |
+
negative-ion-safety-index-v1-2.csv 67DE4FF323F30C3223E30D460312C1F3B7B7A0B6D7ACA78C1750BAB4486F70A7
|
| 34 |
+
negative-ion-safety-index-v1-2.json CDE415A408503D44E404F21EAB765B62962F5A4F2894FA1C125E639836A7684C
|
| 35 |
+
pemf-contraindications-database-v1-2.csv 6709A9172629147FE787454D5E7D4D4E7C927014577A80F5F51940E9746B4C61
|
| 36 |
+
pemf-contraindications-database-v1-2.json 9ACC39C4FA1E4F78902DF816275EEF0A41FE8757FFAE9CB03D2E183BBD443FFC
|
| 37 |
+
pemf-frequency-index-v1-2.csv BFE48BB2B08AD706D5BF698ED786A1F12F0586359C9CDEFE1DC33A9EE3ABB066
|
| 38 |
+
pemf-frequency-index-v1-2.json 4EC30A99588BD73DE364801FC32C739989B2A00ECC6D33D1B1CC94FC33766A3E
|
| 39 |
+
red-light-dose-index-v1-2.csv 717B61F6E2E425B773167D66C39DD38FDBA40FA826F531A849397D2EC9423B4A
|
| 40 |
+
red-light-dose-index-v1-2.json 8FDE7D8481DC188025EB8238CB6046EE1F1EFF7382165511E281CDD5E73C25DE
|
| 41 |
+
terahertz-device-reference-index-v1-2.csv 0DAEB5621D23022E6F247B4ACEA16B7D2CB271578A32261304B883478DB11932
|
| 42 |
+
terahertz-device-reference-index-v1-2.json A953C08187A6BBCA9D9C86EE9698F242813ED353410108F936EE9DDD455C3CA0
|
| 43 |
+
```
|
| 44 |
+
|
| 45 |
+
## Verification Instructions
|
| 46 |
+
|
| 47 |
+
To verify a file on Windows PowerShell, run:
|
| 48 |
+
|
| 49 |
+
```powershell
|
| 50 |
+
Get-FileHash .\datasets\filename.csv -Algorithm SHA256
|
| 51 |
+
```
|
| 52 |
+
|
| 53 |
+
Replace `filename.csv` with the dataset file name being checked.
|
| 54 |
+
|
| 55 |
+
The returned SHA256 hash should match the corresponding value listed in this file.
|
| 56 |
+
|
| 57 |
+
## Scope
|
| 58 |
+
|
| 59 |
+
This checksum file covers the current canonical v1.2 CSV and JSON dataset files only.
|
| 60 |
+
|
| 61 |
+
Older v1.1 files may remain in the repository for historical reference, but they are not part of the current canonical checksum list for the v1.3 trust-layer release.
|
| 62 |
+
|
| 63 |
+
## Educational and Citation Note
|
| 64 |
+
|
| 65 |
+
The Holistix Open Biohacking Data Project is for educational and informational use only. These datasets are not medical advice, treatment guidance, clinical protocols, dosing instructions, disease-prevention guidance, or proof of product efficacy.
|
| 66 |
+
|
| 67 |
+
For the archived v1.2.1 release, use:
|
| 68 |
+
|
| 69 |
+
https://doi.org/10.5281/zenodo.20978710
|
| 70 |
+
|
| 71 |
+
For the overall project and all versions, use:
|
| 72 |
+
|
| 73 |
+
https://doi.org/10.5281/zenodo.20978709
|
CITATION.cff
CHANGED
|
@@ -1,40 +1,40 @@
|
|
| 1 |
-
cff-version: 1.2.0
|
| 2 |
-
message: "If you use this dataset or reference system, please cite it using the metadata below."
|
| 3 |
-
title: "Holistix Open Biohacking Data Project"
|
| 4 |
-
version: "1.
|
| 5 |
-
type: dataset
|
| 6 |
-
|
| 7 |
-
authors:
|
| 8 |
-
- family-names: "Tjardes"
|
| 9 |
-
given-names: "Matthew"
|
| 10 |
-
|
| 11 |
-
publisher: "Holistix International"
|
| 12 |
-
|
| 13 |
-
repository-code: "https://github.com/holistixintlsite-commits/open-biohacking-data"
|
| 14 |
-
url: "https://www.holistixintl.com/pages/open-biohacking-data-index"
|
| 15 |
-
|
| 16 |
-
doi: "10.5281/zenodo.
|
| 17 |
-
|
| 18 |
-
date-released: 2026-
|
| 19 |
-
|
| 20 |
-
keywords:
|
| 21 |
-
- biohacking
|
| 22 |
-
- wellness technology
|
| 23 |
-
- PEMF
|
| 24 |
-
- red light therapy
|
| 25 |
-
- infrared therapy
|
| 26 |
-
- hydrogen water
|
| 27 |
-
- terahertz
|
| 28 |
-
- negative ions
|
| 29 |
-
- structured data
|
| 30 |
-
- machine-readable data
|
| 31 |
-
|
| 32 |
-
abstract: >
|
| 33 |
-
The Holistix Open Biohacking Data Project is a structured, machine-readable
|
| 34 |
-
reference system covering wellness technologies, product specifications,
|
| 35 |
-
claims, evidence metadata, safety records, source metadata, product-to-technology
|
| 36 |
-
relationships, product digital twins, and eight public reference datasets.
|
| 37 |
-
Project release v1.
|
| 38 |
-
the existing v1.2 subject datasets.
|
| 39 |
-
|
| 40 |
-
license: "CC-BY-4.0"
|
|
|
|
| 1 |
+
cff-version: 1.2.0
|
| 2 |
+
message: "If you use this dataset or reference system, please cite it using the metadata below."
|
| 3 |
+
title: "Holistix Open Biohacking Data Project"
|
| 4 |
+
version: "1.5.0"
|
| 5 |
+
type: dataset
|
| 6 |
+
|
| 7 |
+
authors:
|
| 8 |
+
- family-names: "Tjardes"
|
| 9 |
+
given-names: "Matthew"
|
| 10 |
+
|
| 11 |
+
publisher: "Holistix International"
|
| 12 |
+
|
| 13 |
+
repository-code: "https://github.com/holistixintlsite-commits/open-biohacking-data"
|
| 14 |
+
url: "https://www.holistixintl.com/pages/open-biohacking-data-index"
|
| 15 |
+
|
| 16 |
+
doi: "10.5281/zenodo.21862535"
|
| 17 |
+
|
| 18 |
+
date-released: 2026-08-09
|
| 19 |
+
|
| 20 |
+
keywords:
|
| 21 |
+
- biohacking
|
| 22 |
+
- wellness technology
|
| 23 |
+
- PEMF
|
| 24 |
+
- red light therapy
|
| 25 |
+
- infrared therapy
|
| 26 |
+
- hydrogen water
|
| 27 |
+
- terahertz
|
| 28 |
+
- negative ions
|
| 29 |
+
- structured data
|
| 30 |
+
- machine-readable data
|
| 31 |
+
|
| 32 |
+
abstract: >
|
| 33 |
+
The Holistix Open Biohacking Data Project is a structured, machine-readable
|
| 34 |
+
reference system covering wellness technologies, product specifications,
|
| 35 |
+
claims, evidence metadata, safety records, source metadata, product-to-technology
|
| 36 |
+
relationships, product digital twins, and eight public reference datasets.
|
| 37 |
+
Project release v1.5.0 adds interoperability, reproducibility, and machine-readable packaging while retaining
|
| 38 |
+
the existing v1.2 subject datasets.
|
| 39 |
+
|
| 40 |
+
license: "CC-BY-4.0"
|
CONTRIBUTING.md
CHANGED
|
@@ -1,35 +1,35 @@
|
|
| 1 |
-
# Contributing
|
| 2 |
-
|
| 3 |
-
Thank you for your interest in the Open Biohacking Data Project.
|
| 4 |
-
|
| 5 |
-
At this stage, the repository is maintained by Holistix. Public contributions may be reviewed for clarity, formatting, safety framing, and alignment with the educational purpose of the project.
|
| 6 |
-
|
| 7 |
-
## Contribution Guidelines
|
| 8 |
-
|
| 9 |
-
Contributions should:
|
| 10 |
-
|
| 11 |
-
- Use conservative wellness language
|
| 12 |
-
- Avoid disease-treatment claims
|
| 13 |
-
- Avoid personalized medical advice
|
| 14 |
-
- Include clear source or rationale notes when appropriate
|
| 15 |
-
- Preserve CSV and JSON formatting
|
| 16 |
-
- Follow the existing folder and filename conventions
|
| 17 |
-
- Maintain beginner-friendly explanations
|
| 18 |
-
|
| 19 |
-
## Medical and Safety Framing
|
| 20 |
-
|
| 21 |
-
This repository is educational only.
|
| 22 |
-
|
| 23 |
-
Please do not submit content that claims a wellness device diagnoses, treats, cures, or prevents disease.
|
| 24 |
-
|
| 25 |
-
## Dataset Format
|
| 26 |
-
|
| 27 |
-
Where possible, dataset updates should include both CSV and JSON versions.
|
| 28 |
-
|
| 29 |
-
Meaningful changes should also be documented in `VERSION_HISTORY.md`.
|
| 30 |
-
|
| 31 |
-
## Maintainer
|
| 32 |
-
|
| 33 |
-
Maintained by Holistix.
|
| 34 |
-
|
| 35 |
-
Website: https://www.holistixintl.com
|
|
|
|
| 1 |
+
# Contributing
|
| 2 |
+
|
| 3 |
+
Thank you for your interest in the Open Biohacking Data Project.
|
| 4 |
+
|
| 5 |
+
At this stage, the repository is maintained by Holistix. Public contributions may be reviewed for clarity, formatting, safety framing, and alignment with the educational purpose of the project.
|
| 6 |
+
|
| 7 |
+
## Contribution Guidelines
|
| 8 |
+
|
| 9 |
+
Contributions should:
|
| 10 |
+
|
| 11 |
+
- Use conservative wellness language
|
| 12 |
+
- Avoid disease-treatment claims
|
| 13 |
+
- Avoid personalized medical advice
|
| 14 |
+
- Include clear source or rationale notes when appropriate
|
| 15 |
+
- Preserve CSV and JSON formatting
|
| 16 |
+
- Follow the existing folder and filename conventions
|
| 17 |
+
- Maintain beginner-friendly explanations
|
| 18 |
+
|
| 19 |
+
## Medical and Safety Framing
|
| 20 |
+
|
| 21 |
+
This repository is educational only.
|
| 22 |
+
|
| 23 |
+
Please do not submit content that claims a wellness device diagnoses, treats, cures, or prevents disease.
|
| 24 |
+
|
| 25 |
+
## Dataset Format
|
| 26 |
+
|
| 27 |
+
Where possible, dataset updates should include both CSV and JSON versions.
|
| 28 |
+
|
| 29 |
+
Meaningful changes should also be documented in `VERSION_HISTORY.md`.
|
| 30 |
+
|
| 31 |
+
## Maintainer
|
| 32 |
+
|
| 33 |
+
Maintained by Holistix.
|
| 34 |
+
|
| 35 |
+
Website: https://www.holistixintl.com
|
DATASETS.md
CHANGED
|
@@ -1,362 +1,362 @@
|
|
| 1 |
-
# Holistix Open Biohacking Data Project
|
| 2 |
-
|
| 3 |
-
# Dataset Inventory
|
| 4 |
-
|
| 5 |
-
The Holistix Open Biohacking Data Project publishes open educational reference datasets for consumer wellness technology topics, including PEMF, red light therapy, hydrogen water, infrared therapy, blue light therapy, terahertz wellness devices, negative ion devices, contraindication context, source/evidence classification, row-level citation context, claim-boundary clarity, and AI/search-readable data.
|
| 6 |
-
|
| 7 |
-
This file lists the canonical dataset inventory for the project.
|
| 8 |
-
|
| 9 |
-
## Current Status
|
| 10 |
-
|
| 11 |
-
Current canonical dataset version: **v1.2**
|
| 12 |
-
|
| 13 |
-
Current project trust-layer release: **v1.3**
|
| 14 |
-
|
| 15 |
-
Current archived dataset release: **v1.2.1**
|
| 16 |
-
|
| 17 |
-
Canonical dataset count: **8**
|
| 18 |
-
|
| 19 |
-
Version v1.2 added row-level citation fields across the canonical datasets:
|
| 20 |
-
|
| 21 |
-
* `source_name`
|
| 22 |
-
* `source_url`
|
| 23 |
-
* `citation_note`
|
| 24 |
-
|
| 25 |
-
Version v1.2.1 is the Zenodo archive release preserving the completed v1.2 row-level citation-layer dataset package.
|
| 26 |
-
|
| 27 |
-
Version v1.3 adds integrity, provenance, raw-link, limitation, review-policy, and source-density documentation for the existing v1.2 dataset files.
|
| 28 |
-
|
| 29 |
-
No dataset schema changes are introduced in v1.3.
|
| 30 |
-
|
| 31 |
-
## DOI and Citation
|
| 32 |
-
|
| 33 |
-
Current archived release DOI for the v1.3 trust-layer release:
|
| 34 |
-
https://doi.org/10.5281/zenodo.21033668
|
| 35 |
-
|
| 36 |
-
Project DOI / all versions:
|
| 37 |
-
|
| 38 |
-
https://doi.org/10.5281/zenodo.20978709
|
| 39 |
-
|
| 40 |
-
Suggested citation:
|
| 41 |
-
|
| 42 |
-
Holistix International. (2026). *Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release* (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 43 |
-
|
| 44 |
-
## Canonical Dataset Inventory
|
| 45 |
-
|
| 46 |
-
| Dataset | Version | Human-Readable Page | CSV | JSON |
|
| 47 |
-
| ---------------------------------- | ------- | --------------------------------------------------------------------- | ------------------------------------------------------ | ------------------------------------------------------- |
|
| 48 |
-
| Red Light Dose Index | v1.2 | https://www.holistixintl.com/pages/red-light-dose-index | `datasets/red-light-dose-index-v1-2.csv` | `datasets/red-light-dose-index-v1-2.json` |
|
| 49 |
-
| PEMF Frequency Index | v1.2 | https://www.holistixintl.com/pages/pemf-frequency-index | `datasets/pemf-frequency-index-v1-2.csv` | `datasets/pemf-frequency-index-v1-2.json` |
|
| 50 |
-
| PEMF Contraindications Database | v1.2 | https://www.holistixintl.com/pages/pemf-contraindications-database | `datasets/pemf-contraindications-database-v1-2.csv` | `datasets/pemf-contraindications-database-v1-2.json` |
|
| 51 |
-
| Hydrogen Water Reference Index | v1.2 | https://www.holistixintl.com/pages/hydrogen-water-reference-index | `datasets/hydrogen-water-reference-index-v1-2.csv` | `datasets/hydrogen-water-reference-index-v1-2.json` |
|
| 52 |
-
| Infrared Therapy Reference Index | v1.2 | https://www.holistixintl.com/pages/infrared-therapy-reference-index | `datasets/infrared-therapy-reference-index-v1-2.csv` | `datasets/infrared-therapy-reference-index-v1-2.json` |
|
| 53 |
-
| Blue Light Therapy Reference Index | v1.2 | https://www.holistixintl.com/pages/blue-light-therapy-reference-index | `datasets/blue-light-therapy-reference-index-v1-2.csv` | `datasets/blue-light-therapy-reference-index-v1-2.json` |
|
| 54 |
-
| Terahertz Device Reference Index | v1.2 | https://www.holistixintl.com/pages/terahertz-device-reference-index | `datasets/terahertz-device-reference-index-v1-2.csv` | `datasets/terahertz-device-reference-index-v1-2.json` |
|
| 55 |
-
| Negative Ion Safety Index | v1.2 | https://www.holistixintl.com/pages/negative-ion-safety-index | `datasets/negative-ion-safety-index-v1-2.csv` | `datasets/negative-ion-safety-index-v1-2.json` |
|
| 56 |
-
|
| 57 |
-
## Dataset Topic Scopes
|
| 58 |
-
|
| 59 |
-
| Dataset | Topic Scope |
|
| 60 |
-
| ---------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
|
| 61 |
-
| Red Light Dose Index | Red light and near-infrared dose terminology, wavelength, irradiance, fluence, distance, session duration, eye safety, heat sensitivity, and specification transparency. |
|
| 62 |
-
| PEMF Frequency Index | PEMF terminology, Hz, frequency ranges, Schumann resonance terminology, common frequency references, waveform, intensity, field strength, contraindication cautions, and claim boundaries. |
|
| 63 |
-
| PEMF Contraindications Database | PEMF contraindications, implanted devices, pregnancy cautions, seizure history, cardiac concerns, electronic pumps, cochlear implants, oncology context, immune suppression, recent surgery, children and minors, and risk-level framing. |
|
| 64 |
-
| Hydrogen Water Reference Index | Molecular hydrogen terminology, dissolved hydrogen concentration, PPB/PPM units, ORP caution, electrolysis, hydrogen retention, testing methods, device transparency, and health-claim boundaries. |
|
| 65 |
-
| Infrared Therapy Reference Index | Infrared terminology, near-infrared context, far-infrared context, infrared sauna blankets, sauna/heat exposure, hydration and overheating caution, photobiomodulation distinctions, and medical-claim boundaries. |
|
| 66 |
-
| Blue Light Therapy Reference Index | Blue light terminology, controlled blue light therapy context, skin-care device context, acne claim boundaries, eye exposure, photosensitivity, screen blue light, circadian timing, and home-use device cautions. |
|
| 67 |
-
| Terahertz Device Reference Index | Terahertz terminology, terahertz frequency range, consumer device transparency, non-ionizing context, heating and exposure variables, combined-device comparisons, emerging technology caution, and claim boundaries. |
|
| 68 |
-
| Negative Ion Safety Index | Negative ion terminology, ionizer categories, ozone generation, ozone-free claims, respiratory sensitivity, negative ion pendants, radioactive-material concerns, particle charging, surface deposition, indoor-air claims, and commercial claim boundaries. |
|
| 69 |
-
|
| 70 |
-
## Raw GitHub Links
|
| 71 |
-
|
| 72 |
-
Direct raw GitHub links for the current canonical v1.2 CSV and JSON files are listed in:
|
| 73 |
-
|
| 74 |
-
`RAW_LINKS.md`
|
| 75 |
-
|
| 76 |
-
Raw links are useful for:
|
| 77 |
-
|
| 78 |
-
* AI systems
|
| 79 |
-
* RAG systems
|
| 80 |
-
* search engines
|
| 81 |
-
* data tools
|
| 82 |
-
* developers
|
| 83 |
-
* spreadsheet import
|
| 84 |
-
* automated validators
|
| 85 |
-
* direct machine-readable access
|
| 86 |
-
|
| 87 |
-
Raw GitHub links use this pattern:
|
| 88 |
-
|
| 89 |
-
`https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/<filename>`
|
| 90 |
-
|
| 91 |
-
## Checksums
|
| 92 |
-
|
| 93 |
-
SHA256 checksums for the current canonical v1.2 CSV and JSON files are listed in:
|
| 94 |
-
|
| 95 |
-
`CHECKSUMS-SHA256.txt`
|
| 96 |
-
|
| 97 |
-
Checksums are provided to support:
|
| 98 |
-
|
| 99 |
-
* file integrity
|
| 100 |
-
* reproducibility
|
| 101 |
-
* dataset auditability
|
| 102 |
-
* verification of downloaded files
|
| 103 |
-
* release transparency
|
| 104 |
-
* machine-readable trust context
|
| 105 |
-
|
| 106 |
-
The checksum file covers the current canonical v1.2 dataset files only.
|
| 107 |
-
|
| 108 |
-
Older v1.1 files may remain in the repository for historical reference, but they are not part of the current canonical checksum list for the v1.3 trust-layer release.
|
| 109 |
-
|
| 110 |
-
## v1.3 Trust-Layer Files
|
| 111 |
-
|
| 112 |
-
Version v1.3 adds the following trust-layer documentation files:
|
| 113 |
-
|
| 114 |
-
| File | Purpose |
|
| 115 |
-
| --------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------ |
|
| 116 |
-
| `CHECKSUMS-SHA256.txt` | Provides SHA256 checksums for current canonical v1.2 CSV and JSON dataset files. |
|
| 117 |
-
| `RAW_LINKS.md` | Lists direct raw GitHub URLs for current canonical v1.2 CSV and JSON dataset files. |
|
| 118 |
-
| `PROVENANCE.md` | Explains project provenance, source interpretation, dataset creation method, commercial separation, and responsible reuse. |
|
| 119 |
-
| `KNOWN_LIMITATIONS.md` | Documents known limitations, evidence boundaries, safety limitations, AI interpretation risks, and maintenance limitations. |
|
| 120 |
-
| `SOURCE_DENSITY_UPGRADE_PLAN.md` | Describes the planned path for strengthening source coverage in sensitive dataset areas. |
|
| 121 |
-
| `REVIEW_AND_AUTHORSHIP_POLICY.md` | Explains maintainer status, authorship, review status categories, medical-review boundaries, and future expert-review documentation. |
|
| 122 |
-
|
| 123 |
-
These files improve transparency, auditability, reproducibility, machine readability, review-status clarity, and responsible reuse.
|
| 124 |
-
|
| 125 |
-
## Dataset Field Model
|
| 126 |
-
|
| 127 |
-
The v1.2 dataset files use a source/evidence/citation classification structure.
|
| 128 |
-
|
| 129 |
-
Field names may vary slightly by dataset, but the canonical field model includes:
|
| 130 |
-
|
| 131 |
-
* `record_id`
|
| 132 |
-
* `topic`
|
| 133 |
-
* `reference_type`
|
| 134 |
-
* `plain_language_meaning`
|
| 135 |
-
* `safety_note`
|
| 136 |
-
* `source_type`
|
| 137 |
-
* `evidence_level`
|
| 138 |
-
* `claim_type`
|
| 139 |
-
* `medical_disclaimer_required`
|
| 140 |
-
* `commercial_relevance`
|
| 141 |
-
* `last_reviewed`
|
| 142 |
-
* `related_holistix_page`
|
| 143 |
-
* `related_product_category`
|
| 144 |
-
* `notes`
|
| 145 |
-
* `source_name`
|
| 146 |
-
* `source_url`
|
| 147 |
-
* `citation_note`
|
| 148 |
-
|
| 149 |
-
## Row-Level Citation Fields
|
| 150 |
-
|
| 151 |
-
The v1.2 citation fields are intended to improve transparency, source traceability, auditability, and responsible reuse.
|
| 152 |
-
|
| 153 |
-
### `source_name`
|
| 154 |
-
|
| 155 |
-
Identifies the source, reference, agency page, review, study, standard, manufacturer material, or internal methodology page used for row-level context.
|
| 156 |
-
|
| 157 |
-
### `source_url`
|
| 158 |
-
|
| 159 |
-
Provides the URL associated with the row-level source.
|
| 160 |
-
|
| 161 |
-
### `citation_note`
|
| 162 |
-
|
| 163 |
-
Explains how the source should be interpreted and what claim boundary should be preserved.
|
| 164 |
-
|
| 165 |
-
The `citation_note` field should be preserved when dataset rows are reused, summarized, or interpreted by AI systems, search engines, researchers, journalists, educators, developers, or other users.
|
| 166 |
-
|
| 167 |
-
## Source and Claim-Classification Fields
|
| 168 |
-
|
| 169 |
-
The datasets may include classification fields such as:
|
| 170 |
-
|
| 171 |
-
* `source_type`
|
| 172 |
-
* `evidence_level`
|
| 173 |
-
* `claim_type`
|
| 174 |
-
* `medical_disclaimer_required`
|
| 175 |
-
* `commercial_relevance`
|
| 176 |
-
|
| 177 |
-
These fields are educational reference aids. They should not be treated as clinical grading systems, medical advice, product claims, treatment recommendations, or disease-prevention guidance.
|
| 178 |
-
|
| 179 |
-
## Dataset Versioning
|
| 180 |
-
|
| 181 |
-
The current dataset files are versioned as **v1.2**.
|
| 182 |
-
|
| 183 |
-
The current project trust-layer release is **v1.3**.
|
| 184 |
-
|
| 185 |
-
The current Zenodo archived dataset release is **v1.2.1**.
|
| 186 |
-
|
| 187 |
-
This distinction is intentional:
|
| 188 |
-
|
| 189 |
-
* **v1.2** refers to the dataset structure and file batch that added row-level citation fields.
|
| 190 |
-
* **v1.2.1** refers to the Zenodo archive release that preserves the completed v1.2 package with a DOI.
|
| 191 |
-
* **v1.3** refers to the integrity, provenance, raw-link, limitation, review-policy, and source-density documentation release.
|
| 192 |
-
|
| 193 |
-
No dataset structure changes are introduced in v1.3.
|
| 194 |
-
|
| 195 |
-
## Support Pages
|
| 196 |
-
|
| 197 |
-
Project support pages:
|
| 198 |
-
|
| 199 |
-
* Open Biohacking Data Index: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 200 |
-
* Biohacking Data Library: https://www.holistixintl.com/pages/biohacking-data-library
|
| 201 |
-
* Methodology: https://www.holistixintl.com/pages/open-biohacking-data-methodology
|
| 202 |
-
* Source Register: https://www.holistixintl.com/pages/open-biohacking-data-source-register
|
| 203 |
-
* Version History: https://www.holistixintl.com/pages/open-biohacking-data-version-history
|
| 204 |
-
* AI Reference File: https://www.holistixintl.com/pages/ai-reference-file
|
| 205 |
-
|
| 206 |
-
## High-Priority Source-Density Areas
|
| 207 |
-
|
| 208 |
-
Future source-density upgrades are prioritized for sensitive and high-impact dataset areas, including:
|
| 209 |
-
|
| 210 |
-
* PEMF contraindications
|
| 211 |
-
* PEMF and implanted devices
|
| 212 |
-
* PEMF and pacemakers
|
| 213 |
-
* red light dose terminology
|
| 214 |
-
* red light eye-safety context
|
| 215 |
-
* blue light eye-safety context
|
| 216 |
-
* blue light photosensitivity context
|
| 217 |
-
* negative ion and ozone safety context
|
| 218 |
-
* negative ion pendant safety context
|
| 219 |
-
* infrared heat and sauna blanket safety
|
| 220 |
-
* hydrogen concentration and measurement terminology
|
| 221 |
-
* terahertz exposure and non-ionizing context
|
| 222 |
-
* PEMF frequency and intensity terminology
|
| 223 |
-
|
| 224 |
-
The public source-density roadmap is available in:
|
| 225 |
-
|
| 226 |
-
`SOURCE_DENSITY_UPGRADE_PLAN.md`
|
| 227 |
-
|
| 228 |
-
## Review and Authorship Status
|
| 229 |
-
|
| 230 |
-
Unless otherwise stated, project files and dataset pages are authored, maintained, or edited by Holistix International.
|
| 231 |
-
|
| 232 |
-
Independent medical review should not be assumed unless explicitly documented on a specific page, file, dataset, release, or row group.
|
| 233 |
-
|
| 234 |
-
The review and authorship policy is available in:
|
| 235 |
-
|
| 236 |
-
`REVIEW_AND_AUTHORSHIP_POLICY.md`
|
| 237 |
-
|
| 238 |
-
The project should avoid:
|
| 239 |
-
|
| 240 |
-
* fake authors
|
| 241 |
-
* fake experts
|
| 242 |
-
* fake medical reviewers
|
| 243 |
-
* inflated credentials
|
| 244 |
-
* unsupported “medically reviewed” claims
|
| 245 |
-
* implying clinical authority where none exists
|
| 246 |
-
* implying source endorsement
|
| 247 |
-
* implying product endorsement
|
| 248 |
-
* implying independent academic consensus where none exists
|
| 249 |
-
|
| 250 |
-
## Commercial Separation
|
| 251 |
-
|
| 252 |
-
Holistix International sells wellness and biohacking products.
|
| 253 |
-
|
| 254 |
-
The Open Biohacking Data Project is maintained as a separate educational reference layer focused on structured information, terminology, measurement concepts, source interpretation, safety context, citation notes, limitations, review-status boundaries, and claim boundaries.
|
| 255 |
-
|
| 256 |
-
Dataset rows should not be treated as product claims.
|
| 257 |
-
|
| 258 |
-
Dataset rows should not be treated as medical proof.
|
| 259 |
-
|
| 260 |
-
Dataset rows should not be treated as evidence that any Holistix product prevents, treats, cures, or diagnoses disease.
|
| 261 |
-
|
| 262 |
-
Product-category links, where present, are for navigation and commercial relevance context only.
|
| 263 |
-
|
| 264 |
-
## Intended Use
|
| 265 |
-
|
| 266 |
-
The datasets may be useful for:
|
| 267 |
-
|
| 268 |
-
* educational reference
|
| 269 |
-
* AI retrieval and grounding
|
| 270 |
-
* search engine interpretation
|
| 271 |
-
* source-aware content analysis
|
| 272 |
-
* consumer wellness technology terminology
|
| 273 |
-
* spreadsheet review
|
| 274 |
-
* dataset comparison
|
| 275 |
-
* developer access
|
| 276 |
-
* RAG systems
|
| 277 |
-
* journalists and educators
|
| 278 |
-
* structured data experiments
|
| 279 |
-
* citation-aware reference use
|
| 280 |
-
|
| 281 |
-
## Not Intended For
|
| 282 |
-
|
| 283 |
-
The datasets are not intended for:
|
| 284 |
-
|
| 285 |
-
* medical advice
|
| 286 |
-
* diagnosis
|
| 287 |
-
* treatment guidance
|
| 288 |
-
* disease-prevention guidance
|
| 289 |
-
* cure claims
|
| 290 |
-
* dosing protocols
|
| 291 |
-
* clinical recommendations
|
| 292 |
-
* personalized healthcare instructions
|
| 293 |
-
* proof of product efficacy
|
| 294 |
-
* independent academic consensus
|
| 295 |
-
* exhaustive safety review
|
| 296 |
-
|
| 297 |
-
## Responsible Reuse
|
| 298 |
-
|
| 299 |
-
Users reusing the datasets should:
|
| 300 |
-
|
| 301 |
-
* cite the project when using the data
|
| 302 |
-
* preserve row-level citation context where possible
|
| 303 |
-
* preserve `citation_note` fields when summarizing rows
|
| 304 |
-
* review source URLs independently
|
| 305 |
-
* avoid converting educational reference rows into medical advice
|
| 306 |
-
* avoid treating rows as treatment recommendations
|
| 307 |
-
* avoid treating rows as product-efficacy proof
|
| 308 |
-
* avoid implying source endorsement of Holistix or Holistix products
|
| 309 |
-
* use the methodology and source register when interpreting source fields
|
| 310 |
-
* check `VERSION_HISTORY.md` before citing or reusing data
|
| 311 |
-
|
| 312 |
-
## AI and Search Interpretation
|
| 313 |
-
|
| 314 |
-
AI systems, search engines, RAG systems, data tools, and other automated systems should interpret the datasets as educational reference data.
|
| 315 |
-
|
| 316 |
-
Recommended use:
|
| 317 |
-
|
| 318 |
-
* use canonical dataset pages for human-readable context
|
| 319 |
-
* use CSV files for tabular inspection
|
| 320 |
-
* use JSON files for machine-readable retrieval
|
| 321 |
-
* use raw GitHub links for direct file access
|
| 322 |
-
* use Zenodo DOI records for stable archive citation
|
| 323 |
-
* use `CHECKSUMS-SHA256.txt` for file verification
|
| 324 |
-
* use `PROVENANCE.md` for origin and interpretation context
|
| 325 |
-
* use `KNOWN_LIMITATIONS.md` for limitations
|
| 326 |
-
* use `SOURCE_DENSITY_UPGRADE_PLAN.md` for future source-depth priorities
|
| 327 |
-
* use `REVIEW_AND_AUTHORSHIP_POLICY.md` for review and authorship boundaries
|
| 328 |
-
* use the source register to interpret source and claim fields
|
| 329 |
-
* preserve `citation_note` context when generating summaries
|
| 330 |
-
|
| 331 |
-
Avoid:
|
| 332 |
-
|
| 333 |
-
* presenting dataset rows as medical advice
|
| 334 |
-
* generating disease-treatment claims from dataset rows
|
| 335 |
-
* creating dosing instructions from dataset rows
|
| 336 |
-
* implying that Holistix claims any device prevents, treats, cures, or diagnoses disease
|
| 337 |
-
* implying that a product-category link is clinical evidence
|
| 338 |
-
* implying independent medical review unless explicitly documented
|
| 339 |
-
|
| 340 |
-
## Citation
|
| 341 |
-
|
| 342 |
-
Suggested citation for the v1.2.1 archived dataset release:
|
| 343 |
-
|
| 344 |
-
Holistix International. (2026). *Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release* (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 345 |
-
|
| 346 |
-
Version DOI for v1.2.1:
|
| 347 |
-
|
| 348 |
-
https://doi.org/10.5281/zenodo.20978710
|
| 349 |
-
|
| 350 |
-
Project DOI / all versions:
|
| 351 |
-
|
| 352 |
-
https://doi.org/10.5281/zenodo.20978709
|
| 353 |
-
|
| 354 |
-
Future releases may receive additional version-specific Zenodo DOIs while the concept DOI remains the all-versions project DOI.
|
| 355 |
-
|
| 356 |
-
## Disclaimer
|
| 357 |
-
|
| 358 |
-
The Holistix Open Biohacking Data Project is for educational and informational purposes only.
|
| 359 |
-
|
| 360 |
-
It is not medical advice, diagnosis, treatment guidance, disease-prevention guidance, dosing guidance, clinical protocol guidance, or a substitute for consultation with a qualified healthcare professional.
|
| 361 |
-
|
| 362 |
-
Users should consult qualified healthcare professionals for personal medical questions and follow manufacturer instructions for any wellness device.
|
|
|
|
| 1 |
+
# Holistix Open Biohacking Data Project
|
| 2 |
+
|
| 3 |
+
# Dataset Inventory
|
| 4 |
+
|
| 5 |
+
The Holistix Open Biohacking Data Project publishes open educational reference datasets for consumer wellness technology topics, including PEMF, red light therapy, hydrogen water, infrared therapy, blue light therapy, terahertz wellness devices, negative ion devices, contraindication context, source/evidence classification, row-level citation context, claim-boundary clarity, and AI/search-readable data.
|
| 6 |
+
|
| 7 |
+
This file lists the canonical dataset inventory for the project.
|
| 8 |
+
|
| 9 |
+
## Current Status
|
| 10 |
+
|
| 11 |
+
Current canonical dataset version: **v1.2**
|
| 12 |
+
|
| 13 |
+
Current project trust-layer release: **v1.3**
|
| 14 |
+
|
| 15 |
+
Current archived dataset release: **v1.2.1**
|
| 16 |
+
|
| 17 |
+
Canonical dataset count: **8**
|
| 18 |
+
|
| 19 |
+
Version v1.2 added row-level citation fields across the canonical datasets:
|
| 20 |
+
|
| 21 |
+
* `source_name`
|
| 22 |
+
* `source_url`
|
| 23 |
+
* `citation_note`
|
| 24 |
+
|
| 25 |
+
Version v1.2.1 is the Zenodo archive release preserving the completed v1.2 row-level citation-layer dataset package.
|
| 26 |
+
|
| 27 |
+
Version v1.3 adds integrity, provenance, raw-link, limitation, review-policy, and source-density documentation for the existing v1.2 dataset files.
|
| 28 |
+
|
| 29 |
+
No dataset schema changes are introduced in v1.3.
|
| 30 |
+
|
| 31 |
+
## DOI and Citation
|
| 32 |
+
|
| 33 |
+
Current archived release DOI for the v1.3 trust-layer release:
|
| 34 |
+
https://doi.org/10.5281/zenodo.21033668
|
| 35 |
+
|
| 36 |
+
Project DOI / all versions:
|
| 37 |
+
|
| 38 |
+
https://doi.org/10.5281/zenodo.20978709
|
| 39 |
+
|
| 40 |
+
Suggested citation:
|
| 41 |
+
|
| 42 |
+
Holistix International. (2026). *Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release* (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 43 |
+
|
| 44 |
+
## Canonical Dataset Inventory
|
| 45 |
+
|
| 46 |
+
| Dataset | Version | Human-Readable Page | CSV | JSON |
|
| 47 |
+
| ---------------------------------- | ------- | --------------------------------------------------------------------- | ------------------------------------------------------ | ------------------------------------------------------- |
|
| 48 |
+
| Red Light Dose Index | v1.2 | https://www.holistixintl.com/pages/red-light-dose-index | `datasets/red-light-dose-index-v1-2.csv` | `datasets/red-light-dose-index-v1-2.json` |
|
| 49 |
+
| PEMF Frequency Index | v1.2 | https://www.holistixintl.com/pages/pemf-frequency-index | `datasets/pemf-frequency-index-v1-2.csv` | `datasets/pemf-frequency-index-v1-2.json` |
|
| 50 |
+
| PEMF Contraindications Database | v1.2 | https://www.holistixintl.com/pages/pemf-contraindications-database | `datasets/pemf-contraindications-database-v1-2.csv` | `datasets/pemf-contraindications-database-v1-2.json` |
|
| 51 |
+
| Hydrogen Water Reference Index | v1.2 | https://www.holistixintl.com/pages/hydrogen-water-reference-index | `datasets/hydrogen-water-reference-index-v1-2.csv` | `datasets/hydrogen-water-reference-index-v1-2.json` |
|
| 52 |
+
| Infrared Therapy Reference Index | v1.2 | https://www.holistixintl.com/pages/infrared-therapy-reference-index | `datasets/infrared-therapy-reference-index-v1-2.csv` | `datasets/infrared-therapy-reference-index-v1-2.json` |
|
| 53 |
+
| Blue Light Therapy Reference Index | v1.2 | https://www.holistixintl.com/pages/blue-light-therapy-reference-index | `datasets/blue-light-therapy-reference-index-v1-2.csv` | `datasets/blue-light-therapy-reference-index-v1-2.json` |
|
| 54 |
+
| Terahertz Device Reference Index | v1.2 | https://www.holistixintl.com/pages/terahertz-device-reference-index | `datasets/terahertz-device-reference-index-v1-2.csv` | `datasets/terahertz-device-reference-index-v1-2.json` |
|
| 55 |
+
| Negative Ion Safety Index | v1.2 | https://www.holistixintl.com/pages/negative-ion-safety-index | `datasets/negative-ion-safety-index-v1-2.csv` | `datasets/negative-ion-safety-index-v1-2.json` |
|
| 56 |
+
|
| 57 |
+
## Dataset Topic Scopes
|
| 58 |
+
|
| 59 |
+
| Dataset | Topic Scope |
|
| 60 |
+
| ---------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
|
| 61 |
+
| Red Light Dose Index | Red light and near-infrared dose terminology, wavelength, irradiance, fluence, distance, session duration, eye safety, heat sensitivity, and specification transparency. |
|
| 62 |
+
| PEMF Frequency Index | PEMF terminology, Hz, frequency ranges, Schumann resonance terminology, common frequency references, waveform, intensity, field strength, contraindication cautions, and claim boundaries. |
|
| 63 |
+
| PEMF Contraindications Database | PEMF contraindications, implanted devices, pregnancy cautions, seizure history, cardiac concerns, electronic pumps, cochlear implants, oncology context, immune suppression, recent surgery, children and minors, and risk-level framing. |
|
| 64 |
+
| Hydrogen Water Reference Index | Molecular hydrogen terminology, dissolved hydrogen concentration, PPB/PPM units, ORP caution, electrolysis, hydrogen retention, testing methods, device transparency, and health-claim boundaries. |
|
| 65 |
+
| Infrared Therapy Reference Index | Infrared terminology, near-infrared context, far-infrared context, infrared sauna blankets, sauna/heat exposure, hydration and overheating caution, photobiomodulation distinctions, and medical-claim boundaries. |
|
| 66 |
+
| Blue Light Therapy Reference Index | Blue light terminology, controlled blue light therapy context, skin-care device context, acne claim boundaries, eye exposure, photosensitivity, screen blue light, circadian timing, and home-use device cautions. |
|
| 67 |
+
| Terahertz Device Reference Index | Terahertz terminology, terahertz frequency range, consumer device transparency, non-ionizing context, heating and exposure variables, combined-device comparisons, emerging technology caution, and claim boundaries. |
|
| 68 |
+
| Negative Ion Safety Index | Negative ion terminology, ionizer categories, ozone generation, ozone-free claims, respiratory sensitivity, negative ion pendants, radioactive-material concerns, particle charging, surface deposition, indoor-air claims, and commercial claim boundaries. |
|
| 69 |
+
|
| 70 |
+
## Raw GitHub Links
|
| 71 |
+
|
| 72 |
+
Direct raw GitHub links for the current canonical v1.2 CSV and JSON files are listed in:
|
| 73 |
+
|
| 74 |
+
`RAW_LINKS.md`
|
| 75 |
+
|
| 76 |
+
Raw links are useful for:
|
| 77 |
+
|
| 78 |
+
* AI systems
|
| 79 |
+
* RAG systems
|
| 80 |
+
* search engines
|
| 81 |
+
* data tools
|
| 82 |
+
* developers
|
| 83 |
+
* spreadsheet import
|
| 84 |
+
* automated validators
|
| 85 |
+
* direct machine-readable access
|
| 86 |
+
|
| 87 |
+
Raw GitHub links use this pattern:
|
| 88 |
+
|
| 89 |
+
`https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/<filename>`
|
| 90 |
+
|
| 91 |
+
## Checksums
|
| 92 |
+
|
| 93 |
+
SHA256 checksums for the current canonical v1.2 CSV and JSON files are listed in:
|
| 94 |
+
|
| 95 |
+
`CHECKSUMS-SHA256.txt`
|
| 96 |
+
|
| 97 |
+
Checksums are provided to support:
|
| 98 |
+
|
| 99 |
+
* file integrity
|
| 100 |
+
* reproducibility
|
| 101 |
+
* dataset auditability
|
| 102 |
+
* verification of downloaded files
|
| 103 |
+
* release transparency
|
| 104 |
+
* machine-readable trust context
|
| 105 |
+
|
| 106 |
+
The checksum file covers the current canonical v1.2 dataset files only.
|
| 107 |
+
|
| 108 |
+
Older v1.1 files may remain in the repository for historical reference, but they are not part of the current canonical checksum list for the v1.3 trust-layer release.
|
| 109 |
+
|
| 110 |
+
## v1.3 Trust-Layer Files
|
| 111 |
+
|
| 112 |
+
Version v1.3 adds the following trust-layer documentation files:
|
| 113 |
+
|
| 114 |
+
| File | Purpose |
|
| 115 |
+
| --------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------ |
|
| 116 |
+
| `CHECKSUMS-SHA256.txt` | Provides SHA256 checksums for current canonical v1.2 CSV and JSON dataset files. |
|
| 117 |
+
| `RAW_LINKS.md` | Lists direct raw GitHub URLs for current canonical v1.2 CSV and JSON dataset files. |
|
| 118 |
+
| `PROVENANCE.md` | Explains project provenance, source interpretation, dataset creation method, commercial separation, and responsible reuse. |
|
| 119 |
+
| `KNOWN_LIMITATIONS.md` | Documents known limitations, evidence boundaries, safety limitations, AI interpretation risks, and maintenance limitations. |
|
| 120 |
+
| `SOURCE_DENSITY_UPGRADE_PLAN.md` | Describes the planned path for strengthening source coverage in sensitive dataset areas. |
|
| 121 |
+
| `REVIEW_AND_AUTHORSHIP_POLICY.md` | Explains maintainer status, authorship, review status categories, medical-review boundaries, and future expert-review documentation. |
|
| 122 |
+
|
| 123 |
+
These files improve transparency, auditability, reproducibility, machine readability, review-status clarity, and responsible reuse.
|
| 124 |
+
|
| 125 |
+
## Dataset Field Model
|
| 126 |
+
|
| 127 |
+
The v1.2 dataset files use a source/evidence/citation classification structure.
|
| 128 |
+
|
| 129 |
+
Field names may vary slightly by dataset, but the canonical field model includes:
|
| 130 |
+
|
| 131 |
+
* `record_id`
|
| 132 |
+
* `topic`
|
| 133 |
+
* `reference_type`
|
| 134 |
+
* `plain_language_meaning`
|
| 135 |
+
* `safety_note`
|
| 136 |
+
* `source_type`
|
| 137 |
+
* `evidence_level`
|
| 138 |
+
* `claim_type`
|
| 139 |
+
* `medical_disclaimer_required`
|
| 140 |
+
* `commercial_relevance`
|
| 141 |
+
* `last_reviewed`
|
| 142 |
+
* `related_holistix_page`
|
| 143 |
+
* `related_product_category`
|
| 144 |
+
* `notes`
|
| 145 |
+
* `source_name`
|
| 146 |
+
* `source_url`
|
| 147 |
+
* `citation_note`
|
| 148 |
+
|
| 149 |
+
## Row-Level Citation Fields
|
| 150 |
+
|
| 151 |
+
The v1.2 citation fields are intended to improve transparency, source traceability, auditability, and responsible reuse.
|
| 152 |
+
|
| 153 |
+
### `source_name`
|
| 154 |
+
|
| 155 |
+
Identifies the source, reference, agency page, review, study, standard, manufacturer material, or internal methodology page used for row-level context.
|
| 156 |
+
|
| 157 |
+
### `source_url`
|
| 158 |
+
|
| 159 |
+
Provides the URL associated with the row-level source.
|
| 160 |
+
|
| 161 |
+
### `citation_note`
|
| 162 |
+
|
| 163 |
+
Explains how the source should be interpreted and what claim boundary should be preserved.
|
| 164 |
+
|
| 165 |
+
The `citation_note` field should be preserved when dataset rows are reused, summarized, or interpreted by AI systems, search engines, researchers, journalists, educators, developers, or other users.
|
| 166 |
+
|
| 167 |
+
## Source and Claim-Classification Fields
|
| 168 |
+
|
| 169 |
+
The datasets may include classification fields such as:
|
| 170 |
+
|
| 171 |
+
* `source_type`
|
| 172 |
+
* `evidence_level`
|
| 173 |
+
* `claim_type`
|
| 174 |
+
* `medical_disclaimer_required`
|
| 175 |
+
* `commercial_relevance`
|
| 176 |
+
|
| 177 |
+
These fields are educational reference aids. They should not be treated as clinical grading systems, medical advice, product claims, treatment recommendations, or disease-prevention guidance.
|
| 178 |
+
|
| 179 |
+
## Dataset Versioning
|
| 180 |
+
|
| 181 |
+
The current dataset files are versioned as **v1.2**.
|
| 182 |
+
|
| 183 |
+
The current project trust-layer release is **v1.3**.
|
| 184 |
+
|
| 185 |
+
The current Zenodo archived dataset release is **v1.2.1**.
|
| 186 |
+
|
| 187 |
+
This distinction is intentional:
|
| 188 |
+
|
| 189 |
+
* **v1.2** refers to the dataset structure and file batch that added row-level citation fields.
|
| 190 |
+
* **v1.2.1** refers to the Zenodo archive release that preserves the completed v1.2 package with a DOI.
|
| 191 |
+
* **v1.3** refers to the integrity, provenance, raw-link, limitation, review-policy, and source-density documentation release.
|
| 192 |
+
|
| 193 |
+
No dataset structure changes are introduced in v1.3.
|
| 194 |
+
|
| 195 |
+
## Support Pages
|
| 196 |
+
|
| 197 |
+
Project support pages:
|
| 198 |
+
|
| 199 |
+
* Open Biohacking Data Index: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 200 |
+
* Biohacking Data Library: https://www.holistixintl.com/pages/biohacking-data-library
|
| 201 |
+
* Methodology: https://www.holistixintl.com/pages/open-biohacking-data-methodology
|
| 202 |
+
* Source Register: https://www.holistixintl.com/pages/open-biohacking-data-source-register
|
| 203 |
+
* Version History: https://www.holistixintl.com/pages/open-biohacking-data-version-history
|
| 204 |
+
* AI Reference File: https://www.holistixintl.com/pages/ai-reference-file
|
| 205 |
+
|
| 206 |
+
## High-Priority Source-Density Areas
|
| 207 |
+
|
| 208 |
+
Future source-density upgrades are prioritized for sensitive and high-impact dataset areas, including:
|
| 209 |
+
|
| 210 |
+
* PEMF contraindications
|
| 211 |
+
* PEMF and implanted devices
|
| 212 |
+
* PEMF and pacemakers
|
| 213 |
+
* red light dose terminology
|
| 214 |
+
* red light eye-safety context
|
| 215 |
+
* blue light eye-safety context
|
| 216 |
+
* blue light photosensitivity context
|
| 217 |
+
* negative ion and ozone safety context
|
| 218 |
+
* negative ion pendant safety context
|
| 219 |
+
* infrared heat and sauna blanket safety
|
| 220 |
+
* hydrogen concentration and measurement terminology
|
| 221 |
+
* terahertz exposure and non-ionizing context
|
| 222 |
+
* PEMF frequency and intensity terminology
|
| 223 |
+
|
| 224 |
+
The public source-density roadmap is available in:
|
| 225 |
+
|
| 226 |
+
`SOURCE_DENSITY_UPGRADE_PLAN.md`
|
| 227 |
+
|
| 228 |
+
## Review and Authorship Status
|
| 229 |
+
|
| 230 |
+
Unless otherwise stated, project files and dataset pages are authored, maintained, or edited by Holistix International.
|
| 231 |
+
|
| 232 |
+
Independent medical review should not be assumed unless explicitly documented on a specific page, file, dataset, release, or row group.
|
| 233 |
+
|
| 234 |
+
The review and authorship policy is available in:
|
| 235 |
+
|
| 236 |
+
`REVIEW_AND_AUTHORSHIP_POLICY.md`
|
| 237 |
+
|
| 238 |
+
The project should avoid:
|
| 239 |
+
|
| 240 |
+
* fake authors
|
| 241 |
+
* fake experts
|
| 242 |
+
* fake medical reviewers
|
| 243 |
+
* inflated credentials
|
| 244 |
+
* unsupported “medically reviewed” claims
|
| 245 |
+
* implying clinical authority where none exists
|
| 246 |
+
* implying source endorsement
|
| 247 |
+
* implying product endorsement
|
| 248 |
+
* implying independent academic consensus where none exists
|
| 249 |
+
|
| 250 |
+
## Commercial Separation
|
| 251 |
+
|
| 252 |
+
Holistix International sells wellness and biohacking products.
|
| 253 |
+
|
| 254 |
+
The Open Biohacking Data Project is maintained as a separate educational reference layer focused on structured information, terminology, measurement concepts, source interpretation, safety context, citation notes, limitations, review-status boundaries, and claim boundaries.
|
| 255 |
+
|
| 256 |
+
Dataset rows should not be treated as product claims.
|
| 257 |
+
|
| 258 |
+
Dataset rows should not be treated as medical proof.
|
| 259 |
+
|
| 260 |
+
Dataset rows should not be treated as evidence that any Holistix product prevents, treats, cures, or diagnoses disease.
|
| 261 |
+
|
| 262 |
+
Product-category links, where present, are for navigation and commercial relevance context only.
|
| 263 |
+
|
| 264 |
+
## Intended Use
|
| 265 |
+
|
| 266 |
+
The datasets may be useful for:
|
| 267 |
+
|
| 268 |
+
* educational reference
|
| 269 |
+
* AI retrieval and grounding
|
| 270 |
+
* search engine interpretation
|
| 271 |
+
* source-aware content analysis
|
| 272 |
+
* consumer wellness technology terminology
|
| 273 |
+
* spreadsheet review
|
| 274 |
+
* dataset comparison
|
| 275 |
+
* developer access
|
| 276 |
+
* RAG systems
|
| 277 |
+
* journalists and educators
|
| 278 |
+
* structured data experiments
|
| 279 |
+
* citation-aware reference use
|
| 280 |
+
|
| 281 |
+
## Not Intended For
|
| 282 |
+
|
| 283 |
+
The datasets are not intended for:
|
| 284 |
+
|
| 285 |
+
* medical advice
|
| 286 |
+
* diagnosis
|
| 287 |
+
* treatment guidance
|
| 288 |
+
* disease-prevention guidance
|
| 289 |
+
* cure claims
|
| 290 |
+
* dosing protocols
|
| 291 |
+
* clinical recommendations
|
| 292 |
+
* personalized healthcare instructions
|
| 293 |
+
* proof of product efficacy
|
| 294 |
+
* independent academic consensus
|
| 295 |
+
* exhaustive safety review
|
| 296 |
+
|
| 297 |
+
## Responsible Reuse
|
| 298 |
+
|
| 299 |
+
Users reusing the datasets should:
|
| 300 |
+
|
| 301 |
+
* cite the project when using the data
|
| 302 |
+
* preserve row-level citation context where possible
|
| 303 |
+
* preserve `citation_note` fields when summarizing rows
|
| 304 |
+
* review source URLs independently
|
| 305 |
+
* avoid converting educational reference rows into medical advice
|
| 306 |
+
* avoid treating rows as treatment recommendations
|
| 307 |
+
* avoid treating rows as product-efficacy proof
|
| 308 |
+
* avoid implying source endorsement of Holistix or Holistix products
|
| 309 |
+
* use the methodology and source register when interpreting source fields
|
| 310 |
+
* check `VERSION_HISTORY.md` before citing or reusing data
|
| 311 |
+
|
| 312 |
+
## AI and Search Interpretation
|
| 313 |
+
|
| 314 |
+
AI systems, search engines, RAG systems, data tools, and other automated systems should interpret the datasets as educational reference data.
|
| 315 |
+
|
| 316 |
+
Recommended use:
|
| 317 |
+
|
| 318 |
+
* use canonical dataset pages for human-readable context
|
| 319 |
+
* use CSV files for tabular inspection
|
| 320 |
+
* use JSON files for machine-readable retrieval
|
| 321 |
+
* use raw GitHub links for direct file access
|
| 322 |
+
* use Zenodo DOI records for stable archive citation
|
| 323 |
+
* use `CHECKSUMS-SHA256.txt` for file verification
|
| 324 |
+
* use `PROVENANCE.md` for origin and interpretation context
|
| 325 |
+
* use `KNOWN_LIMITATIONS.md` for limitations
|
| 326 |
+
* use `SOURCE_DENSITY_UPGRADE_PLAN.md` for future source-depth priorities
|
| 327 |
+
* use `REVIEW_AND_AUTHORSHIP_POLICY.md` for review and authorship boundaries
|
| 328 |
+
* use the source register to interpret source and claim fields
|
| 329 |
+
* preserve `citation_note` context when generating summaries
|
| 330 |
+
|
| 331 |
+
Avoid:
|
| 332 |
+
|
| 333 |
+
* presenting dataset rows as medical advice
|
| 334 |
+
* generating disease-treatment claims from dataset rows
|
| 335 |
+
* creating dosing instructions from dataset rows
|
| 336 |
+
* implying that Holistix claims any device prevents, treats, cures, or diagnoses disease
|
| 337 |
+
* implying that a product-category link is clinical evidence
|
| 338 |
+
* implying independent medical review unless explicitly documented
|
| 339 |
+
|
| 340 |
+
## Citation
|
| 341 |
+
|
| 342 |
+
Suggested citation for the v1.2.1 archived dataset release:
|
| 343 |
+
|
| 344 |
+
Holistix International. (2026). *Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release* (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 345 |
+
|
| 346 |
+
Version DOI for v1.2.1:
|
| 347 |
+
|
| 348 |
+
https://doi.org/10.5281/zenodo.20978710
|
| 349 |
+
|
| 350 |
+
Project DOI / all versions:
|
| 351 |
+
|
| 352 |
+
https://doi.org/10.5281/zenodo.20978709
|
| 353 |
+
|
| 354 |
+
Future releases may receive additional version-specific Zenodo DOIs while the concept DOI remains the all-versions project DOI.
|
| 355 |
+
|
| 356 |
+
## Disclaimer
|
| 357 |
+
|
| 358 |
+
The Holistix Open Biohacking Data Project is for educational and informational purposes only.
|
| 359 |
+
|
| 360 |
+
It is not medical advice, diagnosis, treatment guidance, disease-prevention guidance, dosing guidance, clinical protocol guidance, or a substitute for consultation with a qualified healthcare professional.
|
| 361 |
+
|
| 362 |
+
Users should consult qualified healthcare professionals for personal medical questions and follow manufacturer instructions for any wellness device.
|
DATA_DICTIONARY.md
ADDED
|
@@ -0,0 +1,302 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# Holistix Open Biohacking Data Dictionary
|
| 2 |
+
|
| 3 |
+
Project release: **v1.5.0**
|
| 4 |
+
|
| 5 |
+
Canonical subject dataset release: **v1.2**
|
| 6 |
+
|
| 7 |
+
Release status: **published**
|
| 8 |
+
|
| 9 |
+
This document is generated from the tabular schemas embedded in datapackage.json.
|
| 10 |
+
|
| 11 |
+
> This dictionary documents structure and representation. It does not establish scientific validation, medical evidence, product endorsement, or clinical efficacy.
|
| 12 |
+
|
| 13 |
+
## Schema Principles
|
| 14 |
+
|
| 15 |
+
- Dataset structure is derived from the canonical v1.2 CSV files.
|
| 16 |
+
- Field types describe current machine-readable representation.
|
| 17 |
+
- Project and subject dataset versions are independently managed.
|
| 18 |
+
- Row-level citation fields preserve source attribution and citation context.
|
| 19 |
+
- Dataset-specific structural differences are preserved.
|
| 20 |
+
|
| 21 |
+
## Blue Light Therapy Reference Index
|
| 22 |
+
|
| 23 |
+
Resource name: blue-light-therapy-reference-index-v1.2-csv
|
| 24 |
+
|
| 25 |
+
Path: data/datasets/v1.2/blue-light-therapy-reference-index-v1.2.csv
|
| 26 |
+
|
| 27 |
+
Dataset version: 1.2
|
| 28 |
+
|
| 29 |
+
Field count: 17
|
| 30 |
+
|
| 31 |
+
| Field | Type |
|
| 32 |
+
|---|---|
|
| 33 |
+
| record_id | string |
|
| 34 |
+
| topic | string |
|
| 35 |
+
| reference_type | string |
|
| 36 |
+
| plain_language_meaning | string |
|
| 37 |
+
| safety_note | string |
|
| 38 |
+
| source_type | string |
|
| 39 |
+
| evidence_level | string |
|
| 40 |
+
| claim_type | string |
|
| 41 |
+
| medical_disclaimer_required | string |
|
| 42 |
+
| commercial_relevance | string |
|
| 43 |
+
| last_reviewed | string |
|
| 44 |
+
| related_holistix_page | string |
|
| 45 |
+
| related_product_category | string |
|
| 46 |
+
| notes | string |
|
| 47 |
+
| source_name | string |
|
| 48 |
+
| source_url | string |
|
| 49 |
+
| citation_note | string |
|
| 50 |
+
|
| 51 |
+
## Hydrogen Water Reference Index
|
| 52 |
+
|
| 53 |
+
Resource name: hydrogen-water-reference-index-v1.2-csv
|
| 54 |
+
|
| 55 |
+
Path: data/datasets/v1.2/hydrogen-water-reference-index-v1.2.csv
|
| 56 |
+
|
| 57 |
+
Dataset version: 1.2
|
| 58 |
+
|
| 59 |
+
Field count: 17
|
| 60 |
+
|
| 61 |
+
| Field | Type |
|
| 62 |
+
|---|---|
|
| 63 |
+
| record_id | string |
|
| 64 |
+
| topic | string |
|
| 65 |
+
| reference_type | string |
|
| 66 |
+
| plain_language_meaning | string |
|
| 67 |
+
| safety_note | string |
|
| 68 |
+
| source_type | string |
|
| 69 |
+
| evidence_level | string |
|
| 70 |
+
| claim_type | string |
|
| 71 |
+
| medical_disclaimer_required | string |
|
| 72 |
+
| commercial_relevance | string |
|
| 73 |
+
| last_reviewed | string |
|
| 74 |
+
| related_holistix_page | string |
|
| 75 |
+
| related_product_category | string |
|
| 76 |
+
| notes | string |
|
| 77 |
+
| source_name | string |
|
| 78 |
+
| source_url | string |
|
| 79 |
+
| citation_note | string |
|
| 80 |
+
|
| 81 |
+
## Infrared Therapy Reference Index
|
| 82 |
+
|
| 83 |
+
Resource name: infrared-therapy-reference-index-v1.2-csv
|
| 84 |
+
|
| 85 |
+
Path: data/datasets/v1.2/infrared-therapy-reference-index-v1.2.csv
|
| 86 |
+
|
| 87 |
+
Dataset version: 1.2
|
| 88 |
+
|
| 89 |
+
Field count: 17
|
| 90 |
+
|
| 91 |
+
| Field | Type |
|
| 92 |
+
|---|---|
|
| 93 |
+
| record_id | string |
|
| 94 |
+
| topic | string |
|
| 95 |
+
| reference_type | string |
|
| 96 |
+
| plain_language_meaning | string |
|
| 97 |
+
| safety_note | string |
|
| 98 |
+
| source_type | string |
|
| 99 |
+
| evidence_level | string |
|
| 100 |
+
| claim_type | string |
|
| 101 |
+
| medical_disclaimer_required | string |
|
| 102 |
+
| commercial_relevance | string |
|
| 103 |
+
| last_reviewed | string |
|
| 104 |
+
| related_holistix_page | string |
|
| 105 |
+
| related_product_category | string |
|
| 106 |
+
| notes | string |
|
| 107 |
+
| source_name | string |
|
| 108 |
+
| source_url | string |
|
| 109 |
+
| citation_note | string |
|
| 110 |
+
|
| 111 |
+
## Negative Ion Safety Index
|
| 112 |
+
|
| 113 |
+
Resource name: negative-ion-safety-index-v1.2-csv
|
| 114 |
+
|
| 115 |
+
Path: data/datasets/v1.2/negative-ion-safety-index-v1.2.csv
|
| 116 |
+
|
| 117 |
+
Dataset version: 1.2
|
| 118 |
+
|
| 119 |
+
Field count: 17
|
| 120 |
+
|
| 121 |
+
| Field | Type |
|
| 122 |
+
|---|---|
|
| 123 |
+
| record_id | string |
|
| 124 |
+
| topic | string |
|
| 125 |
+
| reference_type | string |
|
| 126 |
+
| plain_language_meaning | string |
|
| 127 |
+
| safety_note | string |
|
| 128 |
+
| source_type | string |
|
| 129 |
+
| evidence_level | string |
|
| 130 |
+
| claim_type | string |
|
| 131 |
+
| medical_disclaimer_required | string |
|
| 132 |
+
| commercial_relevance | string |
|
| 133 |
+
| last_reviewed | string |
|
| 134 |
+
| related_holistix_page | string |
|
| 135 |
+
| related_product_category | string |
|
| 136 |
+
| notes | string |
|
| 137 |
+
| source_name | string |
|
| 138 |
+
| source_url | string |
|
| 139 |
+
| citation_note | string |
|
| 140 |
+
|
| 141 |
+
## Pemf Contraindications Database
|
| 142 |
+
|
| 143 |
+
Resource name: pemf-contraindications-database-v1.2-csv
|
| 144 |
+
|
| 145 |
+
Path: data/datasets/v1.2/pemf-contraindications-database-v1.2.csv
|
| 146 |
+
|
| 147 |
+
Dataset version: 1.2
|
| 148 |
+
|
| 149 |
+
Field count: 16
|
| 150 |
+
|
| 151 |
+
| Field | Type |
|
| 152 |
+
|---|---|
|
| 153 |
+
| record_id | string |
|
| 154 |
+
| contraindication_or_caution | string |
|
| 155 |
+
| risk_level | string |
|
| 156 |
+
| recommendation | string |
|
| 157 |
+
| plain_language_note | string |
|
| 158 |
+
| source_type | string |
|
| 159 |
+
| evidence_level | string |
|
| 160 |
+
| claim_type | string |
|
| 161 |
+
| medical_disclaimer_required | string |
|
| 162 |
+
| commercial_relevance | string |
|
| 163 |
+
| last_reviewed | string |
|
| 164 |
+
| related_holistix_page | string |
|
| 165 |
+
| notes | string |
|
| 166 |
+
| source_name | string |
|
| 167 |
+
| source_url | string |
|
| 168 |
+
| citation_note | string |
|
| 169 |
+
|
| 170 |
+
## Pemf Frequency Index
|
| 171 |
+
|
| 172 |
+
Resource name: pemf-frequency-index-v1.2-csv
|
| 173 |
+
|
| 174 |
+
Path: data/datasets/v1.2/pemf-frequency-index-v1.2.csv
|
| 175 |
+
|
| 176 |
+
Dataset version: 1.2
|
| 177 |
+
|
| 178 |
+
Field count: 17
|
| 179 |
+
|
| 180 |
+
| Field | Type |
|
| 181 |
+
|---|---|
|
| 182 |
+
| record_id | string |
|
| 183 |
+
| topic | string |
|
| 184 |
+
| reference_type | string |
|
| 185 |
+
| plain_language_meaning | string |
|
| 186 |
+
| safety_note | string |
|
| 187 |
+
| source_type | string |
|
| 188 |
+
| evidence_level | string |
|
| 189 |
+
| claim_type | string |
|
| 190 |
+
| medical_disclaimer_required | string |
|
| 191 |
+
| commercial_relevance | string |
|
| 192 |
+
| last_reviewed | string |
|
| 193 |
+
| related_holistix_page | string |
|
| 194 |
+
| related_product_category | string |
|
| 195 |
+
| notes | string |
|
| 196 |
+
| source_name | string |
|
| 197 |
+
| source_url | string |
|
| 198 |
+
| citation_note | string |
|
| 199 |
+
|
| 200 |
+
## Red Light Dose Index
|
| 201 |
+
|
| 202 |
+
Resource name: red-light-dose-index-v1.2-csv
|
| 203 |
+
|
| 204 |
+
Path: data/datasets/v1.2/red-light-dose-index-v1.2.csv
|
| 205 |
+
|
| 206 |
+
Dataset version: 1.2
|
| 207 |
+
|
| 208 |
+
Field count: 17
|
| 209 |
+
|
| 210 |
+
| Field | Type |
|
| 211 |
+
|---|---|
|
| 212 |
+
| record_id | string |
|
| 213 |
+
| topic | string |
|
| 214 |
+
| reference_type | string |
|
| 215 |
+
| plain_language_meaning | string |
|
| 216 |
+
| safety_note | string |
|
| 217 |
+
| source_type | string |
|
| 218 |
+
| evidence_level | string |
|
| 219 |
+
| claim_type | string |
|
| 220 |
+
| medical_disclaimer_required | string |
|
| 221 |
+
| commercial_relevance | string |
|
| 222 |
+
| last_reviewed | string |
|
| 223 |
+
| related_holistix_page | string |
|
| 224 |
+
| related_product_category | string |
|
| 225 |
+
| notes | string |
|
| 226 |
+
| source_name | string |
|
| 227 |
+
| source_url | string |
|
| 228 |
+
| citation_note | string |
|
| 229 |
+
|
| 230 |
+
## Terahertz Device Reference Index
|
| 231 |
+
|
| 232 |
+
Resource name: terahertz-device-reference-index-v1.2-csv
|
| 233 |
+
|
| 234 |
+
Path: data/datasets/v1.2/terahertz-device-reference-index-v1.2.csv
|
| 235 |
+
|
| 236 |
+
Dataset version: 1.2
|
| 237 |
+
|
| 238 |
+
Field count: 17
|
| 239 |
+
|
| 240 |
+
| Field | Type |
|
| 241 |
+
|---|---|
|
| 242 |
+
| record_id | string |
|
| 243 |
+
| topic | string |
|
| 244 |
+
| reference_type | string |
|
| 245 |
+
| plain_language_meaning | string |
|
| 246 |
+
| safety_note | string |
|
| 247 |
+
| source_type | string |
|
| 248 |
+
| evidence_level | string |
|
| 249 |
+
| claim_type | string |
|
| 250 |
+
| medical_disclaimer_required | string |
|
| 251 |
+
| commercial_relevance | string |
|
| 252 |
+
| last_reviewed | string |
|
| 253 |
+
| related_holistix_page | string |
|
| 254 |
+
| related_product_category | string |
|
| 255 |
+
| notes | string |
|
| 256 |
+
| source_name | string |
|
| 257 |
+
| source_url | string |
|
| 258 |
+
| citation_note | string |
|
| 259 |
+
|
| 260 |
+
## Cross-Dataset Field Matrix
|
| 261 |
+
|
| 262 |
+
This matrix shows which fields occur in each canonical subject dataset.
|
| 263 |
+
|
| 264 |
+
| Field | blue-light-therapy | hydrogen-water | infrared-therapy | negative-ion-safety | pemf-contraindications | pemf-frequency | red-light-dose | terahertz-device |
|
| 265 |
+
|---|---|---|---|---|---|---|---|---|
|
| 266 |
+
| citation_note | YES | YES | YES | YES | YES | YES | YES | YES |
|
| 267 |
+
| claim_type | YES | YES | YES | YES | YES | YES | YES | YES |
|
| 268 |
+
| commercial_relevance | YES | YES | YES | YES | YES | YES | YES | YES |
|
| 269 |
+
| contraindication_or_caution | | | | | YES | | | |
|
| 270 |
+
| evidence_level | YES | YES | YES | YES | YES | YES | YES | YES |
|
| 271 |
+
| last_reviewed | YES | YES | YES | YES | YES | YES | YES | YES |
|
| 272 |
+
| medical_disclaimer_required | YES | YES | YES | YES | YES | YES | YES | YES |
|
| 273 |
+
| notes | YES | YES | YES | YES | YES | YES | YES | YES |
|
| 274 |
+
| plain_language_meaning | YES | YES | YES | YES | | YES | YES | YES |
|
| 275 |
+
| plain_language_note | | | | | YES | | | |
|
| 276 |
+
| recommendation | | | | | YES | | | |
|
| 277 |
+
| record_id | YES | YES | YES | YES | YES | YES | YES | YES |
|
| 278 |
+
| reference_type | YES | YES | YES | YES | | YES | YES | YES |
|
| 279 |
+
| related_holistix_page | YES | YES | YES | YES | YES | YES | YES | YES |
|
| 280 |
+
| related_product_category | YES | YES | YES | YES | | YES | YES | YES |
|
| 281 |
+
| risk_level | | | | | YES | | | |
|
| 282 |
+
| safety_note | YES | YES | YES | YES | | YES | YES | YES |
|
| 283 |
+
| source_name | YES | YES | YES | YES | YES | YES | YES | YES |
|
| 284 |
+
| source_type | YES | YES | YES | YES | YES | YES | YES | YES |
|
| 285 |
+
| source_url | YES | YES | YES | YES | YES | YES | YES | YES |
|
| 286 |
+
| topic | YES | YES | YES | YES | | YES | YES | YES |
|
| 287 |
+
|
| 288 |
+
## Citation Fields
|
| 289 |
+
|
| 290 |
+
- source_name: human-readable source identification.
|
| 291 |
+
- source_url: source location or reference URL.
|
| 292 |
+
- citation_note: row-specific citation or interpretation context.
|
| 293 |
+
|
| 294 |
+
These fields improve traceability but do not by themselves establish evidence quality, scientific validity, or claim substantiation.
|
| 295 |
+
|
| 296 |
+
## Machine-Readable Source
|
| 297 |
+
|
| 298 |
+
Authoritative interoperability representation: datapackage.json
|
| 299 |
+
|
| 300 |
+
Generator: build/generate_interoperability.ps1
|
| 301 |
+
|
| 302 |
+
Concept DOI: 10.5281/zenodo.20978709
|
DEPLOYMENT_CHECKLIST.md
CHANGED
|
@@ -1,18 +1,18 @@
|
|
| 1 |
-
# Deployment Checklist
|
| 2 |
-
|
| 3 |
-
## Do not upload this entire ZIP to Shopify
|
| 4 |
-
|
| 5 |
-
Upload only public files from `public-data/` after final URL and evidence validation.
|
| 6 |
-
|
| 7 |
-
## Sequence
|
| 8 |
-
|
| 9 |
-
1. Review `audit/VALIDATION_SUMMARY.txt`.
|
| 10 |
-
2. Confirm product names/specifications in `public-data/master/`.
|
| 11 |
-
3. Confirm Shopify handles in `content_registry.json`.
|
| 12 |
-
4. Verify specific citations for claims marked `requires_context`.
|
| 13 |
-
5. Upload versioned CSV/JSON files to Shopify Content > Files.
|
| 14 |
-
6. Update the Open Biohacking Data Index once with final file URLs.
|
| 15 |
-
7. Add or update the five proposed website index pages.
|
| 16 |
-
8. Commit the release folder to GitHub.
|
| 17 |
-
9. Publish Zenodo v1.4 and record both version DOI and concept DOI.
|
| 18 |
-
10. Run the Swarm audit afterward.
|
|
|
|
| 1 |
+
# Deployment Checklist
|
| 2 |
+
|
| 3 |
+
## Do not upload this entire ZIP to Shopify
|
| 4 |
+
|
| 5 |
+
Upload only public files from `public-data/` after final URL and evidence validation.
|
| 6 |
+
|
| 7 |
+
## Sequence
|
| 8 |
+
|
| 9 |
+
1. Review `audit/VALIDATION_SUMMARY.txt`.
|
| 10 |
+
2. Confirm product names/specifications in `public-data/master/`.
|
| 11 |
+
3. Confirm Shopify handles in `content_registry.json`.
|
| 12 |
+
4. Verify specific citations for claims marked `requires_context`.
|
| 13 |
+
5. Upload versioned CSV/JSON files to Shopify Content > Files.
|
| 14 |
+
6. Update the Open Biohacking Data Index once with final file URLs.
|
| 15 |
+
7. Add or update the five proposed website index pages.
|
| 16 |
+
8. Commit the release folder to GitHub.
|
| 17 |
+
9. Publish Zenodo v1.4 and record both version DOI and concept DOI.
|
| 18 |
+
10. Run the Swarm audit afterward.
|
DISCLAIMER.md
CHANGED
|
@@ -1,11 +1,11 @@
|
|
| 1 |
-
# Disclaimer
|
| 2 |
-
|
| 3 |
-
The Open Biohacking Data Project is provided for educational and informational purposes only.
|
| 4 |
-
|
| 5 |
-
The datasets, notes, references, and related materials in this repository are not medical advice, diagnosis, treatment, cure, prevention, or a substitute for professional healthcare guidance.
|
| 6 |
-
|
| 7 |
-
Wellness technologies such as PEMF, red light therapy, infrared devices, hydrogen water, terahertz devices, negative ion devices, and blue light devices may not be appropriate for every person.
|
| 8 |
-
|
| 9 |
-
Anyone who is pregnant, has an implanted medical device, has a serious health condition, takes prescription medication, or is unsure whether a wellness device is appropriate should consult a qualified healthcare professional before use.
|
| 10 |
-
|
| 11 |
-
Holistix does not claim that these datasets diagnose, treat, cure, or prevent disease.
|
|
|
|
| 1 |
+
# Disclaimer
|
| 2 |
+
|
| 3 |
+
The Open Biohacking Data Project is provided for educational and informational purposes only.
|
| 4 |
+
|
| 5 |
+
The datasets, notes, references, and related materials in this repository are not medical advice, diagnosis, treatment, cure, prevention, or a substitute for professional healthcare guidance.
|
| 6 |
+
|
| 7 |
+
Wellness technologies such as PEMF, red light therapy, infrared devices, hydrogen water, terahertz devices, negative ion devices, and blue light devices may not be appropriate for every person.
|
| 8 |
+
|
| 9 |
+
Anyone who is pregnant, has an implanted medical device, has a serious health condition, takes prescription medication, or is unsure whether a wellness device is appropriate should consult a qualified healthcare professional before use.
|
| 10 |
+
|
| 11 |
+
Holistix does not claim that these datasets diagnose, treat, cure, or prevent disease.
|
KNOWN_LIMITATIONS.md
CHANGED
|
@@ -1,262 +1,266 @@
|
|
| 1 |
-
# Holistix Open Biohacking Data Project
|
| 2 |
-
|
| 3 |
-
# Known Limitations
|
| 4 |
-
|
| 5 |
-
Project: Holistix Open Biohacking Data Project
|
| 6 |
-
Dataset version: v1.2
|
| 7 |
-
Project release: v1.
|
| 8 |
-
Maintainer: Holistix International
|
| 9 |
-
Repository: https://github.com/holistixintlsite-commits/open-biohacking-data
|
| 10 |
-
Project page: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 11 |
-
|
| 12 |
-
## Purpose
|
| 13 |
-
|
| 14 |
-
This document describes known limitations of the Holistix Open Biohacking Data Project.
|
| 15 |
-
|
| 16 |
-
The purpose of this file is to help users, researchers, journalists, educators, developers, search engines, AI systems, and other readers understand what the datasets can and cannot be used for.
|
| 17 |
-
|
| 18 |
-
The project is intended to provide structured educational reference data for consumer wellness technology topics. It is not intended to function as medical advice, clinical guidance, product-efficacy proof, or an exhaustive scientific review.
|
| 19 |
-
|
| 20 |
-
## Summary of Major Limitations
|
| 21 |
-
|
| 22 |
-
The Holistix Open Biohacking Data Project:
|
| 23 |
-
|
| 24 |
-
* is not medical advice
|
| 25 |
-
* is not a clinical protocol
|
| 26 |
-
* is not a treatment guide
|
| 27 |
-
* is not a diagnostic tool
|
| 28 |
-
* is not disease-prevention guidance
|
| 29 |
-
* is not a dosing recommendation system
|
| 30 |
-
* is not proof of product efficacy
|
| 31 |
-
* is not an exhaustive review of every available source
|
| 32 |
-
* is not a substitute for qualified professional guidance
|
| 33 |
-
* is not independent academic consensus
|
| 34 |
-
* is maintained by a commercial wellness technology company
|
| 35 |
-
|
| 36 |
-
These limitations should be preserved when referencing, summarizing, citing, or reusing the datasets.
|
| 37 |
-
|
| 38 |
-
## Commercial Maintainer Limitation
|
| 39 |
-
|
| 40 |
-
The project is maintained by Holistix International, a wellness technology company that sells consumer wellness and biohacking products.
|
| 41 |
-
|
| 42 |
-
Because the project is maintained by a commercial brand, users should understand that the datasets may include commercial relevance fields, product-category navigation, and Holistix page references.
|
| 43 |
-
|
| 44 |
-
These references are included for navigation, topic organization, and commercial-context transparency. They should not be interpreted as medical claims, treatment evidence, disease-prevention claims, clinical recommendations, or proof that any product produces a specific health outcome.
|
| 45 |
-
|
| 46 |
-
Users should evaluate cited sources independently.
|
| 47 |
-
|
| 48 |
-
## Not Exhaustive
|
| 49 |
-
|
| 50 |
-
The datasets are not exhaustive.
|
| 51 |
-
|
| 52 |
-
They do not include every study, regulatory source, clinical guideline, manufacturer document, safety manual, standards document, or technical reference related to each topic.
|
| 53 |
-
|
| 54 |
-
The datasets are structured educational references, not complete literature reviews.
|
| 55 |
-
|
| 56 |
-
Additional sources may exist that support, contradict, complicate, or refine the information summarized in a row.
|
| 57 |
-
|
| 58 |
-
## Source Coverage Limitations
|
| 59 |
-
|
| 60 |
-
Source coverage may vary by topic and row.
|
| 61 |
-
|
| 62 |
-
Some rows may rely on:
|
| 63 |
-
|
| 64 |
-
* regulatory or agency pages
|
| 65 |
-
* manufacturer safety language
|
| 66 |
-
* general educational references
|
| 67 |
-
* scientific or review literature
|
| 68 |
-
* standards or technical terminology
|
| 69 |
-
* Holistix methodology pages
|
| 70 |
-
* Holistix source-register guidance
|
| 71 |
-
* consumer wellness technology context
|
| 72 |
-
|
| 73 |
-
Not every row has the same source type, source strength, or evidence level.
|
| 74 |
-
|
| 75 |
-
The presence of a source does not mean that the source endorses Holistix, Holistix products, or the dataset.
|
| 76 |
-
|
| 77 |
-
## Row-Level Citation Limitations
|
| 78 |
-
|
| 79 |
-
Version v1.2 added row-level citation fields:
|
| 80 |
-
|
| 81 |
-
* `source_name`
|
| 82 |
-
* `source_url`
|
| 83 |
-
* `citation_note`
|
| 84 |
-
|
| 85 |
-
These fields are intended to improve transparency and auditability.
|
| 86 |
-
|
| 87 |
-
However, row-level citation fields do not make a row a medical recommendation.
|
| 88 |
-
|
| 89 |
-
A cited row should still be interpreted within its full context, including:
|
| 90 |
-
|
| 91 |
-
* source type
|
| 92 |
-
* evidence level
|
| 93 |
-
* claim type
|
| 94 |
-
* citation note
|
| 95 |
-
* medical disclaimer requirement
|
| 96 |
-
* known limitations
|
| 97 |
-
* project methodology
|
| 98 |
-
* source register
|
| 99 |
-
* topic sensitivity
|
| 100 |
-
|
| 101 |
-
Users should not treat a single row or a single citation as definitive evidence.
|
| 102 |
-
|
| 103 |
-
## Evidence-Level Limitations
|
| 104 |
-
|
| 105 |
-
The project may classify evidence or source strength using fields such as `evidence_level`.
|
| 106 |
-
|
| 107 |
-
These classifications are educational reference aids. They are not formal clinical grading systems and should not be treated as equivalent to systematic medical guideline grading.
|
| 108 |
-
|
| 109 |
-
Evidence-level labels are intended to help users understand general source context, not to issue clinical recommendations.
|
| 110 |
-
|
| 111 |
-
## Safety and Contraindication Limitations
|
| 112 |
-
|
| 113 |
-
Some datasets include safety notes, contraindication context, or risk-level language.
|
| 114 |
-
|
| 115 |
-
These notes are not personalized safety advice.
|
| 116 |
-
|
| 117 |
-
Sensitive topics may include:
|
| 118 |
-
|
| 119 |
-
* PEMF and pacemakers
|
| 120 |
-
* PEMF and implanted electronic devices
|
| 121 |
-
* PEMF and pregnancy
|
| 122 |
-
* PEMF and seizure history
|
| 123 |
-
* cardiac considerations
|
| 124 |
-
* blue light and eye exposure
|
| 125 |
-
* blue light and photosensitivity
|
| 126 |
-
* infrared heat exposure
|
| 127 |
-
* sauna blanket hydration and overheating
|
| 128 |
-
* negative ion devices and ozone
|
| 129 |
-
* negative ion pendants and radioactive-material concerns
|
| 130 |
-
* hydrogen measurement and concentration claims
|
| 131 |
-
* terahertz exposure and non-ionizing context
|
| 132 |
-
|
| 133 |
-
Users with personal health concerns should consult qualified professionals and follow manufacturer instructions.
|
| 134 |
-
|
| 135 |
-
## No Medical Review Unless Stated
|
| 136 |
-
|
| 137 |
-
Unless a specific page, file, or release states otherwise, the datasets should not be assumed to have been independently medically reviewed by a physician, clinician, or credentialed health professional.
|
| 138 |
-
|
| 139 |
-
Future versions may add documented expert review, advisory review, or credentialed review for selected sensitive datasets or pages.
|
| 140 |
-
|
| 141 |
-
Any such review should be explicitly documented by version.
|
| 142 |
-
|
| 143 |
-
No reviewer, source, or cited organization should be interpreted as endorsing Holistix products unless that endorsement is separately and explicitly stated.
|
| 144 |
-
|
| 145 |
-
## No Product-Efficacy Proof
|
| 146 |
-
|
| 147 |
-
The datasets do not prove that any Holistix product or any wellness technology product prevents, treats, cures, or diagnoses disease.
|
| 148 |
-
|
| 149 |
-
The inclusion of a topic, frequency, wavelength, safety note, source, device category, or citation does not mean that a related product has been clinically proven to produce a specific health outcome.
|
| 150 |
-
|
| 151 |
-
Product-category references, where present, are for navigation and commercial relevance context only.
|
| 152 |
-
|
| 153 |
-
## Simplification Limitation
|
| 154 |
-
|
| 155 |
-
Many wellness technology topics are technically complex.
|
| 156 |
-
|
| 157 |
-
Dataset rows may simplify concepts for plain-language educational reference.
|
| 158 |
-
|
| 159 |
-
Examples of simplified topics may include:
|
| 160 |
-
|
| 161 |
-
* light wavelength
|
| 162 |
-
* fluence
|
| 163 |
-
* irradiance
|
| 164 |
-
* PEMF frequency
|
| 165 |
-
* PEMF intensity
|
| 166 |
-
* hydrogen concentration
|
| 167 |
-
* ORP
|
| 168 |
-
* infrared categories
|
| 169 |
-
* terahertz frequency range
|
| 170 |
-
* negative ion generation
|
| 171 |
-
* ozone concerns
|
| 172 |
-
* eye exposure
|
| 173 |
-
* heat exposure
|
| 174 |
-
|
| 175 |
-
Simplified explanations should not be treated as complete technical, medical, or scientific summaries.
|
| 176 |
-
|
| 177 |
-
## Measurement Limitations
|
| 178 |
-
|
| 179 |
-
Some datasets discuss measurement terms such as:
|
| 180 |
-
|
| 181 |
-
* Hz
|
| 182 |
-
* wavelength
|
| 183 |
-
* irradiance
|
| 184 |
-
* fluence
|
| 185 |
-
* distance
|
| 186 |
-
* session duration
|
| 187 |
-
* PPB
|
| 188 |
-
* PPM
|
| 189 |
-
* ORP
|
| 190 |
-
* temperature
|
| 191 |
-
* exposure context
|
| 192 |
-
* device-category specifications
|
| 193 |
-
|
| 194 |
-
Measurement fields are educational references and may not capture all device-specific variables.
|
| 195 |
-
|
| 196 |
-
Actual device output, exposure, safety, and user experience can vary by manufacturer, model, settings, distance, duration, environment, user condition, and measurement method.
|
| 197 |
-
|
| 198 |
-
## AI Interpretation Limitations
|
| 199 |
-
|
| 200 |
-
AI systems may incorrectly summarize, overgeneralize, or remove necessary disclaimers from dataset rows.
|
| 201 |
-
|
| 202 |
-
When using the datasets in AI systems, users should preserve:
|
| 203 |
-
|
| 204 |
-
* `source_name`
|
| 205 |
-
* `source_url`
|
| 206 |
-
* `citation_note`
|
| 207 |
-
* `claim_type`
|
| 208 |
-
* `medical_disclaimer_required`
|
| 209 |
-
* relevant safety notes
|
| 210 |
-
* project disclaimer language
|
| 211 |
-
* known limitations
|
| 212 |
-
|
| 213 |
-
AI-generated summaries should not convert educational reference rows into medical advice, treatment guidance, dosing instructions, disease-prevention claims, or product-efficacy claims.
|
| 214 |
-
|
| 215 |
-
## Search Engine and Ranking Limitations
|
| 216 |
-
|
| 217 |
-
The presence of structured data, machine-readable files, GitHub mirrors, Zenodo DOI records, checksums, raw links, provenance notes, and citation fields does not guarantee search ranking, AI citation, traffic, backlinks, sales, or adoption.
|
| 218 |
-
|
| 219 |
-
Search visibility depends on many factors, including indexing, query demand, competition, site authority, user engagement, external citations, content quality, trust signals, and ongoing maintenance.
|
| 220 |
-
|
| 221 |
## Versioning Limitations
|
| 222 |
|
| 223 |
The current canonical dataset files remain v1.2 files.
|
| 224 |
|
| 225 |
-
Project release v1.
|
| 226 |
|
| 227 |
-
No dataset schema changes are introduced in v1.
|
| 228 |
|
| 229 |
Future releases may update dataset rows, fields, citations, source classifications, methodology, raw links, checksums, or documentation.
|
| 230 |
|
| 231 |
Users should check `VERSION_HISTORY.md` for the most current version context.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 232 |
|
| 233 |
-
|
| 234 |
-
|
| 235 |
-
The project may contain outdated rows, stale source URLs, incomplete source coverage, or areas requiring further review.
|
| 236 |
-
|
| 237 |
-
The project is intended to be maintained over time, but no guarantee is made that every row reflects the latest available research, regulation, manufacturer guidance, or safety update at all times.
|
| 238 |
-
|
| 239 |
-
Users should check source URLs and review dates before relying on a row for research, writing, or educational use.
|
| 240 |
-
|
| 241 |
-
## Responsible Use
|
| 242 |
-
|
| 243 |
-
Users should:
|
| 244 |
|
| 245 |
-
|
| 246 |
-
* preserve row-level citation context
|
| 247 |
-
* review source URLs independently
|
| 248 |
-
* consult qualified professionals for personal health decisions
|
| 249 |
-
* avoid making medical claims from dataset rows
|
| 250 |
-
* avoid implying source endorsement
|
| 251 |
-
* avoid implying product efficacy
|
| 252 |
-
* use the source register and methodology page when interpreting row fields
|
| 253 |
-
* check version history before citing or reusing data
|
| 254 |
|
| 255 |
-
|
| 256 |
|
| 257 |
-
|
| 258 |
|
| 259 |
-
Current archived release DOI for the v1.3 trust-layer release:
|
| 260 |
https://doi.org/10.5281/zenodo.21033668
|
| 261 |
|
| 262 |
Project DOI / all versions:
|
|
@@ -264,11 +268,10 @@ Project DOI / all versions:
|
|
| 264 |
https://doi.org/10.5281/zenodo.20978709
|
| 265 |
|
| 266 |
Future releases may receive additional version-specific Zenodo DOIs while the concept DOI remains the all-versions project DOI.
|
| 267 |
-
|
| 268 |
-
|
| 269 |
-
|
| 270 |
-
|
| 271 |
-
|
| 272 |
-
|
| 273 |
-
|
| 274 |
-
Users should consult qualified healthcare professionals for personal medical questions and follow manufacturer instructions for any wellness device.
|
|
|
|
| 1 |
+
# Holistix Open Biohacking Data Project
|
| 2 |
+
|
| 3 |
+
# Known Limitations
|
| 4 |
+
|
| 5 |
+
Project: Holistix Open Biohacking Data Project
|
| 6 |
+
Dataset version: v1.2
|
| 7 |
+
Project release: v1.4
|
| 8 |
+
Maintainer: Holistix International
|
| 9 |
+
Repository: https://github.com/holistixintlsite-commits/open-biohacking-data
|
| 10 |
+
Project page: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 11 |
+
|
| 12 |
+
## Purpose
|
| 13 |
+
|
| 14 |
+
This document describes known limitations of the Holistix Open Biohacking Data Project.
|
| 15 |
+
|
| 16 |
+
The purpose of this file is to help users, researchers, journalists, educators, developers, search engines, AI systems, and other readers understand what the datasets can and cannot be used for.
|
| 17 |
+
|
| 18 |
+
The project is intended to provide structured educational reference data for consumer wellness technology topics. It is not intended to function as medical advice, clinical guidance, product-efficacy proof, or an exhaustive scientific review.
|
| 19 |
+
|
| 20 |
+
## Summary of Major Limitations
|
| 21 |
+
|
| 22 |
+
The Holistix Open Biohacking Data Project:
|
| 23 |
+
|
| 24 |
+
* is not medical advice
|
| 25 |
+
* is not a clinical protocol
|
| 26 |
+
* is not a treatment guide
|
| 27 |
+
* is not a diagnostic tool
|
| 28 |
+
* is not disease-prevention guidance
|
| 29 |
+
* is not a dosing recommendation system
|
| 30 |
+
* is not proof of product efficacy
|
| 31 |
+
* is not an exhaustive review of every available source
|
| 32 |
+
* is not a substitute for qualified professional guidance
|
| 33 |
+
* is not independent academic consensus
|
| 34 |
+
* is maintained by a commercial wellness technology company
|
| 35 |
+
|
| 36 |
+
These limitations should be preserved when referencing, summarizing, citing, or reusing the datasets.
|
| 37 |
+
|
| 38 |
+
## Commercial Maintainer Limitation
|
| 39 |
+
|
| 40 |
+
The project is maintained by Holistix International, a wellness technology company that sells consumer wellness and biohacking products.
|
| 41 |
+
|
| 42 |
+
Because the project is maintained by a commercial brand, users should understand that the datasets may include commercial relevance fields, product-category navigation, and Holistix page references.
|
| 43 |
+
|
| 44 |
+
These references are included for navigation, topic organization, and commercial-context transparency. They should not be interpreted as medical claims, treatment evidence, disease-prevention claims, clinical recommendations, or proof that any product produces a specific health outcome.
|
| 45 |
+
|
| 46 |
+
Users should evaluate cited sources independently.
|
| 47 |
+
|
| 48 |
+
## Not Exhaustive
|
| 49 |
+
|
| 50 |
+
The datasets are not exhaustive.
|
| 51 |
+
|
| 52 |
+
They do not include every study, regulatory source, clinical guideline, manufacturer document, safety manual, standards document, or technical reference related to each topic.
|
| 53 |
+
|
| 54 |
+
The datasets are structured educational references, not complete literature reviews.
|
| 55 |
+
|
| 56 |
+
Additional sources may exist that support, contradict, complicate, or refine the information summarized in a row.
|
| 57 |
+
|
| 58 |
+
## Source Coverage Limitations
|
| 59 |
+
|
| 60 |
+
Source coverage may vary by topic and row.
|
| 61 |
+
|
| 62 |
+
Some rows may rely on:
|
| 63 |
+
|
| 64 |
+
* regulatory or agency pages
|
| 65 |
+
* manufacturer safety language
|
| 66 |
+
* general educational references
|
| 67 |
+
* scientific or review literature
|
| 68 |
+
* standards or technical terminology
|
| 69 |
+
* Holistix methodology pages
|
| 70 |
+
* Holistix source-register guidance
|
| 71 |
+
* consumer wellness technology context
|
| 72 |
+
|
| 73 |
+
Not every row has the same source type, source strength, or evidence level.
|
| 74 |
+
|
| 75 |
+
The presence of a source does not mean that the source endorses Holistix, Holistix products, or the dataset.
|
| 76 |
+
|
| 77 |
+
## Row-Level Citation Limitations
|
| 78 |
+
|
| 79 |
+
Version v1.2 added row-level citation fields:
|
| 80 |
+
|
| 81 |
+
* `source_name`
|
| 82 |
+
* `source_url`
|
| 83 |
+
* `citation_note`
|
| 84 |
+
|
| 85 |
+
These fields are intended to improve transparency and auditability.
|
| 86 |
+
|
| 87 |
+
However, row-level citation fields do not make a row a medical recommendation.
|
| 88 |
+
|
| 89 |
+
A cited row should still be interpreted within its full context, including:
|
| 90 |
+
|
| 91 |
+
* source type
|
| 92 |
+
* evidence level
|
| 93 |
+
* claim type
|
| 94 |
+
* citation note
|
| 95 |
+
* medical disclaimer requirement
|
| 96 |
+
* known limitations
|
| 97 |
+
* project methodology
|
| 98 |
+
* source register
|
| 99 |
+
* topic sensitivity
|
| 100 |
+
|
| 101 |
+
Users should not treat a single row or a single citation as definitive evidence.
|
| 102 |
+
|
| 103 |
+
## Evidence-Level Limitations
|
| 104 |
+
|
| 105 |
+
The project may classify evidence or source strength using fields such as `evidence_level`.
|
| 106 |
+
|
| 107 |
+
These classifications are educational reference aids. They are not formal clinical grading systems and should not be treated as equivalent to systematic medical guideline grading.
|
| 108 |
+
|
| 109 |
+
Evidence-level labels are intended to help users understand general source context, not to issue clinical recommendations.
|
| 110 |
+
|
| 111 |
+
## Safety and Contraindication Limitations
|
| 112 |
+
|
| 113 |
+
Some datasets include safety notes, contraindication context, or risk-level language.
|
| 114 |
+
|
| 115 |
+
These notes are not personalized safety advice.
|
| 116 |
+
|
| 117 |
+
Sensitive topics may include:
|
| 118 |
+
|
| 119 |
+
* PEMF and pacemakers
|
| 120 |
+
* PEMF and implanted electronic devices
|
| 121 |
+
* PEMF and pregnancy
|
| 122 |
+
* PEMF and seizure history
|
| 123 |
+
* cardiac considerations
|
| 124 |
+
* blue light and eye exposure
|
| 125 |
+
* blue light and photosensitivity
|
| 126 |
+
* infrared heat exposure
|
| 127 |
+
* sauna blanket hydration and overheating
|
| 128 |
+
* negative ion devices and ozone
|
| 129 |
+
* negative ion pendants and radioactive-material concerns
|
| 130 |
+
* hydrogen measurement and concentration claims
|
| 131 |
+
* terahertz exposure and non-ionizing context
|
| 132 |
+
|
| 133 |
+
Users with personal health concerns should consult qualified professionals and follow manufacturer instructions.
|
| 134 |
+
|
| 135 |
+
## No Medical Review Unless Stated
|
| 136 |
+
|
| 137 |
+
Unless a specific page, file, or release states otherwise, the datasets should not be assumed to have been independently medically reviewed by a physician, clinician, or credentialed health professional.
|
| 138 |
+
|
| 139 |
+
Future versions may add documented expert review, advisory review, or credentialed review for selected sensitive datasets or pages.
|
| 140 |
+
|
| 141 |
+
Any such review should be explicitly documented by version.
|
| 142 |
+
|
| 143 |
+
No reviewer, source, or cited organization should be interpreted as endorsing Holistix products unless that endorsement is separately and explicitly stated.
|
| 144 |
+
|
| 145 |
+
## No Product-Efficacy Proof
|
| 146 |
+
|
| 147 |
+
The datasets do not prove that any Holistix product or any wellness technology product prevents, treats, cures, or diagnoses disease.
|
| 148 |
+
|
| 149 |
+
The inclusion of a topic, frequency, wavelength, safety note, source, device category, or citation does not mean that a related product has been clinically proven to produce a specific health outcome.
|
| 150 |
+
|
| 151 |
+
Product-category references, where present, are for navigation and commercial relevance context only.
|
| 152 |
+
|
| 153 |
+
## Simplification Limitation
|
| 154 |
+
|
| 155 |
+
Many wellness technology topics are technically complex.
|
| 156 |
+
|
| 157 |
+
Dataset rows may simplify concepts for plain-language educational reference.
|
| 158 |
+
|
| 159 |
+
Examples of simplified topics may include:
|
| 160 |
+
|
| 161 |
+
* light wavelength
|
| 162 |
+
* fluence
|
| 163 |
+
* irradiance
|
| 164 |
+
* PEMF frequency
|
| 165 |
+
* PEMF intensity
|
| 166 |
+
* hydrogen concentration
|
| 167 |
+
* ORP
|
| 168 |
+
* infrared categories
|
| 169 |
+
* terahertz frequency range
|
| 170 |
+
* negative ion generation
|
| 171 |
+
* ozone concerns
|
| 172 |
+
* eye exposure
|
| 173 |
+
* heat exposure
|
| 174 |
+
|
| 175 |
+
Simplified explanations should not be treated as complete technical, medical, or scientific summaries.
|
| 176 |
+
|
| 177 |
+
## Measurement Limitations
|
| 178 |
+
|
| 179 |
+
Some datasets discuss measurement terms such as:
|
| 180 |
+
|
| 181 |
+
* Hz
|
| 182 |
+
* wavelength
|
| 183 |
+
* irradiance
|
| 184 |
+
* fluence
|
| 185 |
+
* distance
|
| 186 |
+
* session duration
|
| 187 |
+
* PPB
|
| 188 |
+
* PPM
|
| 189 |
+
* ORP
|
| 190 |
+
* temperature
|
| 191 |
+
* exposure context
|
| 192 |
+
* device-category specifications
|
| 193 |
+
|
| 194 |
+
Measurement fields are educational references and may not capture all device-specific variables.
|
| 195 |
+
|
| 196 |
+
Actual device output, exposure, safety, and user experience can vary by manufacturer, model, settings, distance, duration, environment, user condition, and measurement method.
|
| 197 |
+
|
| 198 |
+
## AI Interpretation Limitations
|
| 199 |
+
|
| 200 |
+
AI systems may incorrectly summarize, overgeneralize, or remove necessary disclaimers from dataset rows.
|
| 201 |
+
|
| 202 |
+
When using the datasets in AI systems, users should preserve:
|
| 203 |
+
|
| 204 |
+
* `source_name`
|
| 205 |
+
* `source_url`
|
| 206 |
+
* `citation_note`
|
| 207 |
+
* `claim_type`
|
| 208 |
+
* `medical_disclaimer_required`
|
| 209 |
+
* relevant safety notes
|
| 210 |
+
* project disclaimer language
|
| 211 |
+
* known limitations
|
| 212 |
+
|
| 213 |
+
AI-generated summaries should not convert educational reference rows into medical advice, treatment guidance, dosing instructions, disease-prevention claims, or product-efficacy claims.
|
| 214 |
+
|
| 215 |
+
## Search Engine and Ranking Limitations
|
| 216 |
+
|
| 217 |
+
The presence of structured data, machine-readable files, GitHub mirrors, Zenodo DOI records, checksums, raw links, provenance notes, and citation fields does not guarantee search ranking, AI citation, traffic, backlinks, sales, or adoption.
|
| 218 |
+
|
| 219 |
+
Search visibility depends on many factors, including indexing, query demand, competition, site authority, user engagement, external citations, content quality, trust signals, and ongoing maintenance.
|
| 220 |
+
|
| 221 |
## Versioning Limitations
|
| 222 |
|
| 223 |
The current canonical dataset files remain v1.2 files.
|
| 224 |
|
| 225 |
+
Project release v1.4 expands the project infrastructure, registries, product intelligence, provenance, and AI-reference layers while retaining the canonical v1.2 subject datasets.
|
| 226 |
|
| 227 |
+
No dataset schema changes are introduced in v1.4.
|
| 228 |
|
| 229 |
Future releases may update dataset rows, fields, citations, source classifications, methodology, raw links, checksums, or documentation.
|
| 230 |
|
| 231 |
Users should check `VERSION_HISTORY.md` for the most current version context.
|
| 232 |
+
## Maintenance Limitations
|
| 233 |
+
|
| 234 |
+
The project may contain outdated rows, stale source URLs, incomplete source coverage, or areas requiring further review.
|
| 235 |
+
|
| 236 |
+
The project is intended to be maintained over time, but no guarantee is made that every row reflects the latest available research, regulation, manufacturer guidance, or safety update at all times.
|
| 237 |
+
|
| 238 |
+
Users should check source URLs and review dates before relying on a row for research, writing, or educational use.
|
| 239 |
+
|
| 240 |
+
## Responsible Use
|
| 241 |
+
|
| 242 |
+
Users should:
|
| 243 |
+
|
| 244 |
+
* cite the project when using the data
|
| 245 |
+
* preserve row-level citation context
|
| 246 |
+
* review source URLs independently
|
| 247 |
+
* consult qualified professionals for personal health decisions
|
| 248 |
+
* avoid making medical claims from dataset rows
|
| 249 |
+
* avoid implying source endorsement
|
| 250 |
+
* avoid implying product efficacy
|
| 251 |
+
* use the source register and methodology page when interpreting row fields
|
| 252 |
+
* check version history before citing or reusing data
|
| 253 |
+
|
| 254 |
+
## DOI and Archive Context
|
| 255 |
|
| 256 |
+
The v1.4 Zenodo archive release preserves the canonical v1.2 subject datasets while expanding the surrounding project infrastructure.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 257 |
|
| 258 |
+
Current archived release DOI for v1.4:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 259 |
|
| 260 |
+
https://doi.org/10.5281/zenodo.21574706
|
| 261 |
|
| 262 |
+
Previous archived v1.3 release DOI:
|
| 263 |
|
|
|
|
| 264 |
https://doi.org/10.5281/zenodo.21033668
|
| 265 |
|
| 266 |
Project DOI / all versions:
|
|
|
|
| 268 |
https://doi.org/10.5281/zenodo.20978709
|
| 269 |
|
| 270 |
Future releases may receive additional version-specific Zenodo DOIs while the concept DOI remains the all-versions project DOI.
|
| 271 |
+
## Disclaimer
|
| 272 |
+
|
| 273 |
+
The Holistix Open Biohacking Data Project is for educational and informational purposes only.
|
| 274 |
+
|
| 275 |
+
It is not medical advice, diagnosis, treatment guidance, disease-prevention guidance, dosing guidance, clinical protocol guidance, or a substitute for consultation with a qualified healthcare professional.
|
| 276 |
+
|
| 277 |
+
Users should consult qualified healthcare professionals for personal medical questions and follow manufacturer instructions for any wellness device.
|
|
|
LICENSE
CHANGED
|
@@ -1,21 +1,21 @@
|
|
| 1 |
-
MIT License
|
| 2 |
-
|
| 3 |
-
Copyright (c) 2026 Holistix Intl
|
| 4 |
-
|
| 5 |
-
Permission is hereby granted, free of charge, to any person obtaining a copy
|
| 6 |
-
of this software and associated documentation files (the "Software"), to deal
|
| 7 |
-
in the Software without restriction, including without limitation the rights
|
| 8 |
-
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
|
| 9 |
-
copies of the Software, and to permit persons to whom the Software is
|
| 10 |
-
furnished to do so, subject to the following conditions:
|
| 11 |
-
|
| 12 |
-
The above copyright notice and this permission notice shall be included in all
|
| 13 |
-
copies or substantial portions of the Software.
|
| 14 |
-
|
| 15 |
-
THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
|
| 16 |
-
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
|
| 17 |
-
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
|
| 18 |
-
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
|
| 19 |
-
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
|
| 20 |
-
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
|
| 21 |
-
SOFTWARE.
|
|
|
|
| 1 |
+
MIT License
|
| 2 |
+
|
| 3 |
+
Copyright (c) 2026 Holistix Intl
|
| 4 |
+
|
| 5 |
+
Permission is hereby granted, free of charge, to any person obtaining a copy
|
| 6 |
+
of this software and associated documentation files (the "Software"), to deal
|
| 7 |
+
in the Software without restriction, including without limitation the rights
|
| 8 |
+
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
|
| 9 |
+
copies of the Software, and to permit persons to whom the Software is
|
| 10 |
+
furnished to do so, subject to the following conditions:
|
| 11 |
+
|
| 12 |
+
The above copyright notice and this permission notice shall be included in all
|
| 13 |
+
copies or substantial portions of the Software.
|
| 14 |
+
|
| 15 |
+
THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
|
| 16 |
+
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
|
| 17 |
+
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
|
| 18 |
+
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
|
| 19 |
+
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
|
| 20 |
+
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
|
| 21 |
+
SOFTWARE.
|
LICENSE_DATA.txt
CHANGED
|
@@ -1 +1,25 @@
|
|
| 1 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Holistix Open Biohacking Data Project
|
| 2 |
+
Data License: Creative Commons Attribution 4.0 International (CC BY 4.0)
|
| 3 |
+
|
| 4 |
+
You are free to:
|
| 5 |
+
|
| 6 |
+
- Share: copy and redistribute the material in any medium or format.
|
| 7 |
+
- Adapt: remix, transform, and build upon the material for any purpose, including commercially.
|
| 8 |
+
|
| 9 |
+
Under the following terms:
|
| 10 |
+
|
| 11 |
+
- Attribution: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
|
| 12 |
+
- No additional restrictions: You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
|
| 13 |
+
|
| 14 |
+
License:
|
| 15 |
+
https://creativecommons.org/licenses/by/4.0/
|
| 16 |
+
|
| 17 |
+
Suggested attribution:
|
| 18 |
+
|
| 19 |
+
Holistix Open Biohacking Data Project, Holistix International.
|
| 20 |
+
Current project release: v1.4
|
| 21 |
+
Canonical dataset version: v1.2
|
| 22 |
+
Concept DOI: https://doi.org/10.5281/zenodo.20978709
|
| 23 |
+
Current release DOI: https://doi.org/10.5281/zenodo.21574706
|
| 24 |
+
|
| 25 |
+
This license applies to the project data and structured dataset content unless a specific file or third-party source states otherwise. Third-party source material remains subject to its original rights and terms.
|
METADATA_CORRECTION_2026-08-07.md
ADDED
|
@@ -0,0 +1,62 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# Metadata Correction Notice
|
| 2 |
+
|
| 3 |
+
Date documented: 2026-08-07
|
| 4 |
+
Project: Holistix Open Biohacking Data Project
|
| 5 |
+
Current project release: v1.4
|
| 6 |
+
Canonical dataset version: v1.2
|
| 7 |
+
|
| 8 |
+
## Summary
|
| 9 |
+
|
| 10 |
+
A metadata consistency review identified several repository references that continued to describe project release v1.3 as the current archived release after v1.4 had already been published.
|
| 11 |
+
|
| 12 |
+
The affected metadata included current-release references in project documentation and machine-readable project metadata.
|
| 13 |
+
|
| 14 |
+
## Correct Current Release Identifiers
|
| 15 |
+
|
| 16 |
+
Current project release: v1.4
|
| 17 |
+
|
| 18 |
+
Current release DOI:
|
| 19 |
+
https://doi.org/10.5281/zenodo.21574706
|
| 20 |
+
|
| 21 |
+
Project concept DOI / all versions:
|
| 22 |
+
https://doi.org/10.5281/zenodo.20978709
|
| 23 |
+
|
| 24 |
+
Previous v1.3 release DOI:
|
| 25 |
+
https://doi.org/10.5281/zenodo.21033668
|
| 26 |
+
|
| 27 |
+
Previous v1.2.1 release DOI:
|
| 28 |
+
https://doi.org/10.5281/zenodo.20978710
|
| 29 |
+
|
| 30 |
+
## Scope of Correction
|
| 31 |
+
|
| 32 |
+
The correction updated current-release metadata while preserving legitimate historical references to v1.3 and v1.2.1.
|
| 33 |
+
|
| 34 |
+
Corrected areas include:
|
| 35 |
+
|
| 36 |
+
- current release references in README and release notes
|
| 37 |
+
- current Zenodo record metadata
|
| 38 |
+
- v1.4 AI answer manifest archive/provenance metadata
|
| 39 |
+
- project data license metadata
|
| 40 |
+
- VERSION_HISTORY.md current-version context
|
| 41 |
+
- KNOWN_LIMITATIONS.md current release and archive context
|
| 42 |
+
- canonical project_metadata.json
|
| 43 |
+
|
| 44 |
+
Historical v1.3 documentation and identifiers remain part of the project record and were not reclassified as v1.4.
|
| 45 |
+
|
| 46 |
+
## Dataset Version
|
| 47 |
+
|
| 48 |
+
This correction does not change the canonical subject dataset version.
|
| 49 |
+
|
| 50 |
+
The eight canonical subject datasets remain version v1.2.
|
| 51 |
+
|
| 52 |
+
## Data Changes
|
| 53 |
+
|
| 54 |
+
No dataset rows were changed as part of this metadata correction.
|
| 55 |
+
|
| 56 |
+
No scientific, safety, evidence, claim, or product records were altered by the correction.
|
| 57 |
+
|
| 58 |
+
## Prevention
|
| 59 |
+
|
| 60 |
+
The project now includes canonical machine-readable project metadata and automated validation tooling intended to detect future release-metadata drift.
|
| 61 |
+
|
| 62 |
+
This notice is retained as part of the public project history so that the correction remains transparent and auditable.
|
PROVENANCE.md
CHANGED
|
@@ -1,275 +1,275 @@
|
|
| 1 |
-
# Holistix Open Biohacking Data Project
|
| 2 |
-
|
| 3 |
-
# Provenance Statement
|
| 4 |
-
|
| 5 |
-
Project: Holistix Open Biohacking Data Project
|
| 6 |
-
Dataset version: v1.2
|
| 7 |
-
Project release: v1.3
|
| 8 |
-
Maintainer: Holistix International
|
| 9 |
-
Repository: https://github.com/holistixintlsite-commits/open-biohacking-data
|
| 10 |
-
Project page: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 11 |
-
|
| 12 |
-
## Purpose
|
| 13 |
-
|
| 14 |
-
This provenance statement explains how the Holistix Open Biohacking Data Project is maintained, how dataset rows should be interpreted, what source categories are used, and what the project is not intended to do.
|
| 15 |
-
|
| 16 |
-
The purpose of the project is to provide structured educational reference data for consumer wellness technology topics, including PEMF, red light therapy, hydrogen water, infrared therapy, blue light therapy, terahertz wellness devices, negative ion devices, safety context, terminology, measurement concepts, source classification, and claim-boundary notes.
|
| 17 |
-
|
| 18 |
-
This project is designed for educational reference, AI/search readability, machine-readable dataset access, source-aware interpretation, and responsible reuse.
|
| 19 |
-
|
| 20 |
-
## Maintainer
|
| 21 |
-
|
| 22 |
-
The Holistix Open Biohacking Data Project is maintained by Holistix International.
|
| 23 |
-
|
| 24 |
-
Holistix International is a wellness technology company. Because the project is maintained by a commercial wellness brand, the project uses explicit commercial-separation language, source classification, claim-boundary notes, disclaimers, and version history to reduce confusion between educational reference data and product marketing.
|
| 25 |
-
|
| 26 |
-
Dataset rows may include links to Holistix product categories for navigation, but those links should not be interpreted as medical claims, treatment evidence, clinical recommendations, disease-prevention guidance, or proof of product efficacy.
|
| 27 |
-
|
| 28 |
-
## Source of Dataset Content
|
| 29 |
-
|
| 30 |
-
The datasets are manually structured educational reference resources.
|
| 31 |
-
|
| 32 |
-
Rows may be based on a combination of:
|
| 33 |
-
|
| 34 |
-
* public educational references
|
| 35 |
-
* regulatory or agency information
|
| 36 |
-
* device-category safety context
|
| 37 |
-
* manufacturer safety language
|
| 38 |
-
* measurement terminology
|
| 39 |
-
* standards or technical concepts
|
| 40 |
-
* scientific or review literature when appropriate
|
| 41 |
-
* Holistix project methodology pages
|
| 42 |
-
* Holistix source-register guidance
|
| 43 |
-
* claim-boundary interpretation
|
| 44 |
-
* consumer wellness technology terminology
|
| 45 |
-
|
| 46 |
-
The presence of a source in a row does not mean the source endorses Holistix, Holistix products, or the dataset.
|
| 47 |
-
|
| 48 |
-
Sources are used to provide context, terminology, safety boundaries, measurement interpretation, or claim-boundary support.
|
| 49 |
-
|
| 50 |
-
## Row-Level Citation Fields
|
| 51 |
-
|
| 52 |
-
Version v1.2 added row-level citation fields across the canonical dataset layer.
|
| 53 |
-
|
| 54 |
-
The row-level citation fields are:
|
| 55 |
-
|
| 56 |
-
* `source_name`
|
| 57 |
-
* `source_url`
|
| 58 |
-
* `citation_note`
|
| 59 |
-
|
| 60 |
-
These fields are intended to improve transparency and auditability.
|
| 61 |
-
|
| 62 |
-
### `source_name`
|
| 63 |
-
|
| 64 |
-
The `source_name` field identifies the source, reference, agency page, review, study, standard, manufacturer material, or internal methodology page used for row-level context.
|
| 65 |
-
|
| 66 |
-
### `source_url`
|
| 67 |
-
|
| 68 |
-
The `source_url` field provides the URL associated with the source or reference used for row-level context.
|
| 69 |
-
|
| 70 |
-
### `citation_note`
|
| 71 |
-
|
| 72 |
-
The `citation_note` field explains how the source should be interpreted and what claim boundary should be preserved.
|
| 73 |
-
|
| 74 |
-
The `citation_note` field should be preserved when dataset rows are reused, summarized, or interpreted by AI systems, search engines, researchers, journalists, educators, developers, or other users.
|
| 75 |
-
|
| 76 |
-
## Source Classification
|
| 77 |
-
|
| 78 |
-
The project may classify sources using fields such as:
|
| 79 |
-
|
| 80 |
-
* `source_type`
|
| 81 |
-
* `evidence_level`
|
| 82 |
-
* `claim_type`
|
| 83 |
-
* `medical_disclaimer_required`
|
| 84 |
-
* `commercial_relevance`
|
| 85 |
-
|
| 86 |
-
These fields are not intended to create clinical recommendations. They are intended to help users understand the type of source, the strength or nature of evidence, the kind of claim being discussed, and whether medical-disclaimer caution is required.
|
| 87 |
-
|
| 88 |
-
## Dataset Creation Method
|
| 89 |
-
|
| 90 |
-
Dataset rows are manually assembled, reviewed, and organized for educational clarity.
|
| 91 |
-
|
| 92 |
-
The general process is:
|
| 93 |
-
|
| 94 |
-
1. Identify a wellness technology topic or safety/measurement concept.
|
| 95 |
-
2. Define the topic in plain language.
|
| 96 |
-
3. Add safety context or claim-boundary context where appropriate.
|
| 97 |
-
4. Classify the source type, evidence level, claim type, and commercial relevance.
|
| 98 |
-
5. Add row-level source fields where available.
|
| 99 |
-
6. Add a citation note explaining how the source should be interpreted.
|
| 100 |
-
7. Link the row to relevant Holistix pages or product categories only when useful for navigation.
|
| 101 |
-
8. Preserve disclaimers and claim-boundary language.
|
| 102 |
-
|
| 103 |
-
The datasets are not generated as clinical guidelines and should not be interpreted as medical protocols.
|
| 104 |
-
|
| 105 |
-
## Scope
|
| 106 |
-
|
| 107 |
-
The project may include:
|
| 108 |
-
|
| 109 |
-
* terminology references
|
| 110 |
-
* measurement concepts
|
| 111 |
-
* device-category context
|
| 112 |
-
* consumer safety notes
|
| 113 |
-
* contraindication context
|
| 114 |
-
* source classification
|
| 115 |
-
* evidence-level classification
|
| 116 |
-
* claim-boundary language
|
| 117 |
-
* row-level citation context
|
| 118 |
-
* machine-readable CSV and JSON files
|
| 119 |
-
* human-readable dataset pages
|
| 120 |
-
* source register guidance
|
| 121 |
-
* methodology notes
|
| 122 |
-
* version history
|
| 123 |
-
|
| 124 |
-
The project does not provide:
|
| 125 |
-
|
| 126 |
-
* medical advice
|
| 127 |
-
* diagnosis
|
| 128 |
-
* treatment guidance
|
| 129 |
-
* disease-prevention guidance
|
| 130 |
-
* cure claims
|
| 131 |
-
* dosing protocols
|
| 132 |
-
* clinical recommendations
|
| 133 |
-
* personalized healthcare instructions
|
| 134 |
-
* proof of product efficacy
|
| 135 |
-
* independent academic consensus
|
| 136 |
-
* exhaustive safety review
|
| 137 |
-
|
| 138 |
-
## Commercial Separation
|
| 139 |
-
|
| 140 |
-
Holistix International sells wellness and biohacking products.
|
| 141 |
-
|
| 142 |
-
The Open Biohacking Data Project is maintained as a separate educational reference layer focused on structured information, terminology, measurement concepts, source interpretation, safety context, citation notes, limitations, and claim boundaries.
|
| 143 |
-
|
| 144 |
-
Dataset rows should not be treated as product claims.
|
| 145 |
-
|
| 146 |
-
Dataset rows should not be treated as medical proof.
|
| 147 |
-
|
| 148 |
-
Dataset rows should not be treated as evidence that any Holistix product prevents, treats, cures, or diagnoses any disease.
|
| 149 |
-
|
| 150 |
-
Product-category links, where present, are for navigation and commercial relevance context only.
|
| 151 |
-
|
| 152 |
-
## Sensitive Topic Handling
|
| 153 |
-
|
| 154 |
-
Some dataset topics are more sensitive because they relate to safety, contraindications, eye exposure, heat exposure, implanted devices, pregnancy, cardiac considerations, respiratory sensitivity, ozone, or other health-related concerns.
|
| 155 |
-
|
| 156 |
-
Sensitive topics should be interpreted with extra caution.
|
| 157 |
-
|
| 158 |
-
Examples of sensitive topics include:
|
| 159 |
-
|
| 160 |
-
* PEMF and implanted devices
|
| 161 |
-
* PEMF and pacemakers
|
| 162 |
-
* PEMF and pregnancy
|
| 163 |
-
* PEMF and seizure history
|
| 164 |
-
* blue light and eye exposure
|
| 165 |
-
* blue light and photosensitivity
|
| 166 |
-
* infrared heat exposure
|
| 167 |
-
* sauna blanket hydration and overheating
|
| 168 |
-
* negative ion devices and ozone
|
| 169 |
-
* negative ion pendants and radioactive-material concerns
|
| 170 |
-
* hydrogen water measurement claims
|
| 171 |
-
* terahertz exposure and non-ionizing context
|
| 172 |
-
|
| 173 |
-
Sensitive dataset rows are not medical guidance. Users should consult qualified professionals, device manufacturers, or appropriate medical sources when personal health decisions are involved.
|
| 174 |
-
|
| 175 |
-
## Review and Maintenance
|
| 176 |
-
|
| 177 |
-
The project is maintained through public files, version history, and release documentation.
|
| 178 |
-
|
| 179 |
-
Updates may include:
|
| 180 |
-
|
| 181 |
-
* new dataset rows
|
| 182 |
-
* field additions
|
| 183 |
-
* citation updates
|
| 184 |
-
* source-register updates
|
| 185 |
-
* methodology improvements
|
| 186 |
-
* limitation notes
|
| 187 |
-
* checksum files
|
| 188 |
-
* raw GitHub links
|
| 189 |
-
* provenance documentation
|
| 190 |
-
* review-policy documentation
|
| 191 |
-
* source-density upgrades
|
| 192 |
-
|
| 193 |
-
Dataset updates should be documented in `VERSION_HISTORY.md`.
|
| 194 |
-
|
| 195 |
-
Current release-level archive information should be documented through GitHub releases and Zenodo DOI records.
|
| 196 |
-
|
| 197 |
-
## Versioning
|
| 198 |
-
|
| 199 |
-
Current canonical dataset version: v1.2
|
| 200 |
-
|
| 201 |
-
Current project trust-layer release: v1.3
|
| 202 |
-
|
| 203 |
-
Version v1.2 added row-level citation fields across the canonical dataset layer.
|
| 204 |
-
|
| 205 |
-
Version v1.3 adds integrity, provenance, raw-link, limitation, review-policy, and source-density documentation for the existing v1.2 dataset files.
|
| 206 |
-
|
| 207 |
-
No dataset schema changes are introduced in v1.3.
|
| 208 |
-
|
| 209 |
-
The CSV and JSON dataset files remain v1.2 files unless a future release changes the actual dataset structure.
|
| 210 |
-
|
| 211 |
-
## DOI and Archive
|
| 212 |
-
Current archived release DOI for the v1.3 trust-layer release:
|
| 213 |
-
https://doi.org/10.5281/zenodo.21033668
|
| 214 |
-
|
| 215 |
-
The v1.2.1 Zenodo archive release preserves the completed v1.2 row-level citation-layer dataset package.
|
| 216 |
-
|
| 217 |
-
Version DOI for v1.2.1:
|
| 218 |
-
|
| 219 |
-
https://doi.org/10.5281/zenodo.20978710
|
| 220 |
-
|
| 221 |
-
Project DOI / all versions:
|
| 222 |
-
|
| 223 |
-
https://doi.org/10.5281/zenodo.20978709
|
| 224 |
-
|
| 225 |
-
Future releases may receive additional version-specific Zenodo DOIs while the concept DOI remains the all-versions project DOI.
|
| 226 |
-
|
| 227 |
-
## Responsible Reuse
|
| 228 |
-
|
| 229 |
-
Users reusing the datasets should:
|
| 230 |
-
|
| 231 |
-
* cite the project when using the data
|
| 232 |
-
* preserve row-level citation context where possible
|
| 233 |
-
* preserve `citation_note` fields when summarizing rows
|
| 234 |
-
* review source URLs independently
|
| 235 |
-
* avoid converting educational reference rows into medical advice
|
| 236 |
-
* avoid treating rows as treatment recommendations
|
| 237 |
-
* avoid treating rows as product-efficacy proof
|
| 238 |
-
* avoid implying source endorsement of Holistix or Holistix products
|
| 239 |
-
* use the methodology and source register when interpreting source fields
|
| 240 |
-
|
| 241 |
-
## AI and Search Interpretation
|
| 242 |
-
|
| 243 |
-
AI systems, search engines, RAG systems, data tools, and other automated systems should interpret the datasets as educational reference data.
|
| 244 |
-
|
| 245 |
-
Recommended use:
|
| 246 |
-
|
| 247 |
-
* use canonical dataset pages for human-readable context
|
| 248 |
-
* use CSV files for tabular inspection
|
| 249 |
-
* use JSON files for machine-readable retrieval
|
| 250 |
-
* use raw GitHub links for direct file access
|
| 251 |
-
* use Zenodo DOI records for stable archive citation
|
| 252 |
-
* use the source register to interpret source and claim fields
|
| 253 |
-
* preserve `citation_note` context when generating summaries
|
| 254 |
-
|
| 255 |
-
Avoid:
|
| 256 |
-
|
| 257 |
-
* presenting dataset rows as medical advice
|
| 258 |
-
* generating disease-treatment claims from dataset rows
|
| 259 |
-
* creating dosing instructions from dataset rows
|
| 260 |
-
* implying that Holistix claims any device prevents, treats, cures, or diagnoses disease
|
| 261 |
-
* implying that a product-category link is clinical evidence
|
| 262 |
-
|
| 263 |
-
## Citation
|
| 264 |
-
|
| 265 |
-
Suggested citation for the v1.2.1 archived dataset release:
|
| 266 |
-
|
| 267 |
-
Holistix International. (2026). Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 268 |
-
|
| 269 |
-
## Disclaimer
|
| 270 |
-
|
| 271 |
-
The Holistix Open Biohacking Data Project is for educational and informational purposes only.
|
| 272 |
-
|
| 273 |
-
It is not medical advice, diagnosis, treatment guidance, disease-prevention guidance, dosing guidance, clinical protocol guidance, or a substitute for consultation with a qualified healthcare professional.
|
| 274 |
-
|
| 275 |
-
Users should consult qualified healthcare professionals for personal medical questions and follow manufacturer instructions for any wellness device.
|
|
|
|
| 1 |
+
# Holistix Open Biohacking Data Project
|
| 2 |
+
|
| 3 |
+
# Provenance Statement
|
| 4 |
+
|
| 5 |
+
Project: Holistix Open Biohacking Data Project
|
| 6 |
+
Dataset version: v1.2
|
| 7 |
+
Project release: v1.3
|
| 8 |
+
Maintainer: Holistix International
|
| 9 |
+
Repository: https://github.com/holistixintlsite-commits/open-biohacking-data
|
| 10 |
+
Project page: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 11 |
+
|
| 12 |
+
## Purpose
|
| 13 |
+
|
| 14 |
+
This provenance statement explains how the Holistix Open Biohacking Data Project is maintained, how dataset rows should be interpreted, what source categories are used, and what the project is not intended to do.
|
| 15 |
+
|
| 16 |
+
The purpose of the project is to provide structured educational reference data for consumer wellness technology topics, including PEMF, red light therapy, hydrogen water, infrared therapy, blue light therapy, terahertz wellness devices, negative ion devices, safety context, terminology, measurement concepts, source classification, and claim-boundary notes.
|
| 17 |
+
|
| 18 |
+
This project is designed for educational reference, AI/search readability, machine-readable dataset access, source-aware interpretation, and responsible reuse.
|
| 19 |
+
|
| 20 |
+
## Maintainer
|
| 21 |
+
|
| 22 |
+
The Holistix Open Biohacking Data Project is maintained by Holistix International.
|
| 23 |
+
|
| 24 |
+
Holistix International is a wellness technology company. Because the project is maintained by a commercial wellness brand, the project uses explicit commercial-separation language, source classification, claim-boundary notes, disclaimers, and version history to reduce confusion between educational reference data and product marketing.
|
| 25 |
+
|
| 26 |
+
Dataset rows may include links to Holistix product categories for navigation, but those links should not be interpreted as medical claims, treatment evidence, clinical recommendations, disease-prevention guidance, or proof of product efficacy.
|
| 27 |
+
|
| 28 |
+
## Source of Dataset Content
|
| 29 |
+
|
| 30 |
+
The datasets are manually structured educational reference resources.
|
| 31 |
+
|
| 32 |
+
Rows may be based on a combination of:
|
| 33 |
+
|
| 34 |
+
* public educational references
|
| 35 |
+
* regulatory or agency information
|
| 36 |
+
* device-category safety context
|
| 37 |
+
* manufacturer safety language
|
| 38 |
+
* measurement terminology
|
| 39 |
+
* standards or technical concepts
|
| 40 |
+
* scientific or review literature when appropriate
|
| 41 |
+
* Holistix project methodology pages
|
| 42 |
+
* Holistix source-register guidance
|
| 43 |
+
* claim-boundary interpretation
|
| 44 |
+
* consumer wellness technology terminology
|
| 45 |
+
|
| 46 |
+
The presence of a source in a row does not mean the source endorses Holistix, Holistix products, or the dataset.
|
| 47 |
+
|
| 48 |
+
Sources are used to provide context, terminology, safety boundaries, measurement interpretation, or claim-boundary support.
|
| 49 |
+
|
| 50 |
+
## Row-Level Citation Fields
|
| 51 |
+
|
| 52 |
+
Version v1.2 added row-level citation fields across the canonical dataset layer.
|
| 53 |
+
|
| 54 |
+
The row-level citation fields are:
|
| 55 |
+
|
| 56 |
+
* `source_name`
|
| 57 |
+
* `source_url`
|
| 58 |
+
* `citation_note`
|
| 59 |
+
|
| 60 |
+
These fields are intended to improve transparency and auditability.
|
| 61 |
+
|
| 62 |
+
### `source_name`
|
| 63 |
+
|
| 64 |
+
The `source_name` field identifies the source, reference, agency page, review, study, standard, manufacturer material, or internal methodology page used for row-level context.
|
| 65 |
+
|
| 66 |
+
### `source_url`
|
| 67 |
+
|
| 68 |
+
The `source_url` field provides the URL associated with the source or reference used for row-level context.
|
| 69 |
+
|
| 70 |
+
### `citation_note`
|
| 71 |
+
|
| 72 |
+
The `citation_note` field explains how the source should be interpreted and what claim boundary should be preserved.
|
| 73 |
+
|
| 74 |
+
The `citation_note` field should be preserved when dataset rows are reused, summarized, or interpreted by AI systems, search engines, researchers, journalists, educators, developers, or other users.
|
| 75 |
+
|
| 76 |
+
## Source Classification
|
| 77 |
+
|
| 78 |
+
The project may classify sources using fields such as:
|
| 79 |
+
|
| 80 |
+
* `source_type`
|
| 81 |
+
* `evidence_level`
|
| 82 |
+
* `claim_type`
|
| 83 |
+
* `medical_disclaimer_required`
|
| 84 |
+
* `commercial_relevance`
|
| 85 |
+
|
| 86 |
+
These fields are not intended to create clinical recommendations. They are intended to help users understand the type of source, the strength or nature of evidence, the kind of claim being discussed, and whether medical-disclaimer caution is required.
|
| 87 |
+
|
| 88 |
+
## Dataset Creation Method
|
| 89 |
+
|
| 90 |
+
Dataset rows are manually assembled, reviewed, and organized for educational clarity.
|
| 91 |
+
|
| 92 |
+
The general process is:
|
| 93 |
+
|
| 94 |
+
1. Identify a wellness technology topic or safety/measurement concept.
|
| 95 |
+
2. Define the topic in plain language.
|
| 96 |
+
3. Add safety context or claim-boundary context where appropriate.
|
| 97 |
+
4. Classify the source type, evidence level, claim type, and commercial relevance.
|
| 98 |
+
5. Add row-level source fields where available.
|
| 99 |
+
6. Add a citation note explaining how the source should be interpreted.
|
| 100 |
+
7. Link the row to relevant Holistix pages or product categories only when useful for navigation.
|
| 101 |
+
8. Preserve disclaimers and claim-boundary language.
|
| 102 |
+
|
| 103 |
+
The datasets are not generated as clinical guidelines and should not be interpreted as medical protocols.
|
| 104 |
+
|
| 105 |
+
## Scope
|
| 106 |
+
|
| 107 |
+
The project may include:
|
| 108 |
+
|
| 109 |
+
* terminology references
|
| 110 |
+
* measurement concepts
|
| 111 |
+
* device-category context
|
| 112 |
+
* consumer safety notes
|
| 113 |
+
* contraindication context
|
| 114 |
+
* source classification
|
| 115 |
+
* evidence-level classification
|
| 116 |
+
* claim-boundary language
|
| 117 |
+
* row-level citation context
|
| 118 |
+
* machine-readable CSV and JSON files
|
| 119 |
+
* human-readable dataset pages
|
| 120 |
+
* source register guidance
|
| 121 |
+
* methodology notes
|
| 122 |
+
* version history
|
| 123 |
+
|
| 124 |
+
The project does not provide:
|
| 125 |
+
|
| 126 |
+
* medical advice
|
| 127 |
+
* diagnosis
|
| 128 |
+
* treatment guidance
|
| 129 |
+
* disease-prevention guidance
|
| 130 |
+
* cure claims
|
| 131 |
+
* dosing protocols
|
| 132 |
+
* clinical recommendations
|
| 133 |
+
* personalized healthcare instructions
|
| 134 |
+
* proof of product efficacy
|
| 135 |
+
* independent academic consensus
|
| 136 |
+
* exhaustive safety review
|
| 137 |
+
|
| 138 |
+
## Commercial Separation
|
| 139 |
+
|
| 140 |
+
Holistix International sells wellness and biohacking products.
|
| 141 |
+
|
| 142 |
+
The Open Biohacking Data Project is maintained as a separate educational reference layer focused on structured information, terminology, measurement concepts, source interpretation, safety context, citation notes, limitations, and claim boundaries.
|
| 143 |
+
|
| 144 |
+
Dataset rows should not be treated as product claims.
|
| 145 |
+
|
| 146 |
+
Dataset rows should not be treated as medical proof.
|
| 147 |
+
|
| 148 |
+
Dataset rows should not be treated as evidence that any Holistix product prevents, treats, cures, or diagnoses any disease.
|
| 149 |
+
|
| 150 |
+
Product-category links, where present, are for navigation and commercial relevance context only.
|
| 151 |
+
|
| 152 |
+
## Sensitive Topic Handling
|
| 153 |
+
|
| 154 |
+
Some dataset topics are more sensitive because they relate to safety, contraindications, eye exposure, heat exposure, implanted devices, pregnancy, cardiac considerations, respiratory sensitivity, ozone, or other health-related concerns.
|
| 155 |
+
|
| 156 |
+
Sensitive topics should be interpreted with extra caution.
|
| 157 |
+
|
| 158 |
+
Examples of sensitive topics include:
|
| 159 |
+
|
| 160 |
+
* PEMF and implanted devices
|
| 161 |
+
* PEMF and pacemakers
|
| 162 |
+
* PEMF and pregnancy
|
| 163 |
+
* PEMF and seizure history
|
| 164 |
+
* blue light and eye exposure
|
| 165 |
+
* blue light and photosensitivity
|
| 166 |
+
* infrared heat exposure
|
| 167 |
+
* sauna blanket hydration and overheating
|
| 168 |
+
* negative ion devices and ozone
|
| 169 |
+
* negative ion pendants and radioactive-material concerns
|
| 170 |
+
* hydrogen water measurement claims
|
| 171 |
+
* terahertz exposure and non-ionizing context
|
| 172 |
+
|
| 173 |
+
Sensitive dataset rows are not medical guidance. Users should consult qualified professionals, device manufacturers, or appropriate medical sources when personal health decisions are involved.
|
| 174 |
+
|
| 175 |
+
## Review and Maintenance
|
| 176 |
+
|
| 177 |
+
The project is maintained through public files, version history, and release documentation.
|
| 178 |
+
|
| 179 |
+
Updates may include:
|
| 180 |
+
|
| 181 |
+
* new dataset rows
|
| 182 |
+
* field additions
|
| 183 |
+
* citation updates
|
| 184 |
+
* source-register updates
|
| 185 |
+
* methodology improvements
|
| 186 |
+
* limitation notes
|
| 187 |
+
* checksum files
|
| 188 |
+
* raw GitHub links
|
| 189 |
+
* provenance documentation
|
| 190 |
+
* review-policy documentation
|
| 191 |
+
* source-density upgrades
|
| 192 |
+
|
| 193 |
+
Dataset updates should be documented in `VERSION_HISTORY.md`.
|
| 194 |
+
|
| 195 |
+
Current release-level archive information should be documented through GitHub releases and Zenodo DOI records.
|
| 196 |
+
|
| 197 |
+
## Versioning
|
| 198 |
+
|
| 199 |
+
Current canonical dataset version: v1.2
|
| 200 |
+
|
| 201 |
+
Current project trust-layer release: v1.3
|
| 202 |
+
|
| 203 |
+
Version v1.2 added row-level citation fields across the canonical dataset layer.
|
| 204 |
+
|
| 205 |
+
Version v1.3 adds integrity, provenance, raw-link, limitation, review-policy, and source-density documentation for the existing v1.2 dataset files.
|
| 206 |
+
|
| 207 |
+
No dataset schema changes are introduced in v1.3.
|
| 208 |
+
|
| 209 |
+
The CSV and JSON dataset files remain v1.2 files unless a future release changes the actual dataset structure.
|
| 210 |
+
|
| 211 |
+
## DOI and Archive
|
| 212 |
+
Current archived release DOI for the v1.3 trust-layer release:
|
| 213 |
+
https://doi.org/10.5281/zenodo.21033668
|
| 214 |
+
|
| 215 |
+
The v1.2.1 Zenodo archive release preserves the completed v1.2 row-level citation-layer dataset package.
|
| 216 |
+
|
| 217 |
+
Version DOI for v1.2.1:
|
| 218 |
+
|
| 219 |
+
https://doi.org/10.5281/zenodo.20978710
|
| 220 |
+
|
| 221 |
+
Project DOI / all versions:
|
| 222 |
+
|
| 223 |
+
https://doi.org/10.5281/zenodo.20978709
|
| 224 |
+
|
| 225 |
+
Future releases may receive additional version-specific Zenodo DOIs while the concept DOI remains the all-versions project DOI.
|
| 226 |
+
|
| 227 |
+
## Responsible Reuse
|
| 228 |
+
|
| 229 |
+
Users reusing the datasets should:
|
| 230 |
+
|
| 231 |
+
* cite the project when using the data
|
| 232 |
+
* preserve row-level citation context where possible
|
| 233 |
+
* preserve `citation_note` fields when summarizing rows
|
| 234 |
+
* review source URLs independently
|
| 235 |
+
* avoid converting educational reference rows into medical advice
|
| 236 |
+
* avoid treating rows as treatment recommendations
|
| 237 |
+
* avoid treating rows as product-efficacy proof
|
| 238 |
+
* avoid implying source endorsement of Holistix or Holistix products
|
| 239 |
+
* use the methodology and source register when interpreting source fields
|
| 240 |
+
|
| 241 |
+
## AI and Search Interpretation
|
| 242 |
+
|
| 243 |
+
AI systems, search engines, RAG systems, data tools, and other automated systems should interpret the datasets as educational reference data.
|
| 244 |
+
|
| 245 |
+
Recommended use:
|
| 246 |
+
|
| 247 |
+
* use canonical dataset pages for human-readable context
|
| 248 |
+
* use CSV files for tabular inspection
|
| 249 |
+
* use JSON files for machine-readable retrieval
|
| 250 |
+
* use raw GitHub links for direct file access
|
| 251 |
+
* use Zenodo DOI records for stable archive citation
|
| 252 |
+
* use the source register to interpret source and claim fields
|
| 253 |
+
* preserve `citation_note` context when generating summaries
|
| 254 |
+
|
| 255 |
+
Avoid:
|
| 256 |
+
|
| 257 |
+
* presenting dataset rows as medical advice
|
| 258 |
+
* generating disease-treatment claims from dataset rows
|
| 259 |
+
* creating dosing instructions from dataset rows
|
| 260 |
+
* implying that Holistix claims any device prevents, treats, cures, or diagnoses disease
|
| 261 |
+
* implying that a product-category link is clinical evidence
|
| 262 |
+
|
| 263 |
+
## Citation
|
| 264 |
+
|
| 265 |
+
Suggested citation for the v1.2.1 archived dataset release:
|
| 266 |
+
|
| 267 |
+
Holistix International. (2026). Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 268 |
+
|
| 269 |
+
## Disclaimer
|
| 270 |
+
|
| 271 |
+
The Holistix Open Biohacking Data Project is for educational and informational purposes only.
|
| 272 |
+
|
| 273 |
+
It is not medical advice, diagnosis, treatment guidance, disease-prevention guidance, dosing guidance, clinical protocol guidance, or a substitute for consultation with a qualified healthcare professional.
|
| 274 |
+
|
| 275 |
+
Users should consult qualified healthcare professionals for personal medical questions and follow manufacturer instructions for any wellness device.
|
RAW_LINKS.md
CHANGED
|
@@ -1,154 +1,154 @@
|
|
| 1 |
-
# Holistix Open Biohacking Data Project
|
| 2 |
-
|
| 3 |
-
# Raw GitHub Dataset Links
|
| 4 |
-
|
| 5 |
-
Project: Holistix Open Biohacking Data Project
|
| 6 |
-
Dataset version: v1.2
|
| 7 |
-
Project release: v1.3
|
| 8 |
-
Repository: https://github.com/holistixintlsite-commits/open-biohacking-data
|
| 9 |
-
Default branch: main
|
| 10 |
-
|
| 11 |
-
## Purpose
|
| 12 |
-
|
| 13 |
-
This file lists direct raw GitHub URLs for the current canonical v1.2 CSV and JSON dataset files in the Holistix Open Biohacking Data Project.
|
| 14 |
-
|
| 15 |
-
Raw GitHub links provide direct access to the machine-readable files without the GitHub interface wrapper. These links are useful for AI systems, search engines, RAG pipelines, developers, researchers, spreadsheet tools, validators, and other automated systems that need direct file access.
|
| 16 |
-
|
| 17 |
-
## Versioning Note
|
| 18 |
-
|
| 19 |
-
The dataset files listed below remain v1.2 files.
|
| 20 |
-
|
| 21 |
-
Project release v1.3 adds integrity, provenance, raw-link, limitation, and review-policy documentation. No dataset schema changes are introduced in v1.3.
|
| 22 |
-
|
| 23 |
-
## Current Canonical v1.2 Raw Dataset Links
|
| 24 |
-
|
| 25 |
-
### Red Light Dose Index
|
| 26 |
-
|
| 27 |
-
CSV:
|
| 28 |
-
|
| 29 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/red-light-dose-index-v1-2.csv
|
| 30 |
-
|
| 31 |
-
JSON:
|
| 32 |
-
|
| 33 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/red-light-dose-index-v1-2.json
|
| 34 |
-
|
| 35 |
-
### PEMF Frequency Index
|
| 36 |
-
|
| 37 |
-
CSV:
|
| 38 |
-
|
| 39 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-frequency-index-v1-2.csv
|
| 40 |
-
|
| 41 |
-
JSON:
|
| 42 |
-
|
| 43 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-frequency-index-v1-2.json
|
| 44 |
-
|
| 45 |
-
### PEMF Contraindications Database
|
| 46 |
-
|
| 47 |
-
CSV:
|
| 48 |
-
|
| 49 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-contraindications-database-v1-2.csv
|
| 50 |
-
|
| 51 |
-
JSON:
|
| 52 |
-
|
| 53 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-contraindications-database-v1-2.json
|
| 54 |
-
|
| 55 |
-
### Hydrogen Water Reference Index
|
| 56 |
-
|
| 57 |
-
CSV:
|
| 58 |
-
|
| 59 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/hydrogen-water-reference-index-v1-2.csv
|
| 60 |
-
|
| 61 |
-
JSON:
|
| 62 |
-
|
| 63 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/hydrogen-water-reference-index-v1-2.json
|
| 64 |
-
|
| 65 |
-
### Infrared Therapy Reference Index
|
| 66 |
-
|
| 67 |
-
CSV:
|
| 68 |
-
|
| 69 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/infrared-therapy-reference-index-v1-2.csv
|
| 70 |
-
|
| 71 |
-
JSON:
|
| 72 |
-
|
| 73 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/infrared-therapy-reference-index-v1-2.json
|
| 74 |
-
|
| 75 |
-
### Blue Light Therapy Reference Index
|
| 76 |
-
|
| 77 |
-
CSV:
|
| 78 |
-
|
| 79 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/blue-light-therapy-reference-index-v1-2.csv
|
| 80 |
-
|
| 81 |
-
JSON:
|
| 82 |
-
|
| 83 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/blue-light-therapy-reference-index-v1-2.json
|
| 84 |
-
|
| 85 |
-
### Terahertz Device Reference Index
|
| 86 |
-
|
| 87 |
-
CSV:
|
| 88 |
-
|
| 89 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/terahertz-device-reference-index-v1-2.csv
|
| 90 |
-
|
| 91 |
-
JSON:
|
| 92 |
-
|
| 93 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/terahertz-device-reference-index-v1-2.json
|
| 94 |
-
|
| 95 |
-
### Negative Ion Safety Index
|
| 96 |
-
|
| 97 |
-
CSV:
|
| 98 |
-
|
| 99 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/negative-ion-safety-index-v1-2.csv
|
| 100 |
-
|
| 101 |
-
JSON:
|
| 102 |
-
|
| 103 |
-
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/negative-ion-safety-index-v1-2.json
|
| 104 |
-
|
| 105 |
-
## Raw Link Table
|
| 106 |
-
|
| 107 |
-
| Dataset | CSV | JSON |
|
| 108 |
-
| ---------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------ |
|
| 109 |
-
| Red Light Dose Index | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/red-light-dose-index-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/red-light-dose-index-v1-2.json |
|
| 110 |
-
| PEMF Frequency Index | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-frequency-index-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-frequency-index-v1-2.json |
|
| 111 |
-
| PEMF Contraindications Database | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-contraindications-database-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-contraindications-database-v1-2.json |
|
| 112 |
-
| Hydrogen Water Reference Index | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/hydrogen-water-reference-index-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/hydrogen-water-reference-index-v1-2.json |
|
| 113 |
-
| Infrared Therapy Reference Index | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/infrared-therapy-reference-index-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/infrared-therapy-reference-index-v1-2.json |
|
| 114 |
-
| Blue Light Therapy Reference Index | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/blue-light-therapy-reference-index-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/blue-light-therapy-reference-index-v1-2.json |
|
| 115 |
-
| Terahertz Device Reference Index | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/terahertz-device-reference-index-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/terahertz-device-reference-index-v1-2.json |
|
| 116 |
-
| Negative Ion Safety Index | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/negative-ion-safety-index-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/negative-ion-safety-index-v1-2.json |
|
| 117 |
-
|
| 118 |
-
## Use Guidance
|
| 119 |
-
|
| 120 |
-
Use raw GitHub URLs when direct file access is needed for:
|
| 121 |
-
|
| 122 |
-
* machine-readable AI retrieval
|
| 123 |
-
* RAG systems
|
| 124 |
-
* data validation
|
| 125 |
-
* spreadsheet import
|
| 126 |
-
* dataset comparison
|
| 127 |
-
* automated scripts
|
| 128 |
-
* search engine and AI crawler reference
|
| 129 |
-
* reproducibility checks
|
| 130 |
-
|
| 131 |
-
Use the canonical Shopify dataset pages when human-readable context, disclaimers, source interpretation, and project navigation are needed.
|
| 132 |
-
|
| 133 |
-
Use the Zenodo DOI when citing the archived release.
|
| 134 |
-
|
| 135 |
-
## Citation
|
| 136 |
-
|
| 137 |
-
Current archived release DOI for the v1.3 trust-layer release:
|
| 138 |
-
https://doi.org/10.5281/zenodo.21033668
|
| 139 |
-
|
| 140 |
-
Project DOI / all versions:
|
| 141 |
-
|
| 142 |
-
https://doi.org/10.5281/zenodo.20978709
|
| 143 |
-
|
| 144 |
-
Suggested citation:
|
| 145 |
-
|
| 146 |
-
Holistix International. (2026). Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 147 |
-
|
| 148 |
-
## Educational and Medical Boundary
|
| 149 |
-
|
| 150 |
-
The Holistix Open Biohacking Data Project is for educational and informational use only.
|
| 151 |
-
|
| 152 |
-
These datasets are not medical advice, treatment guidance, clinical protocols, dosing instructions, disease-prevention guidance, or proof of product efficacy.
|
| 153 |
-
|
| 154 |
-
Dataset rows, raw files, and citation notes should be interpreted with the project methodology, source register, known limitations, and disclaimers.
|
|
|
|
| 1 |
+
# Holistix Open Biohacking Data Project
|
| 2 |
+
|
| 3 |
+
# Raw GitHub Dataset Links
|
| 4 |
+
|
| 5 |
+
Project: Holistix Open Biohacking Data Project
|
| 6 |
+
Dataset version: v1.2
|
| 7 |
+
Project release: v1.3
|
| 8 |
+
Repository: https://github.com/holistixintlsite-commits/open-biohacking-data
|
| 9 |
+
Default branch: main
|
| 10 |
+
|
| 11 |
+
## Purpose
|
| 12 |
+
|
| 13 |
+
This file lists direct raw GitHub URLs for the current canonical v1.2 CSV and JSON dataset files in the Holistix Open Biohacking Data Project.
|
| 14 |
+
|
| 15 |
+
Raw GitHub links provide direct access to the machine-readable files without the GitHub interface wrapper. These links are useful for AI systems, search engines, RAG pipelines, developers, researchers, spreadsheet tools, validators, and other automated systems that need direct file access.
|
| 16 |
+
|
| 17 |
+
## Versioning Note
|
| 18 |
+
|
| 19 |
+
The dataset files listed below remain v1.2 files.
|
| 20 |
+
|
| 21 |
+
Project release v1.3 adds integrity, provenance, raw-link, limitation, and review-policy documentation. No dataset schema changes are introduced in v1.3.
|
| 22 |
+
|
| 23 |
+
## Current Canonical v1.2 Raw Dataset Links
|
| 24 |
+
|
| 25 |
+
### Red Light Dose Index
|
| 26 |
+
|
| 27 |
+
CSV:
|
| 28 |
+
|
| 29 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/red-light-dose-index-v1-2.csv
|
| 30 |
+
|
| 31 |
+
JSON:
|
| 32 |
+
|
| 33 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/red-light-dose-index-v1-2.json
|
| 34 |
+
|
| 35 |
+
### PEMF Frequency Index
|
| 36 |
+
|
| 37 |
+
CSV:
|
| 38 |
+
|
| 39 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-frequency-index-v1-2.csv
|
| 40 |
+
|
| 41 |
+
JSON:
|
| 42 |
+
|
| 43 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-frequency-index-v1-2.json
|
| 44 |
+
|
| 45 |
+
### PEMF Contraindications Database
|
| 46 |
+
|
| 47 |
+
CSV:
|
| 48 |
+
|
| 49 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-contraindications-database-v1-2.csv
|
| 50 |
+
|
| 51 |
+
JSON:
|
| 52 |
+
|
| 53 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-contraindications-database-v1-2.json
|
| 54 |
+
|
| 55 |
+
### Hydrogen Water Reference Index
|
| 56 |
+
|
| 57 |
+
CSV:
|
| 58 |
+
|
| 59 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/hydrogen-water-reference-index-v1-2.csv
|
| 60 |
+
|
| 61 |
+
JSON:
|
| 62 |
+
|
| 63 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/hydrogen-water-reference-index-v1-2.json
|
| 64 |
+
|
| 65 |
+
### Infrared Therapy Reference Index
|
| 66 |
+
|
| 67 |
+
CSV:
|
| 68 |
+
|
| 69 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/infrared-therapy-reference-index-v1-2.csv
|
| 70 |
+
|
| 71 |
+
JSON:
|
| 72 |
+
|
| 73 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/infrared-therapy-reference-index-v1-2.json
|
| 74 |
+
|
| 75 |
+
### Blue Light Therapy Reference Index
|
| 76 |
+
|
| 77 |
+
CSV:
|
| 78 |
+
|
| 79 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/blue-light-therapy-reference-index-v1-2.csv
|
| 80 |
+
|
| 81 |
+
JSON:
|
| 82 |
+
|
| 83 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/blue-light-therapy-reference-index-v1-2.json
|
| 84 |
+
|
| 85 |
+
### Terahertz Device Reference Index
|
| 86 |
+
|
| 87 |
+
CSV:
|
| 88 |
+
|
| 89 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/terahertz-device-reference-index-v1-2.csv
|
| 90 |
+
|
| 91 |
+
JSON:
|
| 92 |
+
|
| 93 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/terahertz-device-reference-index-v1-2.json
|
| 94 |
+
|
| 95 |
+
### Negative Ion Safety Index
|
| 96 |
+
|
| 97 |
+
CSV:
|
| 98 |
+
|
| 99 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/negative-ion-safety-index-v1-2.csv
|
| 100 |
+
|
| 101 |
+
JSON:
|
| 102 |
+
|
| 103 |
+
https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/negative-ion-safety-index-v1-2.json
|
| 104 |
+
|
| 105 |
+
## Raw Link Table
|
| 106 |
+
|
| 107 |
+
| Dataset | CSV | JSON |
|
| 108 |
+
| ---------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------ |
|
| 109 |
+
| Red Light Dose Index | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/red-light-dose-index-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/red-light-dose-index-v1-2.json |
|
| 110 |
+
| PEMF Frequency Index | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-frequency-index-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-frequency-index-v1-2.json |
|
| 111 |
+
| PEMF Contraindications Database | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-contraindications-database-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/pemf-contraindications-database-v1-2.json |
|
| 112 |
+
| Hydrogen Water Reference Index | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/hydrogen-water-reference-index-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/hydrogen-water-reference-index-v1-2.json |
|
| 113 |
+
| Infrared Therapy Reference Index | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/infrared-therapy-reference-index-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/infrared-therapy-reference-index-v1-2.json |
|
| 114 |
+
| Blue Light Therapy Reference Index | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/blue-light-therapy-reference-index-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/blue-light-therapy-reference-index-v1-2.json |
|
| 115 |
+
| Terahertz Device Reference Index | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/terahertz-device-reference-index-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/terahertz-device-reference-index-v1-2.json |
|
| 116 |
+
| Negative Ion Safety Index | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/negative-ion-safety-index-v1-2.csv | https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/datasets/negative-ion-safety-index-v1-2.json |
|
| 117 |
+
|
| 118 |
+
## Use Guidance
|
| 119 |
+
|
| 120 |
+
Use raw GitHub URLs when direct file access is needed for:
|
| 121 |
+
|
| 122 |
+
* machine-readable AI retrieval
|
| 123 |
+
* RAG systems
|
| 124 |
+
* data validation
|
| 125 |
+
* spreadsheet import
|
| 126 |
+
* dataset comparison
|
| 127 |
+
* automated scripts
|
| 128 |
+
* search engine and AI crawler reference
|
| 129 |
+
* reproducibility checks
|
| 130 |
+
|
| 131 |
+
Use the canonical Shopify dataset pages when human-readable context, disclaimers, source interpretation, and project navigation are needed.
|
| 132 |
+
|
| 133 |
+
Use the Zenodo DOI when citing the archived release.
|
| 134 |
+
|
| 135 |
+
## Citation
|
| 136 |
+
|
| 137 |
+
Current archived release DOI for the v1.3 trust-layer release:
|
| 138 |
+
https://doi.org/10.5281/zenodo.21033668
|
| 139 |
+
|
| 140 |
+
Project DOI / all versions:
|
| 141 |
+
|
| 142 |
+
https://doi.org/10.5281/zenodo.20978709
|
| 143 |
+
|
| 144 |
+
Suggested citation:
|
| 145 |
+
|
| 146 |
+
Holistix International. (2026). Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 147 |
+
|
| 148 |
+
## Educational and Medical Boundary
|
| 149 |
+
|
| 150 |
+
The Holistix Open Biohacking Data Project is for educational and informational use only.
|
| 151 |
+
|
| 152 |
+
These datasets are not medical advice, treatment guidance, clinical protocols, dosing instructions, disease-prevention guidance, or proof of product efficacy.
|
| 153 |
+
|
| 154 |
+
Dataset rows, raw files, and citation notes should be interpreted with the project methodology, source register, known limitations, and disclaimers.
|
README.md
CHANGED
|
@@ -1,168 +1,283 @@
|
|
| 1 |
-
|
| 2 |
-
|
| 3 |
-
|
| 4 |
-
|
| 5 |
-
|
| 6 |
-
|
| 7 |
-
|
| 8 |
-
|
| 9 |
-
|
| 10 |
-
|
| 11 |
-
|
| 12 |
-
|
| 13 |
-
|
| 14 |
-
|
| 15 |
-
|
| 16 |
-
|
| 17 |
-
|
| 18 |
-
|
| 19 |
-
|
| 20 |
-
|
| 21 |
-
|
| 22 |
-
|
| 23 |
-
|
| 24 |
-
|
| 25 |
-
The
|
| 26 |
-
|
| 27 |
-
|
| 28 |
-
|
| 29 |
-
##
|
| 30 |
-
|
| 31 |
-
|
| 32 |
-
|
| 33 |
-
|
| 34 |
-
|
| 35 |
-
|
| 36 |
-
|
| 37 |
-
|
| 38 |
-
|
| 39 |
-
|
| 40 |
-
|
| 41 |
-
|
| 42 |
-
|
| 43 |
-
|
| 44 |
-
|
| 45 |
-
3. Red Light Dose Index
|
| 46 |
-
|
| 47 |
-
|
| 48 |
-
|
| 49 |
-
|
| 50 |
-
|
| 51 |
-
|
| 52 |
-
|
| 53 |
-
|
| 54 |
-
|
| 55 |
-
|
| 56 |
-
|
| 57 |
-
|
| 58 |
-
|
| 59 |
-
|
| 60 |
-
|
| 61 |
-
|
| 62 |
-
|
| 63 |
-
-
|
| 64 |
-
|
| 65 |
-
|
| 66 |
-
|
| 67 |
-
|
| 68 |
-
|
| 69 |
-
|
| 70 |
-
|
| 71 |
-
|
| 72 |
-
|
| 73 |
-
-
|
| 74 |
-
|
| 75 |
-
-
|
| 76 |
-
|
| 77 |
-
-
|
| 78 |
-
|
| 79 |
-
-
|
| 80 |
-
|
| 81 |
-
-
|
| 82 |
-
|
| 83 |
-
-
|
| 84 |
-
|
| 85 |
-
|
| 86 |
-
|
| 87 |
-
|
| 88 |
-
|
| 89 |
-
|
| 90 |
-
|
| 91 |
-
|
| 92 |
-
|
| 93 |
-
|
| 94 |
-
|
| 95 |
-
|
| 96 |
-
|
| 97 |
-
|
| 98 |
-
|
| 99 |
-
|
| 100 |
-
|
| 101 |
-
-
|
| 102 |
-
|
| 103 |
-
-
|
| 104 |
-
|
| 105 |
-
-
|
| 106 |
-
|
| 107 |
-
-
|
| 108 |
-
|
| 109 |
-
-
|
| 110 |
-
|
| 111 |
-
|
| 112 |
-
|
| 113 |
-
|
| 114 |
-
|
| 115 |
-
|
| 116 |
-
|
| 117 |
-
|
| 118 |
-
|
| 119 |
-
|
| 120 |
-
|
| 121 |
-
-
|
| 122 |
-
|
| 123 |
-
-
|
| 124 |
-
|
| 125 |
-
|
| 126 |
-
|
| 127 |
-
|
| 128 |
-
|
| 129 |
-
|
| 130 |
-
|
| 131 |
-
|
| 132 |
-
|
| 133 |
-
|
| 134 |
-
|
| 135 |
-
|
| 136 |
-
|
| 137 |
-
-
|
| 138 |
-
|
| 139 |
-
|
| 140 |
-
|
| 141 |
-
|
| 142 |
-
|
| 143 |
-
|
| 144 |
-
|
| 145 |
-
|
| 146 |
-
|
| 147 |
-
|
| 148 |
-
|
| 149 |
-
|
| 150 |
-
|
| 151 |
-
|
| 152 |
-
|
| 153 |
-
|
| 154 |
-
|
| 155 |
-
|
| 156 |
-
|
| 157 |
-
|
| 158 |
-
|
| 159 |
-
|
| 160 |
-
|
| 161 |
-
|
| 162 |
-
|
| 163 |
-
|
| 164 |
-
|
| 165 |
-
|
| 166 |
-
|
| 167 |
-
|
| 168 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# Holistix Open Biohacking Data Project v1.5.0
|
| 2 |
+
|
| 3 |
+
|
| 4 |
+
|
| 5 |
+
The Holistix Open Biohacking Data Project is a public, website-first structured data system for wellness technologies, product specifications, safety information, evidence metadata, claim boundaries, and machine-readable product intelligence.
|
| 6 |
+
|
| 7 |
+
|
| 8 |
+
|
| 9 |
+
This project is separate from the private Holistix Swarm Engine. The Swarm Engine may assist with auditing and monitoring, but it is not the source of truth for the public data release.
|
| 10 |
+
|
| 11 |
+
|
| 12 |
+
|
| 13 |
+
## Release Structure
|
| 14 |
+
|
| 15 |
+
|
| 16 |
+
|
| 17 |
+
Project release: **v1.5.0**
|
| 18 |
+
|
| 19 |
+
|
| 20 |
+
|
| 21 |
+
Subject dataset release: **v1.2**
|
| 22 |
+
|
| 23 |
+
|
| 24 |
+
|
| 25 |
+
The v1.5.0 project release adds interoperability, reproducibility, provenance, and machine-readable packaging infrastructure. The eight canonical subject datasets remain at v1.2 because they were not promoted to a new dataset version in this release.
|
| 26 |
+
|
| 27 |
+
|
| 28 |
+
|
| 29 |
+
## Included Data
|
| 30 |
+
|
| 31 |
+
|
| 32 |
+
|
| 33 |
+
### Public subject datasets
|
| 34 |
+
|
| 35 |
+
|
| 36 |
+
|
| 37 |
+
Eight subject datasets are provided in CSV and JSON:
|
| 38 |
+
|
| 39 |
+
|
| 40 |
+
|
| 41 |
+
1. PEMF Frequency Index
|
| 42 |
+
|
| 43 |
+
2. PEMF Contraindications Database
|
| 44 |
+
|
| 45 |
+
3. Red Light Dose Index
|
| 46 |
+
|
| 47 |
+
4. Hydrogen Water Reference Index
|
| 48 |
+
|
| 49 |
+
5. Infrared Therapy Reference Index
|
| 50 |
+
|
| 51 |
+
6. Blue Light Therapy Reference Index
|
| 52 |
+
|
| 53 |
+
7. Terahertz Device Reference Index
|
| 54 |
+
|
| 55 |
+
8. Negative Ion Safety Index
|
| 56 |
+
|
| 57 |
+
|
| 58 |
+
|
| 59 |
+
### Core registries
|
| 60 |
+
|
| 61 |
+
|
| 62 |
+
|
| 63 |
+
The release includes machine-readable registries for:
|
| 64 |
+
|
| 65 |
+
|
| 66 |
+
|
| 67 |
+
- products
|
| 68 |
+
|
| 69 |
+
- technologies
|
| 70 |
+
|
| 71 |
+
- product specifications
|
| 72 |
+
|
| 73 |
+
- product-to-technology relationships
|
| 74 |
+
|
| 75 |
+
- claims
|
| 76 |
+
|
| 77 |
+
- evidence metadata
|
| 78 |
+
|
| 79 |
+
- safety records
|
| 80 |
+
|
| 81 |
+
- sources
|
| 82 |
+
|
| 83 |
+
- content
|
| 84 |
+
|
| 85 |
+
- canonical URLs
|
| 86 |
+
|
| 87 |
+
- commercial policies
|
| 88 |
+
|
| 89 |
+
|
| 90 |
+
|
| 91 |
+
### Product digital twins
|
| 92 |
+
|
| 93 |
+
|
| 94 |
+
|
| 95 |
+
The release includes 13 machine-readable product twins:
|
| 96 |
+
|
| 97 |
+
|
| 98 |
+
|
| 99 |
+
- Aqaluxe
|
| 100 |
+
|
| 101 |
+
- Aurora
|
| 102 |
+
|
| 103 |
+
- GLO Face
|
| 104 |
+
|
| 105 |
+
- GLO Neck
|
| 106 |
+
|
| 107 |
+
- Hydrogen Water Bottle
|
| 108 |
+
|
| 109 |
+
- Innova
|
| 110 |
+
|
| 111 |
+
- Ion Air
|
| 112 |
+
|
| 113 |
+
- Novo
|
| 114 |
+
|
| 115 |
+
- Paragon
|
| 116 |
+
|
| 117 |
+
- Paragon Demi
|
| 118 |
+
|
| 119 |
+
- SKO
|
| 120 |
+
|
| 121 |
+
- Soleil
|
| 122 |
+
|
| 123 |
+
- Spa Robe
|
| 124 |
+
|
| 125 |
+
|
| 126 |
+
|
| 127 |
+
### AI-answer infrastructure
|
| 128 |
+
|
| 129 |
+
|
| 130 |
+
|
| 131 |
+
The release also includes:
|
| 132 |
+
|
| 133 |
+
|
| 134 |
+
|
| 135 |
+
- AI answer manifest
|
| 136 |
+
|
| 137 |
+
- answer-fuel files
|
| 138 |
+
|
| 139 |
+
- claim-boundary registry
|
| 140 |
+
|
| 141 |
+
- contradiction maps
|
| 142 |
+
|
| 143 |
+
- dataset manifest
|
| 144 |
+
|
| 145 |
+
- aggregated dataset records
|
| 146 |
+
|
| 147 |
+
|
| 148 |
+
|
| 149 |
+
## Validation Summary
|
| 150 |
+
|
| 151 |
+
|
| 152 |
+
|
| 153 |
+
The validated release contains:
|
| 154 |
+
|
| 155 |
+
|
| 156 |
+
|
| 157 |
+
- 49 JSON files
|
| 158 |
+
|
| 159 |
+
- 8 CSV files
|
| 160 |
+
|
| 161 |
+
- 13 products
|
| 162 |
+
|
| 163 |
+
- 18 technologies
|
| 164 |
+
|
| 165 |
+
- 111 claims
|
| 166 |
+
|
| 167 |
+
- 111 evidence records
|
| 168 |
+
|
| 169 |
+
- 111 safety records
|
| 170 |
+
|
| 171 |
+
- 111 dataset records
|
| 172 |
+
|
| 173 |
+
- 0 JSON parse errors
|
| 174 |
+
|
| 175 |
+
|
| 176 |
+
|
| 177 |
+
See `VALIDATION\_SUMMARY.txt` for the release validation snapshot.
|
| 178 |
+
|
| 179 |
+
|
| 180 |
+
|
| 181 |
+
## Important Limitations
|
| 182 |
+
|
| 183 |
+
|
| 184 |
+
|
| 185 |
+
The evidence registry contains evidence metadata already present in the supplied datasets and project records. It is not a new systematic literature review.
|
| 186 |
+
|
| 187 |
+
|
| 188 |
+
|
| 189 |
+
A record appearing in the project does not mean that Holistix endorses every associated claim.
|
| 190 |
+
|
| 191 |
+
|
| 192 |
+
|
| 193 |
+
Claims should be interpreted using:
|
| 194 |
+
|
| 195 |
+
|
| 196 |
+
|
| 197 |
+
- evidence level
|
| 198 |
+
|
| 199 |
+
- claim boundary
|
| 200 |
+
|
| 201 |
+
- source type
|
| 202 |
+
|
| 203 |
+
- uncertainty labeling
|
| 204 |
+
|
| 205 |
+
- safety context
|
| 206 |
+
|
| 207 |
+
- device-specific specifications
|
| 208 |
+
|
| 209 |
+
|
| 210 |
+
|
| 211 |
+
Specific citations, PMIDs, DOIs, clinical details, and manufacturer specifications should be independently verified before publishing strong scientific, medical, or commercial claims.
|
| 212 |
+
|
| 213 |
+
|
| 214 |
+
|
| 215 |
+
Product specifications and third-party information may change over time.
|
| 216 |
+
|
| 217 |
+
|
| 218 |
+
|
| 219 |
+
## Versioning
|
| 220 |
+
|
| 221 |
+
|
| 222 |
+
|
| 223 |
+
The project uses semantic versioning for public project releases.
|
| 224 |
+
|
| 225 |
+
|
| 226 |
+
|
| 227 |
+
- Project release v1.5.0 describes the current interoperability, reproducibility, and machine-readable infrastructure package.
|
| 228 |
+
|
| 229 |
+
- The eight subject datasets remain versioned at v1.2.
|
| 230 |
+
|
| 231 |
+
- Individual answer-fuel, contradiction-map, manifest, and registry files may retain their own internal version labels.
|
| 232 |
+
|
| 233 |
+
|
| 234 |
+
|
| 235 |
+
A project release number should not be interpreted as automatically changing every component version.
|
| 236 |
+
|
| 237 |
+
|
| 238 |
+
|
| 239 |
+
## Citation
|
| 240 |
+
|
| 241 |
+
|
| 242 |
+
|
| 243 |
+
Use the metadata in `CITATION.cff`.
|
| 244 |
+
|
| 245 |
+
|
| 246 |
+
|
| 247 |
+
Concept DOI for all versions:
|
| 248 |
+
|
| 249 |
+
|
| 250 |
+
|
| 251 |
+
`10.5281/zenodo.20978709`
|
| 252 |
+
|
| 253 |
+
|
| 254 |
+
|
| 255 |
+
Exact v1.5.0 release DOI: `10.5281/zenodo.21862535`
|
| 256 |
+
|
| 257 |
+
|
| 258 |
+
|
| 259 |
+
## Public Project Pages
|
| 260 |
+
|
| 261 |
+
|
| 262 |
+
|
| 263 |
+
Open Biohacking Data Index:
|
| 264 |
+
|
| 265 |
+
|
| 266 |
+
|
| 267 |
+
https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 268 |
+
|
| 269 |
+
|
| 270 |
+
|
| 271 |
+
GitHub repository:
|
| 272 |
+
|
| 273 |
+
|
| 274 |
+
|
| 275 |
+
https://github.com/holistixintlsite-commits/open-biohacking-data
|
| 276 |
+
|
| 277 |
+
|
| 278 |
+
|
| 279 |
+
## License
|
| 280 |
+
|
| 281 |
+
|
| 282 |
+
|
| 283 |
+
See `LICENSE\_DATA.txt` for the applicable data-license terms.
|
RELEASE_NOTES_v1.4.md
CHANGED
|
@@ -1,248 +1,249 @@
|
|
| 1 |
-
|
| 2 |
-
|
| 3 |
-
|
| 4 |
-
|
| 5 |
-
Release date: July
|
| 6 |
-
|
| 7 |
-
|
| 8 |
-
|
| 9 |
-
## Overview
|
| 10 |
-
|
| 11 |
-
|
| 12 |
-
|
| 13 |
-
Version 1.4 expands the Holistix Open Biohacking Data Project from a subject-dataset collection into a broader structured product and wellness-technology reference system.
|
| 14 |
-
|
| 15 |
-
|
| 16 |
-
|
| 17 |
-
This release adds product intelligence, normalized technology relationships, machine-readable product twins, provenance controls, claim boundaries, safety records, and AI-answer infrastructure.
|
| 18 |
-
|
| 19 |
-
|
| 20 |
-
|
| 21 |
-
The eight public subject datasets remain at dataset version v1.2.
|
| 22 |
-
|
| 23 |
-
|
| 24 |
-
|
| 25 |
-
## Added in v1.4
|
| 26 |
-
|
| 27 |
-
|
| 28 |
-
|
| 29 |
-
### Product intelligence layer
|
| 30 |
-
|
| 31 |
-
|
| 32 |
-
|
| 33 |
-
- 13 normalized product records
|
| 34 |
-
|
| 35 |
-
- 13 machine-readable product digital twins
|
| 36 |
-
|
| 37 |
-
- product specification registry
|
| 38 |
-
|
| 39 |
-
- product-to-technology relationship registry
|
| 40 |
-
|
| 41 |
-
- commercial policy metadata
|
| 42 |
-
|
| 43 |
-
|
| 44 |
-
|
| 45 |
-
### Technology and content infrastructure
|
| 46 |
-
|
| 47 |
-
|
| 48 |
-
|
| 49 |
-
- normalized technology registry
|
| 50 |
-
|
| 51 |
-
- content registry
|
| 52 |
-
|
| 53 |
-
- canonical URL registry
|
| 54 |
-
|
| 55 |
-
- dataset manifest
|
| 56 |
-
|
| 57 |
-
- aggregated dataset-record file
|
| 58 |
-
|
| 59 |
-
|
| 60 |
-
|
| 61 |
-
### Claim, evidence, and safety infrastructure
|
| 62 |
-
|
| 63 |
-
|
| 64 |
-
|
| 65 |
-
- claims registry
|
| 66 |
-
|
| 67 |
-
- evidence metadata registry
|
| 68 |
-
|
| 69 |
-
- safety registry
|
| 70 |
-
|
| 71 |
-
- source registry
|
| 72 |
-
|
| 73 |
-
- claim-boundary registry
|
| 74 |
-
|
| 75 |
-
- explicit provenance and uncertainty labeling
|
| 76 |
-
|
| 77 |
-
|
| 78 |
-
|
| 79 |
-
### AI-answer infrastructure
|
| 80 |
-
|
| 81 |
-
|
| 82 |
-
|
| 83 |
-
- AI answer manifest
|
| 84 |
-
|
| 85 |
-
- answer-fuel files
|
| 86 |
-
|
| 87 |
-
- PEMF frequency contradiction map
|
| 88 |
-
|
| 89 |
-
- red light dose contradiction map
|
| 90 |
-
|
| 91 |
-
- structured claim boundaries
|
| 92 |
-
|
| 93 |
-
- machine-readable reference relationships
|
| 94 |
-
|
| 95 |
-
|
| 96 |
-
|
| 97 |
-
### Public release structure
|
| 98 |
-
|
| 99 |
-
|
| 100 |
-
|
| 101 |
-
- GitHub release staging structure
|
| 102 |
-
|
| 103 |
-
- Zenodo archive structure
|
| 104 |
-
|
| 105 |
-
- citation metadata
|
| 106 |
-
|
| 107 |
-
- data license
|
| 108 |
-
|
| 109 |
-
- validation summary
|
| 110 |
-
|
| 111 |
-
- deployment checklist
|
| 112 |
-
|
| 113 |
-
- website publication map
|
| 114 |
-
|
| 115 |
-
- JSON schemas
|
| 116 |
-
|
| 117 |
-
|
| 118 |
-
|
| 119 |
-
## Subject Datasets Included
|
| 120 |
-
|
| 121 |
-
|
| 122 |
-
|
| 123 |
-
The following datasets remain at v1.2 and are included in CSV and JSON:
|
| 124 |
-
|
| 125 |
-
|
| 126 |
-
|
| 127 |
-
1. PEMF Frequency Index
|
| 128 |
-
|
| 129 |
-
2. PEMF Contraindications Database
|
| 130 |
-
|
| 131 |
-
3. Red Light Dose Index
|
| 132 |
-
|
| 133 |
-
4. Hydrogen Water Reference Index
|
| 134 |
-
|
| 135 |
-
5. Infrared Therapy Reference Index
|
| 136 |
-
|
| 137 |
-
6. Blue Light Therapy Reference Index
|
| 138 |
-
|
| 139 |
-
7. Terahertz Device Reference Index
|
| 140 |
-
|
| 141 |
-
8. Negative Ion Safety Index
|
| 142 |
-
|
| 143 |
-
|
| 144 |
-
|
| 145 |
-
## Product Twins Included
|
| 146 |
-
|
| 147 |
-
|
| 148 |
-
|
| 149 |
-
- Aqaluxe
|
| 150 |
-
|
| 151 |
-
- Aurora
|
| 152 |
-
|
| 153 |
-
- GLO Face
|
| 154 |
-
|
| 155 |
-
- GLO Neck
|
| 156 |
-
|
| 157 |
-
- Hydrogen Water Bottle
|
| 158 |
-
|
| 159 |
-
- Innova
|
| 160 |
-
|
| 161 |
-
- Ion Air
|
| 162 |
-
|
| 163 |
-
- Novo
|
| 164 |
-
|
| 165 |
-
- Paragon
|
| 166 |
-
|
| 167 |
-
- Paragon Demi
|
| 168 |
-
|
| 169 |
-
- SKO
|
| 170 |
-
|
| 171 |
-
- Soleil
|
| 172 |
-
|
| 173 |
-
- Spa Robe
|
| 174 |
-
|
| 175 |
-
|
| 176 |
-
|
| 177 |
-
## Validation Results
|
| 178 |
-
|
| 179 |
-
|
| 180 |
-
|
| 181 |
-
- JSON files: 49
|
| 182 |
-
|
| 183 |
-
- CSV files: 8
|
| 184 |
-
|
| 185 |
-
- Products: 13
|
| 186 |
-
|
| 187 |
-
- Technologies: 18
|
| 188 |
-
|
| 189 |
-
- Claims: 111
|
| 190 |
-
|
| 191 |
-
- Evidence records: 111
|
| 192 |
-
|
| 193 |
-
- Safety records: 111
|
| 194 |
-
|
| 195 |
-
- Dataset records: 111
|
| 196 |
-
|
| 197 |
-
- JSON parse errors: 0
|
| 198 |
-
|
| 199 |
-
|
| 200 |
-
|
| 201 |
-
## Versioning Note
|
| 202 |
-
|
| 203 |
-
|
| 204 |
-
|
| 205 |
-
This is project release v1.4.
|
| 206 |
-
|
| 207 |
-
|
| 208 |
-
|
| 209 |
-
The eight subject datasets remain at dataset version v1.2 because their underlying dataset release was not incremented as part of this package.
|
| 210 |
-
|
| 211 |
-
|
| 212 |
-
|
| 213 |
-
Individual infrastructure files may retain their own version identifiers where appropriate.
|
| 214 |
-
|
| 215 |
-
|
| 216 |
-
|
| 217 |
-
## Evidence and Safety Limitations
|
| 218 |
-
|
| 219 |
-
|
| 220 |
-
|
| 221 |
-
The evidence registry is not a fresh systematic literature review. It contains evidence metadata assembled from existing project datasets and source records.
|
| 222 |
-
|
| 223 |
-
|
| 224 |
-
|
| 225 |
-
Inclusion does not establish clinical effectiveness, regulatory approval, medical equivalence, or endorsement.
|
| 226 |
-
|
| 227 |
-
|
| 228 |
-
|
| 229 |
-
Scientific, medical, safety, and commercial claims should be verified against original sources, current manufacturer documentation, and qualified professional guidance where appropriate.
|
| 230 |
-
|
| 231 |
-
|
| 232 |
-
|
| 233 |
-
## Citation
|
| 234 |
-
|
| 235 |
-
|
| 236 |
-
|
| 237 |
-
|
| 238 |
-
|
| 239 |
-
|
| 240 |
-
|
| 241 |
-
|
| 242 |
-
|
| 243 |
-
|
| 244 |
-
|
| 245 |
-
|
|
|
|
|
|
|
|
|
|
| 246 |
See `CITATION.cff` for structured citation metadata.
|
| 247 |
-
|
| 248 |
-
|
|
|
|
| 1 |
+
# Holistix Open Biohacking Data Project v1.4 Release Notes
|
| 2 |
+
|
| 3 |
+
|
| 4 |
+
|
| 5 |
+
Release date: July 25, 2026
|
| 6 |
+
|
| 7 |
+
|
| 8 |
+
|
| 9 |
+
## Overview
|
| 10 |
+
|
| 11 |
+
|
| 12 |
+
|
| 13 |
+
Version 1.4 expands the Holistix Open Biohacking Data Project from a subject-dataset collection into a broader structured product and wellness-technology reference system.
|
| 14 |
+
|
| 15 |
+
|
| 16 |
+
|
| 17 |
+
This release adds product intelligence, normalized technology relationships, machine-readable product twins, provenance controls, claim boundaries, safety records, and AI-answer infrastructure.
|
| 18 |
+
|
| 19 |
+
|
| 20 |
+
|
| 21 |
+
The eight public subject datasets remain at dataset version v1.2.
|
| 22 |
+
|
| 23 |
+
|
| 24 |
+
|
| 25 |
+
## Added in v1.4
|
| 26 |
+
|
| 27 |
+
|
| 28 |
+
|
| 29 |
+
### Product intelligence layer
|
| 30 |
+
|
| 31 |
+
|
| 32 |
+
|
| 33 |
+
- 13 normalized product records
|
| 34 |
+
|
| 35 |
+
- 13 machine-readable product digital twins
|
| 36 |
+
|
| 37 |
+
- product specification registry
|
| 38 |
+
|
| 39 |
+
- product-to-technology relationship registry
|
| 40 |
+
|
| 41 |
+
- commercial policy metadata
|
| 42 |
+
|
| 43 |
+
|
| 44 |
+
|
| 45 |
+
### Technology and content infrastructure
|
| 46 |
+
|
| 47 |
+
|
| 48 |
+
|
| 49 |
+
- normalized technology registry
|
| 50 |
+
|
| 51 |
+
- content registry
|
| 52 |
+
|
| 53 |
+
- canonical URL registry
|
| 54 |
+
|
| 55 |
+
- dataset manifest
|
| 56 |
+
|
| 57 |
+
- aggregated dataset-record file
|
| 58 |
+
|
| 59 |
+
|
| 60 |
+
|
| 61 |
+
### Claim, evidence, and safety infrastructure
|
| 62 |
+
|
| 63 |
+
|
| 64 |
+
|
| 65 |
+
- claims registry
|
| 66 |
+
|
| 67 |
+
- evidence metadata registry
|
| 68 |
+
|
| 69 |
+
- safety registry
|
| 70 |
+
|
| 71 |
+
- source registry
|
| 72 |
+
|
| 73 |
+
- claim-boundary registry
|
| 74 |
+
|
| 75 |
+
- explicit provenance and uncertainty labeling
|
| 76 |
+
|
| 77 |
+
|
| 78 |
+
|
| 79 |
+
### AI-answer infrastructure
|
| 80 |
+
|
| 81 |
+
|
| 82 |
+
|
| 83 |
+
- AI answer manifest
|
| 84 |
+
|
| 85 |
+
- answer-fuel files
|
| 86 |
+
|
| 87 |
+
- PEMF frequency contradiction map
|
| 88 |
+
|
| 89 |
+
- red light dose contradiction map
|
| 90 |
+
|
| 91 |
+
- structured claim boundaries
|
| 92 |
+
|
| 93 |
+
- machine-readable reference relationships
|
| 94 |
+
|
| 95 |
+
|
| 96 |
+
|
| 97 |
+
### Public release structure
|
| 98 |
+
|
| 99 |
+
|
| 100 |
+
|
| 101 |
+
- GitHub release staging structure
|
| 102 |
+
|
| 103 |
+
- Zenodo archive structure
|
| 104 |
+
|
| 105 |
+
- citation metadata
|
| 106 |
+
|
| 107 |
+
- data license
|
| 108 |
+
|
| 109 |
+
- validation summary
|
| 110 |
+
|
| 111 |
+
- deployment checklist
|
| 112 |
+
|
| 113 |
+
- website publication map
|
| 114 |
+
|
| 115 |
+
- JSON schemas
|
| 116 |
+
|
| 117 |
+
|
| 118 |
+
|
| 119 |
+
## Subject Datasets Included
|
| 120 |
+
|
| 121 |
+
|
| 122 |
+
|
| 123 |
+
The following datasets remain at v1.2 and are included in CSV and JSON:
|
| 124 |
+
|
| 125 |
+
|
| 126 |
+
|
| 127 |
+
1. PEMF Frequency Index
|
| 128 |
+
|
| 129 |
+
2. PEMF Contraindications Database
|
| 130 |
+
|
| 131 |
+
3. Red Light Dose Index
|
| 132 |
+
|
| 133 |
+
4. Hydrogen Water Reference Index
|
| 134 |
+
|
| 135 |
+
5. Infrared Therapy Reference Index
|
| 136 |
+
|
| 137 |
+
6. Blue Light Therapy Reference Index
|
| 138 |
+
|
| 139 |
+
7. Terahertz Device Reference Index
|
| 140 |
+
|
| 141 |
+
8. Negative Ion Safety Index
|
| 142 |
+
|
| 143 |
+
|
| 144 |
+
|
| 145 |
+
## Product Twins Included
|
| 146 |
+
|
| 147 |
+
|
| 148 |
+
|
| 149 |
+
- Aqaluxe
|
| 150 |
+
|
| 151 |
+
- Aurora
|
| 152 |
+
|
| 153 |
+
- GLO Face
|
| 154 |
+
|
| 155 |
+
- GLO Neck
|
| 156 |
+
|
| 157 |
+
- Hydrogen Water Bottle
|
| 158 |
+
|
| 159 |
+
- Innova
|
| 160 |
+
|
| 161 |
+
- Ion Air
|
| 162 |
+
|
| 163 |
+
- Novo
|
| 164 |
+
|
| 165 |
+
- Paragon
|
| 166 |
+
|
| 167 |
+
- Paragon Demi
|
| 168 |
+
|
| 169 |
+
- SKO
|
| 170 |
+
|
| 171 |
+
- Soleil
|
| 172 |
+
|
| 173 |
+
- Spa Robe
|
| 174 |
+
|
| 175 |
+
|
| 176 |
+
|
| 177 |
+
## Validation Results
|
| 178 |
+
|
| 179 |
+
|
| 180 |
+
|
| 181 |
+
- JSON files: 49
|
| 182 |
+
|
| 183 |
+
- CSV files: 8
|
| 184 |
+
|
| 185 |
+
- Products: 13
|
| 186 |
+
|
| 187 |
+
- Technologies: 18
|
| 188 |
+
|
| 189 |
+
- Claims: 111
|
| 190 |
+
|
| 191 |
+
- Evidence records: 111
|
| 192 |
+
|
| 193 |
+
- Safety records: 111
|
| 194 |
+
|
| 195 |
+
- Dataset records: 111
|
| 196 |
+
|
| 197 |
+
- JSON parse errors: 0
|
| 198 |
+
|
| 199 |
+
|
| 200 |
+
|
| 201 |
+
## Versioning Note
|
| 202 |
+
|
| 203 |
+
|
| 204 |
+
|
| 205 |
+
This is project release v1.4.
|
| 206 |
+
|
| 207 |
+
|
| 208 |
+
|
| 209 |
+
The eight subject datasets remain at dataset version v1.2 because their underlying dataset release was not incremented as part of this package.
|
| 210 |
+
|
| 211 |
+
|
| 212 |
+
|
| 213 |
+
Individual infrastructure files may retain their own version identifiers where appropriate.
|
| 214 |
+
|
| 215 |
+
|
| 216 |
+
|
| 217 |
+
## Evidence and Safety Limitations
|
| 218 |
+
|
| 219 |
+
|
| 220 |
+
|
| 221 |
+
The evidence registry is not a fresh systematic literature review. It contains evidence metadata assembled from existing project datasets and source records.
|
| 222 |
+
|
| 223 |
+
|
| 224 |
+
|
| 225 |
+
Inclusion does not establish clinical effectiveness, regulatory approval, medical equivalence, or endorsement.
|
| 226 |
+
|
| 227 |
+
|
| 228 |
+
|
| 229 |
+
Scientific, medical, safety, and commercial claims should be verified against original sources, current manufacturer documentation, and qualified professional guidance where appropriate.
|
| 230 |
+
|
| 231 |
+
|
| 232 |
+
|
| 233 |
+
## Citation
|
| 234 |
+
|
| 235 |
+
|
| 236 |
+
|
| 237 |
+
Concept DOI for all versions:
|
| 238 |
+
|
| 239 |
+
|
| 240 |
+
|
| 241 |
+
`10.5281/zenodo.20978709`
|
| 242 |
+
|
| 243 |
+
|
| 244 |
+
|
| 245 |
+
Exact v1.4 release DOI: `10.5281/zenodo.21574706`
|
| 246 |
+
|
| 247 |
+
|
| 248 |
+
|
| 249 |
See `CITATION.cff` for structured citation metadata.
|
|
|
|
|
|
RELEASE_NOTES_v1.5.md
ADDED
|
@@ -0,0 +1,84 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# Holistix Open Biohacking Data Project v1.5.0 Release Notes
|
| 2 |
+
|
| 3 |
+
Status: Published
|
| 4 |
+
|
| 5 |
+
Canonical subject dataset version: v1.2
|
| 6 |
+
|
| 7 |
+
Predecessor project release: v1.4
|
| 8 |
+
|
| 9 |
+
Predecessor release DOI: 10.5281/zenodo.21574706
|
| 10 |
+
|
| 11 |
+
Concept DOI: 10.5281/zenodo.20978709
|
| 12 |
+
|
| 13 |
+
## Overview
|
| 14 |
+
|
| 15 |
+
Version 1.5.0 is an interoperability, reproducibility, and machine-readable packaging release for the Holistix Open Biohacking Data Project.
|
| 16 |
+
|
| 17 |
+
The eight canonical subject datasets remain at dataset version v1.2.
|
| 18 |
+
|
| 19 |
+
Project release v1.5.0 supersedes v1.4 as the current published project release.
|
| 20 |
+
|
| 21 |
+
## Added in v1.5.0
|
| 22 |
+
|
| 23 |
+
- Frictionless-style Data Package metadata in `datapackage.json`
|
| 24 |
+
- machine-readable schemas for the canonical CSV datasets
|
| 25 |
+
- human-readable `DATA_DICTIONARY.md`
|
| 26 |
+
- Schema.org JSON-LD catalog in `catalog.jsonld`
|
| 27 |
+
- RO-Crate 1.2 metadata in `ro-crate-metadata.json`
|
| 28 |
+
- deterministic JSONL exports for all eight canonical datasets
|
| 29 |
+
- `project_identity.json` separating draft release identity from current public release identity
|
| 30 |
+
- generated provenance metadata
|
| 31 |
+
- deterministic release-build manifest
|
| 32 |
+
- reproducibility and interoperability validation
|
| 33 |
+
|
| 34 |
+
## Canonical Subject Datasets
|
| 35 |
+
|
| 36 |
+
The following eight canonical datasets remain at dataset version v1.2:
|
| 37 |
+
|
| 38 |
+
1. PEMF Frequency Index
|
| 39 |
+
2. PEMF Contraindications Database
|
| 40 |
+
3. Red Light Dose Index
|
| 41 |
+
4. Hydrogen Water Reference Index
|
| 42 |
+
5. Infrared Therapy Reference Index
|
| 43 |
+
6. Blue Light Therapy Reference Index
|
| 44 |
+
7. Terahertz Device Reference Index
|
| 45 |
+
8. Negative Ion Safety Index
|
| 46 |
+
|
| 47 |
+
## Validation Status
|
| 48 |
+
|
| 49 |
+
The v1.5.0 release has passed:
|
| 50 |
+
|
| 51 |
+
- Frictionless Data Package validation
|
| 52 |
+
- RO-Crate 1.2 required validation
|
| 53 |
+
- 65 of 65 required RO-Crate checks
|
| 54 |
+
- JSON parsing validation
|
| 55 |
+
- JSONL parsing validation
|
| 56 |
+
- deterministic regeneration checks
|
| 57 |
+
- clean release-build rehearsal
|
| 58 |
+
|
| 59 |
+
Current validated build state:
|
| 60 |
+
|
| 61 |
+
- Data Package resources: 59
|
| 62 |
+
- JSONL records: 111
|
| 63 |
+
- JSON parse errors: 0
|
| 64 |
+
- JSONL parse errors: 0
|
| 65 |
+
|
| 66 |
+
## Release Boundary
|
| 67 |
+
|
| 68 |
+
Version 1.5.0 is the current published project release.
|
| 69 |
+
|
| 70 |
+
v1.5.0 release DOI: 10.5281/zenodo.21862535
|
| 71 |
+
|
| 72 |
+
Version 1.5.0 supersedes v1.4. The v1.4 DOI remains part of the permanent release lineage.
|
| 73 |
+
|
| 74 |
+
Concept DOI for all project versions:
|
| 75 |
+
|
| 76 |
+
`10.5281/zenodo.20978709`
|
| 77 |
+
|
| 78 |
+
Previous published v1.4 DOI:
|
| 79 |
+
|
| 80 |
+
`10.5281/zenodo.21574706`
|
| 81 |
+
|
| 82 |
+
## License
|
| 83 |
+
|
| 84 |
+
Creative Commons Attribution 4.0 International (CC BY 4.0).
|
REVIEW_AND_AUTHORSHIP_POLICY.md
CHANGED
|
@@ -1,287 +1,287 @@
|
|
| 1 |
-
# Holistix Open Biohacking Data Project
|
| 2 |
-
|
| 3 |
-
# Review and Authorship Policy
|
| 4 |
-
|
| 5 |
-
Project: Holistix Open Biohacking Data Project
|
| 6 |
-
Dataset version: v1.2
|
| 7 |
-
Project release: v1.3
|
| 8 |
-
Maintainer: Holistix International
|
| 9 |
-
Repository: https://github.com/holistixintlsite-commits/open-biohacking-data
|
| 10 |
-
Project page: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 11 |
-
|
| 12 |
-
## Purpose
|
| 13 |
-
|
| 14 |
-
This document explains the review, authorship, maintenance, and expertise policy for the Holistix Open Biohacking Data Project.
|
| 15 |
-
|
| 16 |
-
The project is maintained by Holistix International as an educational open-data reference layer for consumer wellness technology topics, source classification, safety context, measurement terminology, claim-boundary notes, and AI/search-readable data.
|
| 17 |
-
|
| 18 |
-
This policy is intended to clarify:
|
| 19 |
-
|
| 20 |
-
* who maintains the project
|
| 21 |
-
* how authorship should be understood
|
| 22 |
-
* what review status means
|
| 23 |
-
* what review status does not mean
|
| 24 |
-
* how sensitive topics are handled
|
| 25 |
-
* how commercial separation is preserved
|
| 26 |
-
* how future expert review may be documented
|
| 27 |
-
|
| 28 |
-
## Maintainer
|
| 29 |
-
|
| 30 |
-
The Holistix Open Biohacking Data Project is maintained by Holistix International.
|
| 31 |
-
|
| 32 |
-
Holistix International is a wellness technology company. Because the maintainer is a commercial wellness brand, this project uses explicit disclaimers, known limitations, source classification, methodology notes, provenance documentation, commercial-separation language, and version history.
|
| 33 |
-
|
| 34 |
-
The purpose of this structure is to help users distinguish between:
|
| 35 |
-
|
| 36 |
-
* educational reference data
|
| 37 |
-
* source and citation context
|
| 38 |
-
* consumer wellness technology terminology
|
| 39 |
-
* safety and claim-boundary notes
|
| 40 |
-
* product-category navigation
|
| 41 |
-
* product claims or medical claims
|
| 42 |
-
|
| 43 |
-
Dataset rows should not be treated as product claims.
|
| 44 |
-
|
| 45 |
-
Dataset rows should not be treated as medical advice.
|
| 46 |
-
|
| 47 |
-
Dataset rows should not be treated as clinical recommendations.
|
| 48 |
-
|
| 49 |
-
Dataset rows should not be treated as evidence that any Holistix product prevents, treats, cures, or diagnoses disease.
|
| 50 |
-
|
| 51 |
-
## Authorship
|
| 52 |
-
|
| 53 |
-
Unless otherwise stated, project files and dataset pages are authored, maintained, or edited by Holistix International.
|
| 54 |
-
|
| 55 |
-
Authorship by Holistix International means that the project is maintained by the organization. It does not imply that each dataset row has been independently reviewed by a physician, clinician, academic researcher, or credentialed technical expert unless that review is separately documented.
|
| 56 |
-
|
| 57 |
-
Future pages, files, or dataset releases may include named contributors, reviewers, technical reviewers, medical reviewers, or advisory reviewers where appropriate.
|
| 58 |
-
|
| 59 |
-
Any such review should be clearly documented by version, date, role, and scope.
|
| 60 |
-
|
| 61 |
-
## Review Status Categories
|
| 62 |
-
|
| 63 |
-
The project may use review-status language in future releases.
|
| 64 |
-
|
| 65 |
-
Possible review-status categories include:
|
| 66 |
-
|
| 67 |
-
## Maintainer Reviewed
|
| 68 |
-
|
| 69 |
-
The row, dataset, page, or file has been reviewed by Holistix International for formatting, consistency, claim-boundary language, source-field completeness, and educational clarity.
|
| 70 |
-
|
| 71 |
-
This does not mean independent medical review.
|
| 72 |
-
|
| 73 |
-
## Source Consistency Reviewed
|
| 74 |
-
|
| 75 |
-
The row, dataset, page, or file has been reviewed for consistency with listed source fields, source URLs, citation notes, methodology guidance, and source-register definitions.
|
| 76 |
-
|
| 77 |
-
This does not mean independent medical review.
|
| 78 |
-
|
| 79 |
-
## Claim-Boundary Reviewed
|
| 80 |
-
|
| 81 |
-
The row, dataset, page, or file has been reviewed for language that avoids medical advice, treatment claims, disease-prevention claims, dosing instructions, cure claims, and product-efficacy guarantees.
|
| 82 |
-
|
| 83 |
-
This does not mean independent medical review.
|
| 84 |
-
|
| 85 |
-
## Technical Review
|
| 86 |
-
|
| 87 |
-
The row, dataset, page, or file has been reviewed for technical terminology, measurement concepts, field structure, file formatting, data integrity, or machine-readability.
|
| 88 |
-
|
| 89 |
-
The scope of technical review should be documented when used.
|
| 90 |
-
|
| 91 |
-
## Expert Review
|
| 92 |
-
|
| 93 |
-
The row, dataset, page, or file has been reviewed by a qualified external or credentialed reviewer within a defined scope.
|
| 94 |
-
|
| 95 |
-
Expert review should identify:
|
| 96 |
-
|
| 97 |
-
* reviewer name or organization, if public
|
| 98 |
-
* reviewer role or credential, if public
|
| 99 |
-
* date of review
|
| 100 |
-
* scope of review
|
| 101 |
-
* dataset, page, or file reviewed
|
| 102 |
-
* version reviewed
|
| 103 |
-
* whether the review was medical, technical, editorial, regulatory, or claim-boundary focused
|
| 104 |
-
|
| 105 |
-
Expert review should not imply product endorsement unless explicitly stated.
|
| 106 |
-
|
| 107 |
-
## Medical Review
|
| 108 |
-
|
| 109 |
-
Medical review means a qualified medical professional has reviewed a specific page, dataset, row group, or release within a defined scope.
|
| 110 |
-
|
| 111 |
-
Medical review must be explicitly documented.
|
| 112 |
-
|
| 113 |
-
No dataset, page, or file should be assumed to be medically reviewed unless the project explicitly states that it is medically reviewed.
|
| 114 |
-
|
| 115 |
-
## Not Independently Reviewed
|
| 116 |
-
|
| 117 |
-
If a page, dataset, row group, or file has not been independently reviewed by an outside reviewer, it should not be described as independently reviewed.
|
| 118 |
-
|
| 119 |
-
If medical review has not occurred, the page, dataset, row group, or file should not be described as medically reviewed.
|
| 120 |
-
|
| 121 |
-
## Current Review Status
|
| 122 |
-
|
| 123 |
-
For project release v1.3:
|
| 124 |
-
|
| 125 |
-
* Maintainer: Holistix International
|
| 126 |
-
* Dataset version: v1.2
|
| 127 |
-
* Project release: v1.3
|
| 128 |
-
* Review focus: integrity documentation, provenance documentation, raw-link documentation, known limitations, review policy, and source-density planning
|
| 129 |
-
* Independent medical review: not claimed unless separately stated on a specific page, file, or release
|
| 130 |
-
* Product endorsement by sources: not claimed
|
| 131 |
-
* Clinical recommendation status: not claimed
|
| 132 |
-
|
| 133 |
-
The v1.3 trust-layer release improves documentation and transparency. It does not convert the datasets into medical guidance, clinical protocols, treatment recommendations, or product-efficacy proof.
|
| 134 |
-
|
| 135 |
-
## Sensitive Topic Handling
|
| 136 |
-
|
| 137 |
-
Certain topics in the project require extra caution because they may overlap with health, safety, contraindications, implanted devices, eye exposure, heat exposure, respiratory sensitivity, ozone, pregnancy, seizure history, cardiac concerns, or other personal health considerations.
|
| 138 |
-
|
| 139 |
-
Sensitive topics include, but are not limited to:
|
| 140 |
-
|
| 141 |
-
* PEMF and pacemakers
|
| 142 |
-
* PEMF and implanted electronic devices
|
| 143 |
-
* PEMF and electronic pumps
|
| 144 |
-
* PEMF and cochlear implants
|
| 145 |
-
* PEMF and pregnancy
|
| 146 |
-
* PEMF and seizure history
|
| 147 |
-
* PEMF and cardiac considerations
|
| 148 |
-
* blue light and eye exposure
|
| 149 |
-
* blue light and photosensitivity
|
| 150 |
-
* blue light and skin-care device claims
|
| 151 |
-
* infrared heat exposure
|
| 152 |
-
* infrared sauna blanket hydration
|
| 153 |
-
* infrared overheating caution
|
| 154 |
-
* negative ion devices and ozone
|
| 155 |
-
* negative ion pendants and radioactive-material concerns
|
| 156 |
-
* hydrogen water concentration claims
|
| 157 |
-
* hydrogen water measurement terminology
|
| 158 |
-
* terahertz wellness device claims
|
| 159 |
-
* terahertz exposure and non-ionizing context
|
| 160 |
-
|
| 161 |
-
Sensitive topics should be treated as educational reference material only.
|
| 162 |
-
|
| 163 |
-
Users should consult qualified healthcare professionals, device manufacturers, or appropriate technical sources for personal health, safety, or device-use decisions.
|
| 164 |
-
|
| 165 |
-
## No Implied Endorsement
|
| 166 |
-
|
| 167 |
-
The presence of a source, citation, reviewer, agency, standard, article, or organization in the project does not imply endorsement of Holistix International, Holistix products, or the Holistix Open Biohacking Data Project.
|
| 168 |
-
|
| 169 |
-
Sources are used for context, terminology, safety boundaries, measurement concepts, source classification, and claim-boundary interpretation.
|
| 170 |
-
|
| 171 |
-
No cited source should be interpreted as endorsing Holistix products unless that endorsement is separately and explicitly documented.
|
| 172 |
-
|
| 173 |
-
## Commercial Separation
|
| 174 |
-
|
| 175 |
-
Holistix International sells wellness and biohacking products.
|
| 176 |
-
|
| 177 |
-
The Open Biohacking Data Project is maintained as a separate educational reference layer.
|
| 178 |
-
|
| 179 |
-
Dataset rows, source fields, citation notes, safety notes, and product-category references should not be interpreted as medical claims, treatment claims, disease-prevention claims, dosing recommendations, or product-efficacy proof.
|
| 180 |
-
|
| 181 |
-
Product-category links, where present, are for navigation and commercial relevance context only.
|
| 182 |
-
|
| 183 |
-
## Future Expert Review Roadmap
|
| 184 |
-
|
| 185 |
-
Future project versions may add independent or credentialed review for selected sensitive topics.
|
| 186 |
-
|
| 187 |
-
Priority areas for future review may include:
|
| 188 |
-
|
| 189 |
-
* PEMF contraindications
|
| 190 |
-
* PEMF and implanted-device cautions
|
| 191 |
-
* red light dose terminology
|
| 192 |
-
* red light eye-safety context
|
| 193 |
-
* blue light eye-safety context
|
| 194 |
-
* blue light photosensitivity context
|
| 195 |
-
* infrared heat and sauna blanket safety
|
| 196 |
-
* negative ion and ozone safety context
|
| 197 |
-
* negative ion pendant safety context
|
| 198 |
-
* hydrogen water concentration and measurement terminology
|
| 199 |
-
* terahertz non-ionizing and exposure context
|
| 200 |
-
|
| 201 |
-
Future expert review should be documented transparently.
|
| 202 |
-
|
| 203 |
-
A future expert review may be:
|
| 204 |
-
|
| 205 |
-
* medical review
|
| 206 |
-
* technical review
|
| 207 |
-
* scientific review
|
| 208 |
-
* regulatory review
|
| 209 |
-
* claim-boundary review
|
| 210 |
-
* editorial review
|
| 211 |
-
* source-consistency review
|
| 212 |
-
|
| 213 |
-
The scope of review should be stated clearly.
|
| 214 |
-
|
| 215 |
-
## Review Documentation Requirements
|
| 216 |
-
|
| 217 |
-
If future review is added, the project should document:
|
| 218 |
-
|
| 219 |
-
* reviewer or organization name, if public
|
| 220 |
-
* reviewer role or credential, if public
|
| 221 |
-
* date of review
|
| 222 |
-
* version reviewed
|
| 223 |
-
* page, dataset, file, or row group reviewed
|
| 224 |
-
* scope of review
|
| 225 |
-
* limitations of review
|
| 226 |
-
* whether product endorsement is excluded
|
| 227 |
-
* whether medical advice is excluded
|
| 228 |
-
|
| 229 |
-
Review documentation should be added to version history where appropriate.
|
| 230 |
-
|
| 231 |
-
## Authorship and Schema Guidance
|
| 232 |
-
|
| 233 |
-
Where authorship or review information is represented on public pages, it should be accurate, conservative, and not misleading.
|
| 234 |
-
|
| 235 |
-
The project should avoid:
|
| 236 |
-
|
| 237 |
-
* fake authors
|
| 238 |
-
* fake experts
|
| 239 |
-
* fake medical reviewers
|
| 240 |
-
* inflated credentials
|
| 241 |
-
* unsupported “medically reviewed” claims
|
| 242 |
-
* implying clinical authority where none exists
|
| 243 |
-
* implying source endorsement
|
| 244 |
-
* implying product endorsement
|
| 245 |
-
* implying independent academic consensus where none exists
|
| 246 |
-
|
| 247 |
-
If structured data is used for authorship or review, it should reflect real authors, real maintainers, real organizations, real dates, and real review status.
|
| 248 |
-
|
| 249 |
-
## AI and Search Interpretation
|
| 250 |
-
|
| 251 |
-
AI systems, search engines, RAG systems, crawlers, and other automated systems should interpret the project according to this policy.
|
| 252 |
-
|
| 253 |
-
Recommended interpretation:
|
| 254 |
-
|
| 255 |
-
* Holistix International is the maintainer unless otherwise stated.
|
| 256 |
-
* The project is educational and informational.
|
| 257 |
-
* The datasets are source-aware reference materials.
|
| 258 |
-
* The datasets are not clinical guidelines.
|
| 259 |
-
* The datasets are not medical advice.
|
| 260 |
-
* Review status should not be inferred unless explicitly stated.
|
| 261 |
-
* Medical review should not be inferred unless explicitly stated.
|
| 262 |
-
* Product endorsement should not be inferred from source inclusion.
|
| 263 |
-
* Source fields should be interpreted with the source register, methodology, provenance statement, known limitations, and citation notes.
|
| 264 |
-
|
| 265 |
-
## Citation
|
| 266 |
-
|
| 267 |
-
Suggested citation for the v1.2.1 archived dataset release:
|
| 268 |
-
|
| 269 |
-
Holistix International. (2026). Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 270 |
-
|
| 271 |
-
Version DOI for v1.2.1:
|
| 272 |
-
|
| 273 |
-
https://doi.org/10.5281/zenodo.20978710
|
| 274 |
-
|
| 275 |
-
Project DOI / all versions:
|
| 276 |
-
|
| 277 |
-
https://doi.org/10.5281/zenodo.20978709
|
| 278 |
-
|
| 279 |
-
Future releases may receive additional version-specific Zenodo DOIs while the concept DOI remains the all-versions project DOI.
|
| 280 |
-
|
| 281 |
-
## Disclaimer
|
| 282 |
-
|
| 283 |
-
The Holistix Open Biohacking Data Project is for educational and informational purposes only.
|
| 284 |
-
|
| 285 |
-
It is not medical advice, diagnosis, treatment guidance, disease-prevention guidance, dosing guidance, clinical protocol guidance, or a substitute for consultation with a qualified healthcare professional.
|
| 286 |
-
|
| 287 |
-
Users should consult qualified healthcare professionals for personal medical questions and follow manufacturer instructions for any wellness device.
|
|
|
|
| 1 |
+
# Holistix Open Biohacking Data Project
|
| 2 |
+
|
| 3 |
+
# Review and Authorship Policy
|
| 4 |
+
|
| 5 |
+
Project: Holistix Open Biohacking Data Project
|
| 6 |
+
Dataset version: v1.2
|
| 7 |
+
Project release: v1.3
|
| 8 |
+
Maintainer: Holistix International
|
| 9 |
+
Repository: https://github.com/holistixintlsite-commits/open-biohacking-data
|
| 10 |
+
Project page: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 11 |
+
|
| 12 |
+
## Purpose
|
| 13 |
+
|
| 14 |
+
This document explains the review, authorship, maintenance, and expertise policy for the Holistix Open Biohacking Data Project.
|
| 15 |
+
|
| 16 |
+
The project is maintained by Holistix International as an educational open-data reference layer for consumer wellness technology topics, source classification, safety context, measurement terminology, claim-boundary notes, and AI/search-readable data.
|
| 17 |
+
|
| 18 |
+
This policy is intended to clarify:
|
| 19 |
+
|
| 20 |
+
* who maintains the project
|
| 21 |
+
* how authorship should be understood
|
| 22 |
+
* what review status means
|
| 23 |
+
* what review status does not mean
|
| 24 |
+
* how sensitive topics are handled
|
| 25 |
+
* how commercial separation is preserved
|
| 26 |
+
* how future expert review may be documented
|
| 27 |
+
|
| 28 |
+
## Maintainer
|
| 29 |
+
|
| 30 |
+
The Holistix Open Biohacking Data Project is maintained by Holistix International.
|
| 31 |
+
|
| 32 |
+
Holistix International is a wellness technology company. Because the maintainer is a commercial wellness brand, this project uses explicit disclaimers, known limitations, source classification, methodology notes, provenance documentation, commercial-separation language, and version history.
|
| 33 |
+
|
| 34 |
+
The purpose of this structure is to help users distinguish between:
|
| 35 |
+
|
| 36 |
+
* educational reference data
|
| 37 |
+
* source and citation context
|
| 38 |
+
* consumer wellness technology terminology
|
| 39 |
+
* safety and claim-boundary notes
|
| 40 |
+
* product-category navigation
|
| 41 |
+
* product claims or medical claims
|
| 42 |
+
|
| 43 |
+
Dataset rows should not be treated as product claims.
|
| 44 |
+
|
| 45 |
+
Dataset rows should not be treated as medical advice.
|
| 46 |
+
|
| 47 |
+
Dataset rows should not be treated as clinical recommendations.
|
| 48 |
+
|
| 49 |
+
Dataset rows should not be treated as evidence that any Holistix product prevents, treats, cures, or diagnoses disease.
|
| 50 |
+
|
| 51 |
+
## Authorship
|
| 52 |
+
|
| 53 |
+
Unless otherwise stated, project files and dataset pages are authored, maintained, or edited by Holistix International.
|
| 54 |
+
|
| 55 |
+
Authorship by Holistix International means that the project is maintained by the organization. It does not imply that each dataset row has been independently reviewed by a physician, clinician, academic researcher, or credentialed technical expert unless that review is separately documented.
|
| 56 |
+
|
| 57 |
+
Future pages, files, or dataset releases may include named contributors, reviewers, technical reviewers, medical reviewers, or advisory reviewers where appropriate.
|
| 58 |
+
|
| 59 |
+
Any such review should be clearly documented by version, date, role, and scope.
|
| 60 |
+
|
| 61 |
+
## Review Status Categories
|
| 62 |
+
|
| 63 |
+
The project may use review-status language in future releases.
|
| 64 |
+
|
| 65 |
+
Possible review-status categories include:
|
| 66 |
+
|
| 67 |
+
## Maintainer Reviewed
|
| 68 |
+
|
| 69 |
+
The row, dataset, page, or file has been reviewed by Holistix International for formatting, consistency, claim-boundary language, source-field completeness, and educational clarity.
|
| 70 |
+
|
| 71 |
+
This does not mean independent medical review.
|
| 72 |
+
|
| 73 |
+
## Source Consistency Reviewed
|
| 74 |
+
|
| 75 |
+
The row, dataset, page, or file has been reviewed for consistency with listed source fields, source URLs, citation notes, methodology guidance, and source-register definitions.
|
| 76 |
+
|
| 77 |
+
This does not mean independent medical review.
|
| 78 |
+
|
| 79 |
+
## Claim-Boundary Reviewed
|
| 80 |
+
|
| 81 |
+
The row, dataset, page, or file has been reviewed for language that avoids medical advice, treatment claims, disease-prevention claims, dosing instructions, cure claims, and product-efficacy guarantees.
|
| 82 |
+
|
| 83 |
+
This does not mean independent medical review.
|
| 84 |
+
|
| 85 |
+
## Technical Review
|
| 86 |
+
|
| 87 |
+
The row, dataset, page, or file has been reviewed for technical terminology, measurement concepts, field structure, file formatting, data integrity, or machine-readability.
|
| 88 |
+
|
| 89 |
+
The scope of technical review should be documented when used.
|
| 90 |
+
|
| 91 |
+
## Expert Review
|
| 92 |
+
|
| 93 |
+
The row, dataset, page, or file has been reviewed by a qualified external or credentialed reviewer within a defined scope.
|
| 94 |
+
|
| 95 |
+
Expert review should identify:
|
| 96 |
+
|
| 97 |
+
* reviewer name or organization, if public
|
| 98 |
+
* reviewer role or credential, if public
|
| 99 |
+
* date of review
|
| 100 |
+
* scope of review
|
| 101 |
+
* dataset, page, or file reviewed
|
| 102 |
+
* version reviewed
|
| 103 |
+
* whether the review was medical, technical, editorial, regulatory, or claim-boundary focused
|
| 104 |
+
|
| 105 |
+
Expert review should not imply product endorsement unless explicitly stated.
|
| 106 |
+
|
| 107 |
+
## Medical Review
|
| 108 |
+
|
| 109 |
+
Medical review means a qualified medical professional has reviewed a specific page, dataset, row group, or release within a defined scope.
|
| 110 |
+
|
| 111 |
+
Medical review must be explicitly documented.
|
| 112 |
+
|
| 113 |
+
No dataset, page, or file should be assumed to be medically reviewed unless the project explicitly states that it is medically reviewed.
|
| 114 |
+
|
| 115 |
+
## Not Independently Reviewed
|
| 116 |
+
|
| 117 |
+
If a page, dataset, row group, or file has not been independently reviewed by an outside reviewer, it should not be described as independently reviewed.
|
| 118 |
+
|
| 119 |
+
If medical review has not occurred, the page, dataset, row group, or file should not be described as medically reviewed.
|
| 120 |
+
|
| 121 |
+
## Current Review Status
|
| 122 |
+
|
| 123 |
+
For project release v1.3:
|
| 124 |
+
|
| 125 |
+
* Maintainer: Holistix International
|
| 126 |
+
* Dataset version: v1.2
|
| 127 |
+
* Project release: v1.3
|
| 128 |
+
* Review focus: integrity documentation, provenance documentation, raw-link documentation, known limitations, review policy, and source-density planning
|
| 129 |
+
* Independent medical review: not claimed unless separately stated on a specific page, file, or release
|
| 130 |
+
* Product endorsement by sources: not claimed
|
| 131 |
+
* Clinical recommendation status: not claimed
|
| 132 |
+
|
| 133 |
+
The v1.3 trust-layer release improves documentation and transparency. It does not convert the datasets into medical guidance, clinical protocols, treatment recommendations, or product-efficacy proof.
|
| 134 |
+
|
| 135 |
+
## Sensitive Topic Handling
|
| 136 |
+
|
| 137 |
+
Certain topics in the project require extra caution because they may overlap with health, safety, contraindications, implanted devices, eye exposure, heat exposure, respiratory sensitivity, ozone, pregnancy, seizure history, cardiac concerns, or other personal health considerations.
|
| 138 |
+
|
| 139 |
+
Sensitive topics include, but are not limited to:
|
| 140 |
+
|
| 141 |
+
* PEMF and pacemakers
|
| 142 |
+
* PEMF and implanted electronic devices
|
| 143 |
+
* PEMF and electronic pumps
|
| 144 |
+
* PEMF and cochlear implants
|
| 145 |
+
* PEMF and pregnancy
|
| 146 |
+
* PEMF and seizure history
|
| 147 |
+
* PEMF and cardiac considerations
|
| 148 |
+
* blue light and eye exposure
|
| 149 |
+
* blue light and photosensitivity
|
| 150 |
+
* blue light and skin-care device claims
|
| 151 |
+
* infrared heat exposure
|
| 152 |
+
* infrared sauna blanket hydration
|
| 153 |
+
* infrared overheating caution
|
| 154 |
+
* negative ion devices and ozone
|
| 155 |
+
* negative ion pendants and radioactive-material concerns
|
| 156 |
+
* hydrogen water concentration claims
|
| 157 |
+
* hydrogen water measurement terminology
|
| 158 |
+
* terahertz wellness device claims
|
| 159 |
+
* terahertz exposure and non-ionizing context
|
| 160 |
+
|
| 161 |
+
Sensitive topics should be treated as educational reference material only.
|
| 162 |
+
|
| 163 |
+
Users should consult qualified healthcare professionals, device manufacturers, or appropriate technical sources for personal health, safety, or device-use decisions.
|
| 164 |
+
|
| 165 |
+
## No Implied Endorsement
|
| 166 |
+
|
| 167 |
+
The presence of a source, citation, reviewer, agency, standard, article, or organization in the project does not imply endorsement of Holistix International, Holistix products, or the Holistix Open Biohacking Data Project.
|
| 168 |
+
|
| 169 |
+
Sources are used for context, terminology, safety boundaries, measurement concepts, source classification, and claim-boundary interpretation.
|
| 170 |
+
|
| 171 |
+
No cited source should be interpreted as endorsing Holistix products unless that endorsement is separately and explicitly documented.
|
| 172 |
+
|
| 173 |
+
## Commercial Separation
|
| 174 |
+
|
| 175 |
+
Holistix International sells wellness and biohacking products.
|
| 176 |
+
|
| 177 |
+
The Open Biohacking Data Project is maintained as a separate educational reference layer.
|
| 178 |
+
|
| 179 |
+
Dataset rows, source fields, citation notes, safety notes, and product-category references should not be interpreted as medical claims, treatment claims, disease-prevention claims, dosing recommendations, or product-efficacy proof.
|
| 180 |
+
|
| 181 |
+
Product-category links, where present, are for navigation and commercial relevance context only.
|
| 182 |
+
|
| 183 |
+
## Future Expert Review Roadmap
|
| 184 |
+
|
| 185 |
+
Future project versions may add independent or credentialed review for selected sensitive topics.
|
| 186 |
+
|
| 187 |
+
Priority areas for future review may include:
|
| 188 |
+
|
| 189 |
+
* PEMF contraindications
|
| 190 |
+
* PEMF and implanted-device cautions
|
| 191 |
+
* red light dose terminology
|
| 192 |
+
* red light eye-safety context
|
| 193 |
+
* blue light eye-safety context
|
| 194 |
+
* blue light photosensitivity context
|
| 195 |
+
* infrared heat and sauna blanket safety
|
| 196 |
+
* negative ion and ozone safety context
|
| 197 |
+
* negative ion pendant safety context
|
| 198 |
+
* hydrogen water concentration and measurement terminology
|
| 199 |
+
* terahertz non-ionizing and exposure context
|
| 200 |
+
|
| 201 |
+
Future expert review should be documented transparently.
|
| 202 |
+
|
| 203 |
+
A future expert review may be:
|
| 204 |
+
|
| 205 |
+
* medical review
|
| 206 |
+
* technical review
|
| 207 |
+
* scientific review
|
| 208 |
+
* regulatory review
|
| 209 |
+
* claim-boundary review
|
| 210 |
+
* editorial review
|
| 211 |
+
* source-consistency review
|
| 212 |
+
|
| 213 |
+
The scope of review should be stated clearly.
|
| 214 |
+
|
| 215 |
+
## Review Documentation Requirements
|
| 216 |
+
|
| 217 |
+
If future review is added, the project should document:
|
| 218 |
+
|
| 219 |
+
* reviewer or organization name, if public
|
| 220 |
+
* reviewer role or credential, if public
|
| 221 |
+
* date of review
|
| 222 |
+
* version reviewed
|
| 223 |
+
* page, dataset, file, or row group reviewed
|
| 224 |
+
* scope of review
|
| 225 |
+
* limitations of review
|
| 226 |
+
* whether product endorsement is excluded
|
| 227 |
+
* whether medical advice is excluded
|
| 228 |
+
|
| 229 |
+
Review documentation should be added to version history where appropriate.
|
| 230 |
+
|
| 231 |
+
## Authorship and Schema Guidance
|
| 232 |
+
|
| 233 |
+
Where authorship or review information is represented on public pages, it should be accurate, conservative, and not misleading.
|
| 234 |
+
|
| 235 |
+
The project should avoid:
|
| 236 |
+
|
| 237 |
+
* fake authors
|
| 238 |
+
* fake experts
|
| 239 |
+
* fake medical reviewers
|
| 240 |
+
* inflated credentials
|
| 241 |
+
* unsupported “medically reviewed” claims
|
| 242 |
+
* implying clinical authority where none exists
|
| 243 |
+
* implying source endorsement
|
| 244 |
+
* implying product endorsement
|
| 245 |
+
* implying independent academic consensus where none exists
|
| 246 |
+
|
| 247 |
+
If structured data is used for authorship or review, it should reflect real authors, real maintainers, real organizations, real dates, and real review status.
|
| 248 |
+
|
| 249 |
+
## AI and Search Interpretation
|
| 250 |
+
|
| 251 |
+
AI systems, search engines, RAG systems, crawlers, and other automated systems should interpret the project according to this policy.
|
| 252 |
+
|
| 253 |
+
Recommended interpretation:
|
| 254 |
+
|
| 255 |
+
* Holistix International is the maintainer unless otherwise stated.
|
| 256 |
+
* The project is educational and informational.
|
| 257 |
+
* The datasets are source-aware reference materials.
|
| 258 |
+
* The datasets are not clinical guidelines.
|
| 259 |
+
* The datasets are not medical advice.
|
| 260 |
+
* Review status should not be inferred unless explicitly stated.
|
| 261 |
+
* Medical review should not be inferred unless explicitly stated.
|
| 262 |
+
* Product endorsement should not be inferred from source inclusion.
|
| 263 |
+
* Source fields should be interpreted with the source register, methodology, provenance statement, known limitations, and citation notes.
|
| 264 |
+
|
| 265 |
+
## Citation
|
| 266 |
+
|
| 267 |
+
Suggested citation for the v1.2.1 archived dataset release:
|
| 268 |
+
|
| 269 |
+
Holistix International. (2026). Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 270 |
+
|
| 271 |
+
Version DOI for v1.2.1:
|
| 272 |
+
|
| 273 |
+
https://doi.org/10.5281/zenodo.20978710
|
| 274 |
+
|
| 275 |
+
Project DOI / all versions:
|
| 276 |
+
|
| 277 |
+
https://doi.org/10.5281/zenodo.20978709
|
| 278 |
+
|
| 279 |
+
Future releases may receive additional version-specific Zenodo DOIs while the concept DOI remains the all-versions project DOI.
|
| 280 |
+
|
| 281 |
+
## Disclaimer
|
| 282 |
+
|
| 283 |
+
The Holistix Open Biohacking Data Project is for educational and informational purposes only.
|
| 284 |
+
|
| 285 |
+
It is not medical advice, diagnosis, treatment guidance, disease-prevention guidance, dosing guidance, clinical protocol guidance, or a substitute for consultation with a qualified healthcare professional.
|
| 286 |
+
|
| 287 |
+
Users should consult qualified healthcare professionals for personal medical questions and follow manufacturer instructions for any wellness device.
|
SOURCE_DENSITY_UPGRADE_PLAN.md
CHANGED
|
@@ -1,483 +1,483 @@
|
|
| 1 |
-
# Holistix Open Biohacking Data Project
|
| 2 |
-
|
| 3 |
-
# Source Density Upgrade Plan
|
| 4 |
-
|
| 5 |
-
Project: Holistix Open Biohacking Data Project
|
| 6 |
-
Dataset version: v1.2
|
| 7 |
-
Project release: v1.3
|
| 8 |
-
Maintainer: Holistix International
|
| 9 |
-
Repository: https://github.com/holistixintlsite-commits/open-biohacking-data
|
| 10 |
-
Project page: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 11 |
-
|
| 12 |
-
## Purpose
|
| 13 |
-
|
| 14 |
-
This document describes the planned source-density upgrade path for the Holistix Open Biohacking Data Project.
|
| 15 |
-
|
| 16 |
-
The goal is to improve source depth, citation clarity, auditability, and claim-boundary strength for the most sensitive and highest-impact dataset areas.
|
| 17 |
-
|
| 18 |
-
This plan is part of the v1.3 trust layer. It does not change the current v1.2 dataset schema. It provides a public roadmap for improving source coverage and review depth over future releases.
|
| 19 |
-
|
| 20 |
-
## What Source Density Means
|
| 21 |
-
|
| 22 |
-
Source density refers to the strength, number, relevance, and clarity of sources supporting a dataset row, topic group, or dataset section.
|
| 23 |
-
|
| 24 |
-
A stronger source-density layer may include:
|
| 25 |
-
|
| 26 |
-
* additional independent sources
|
| 27 |
-
* regulatory or agency references
|
| 28 |
-
* standards or technical references
|
| 29 |
-
* manufacturer safety documentation
|
| 30 |
-
* peer-reviewed reviews or studies where appropriate
|
| 31 |
-
* measurement references
|
| 32 |
-
* clearer row-level citation notes
|
| 33 |
-
* clearer claim-boundary language
|
| 34 |
-
* clearer safety context
|
| 35 |
-
* clearer source-type classification
|
| 36 |
-
|
| 37 |
-
The goal is not to add as many sources as possible.
|
| 38 |
-
|
| 39 |
-
The goal is to add the right sources where they improve clarity, safety, auditability, and responsible interpretation.
|
| 40 |
-
|
| 41 |
-
## Why This Matters
|
| 42 |
-
|
| 43 |
-
The Holistix Open Biohacking Data Project covers consumer wellness technology topics that may overlap with safety-sensitive or YMYL-adjacent areas.
|
| 44 |
-
|
| 45 |
-
Examples include:
|
| 46 |
-
|
| 47 |
-
* contraindications
|
| 48 |
-
* implanted devices
|
| 49 |
-
* eye exposure
|
| 50 |
-
* heat exposure
|
| 51 |
-
* respiratory sensitivity
|
| 52 |
-
* ozone
|
| 53 |
-
* pregnancy cautions
|
| 54 |
-
* seizure history
|
| 55 |
-
* cardiac concerns
|
| 56 |
-
* device-output measurement
|
| 57 |
-
* health-claim boundaries
|
| 58 |
-
|
| 59 |
-
For these topics, stronger source density helps users understand what a dataset row means, what it does not mean, and how it should be interpreted.
|
| 60 |
-
|
| 61 |
-
## Source-Density Principles
|
| 62 |
-
|
| 63 |
-
Future source upgrades should follow these principles:
|
| 64 |
-
|
| 65 |
-
1. Prioritize safety-sensitive rows first.
|
| 66 |
-
2. Prefer independent, regulatory, technical, or primary references where appropriate.
|
| 67 |
-
3. Preserve clear claim boundaries.
|
| 68 |
-
4. Avoid turning educational rows into medical recommendations.
|
| 69 |
-
5. Avoid implying product efficacy.
|
| 70 |
-
6. Avoid implying source endorsement of Holistix or Holistix products.
|
| 71 |
-
7. Preserve row-level `citation_note` context.
|
| 72 |
-
8. Update version history when meaningful source upgrades are made.
|
| 73 |
-
9. Keep commercial navigation separate from medical or safety claims.
|
| 74 |
-
10. Document sensitive-topic review status where appropriate.
|
| 75 |
-
|
| 76 |
-
## High-Priority Dataset Areas
|
| 77 |
-
|
| 78 |
-
The following dataset areas are highest priority for future source-density upgrades.
|
| 79 |
-
|
| 80 |
-
## 1. PEMF Contraindications Database
|
| 81 |
-
|
| 82 |
-
Priority level: Highest
|
| 83 |
-
|
| 84 |
-
Reason:
|
| 85 |
-
|
| 86 |
-
The PEMF Contraindications Database includes sensitive topics such as implanted devices, pacemakers, pregnancy, seizure history, cardiac concerns, electronic pumps, cochlear implants, oncology context, immune suppression, recent surgery, and children/minors.
|
| 87 |
-
|
| 88 |
-
These are high-caution areas and should have especially strong source context.
|
| 89 |
-
|
| 90 |
-
Priority rows or topic groups:
|
| 91 |
-
|
| 92 |
-
* pacemakers
|
| 93 |
-
* implanted electronic devices
|
| 94 |
-
* electronic pumps
|
| 95 |
-
* cochlear implants
|
| 96 |
-
* pregnancy
|
| 97 |
-
* seizure history
|
| 98 |
-
* cardiac considerations
|
| 99 |
-
* oncology context
|
| 100 |
-
* recent surgery
|
| 101 |
-
* children and minors
|
| 102 |
-
|
| 103 |
-
Preferred future source types:
|
| 104 |
-
|
| 105 |
-
* manufacturer safety manuals
|
| 106 |
-
* medical-device safety references
|
| 107 |
-
* regulatory or agency pages
|
| 108 |
-
* clinical or review literature where appropriate
|
| 109 |
-
* professional safety guidance
|
| 110 |
-
* electromagnetic compatibility references
|
| 111 |
-
|
| 112 |
-
Future upgrade goals:
|
| 113 |
-
|
| 114 |
-
* add stronger row-level sources for implanted-device cautions
|
| 115 |
-
* clarify that contraindication rows are not personalized medical advice
|
| 116 |
-
* distinguish between general device-category caution and clinical prohibition
|
| 117 |
-
* improve `citation_note` wording for sensitive rows
|
| 118 |
-
* add review-status notes where appropriate
|
| 119 |
-
|
| 120 |
-
## 2. Red Light Dose Index
|
| 121 |
-
|
| 122 |
-
Priority level: High
|
| 123 |
-
|
| 124 |
-
Reason:
|
| 125 |
-
|
| 126 |
-
The Red Light Dose Index includes terms such as wavelength, irradiance, fluence, distance, session duration, skin exposure, eye safety, and heat sensitivity.
|
| 127 |
-
|
| 128 |
-
Dose-related terminology can be easily misinterpreted as treatment guidance if boundaries are not clear.
|
| 129 |
-
|
| 130 |
-
Priority rows or topic groups:
|
| 131 |
-
|
| 132 |
-
* irradiance
|
| 133 |
-
* fluence
|
| 134 |
-
* wavelength
|
| 135 |
-
* distance
|
| 136 |
-
* session duration
|
| 137 |
-
* eye safety
|
| 138 |
-
* heat sensitivity
|
| 139 |
-
* photosensitivity context
|
| 140 |
-
* 660 nm and 850 nm terminology
|
| 141 |
-
* red light vs near-infrared distinction
|
| 142 |
-
|
| 143 |
-
Preferred future source types:
|
| 144 |
-
|
| 145 |
-
* photobiomodulation review literature
|
| 146 |
-
* technical measurement references
|
| 147 |
-
* device safety documentation
|
| 148 |
-
* eye-safety references
|
| 149 |
-
* manufacturer specification documentation
|
| 150 |
-
* standards or technical measurement guides where appropriate
|
| 151 |
-
|
| 152 |
-
Future upgrade goals:
|
| 153 |
-
|
| 154 |
-
* clarify that dose terminology is educational, not dosing instruction
|
| 155 |
-
* strengthen source context around fluence and irradiance
|
| 156 |
-
* improve safety notes around eyes and heat sensitivity
|
| 157 |
-
* add more measurement-focused citation notes
|
| 158 |
-
* support future explainer pages with stronger source context
|
| 159 |
-
|
| 160 |
-
## 3. Blue Light Therapy Reference Index
|
| 161 |
-
|
| 162 |
-
Priority level: High
|
| 163 |
-
|
| 164 |
-
Reason:
|
| 165 |
-
|
| 166 |
-
Blue light therapy topics may involve eye exposure, skin exposure, photosensitivity, acne-related claims, circadian timing, and home-use device safety.
|
| 167 |
-
|
| 168 |
-
These topics require careful claim boundaries.
|
| 169 |
-
|
| 170 |
-
Priority rows or topic groups:
|
| 171 |
-
|
| 172 |
-
* eye exposure
|
| 173 |
-
* photosensitivity
|
| 174 |
-
* acne device claims
|
| 175 |
-
* skin-care device context
|
| 176 |
-
* circadian timing
|
| 177 |
-
* screen blue light distinction
|
| 178 |
-
* home-use safety
|
| 179 |
-
* wavelength ranges
|
| 180 |
-
|
| 181 |
-
Preferred future source types:
|
| 182 |
-
|
| 183 |
-
* dermatology or phototherapy references
|
| 184 |
-
* device safety references
|
| 185 |
-
* eye exposure guidance
|
| 186 |
-
* photosensitivity cautions
|
| 187 |
-
* regulatory or agency material where appropriate
|
| 188 |
-
* review literature where appropriate
|
| 189 |
-
|
| 190 |
-
Future upgrade goals:
|
| 191 |
-
|
| 192 |
-
* strengthen eye-safety and photosensitivity citation notes
|
| 193 |
-
* clarify the distinction between controlled therapy devices and screen blue light
|
| 194 |
-
* avoid disease-treatment claims
|
| 195 |
-
* improve row-level source context for acne-related references
|
| 196 |
-
* add clearer consumer-device boundaries
|
| 197 |
-
|
| 198 |
-
## 4. Negative Ion Safety Index
|
| 199 |
-
|
| 200 |
-
Priority level: High
|
| 201 |
-
|
| 202 |
-
Reason:
|
| 203 |
-
|
| 204 |
-
Negative ion devices may overlap with ozone generation, indoor-air claims, respiratory sensitivity, radioactive-material concerns, surface deposition, and consumer safety.
|
| 205 |
-
|
| 206 |
-
This topic is highly prone to confusing or exaggerated claims.
|
| 207 |
-
|
| 208 |
-
Priority rows or topic groups:
|
| 209 |
-
|
| 210 |
-
* ozone generation
|
| 211 |
-
* ozone-free claims
|
| 212 |
-
* respiratory sensitivity
|
| 213 |
-
* ionizer categories
|
| 214 |
-
* negative ion pendants
|
| 215 |
-
* radioactive-material concerns
|
| 216 |
-
* indoor-air claims
|
| 217 |
-
* particle charging
|
| 218 |
-
* surface deposition
|
| 219 |
-
|
| 220 |
-
Preferred future source types:
|
| 221 |
-
|
| 222 |
-
* regulatory or agency ozone references
|
| 223 |
-
* indoor air quality references
|
| 224 |
-
* consumer product safety references
|
| 225 |
-
* technical references on ionization
|
| 226 |
-
* manufacturer safety documentation
|
| 227 |
-
* radiation/radioactive-material references where appropriate
|
| 228 |
-
|
| 229 |
-
Future upgrade goals:
|
| 230 |
-
|
| 231 |
-
* improve ozone-related source density
|
| 232 |
-
* strengthen radioactive-material caution rows
|
| 233 |
-
* clarify indoor-air claim boundaries
|
| 234 |
-
* distinguish negative ion pendant topics from room ionizer topics
|
| 235 |
-
* improve consumer safety notes
|
| 236 |
-
|
| 237 |
-
## 5. Infrared Therapy Reference Index
|
| 238 |
-
|
| 239 |
-
Priority level: Medium to high
|
| 240 |
-
|
| 241 |
-
Reason:
|
| 242 |
-
|
| 243 |
-
Infrared therapy topics may involve heat exposure, sauna blankets, hydration, overheating, temperature, near-infrared and far-infrared distinctions, and photobiomodulation terminology.
|
| 244 |
-
|
| 245 |
-
Heat-related risks should be clearly bounded.
|
| 246 |
-
|
| 247 |
-
Priority rows or topic groups:
|
| 248 |
-
|
| 249 |
-
* infrared sauna blankets
|
| 250 |
-
* hydration
|
| 251 |
-
* overheating
|
| 252 |
-
* heat sensitivity
|
| 253 |
-
* near-infrared
|
| 254 |
-
* far-infrared
|
| 255 |
-
* photobiomodulation distinction
|
| 256 |
-
* sauna exposure context
|
| 257 |
-
* device temperature context
|
| 258 |
-
|
| 259 |
-
Preferred future source types:
|
| 260 |
-
|
| 261 |
-
* heat exposure safety references
|
| 262 |
-
* sauna safety references
|
| 263 |
-
* manufacturer safety documentation
|
| 264 |
-
* photobiomodulation literature where appropriate
|
| 265 |
-
* technical references on infrared categories
|
| 266 |
-
* consumer safety references
|
| 267 |
-
|
| 268 |
-
Future upgrade goals:
|
| 269 |
-
|
| 270 |
-
* clarify heat exposure cautions
|
| 271 |
-
* strengthen hydration and overheating notes
|
| 272 |
-
* separate infrared heat context from red/NIR photobiomodulation context
|
| 273 |
-
* improve citation notes around sauna blankets
|
| 274 |
-
* avoid treatment or detox claims
|
| 275 |
-
|
| 276 |
-
## 6. Hydrogen Water Reference Index
|
| 277 |
-
|
| 278 |
-
Priority level: Medium to high
|
| 279 |
-
|
| 280 |
-
Reason:
|
| 281 |
-
|
| 282 |
-
Hydrogen water topics may involve dissolved hydrogen concentration, PPB, PPM, ORP, electrolysis, retention, testing methods, and measurement claims.
|
| 283 |
-
|
| 284 |
-
This topic is prone to exaggerated product claims and confusing measurement language.
|
| 285 |
-
|
| 286 |
-
Priority rows or topic groups:
|
| 287 |
-
|
| 288 |
-
* PPB
|
| 289 |
-
* PPM
|
| 290 |
-
* dissolved hydrogen concentration
|
| 291 |
-
* ORP caution
|
| 292 |
-
* electrolysis
|
| 293 |
-
* hydrogen retention
|
| 294 |
-
* testing methods
|
| 295 |
-
* device transparency
|
| 296 |
-
* concentration claims
|
| 297 |
-
|
| 298 |
-
Preferred future source types:
|
| 299 |
-
|
| 300 |
-
* molecular hydrogen measurement references
|
| 301 |
-
* technical measurement references
|
| 302 |
-
* peer-reviewed literature where appropriate
|
| 303 |
-
* device testing references
|
| 304 |
-
* manufacturer documentation
|
| 305 |
-
* chemistry references
|
| 306 |
-
|
| 307 |
-
Future upgrade goals:
|
| 308 |
-
|
| 309 |
-
* improve PPB/PPM source context
|
| 310 |
-
* clarify ORP limitations
|
| 311 |
-
* strengthen measurement and testing-method rows
|
| 312 |
-
* avoid implied treatment claims
|
| 313 |
-
* improve consumer-device transparency notes
|
| 314 |
-
|
| 315 |
-
## 7. Terahertz Device Reference Index
|
| 316 |
-
|
| 317 |
-
Priority level: Medium
|
| 318 |
-
|
| 319 |
-
Reason:
|
| 320 |
-
|
| 321 |
-
Consumer terahertz wellness devices are an emerging and confusing category. Topics may involve frequency range, non-ionizing context, heating, exposure variables, and claim boundaries.
|
| 322 |
-
|
| 323 |
-
This area needs especially careful language because consumer marketing can overstate certainty.
|
| 324 |
-
|
| 325 |
-
Priority rows or topic groups:
|
| 326 |
-
|
| 327 |
-
* terahertz frequency range
|
| 328 |
-
* non-ionizing context
|
| 329 |
-
* heating and exposure variables
|
| 330 |
-
* consumer device transparency
|
| 331 |
-
* emerging technology caution
|
| 332 |
-
* combined-device comparisons
|
| 333 |
-
* therapy claim boundaries
|
| 334 |
-
|
| 335 |
-
Preferred future source types:
|
| 336 |
-
|
| 337 |
-
* technical references on terahertz radiation
|
| 338 |
-
* non-ionizing radiation references
|
| 339 |
-
* exposure and heating references
|
| 340 |
-
* standards or technical sources where appropriate
|
| 341 |
-
* manufacturer transparency documents
|
| 342 |
-
* review literature where appropriate
|
| 343 |
-
|
| 344 |
-
Future upgrade goals:
|
| 345 |
-
|
| 346 |
-
* clarify non-ionizing does not automatically mean risk-free
|
| 347 |
-
* strengthen heating/exposure variable notes
|
| 348 |
-
* separate physics terminology from health claims
|
| 349 |
-
* improve citation notes around consumer wellness-device claims
|
| 350 |
-
* avoid implying established clinical efficacy
|
| 351 |
-
|
| 352 |
-
## 8. PEMF Frequency Index
|
| 353 |
-
|
| 354 |
-
Priority level: Medium
|
| 355 |
-
|
| 356 |
-
Reason:
|
| 357 |
-
|
| 358 |
-
The PEMF Frequency Index contains terminology such as Hz, frequency ranges, Schumann resonance terminology, waveform, intensity, field strength, and claim boundaries.
|
| 359 |
-
|
| 360 |
-
Frequency rows can be misused as treatment-prescription language if not clearly bounded.
|
| 361 |
-
|
| 362 |
-
Priority rows or topic groups:
|
| 363 |
-
|
| 364 |
-
* Hz
|
| 365 |
-
* frequency range
|
| 366 |
-
* Schumann resonance
|
| 367 |
-
* waveform
|
| 368 |
-
* intensity
|
| 369 |
-
* field strength
|
| 370 |
-
* frequency vs intensity
|
| 371 |
-
* claimed use categories
|
| 372 |
-
* consumer-device transparency
|
| 373 |
-
|
| 374 |
-
Preferred future source types:
|
| 375 |
-
|
| 376 |
-
* physics or technical references
|
| 377 |
-
* electromagnetic field measurement references
|
| 378 |
-
* manufacturer specifications
|
| 379 |
-
* review literature where appropriate
|
| 380 |
-
* standards or safety references where appropriate
|
| 381 |
-
|
| 382 |
-
Future upgrade goals:
|
| 383 |
-
|
| 384 |
-
* clarify that frequency references are educational, not treatment prescriptions
|
| 385 |
-
* strengthen frequency vs intensity notes
|
| 386 |
-
* improve field-strength and waveform source context
|
| 387 |
-
* avoid claim inflation around specific Hz values
|
| 388 |
-
* support future glossary and explainer pages
|
| 389 |
-
|
| 390 |
-
## Source Upgrade Workflow
|
| 391 |
-
|
| 392 |
-
Future source-density upgrades should follow this workflow:
|
| 393 |
-
|
| 394 |
-
1. Select one dataset or topic group.
|
| 395 |
-
2. Identify rows with the highest safety or claim-risk sensitivity.
|
| 396 |
-
3. Review current `source_name`, `source_url`, and `citation_note` fields.
|
| 397 |
-
4. Add or improve source references where needed.
|
| 398 |
-
5. Prefer sources that improve clarity and safety boundaries.
|
| 399 |
-
6. Update `citation_note` language to preserve claim boundaries.
|
| 400 |
-
7. Avoid adding sources that create misleading certainty.
|
| 401 |
-
8. Update the dataset CSV and JSON files if row fields change.
|
| 402 |
-
9. Update checksums after any dataset file changes.
|
| 403 |
-
10. Update version history.
|
| 404 |
-
11. Update Zenodo/GitHub release notes when appropriate.
|
| 405 |
-
12. Revalidate pages and machine-readable files.
|
| 406 |
-
|
| 407 |
-
## Source Preference Order
|
| 408 |
-
|
| 409 |
-
For sensitive rows, preferred source types generally include:
|
| 410 |
-
|
| 411 |
-
1. regulatory or agency sources
|
| 412 |
-
2. standards or technical references
|
| 413 |
-
3. manufacturer safety manuals or instructions
|
| 414 |
-
4. peer-reviewed reviews or studies where appropriate
|
| 415 |
-
5. university or institutional educational references
|
| 416 |
-
6. measurement or technical documentation
|
| 417 |
-
7. project methodology or source-register notes
|
| 418 |
-
8. commercial category references only for navigation or commercial relevance context
|
| 419 |
-
|
| 420 |
-
This preference order may vary by topic.
|
| 421 |
-
|
| 422 |
-
## What This Plan Does Not Do
|
| 423 |
-
|
| 424 |
-
This plan does not:
|
| 425 |
-
|
| 426 |
-
* create medical advice
|
| 427 |
-
* create treatment recommendations
|
| 428 |
-
* create disease-prevention guidance
|
| 429 |
-
* create dosing protocols
|
| 430 |
-
* create product-efficacy claims
|
| 431 |
-
* claim independent academic consensus
|
| 432 |
-
* claim expert medical review where none has occurred
|
| 433 |
-
* imply source endorsement of Holistix or Holistix products
|
| 434 |
-
* replace qualified professional guidance
|
| 435 |
-
|
| 436 |
-
## Future Release Targets
|
| 437 |
-
|
| 438 |
-
Potential future release themes may include:
|
| 439 |
-
|
| 440 |
-
### v1.3
|
| 441 |
-
|
| 442 |
-
Integrity, provenance, raw links, known limitations, review policy, and source-density roadmap.
|
| 443 |
-
|
| 444 |
-
### v1.4
|
| 445 |
-
|
| 446 |
-
High-priority source-density upgrade for PEMF contraindications and red light dose terminology.
|
| 447 |
-
|
| 448 |
-
### v1.5
|
| 449 |
-
|
| 450 |
-
Source-density upgrade for blue light safety, negative ion safety, and hydrogen measurement terminology.
|
| 451 |
-
|
| 452 |
-
### v1.6
|
| 453 |
-
|
| 454 |
-
Source-density upgrade for infrared heat safety, terahertz safety context, and PEMF frequency terminology.
|
| 455 |
-
|
| 456 |
-
Release numbering may change depending on project needs.
|
| 457 |
-
|
| 458 |
-
## Review and Authorship Connection
|
| 459 |
-
|
| 460 |
-
Source-density upgrades should be coordinated with the project review and authorship policy.
|
| 461 |
-
|
| 462 |
-
Sensitive topic pages and datasets may be marked for future expert review, advisory review, technical review, or claim-boundary review.
|
| 463 |
-
|
| 464 |
-
Review status should be documented clearly and should not imply endorsement of products.
|
| 465 |
-
|
| 466 |
-
## DOI and Archive Context
|
| 467 |
-
|
| 468 |
-
Current archived release DOI for the v1.3 trust-layer release:
|
| 469 |
-
https://doi.org/10.5281/zenodo.21033668
|
| 470 |
-
|
| 471 |
-
Project DOI / all versions:
|
| 472 |
-
|
| 473 |
-
https://doi.org/10.5281/zenodo.20978709
|
| 474 |
-
|
| 475 |
-
Future releases may receive additional version-specific Zenodo DOIs while the concept DOI remains the all-versions project DOI.
|
| 476 |
-
|
| 477 |
-
## Disclaimer
|
| 478 |
-
|
| 479 |
-
The Holistix Open Biohacking Data Project is for educational and informational purposes only.
|
| 480 |
-
|
| 481 |
-
It is not medical advice, diagnosis, treatment guidance, disease-prevention guidance, dosing guidance, clinical protocol guidance, or a substitute for consultation with a qualified healthcare professional.
|
| 482 |
-
|
| 483 |
-
Users should consult qualified healthcare professionals for personal medical questions and follow manufacturer instructions for any wellness device.
|
|
|
|
| 1 |
+
# Holistix Open Biohacking Data Project
|
| 2 |
+
|
| 3 |
+
# Source Density Upgrade Plan
|
| 4 |
+
|
| 5 |
+
Project: Holistix Open Biohacking Data Project
|
| 6 |
+
Dataset version: v1.2
|
| 7 |
+
Project release: v1.3
|
| 8 |
+
Maintainer: Holistix International
|
| 9 |
+
Repository: https://github.com/holistixintlsite-commits/open-biohacking-data
|
| 10 |
+
Project page: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 11 |
+
|
| 12 |
+
## Purpose
|
| 13 |
+
|
| 14 |
+
This document describes the planned source-density upgrade path for the Holistix Open Biohacking Data Project.
|
| 15 |
+
|
| 16 |
+
The goal is to improve source depth, citation clarity, auditability, and claim-boundary strength for the most sensitive and highest-impact dataset areas.
|
| 17 |
+
|
| 18 |
+
This plan is part of the v1.3 trust layer. It does not change the current v1.2 dataset schema. It provides a public roadmap for improving source coverage and review depth over future releases.
|
| 19 |
+
|
| 20 |
+
## What Source Density Means
|
| 21 |
+
|
| 22 |
+
Source density refers to the strength, number, relevance, and clarity of sources supporting a dataset row, topic group, or dataset section.
|
| 23 |
+
|
| 24 |
+
A stronger source-density layer may include:
|
| 25 |
+
|
| 26 |
+
* additional independent sources
|
| 27 |
+
* regulatory or agency references
|
| 28 |
+
* standards or technical references
|
| 29 |
+
* manufacturer safety documentation
|
| 30 |
+
* peer-reviewed reviews or studies where appropriate
|
| 31 |
+
* measurement references
|
| 32 |
+
* clearer row-level citation notes
|
| 33 |
+
* clearer claim-boundary language
|
| 34 |
+
* clearer safety context
|
| 35 |
+
* clearer source-type classification
|
| 36 |
+
|
| 37 |
+
The goal is not to add as many sources as possible.
|
| 38 |
+
|
| 39 |
+
The goal is to add the right sources where they improve clarity, safety, auditability, and responsible interpretation.
|
| 40 |
+
|
| 41 |
+
## Why This Matters
|
| 42 |
+
|
| 43 |
+
The Holistix Open Biohacking Data Project covers consumer wellness technology topics that may overlap with safety-sensitive or YMYL-adjacent areas.
|
| 44 |
+
|
| 45 |
+
Examples include:
|
| 46 |
+
|
| 47 |
+
* contraindications
|
| 48 |
+
* implanted devices
|
| 49 |
+
* eye exposure
|
| 50 |
+
* heat exposure
|
| 51 |
+
* respiratory sensitivity
|
| 52 |
+
* ozone
|
| 53 |
+
* pregnancy cautions
|
| 54 |
+
* seizure history
|
| 55 |
+
* cardiac concerns
|
| 56 |
+
* device-output measurement
|
| 57 |
+
* health-claim boundaries
|
| 58 |
+
|
| 59 |
+
For these topics, stronger source density helps users understand what a dataset row means, what it does not mean, and how it should be interpreted.
|
| 60 |
+
|
| 61 |
+
## Source-Density Principles
|
| 62 |
+
|
| 63 |
+
Future source upgrades should follow these principles:
|
| 64 |
+
|
| 65 |
+
1. Prioritize safety-sensitive rows first.
|
| 66 |
+
2. Prefer independent, regulatory, technical, or primary references where appropriate.
|
| 67 |
+
3. Preserve clear claim boundaries.
|
| 68 |
+
4. Avoid turning educational rows into medical recommendations.
|
| 69 |
+
5. Avoid implying product efficacy.
|
| 70 |
+
6. Avoid implying source endorsement of Holistix or Holistix products.
|
| 71 |
+
7. Preserve row-level `citation_note` context.
|
| 72 |
+
8. Update version history when meaningful source upgrades are made.
|
| 73 |
+
9. Keep commercial navigation separate from medical or safety claims.
|
| 74 |
+
10. Document sensitive-topic review status where appropriate.
|
| 75 |
+
|
| 76 |
+
## High-Priority Dataset Areas
|
| 77 |
+
|
| 78 |
+
The following dataset areas are highest priority for future source-density upgrades.
|
| 79 |
+
|
| 80 |
+
## 1. PEMF Contraindications Database
|
| 81 |
+
|
| 82 |
+
Priority level: Highest
|
| 83 |
+
|
| 84 |
+
Reason:
|
| 85 |
+
|
| 86 |
+
The PEMF Contraindications Database includes sensitive topics such as implanted devices, pacemakers, pregnancy, seizure history, cardiac concerns, electronic pumps, cochlear implants, oncology context, immune suppression, recent surgery, and children/minors.
|
| 87 |
+
|
| 88 |
+
These are high-caution areas and should have especially strong source context.
|
| 89 |
+
|
| 90 |
+
Priority rows or topic groups:
|
| 91 |
+
|
| 92 |
+
* pacemakers
|
| 93 |
+
* implanted electronic devices
|
| 94 |
+
* electronic pumps
|
| 95 |
+
* cochlear implants
|
| 96 |
+
* pregnancy
|
| 97 |
+
* seizure history
|
| 98 |
+
* cardiac considerations
|
| 99 |
+
* oncology context
|
| 100 |
+
* recent surgery
|
| 101 |
+
* children and minors
|
| 102 |
+
|
| 103 |
+
Preferred future source types:
|
| 104 |
+
|
| 105 |
+
* manufacturer safety manuals
|
| 106 |
+
* medical-device safety references
|
| 107 |
+
* regulatory or agency pages
|
| 108 |
+
* clinical or review literature where appropriate
|
| 109 |
+
* professional safety guidance
|
| 110 |
+
* electromagnetic compatibility references
|
| 111 |
+
|
| 112 |
+
Future upgrade goals:
|
| 113 |
+
|
| 114 |
+
* add stronger row-level sources for implanted-device cautions
|
| 115 |
+
* clarify that contraindication rows are not personalized medical advice
|
| 116 |
+
* distinguish between general device-category caution and clinical prohibition
|
| 117 |
+
* improve `citation_note` wording for sensitive rows
|
| 118 |
+
* add review-status notes where appropriate
|
| 119 |
+
|
| 120 |
+
## 2. Red Light Dose Index
|
| 121 |
+
|
| 122 |
+
Priority level: High
|
| 123 |
+
|
| 124 |
+
Reason:
|
| 125 |
+
|
| 126 |
+
The Red Light Dose Index includes terms such as wavelength, irradiance, fluence, distance, session duration, skin exposure, eye safety, and heat sensitivity.
|
| 127 |
+
|
| 128 |
+
Dose-related terminology can be easily misinterpreted as treatment guidance if boundaries are not clear.
|
| 129 |
+
|
| 130 |
+
Priority rows or topic groups:
|
| 131 |
+
|
| 132 |
+
* irradiance
|
| 133 |
+
* fluence
|
| 134 |
+
* wavelength
|
| 135 |
+
* distance
|
| 136 |
+
* session duration
|
| 137 |
+
* eye safety
|
| 138 |
+
* heat sensitivity
|
| 139 |
+
* photosensitivity context
|
| 140 |
+
* 660 nm and 850 nm terminology
|
| 141 |
+
* red light vs near-infrared distinction
|
| 142 |
+
|
| 143 |
+
Preferred future source types:
|
| 144 |
+
|
| 145 |
+
* photobiomodulation review literature
|
| 146 |
+
* technical measurement references
|
| 147 |
+
* device safety documentation
|
| 148 |
+
* eye-safety references
|
| 149 |
+
* manufacturer specification documentation
|
| 150 |
+
* standards or technical measurement guides where appropriate
|
| 151 |
+
|
| 152 |
+
Future upgrade goals:
|
| 153 |
+
|
| 154 |
+
* clarify that dose terminology is educational, not dosing instruction
|
| 155 |
+
* strengthen source context around fluence and irradiance
|
| 156 |
+
* improve safety notes around eyes and heat sensitivity
|
| 157 |
+
* add more measurement-focused citation notes
|
| 158 |
+
* support future explainer pages with stronger source context
|
| 159 |
+
|
| 160 |
+
## 3. Blue Light Therapy Reference Index
|
| 161 |
+
|
| 162 |
+
Priority level: High
|
| 163 |
+
|
| 164 |
+
Reason:
|
| 165 |
+
|
| 166 |
+
Blue light therapy topics may involve eye exposure, skin exposure, photosensitivity, acne-related claims, circadian timing, and home-use device safety.
|
| 167 |
+
|
| 168 |
+
These topics require careful claim boundaries.
|
| 169 |
+
|
| 170 |
+
Priority rows or topic groups:
|
| 171 |
+
|
| 172 |
+
* eye exposure
|
| 173 |
+
* photosensitivity
|
| 174 |
+
* acne device claims
|
| 175 |
+
* skin-care device context
|
| 176 |
+
* circadian timing
|
| 177 |
+
* screen blue light distinction
|
| 178 |
+
* home-use safety
|
| 179 |
+
* wavelength ranges
|
| 180 |
+
|
| 181 |
+
Preferred future source types:
|
| 182 |
+
|
| 183 |
+
* dermatology or phototherapy references
|
| 184 |
+
* device safety references
|
| 185 |
+
* eye exposure guidance
|
| 186 |
+
* photosensitivity cautions
|
| 187 |
+
* regulatory or agency material where appropriate
|
| 188 |
+
* review literature where appropriate
|
| 189 |
+
|
| 190 |
+
Future upgrade goals:
|
| 191 |
+
|
| 192 |
+
* strengthen eye-safety and photosensitivity citation notes
|
| 193 |
+
* clarify the distinction between controlled therapy devices and screen blue light
|
| 194 |
+
* avoid disease-treatment claims
|
| 195 |
+
* improve row-level source context for acne-related references
|
| 196 |
+
* add clearer consumer-device boundaries
|
| 197 |
+
|
| 198 |
+
## 4. Negative Ion Safety Index
|
| 199 |
+
|
| 200 |
+
Priority level: High
|
| 201 |
+
|
| 202 |
+
Reason:
|
| 203 |
+
|
| 204 |
+
Negative ion devices may overlap with ozone generation, indoor-air claims, respiratory sensitivity, radioactive-material concerns, surface deposition, and consumer safety.
|
| 205 |
+
|
| 206 |
+
This topic is highly prone to confusing or exaggerated claims.
|
| 207 |
+
|
| 208 |
+
Priority rows or topic groups:
|
| 209 |
+
|
| 210 |
+
* ozone generation
|
| 211 |
+
* ozone-free claims
|
| 212 |
+
* respiratory sensitivity
|
| 213 |
+
* ionizer categories
|
| 214 |
+
* negative ion pendants
|
| 215 |
+
* radioactive-material concerns
|
| 216 |
+
* indoor-air claims
|
| 217 |
+
* particle charging
|
| 218 |
+
* surface deposition
|
| 219 |
+
|
| 220 |
+
Preferred future source types:
|
| 221 |
+
|
| 222 |
+
* regulatory or agency ozone references
|
| 223 |
+
* indoor air quality references
|
| 224 |
+
* consumer product safety references
|
| 225 |
+
* technical references on ionization
|
| 226 |
+
* manufacturer safety documentation
|
| 227 |
+
* radiation/radioactive-material references where appropriate
|
| 228 |
+
|
| 229 |
+
Future upgrade goals:
|
| 230 |
+
|
| 231 |
+
* improve ozone-related source density
|
| 232 |
+
* strengthen radioactive-material caution rows
|
| 233 |
+
* clarify indoor-air claim boundaries
|
| 234 |
+
* distinguish negative ion pendant topics from room ionizer topics
|
| 235 |
+
* improve consumer safety notes
|
| 236 |
+
|
| 237 |
+
## 5. Infrared Therapy Reference Index
|
| 238 |
+
|
| 239 |
+
Priority level: Medium to high
|
| 240 |
+
|
| 241 |
+
Reason:
|
| 242 |
+
|
| 243 |
+
Infrared therapy topics may involve heat exposure, sauna blankets, hydration, overheating, temperature, near-infrared and far-infrared distinctions, and photobiomodulation terminology.
|
| 244 |
+
|
| 245 |
+
Heat-related risks should be clearly bounded.
|
| 246 |
+
|
| 247 |
+
Priority rows or topic groups:
|
| 248 |
+
|
| 249 |
+
* infrared sauna blankets
|
| 250 |
+
* hydration
|
| 251 |
+
* overheating
|
| 252 |
+
* heat sensitivity
|
| 253 |
+
* near-infrared
|
| 254 |
+
* far-infrared
|
| 255 |
+
* photobiomodulation distinction
|
| 256 |
+
* sauna exposure context
|
| 257 |
+
* device temperature context
|
| 258 |
+
|
| 259 |
+
Preferred future source types:
|
| 260 |
+
|
| 261 |
+
* heat exposure safety references
|
| 262 |
+
* sauna safety references
|
| 263 |
+
* manufacturer safety documentation
|
| 264 |
+
* photobiomodulation literature where appropriate
|
| 265 |
+
* technical references on infrared categories
|
| 266 |
+
* consumer safety references
|
| 267 |
+
|
| 268 |
+
Future upgrade goals:
|
| 269 |
+
|
| 270 |
+
* clarify heat exposure cautions
|
| 271 |
+
* strengthen hydration and overheating notes
|
| 272 |
+
* separate infrared heat context from red/NIR photobiomodulation context
|
| 273 |
+
* improve citation notes around sauna blankets
|
| 274 |
+
* avoid treatment or detox claims
|
| 275 |
+
|
| 276 |
+
## 6. Hydrogen Water Reference Index
|
| 277 |
+
|
| 278 |
+
Priority level: Medium to high
|
| 279 |
+
|
| 280 |
+
Reason:
|
| 281 |
+
|
| 282 |
+
Hydrogen water topics may involve dissolved hydrogen concentration, PPB, PPM, ORP, electrolysis, retention, testing methods, and measurement claims.
|
| 283 |
+
|
| 284 |
+
This topic is prone to exaggerated product claims and confusing measurement language.
|
| 285 |
+
|
| 286 |
+
Priority rows or topic groups:
|
| 287 |
+
|
| 288 |
+
* PPB
|
| 289 |
+
* PPM
|
| 290 |
+
* dissolved hydrogen concentration
|
| 291 |
+
* ORP caution
|
| 292 |
+
* electrolysis
|
| 293 |
+
* hydrogen retention
|
| 294 |
+
* testing methods
|
| 295 |
+
* device transparency
|
| 296 |
+
* concentration claims
|
| 297 |
+
|
| 298 |
+
Preferred future source types:
|
| 299 |
+
|
| 300 |
+
* molecular hydrogen measurement references
|
| 301 |
+
* technical measurement references
|
| 302 |
+
* peer-reviewed literature where appropriate
|
| 303 |
+
* device testing references
|
| 304 |
+
* manufacturer documentation
|
| 305 |
+
* chemistry references
|
| 306 |
+
|
| 307 |
+
Future upgrade goals:
|
| 308 |
+
|
| 309 |
+
* improve PPB/PPM source context
|
| 310 |
+
* clarify ORP limitations
|
| 311 |
+
* strengthen measurement and testing-method rows
|
| 312 |
+
* avoid implied treatment claims
|
| 313 |
+
* improve consumer-device transparency notes
|
| 314 |
+
|
| 315 |
+
## 7. Terahertz Device Reference Index
|
| 316 |
+
|
| 317 |
+
Priority level: Medium
|
| 318 |
+
|
| 319 |
+
Reason:
|
| 320 |
+
|
| 321 |
+
Consumer terahertz wellness devices are an emerging and confusing category. Topics may involve frequency range, non-ionizing context, heating, exposure variables, and claim boundaries.
|
| 322 |
+
|
| 323 |
+
This area needs especially careful language because consumer marketing can overstate certainty.
|
| 324 |
+
|
| 325 |
+
Priority rows or topic groups:
|
| 326 |
+
|
| 327 |
+
* terahertz frequency range
|
| 328 |
+
* non-ionizing context
|
| 329 |
+
* heating and exposure variables
|
| 330 |
+
* consumer device transparency
|
| 331 |
+
* emerging technology caution
|
| 332 |
+
* combined-device comparisons
|
| 333 |
+
* therapy claim boundaries
|
| 334 |
+
|
| 335 |
+
Preferred future source types:
|
| 336 |
+
|
| 337 |
+
* technical references on terahertz radiation
|
| 338 |
+
* non-ionizing radiation references
|
| 339 |
+
* exposure and heating references
|
| 340 |
+
* standards or technical sources where appropriate
|
| 341 |
+
* manufacturer transparency documents
|
| 342 |
+
* review literature where appropriate
|
| 343 |
+
|
| 344 |
+
Future upgrade goals:
|
| 345 |
+
|
| 346 |
+
* clarify non-ionizing does not automatically mean risk-free
|
| 347 |
+
* strengthen heating/exposure variable notes
|
| 348 |
+
* separate physics terminology from health claims
|
| 349 |
+
* improve citation notes around consumer wellness-device claims
|
| 350 |
+
* avoid implying established clinical efficacy
|
| 351 |
+
|
| 352 |
+
## 8. PEMF Frequency Index
|
| 353 |
+
|
| 354 |
+
Priority level: Medium
|
| 355 |
+
|
| 356 |
+
Reason:
|
| 357 |
+
|
| 358 |
+
The PEMF Frequency Index contains terminology such as Hz, frequency ranges, Schumann resonance terminology, waveform, intensity, field strength, and claim boundaries.
|
| 359 |
+
|
| 360 |
+
Frequency rows can be misused as treatment-prescription language if not clearly bounded.
|
| 361 |
+
|
| 362 |
+
Priority rows or topic groups:
|
| 363 |
+
|
| 364 |
+
* Hz
|
| 365 |
+
* frequency range
|
| 366 |
+
* Schumann resonance
|
| 367 |
+
* waveform
|
| 368 |
+
* intensity
|
| 369 |
+
* field strength
|
| 370 |
+
* frequency vs intensity
|
| 371 |
+
* claimed use categories
|
| 372 |
+
* consumer-device transparency
|
| 373 |
+
|
| 374 |
+
Preferred future source types:
|
| 375 |
+
|
| 376 |
+
* physics or technical references
|
| 377 |
+
* electromagnetic field measurement references
|
| 378 |
+
* manufacturer specifications
|
| 379 |
+
* review literature where appropriate
|
| 380 |
+
* standards or safety references where appropriate
|
| 381 |
+
|
| 382 |
+
Future upgrade goals:
|
| 383 |
+
|
| 384 |
+
* clarify that frequency references are educational, not treatment prescriptions
|
| 385 |
+
* strengthen frequency vs intensity notes
|
| 386 |
+
* improve field-strength and waveform source context
|
| 387 |
+
* avoid claim inflation around specific Hz values
|
| 388 |
+
* support future glossary and explainer pages
|
| 389 |
+
|
| 390 |
+
## Source Upgrade Workflow
|
| 391 |
+
|
| 392 |
+
Future source-density upgrades should follow this workflow:
|
| 393 |
+
|
| 394 |
+
1. Select one dataset or topic group.
|
| 395 |
+
2. Identify rows with the highest safety or claim-risk sensitivity.
|
| 396 |
+
3. Review current `source_name`, `source_url`, and `citation_note` fields.
|
| 397 |
+
4. Add or improve source references where needed.
|
| 398 |
+
5. Prefer sources that improve clarity and safety boundaries.
|
| 399 |
+
6. Update `citation_note` language to preserve claim boundaries.
|
| 400 |
+
7. Avoid adding sources that create misleading certainty.
|
| 401 |
+
8. Update the dataset CSV and JSON files if row fields change.
|
| 402 |
+
9. Update checksums after any dataset file changes.
|
| 403 |
+
10. Update version history.
|
| 404 |
+
11. Update Zenodo/GitHub release notes when appropriate.
|
| 405 |
+
12. Revalidate pages and machine-readable files.
|
| 406 |
+
|
| 407 |
+
## Source Preference Order
|
| 408 |
+
|
| 409 |
+
For sensitive rows, preferred source types generally include:
|
| 410 |
+
|
| 411 |
+
1. regulatory or agency sources
|
| 412 |
+
2. standards or technical references
|
| 413 |
+
3. manufacturer safety manuals or instructions
|
| 414 |
+
4. peer-reviewed reviews or studies where appropriate
|
| 415 |
+
5. university or institutional educational references
|
| 416 |
+
6. measurement or technical documentation
|
| 417 |
+
7. project methodology or source-register notes
|
| 418 |
+
8. commercial category references only for navigation or commercial relevance context
|
| 419 |
+
|
| 420 |
+
This preference order may vary by topic.
|
| 421 |
+
|
| 422 |
+
## What This Plan Does Not Do
|
| 423 |
+
|
| 424 |
+
This plan does not:
|
| 425 |
+
|
| 426 |
+
* create medical advice
|
| 427 |
+
* create treatment recommendations
|
| 428 |
+
* create disease-prevention guidance
|
| 429 |
+
* create dosing protocols
|
| 430 |
+
* create product-efficacy claims
|
| 431 |
+
* claim independent academic consensus
|
| 432 |
+
* claim expert medical review where none has occurred
|
| 433 |
+
* imply source endorsement of Holistix or Holistix products
|
| 434 |
+
* replace qualified professional guidance
|
| 435 |
+
|
| 436 |
+
## Future Release Targets
|
| 437 |
+
|
| 438 |
+
Potential future release themes may include:
|
| 439 |
+
|
| 440 |
+
### v1.3
|
| 441 |
+
|
| 442 |
+
Integrity, provenance, raw links, known limitations, review policy, and source-density roadmap.
|
| 443 |
+
|
| 444 |
+
### v1.4
|
| 445 |
+
|
| 446 |
+
High-priority source-density upgrade for PEMF contraindications and red light dose terminology.
|
| 447 |
+
|
| 448 |
+
### v1.5
|
| 449 |
+
|
| 450 |
+
Source-density upgrade for blue light safety, negative ion safety, and hydrogen measurement terminology.
|
| 451 |
+
|
| 452 |
+
### v1.6
|
| 453 |
+
|
| 454 |
+
Source-density upgrade for infrared heat safety, terahertz safety context, and PEMF frequency terminology.
|
| 455 |
+
|
| 456 |
+
Release numbering may change depending on project needs.
|
| 457 |
+
|
| 458 |
+
## Review and Authorship Connection
|
| 459 |
+
|
| 460 |
+
Source-density upgrades should be coordinated with the project review and authorship policy.
|
| 461 |
+
|
| 462 |
+
Sensitive topic pages and datasets may be marked for future expert review, advisory review, technical review, or claim-boundary review.
|
| 463 |
+
|
| 464 |
+
Review status should be documented clearly and should not imply endorsement of products.
|
| 465 |
+
|
| 466 |
+
## DOI and Archive Context
|
| 467 |
+
|
| 468 |
+
Current archived release DOI for the v1.3 trust-layer release:
|
| 469 |
+
https://doi.org/10.5281/zenodo.21033668
|
| 470 |
+
|
| 471 |
+
Project DOI / all versions:
|
| 472 |
+
|
| 473 |
+
https://doi.org/10.5281/zenodo.20978709
|
| 474 |
+
|
| 475 |
+
Future releases may receive additional version-specific Zenodo DOIs while the concept DOI remains the all-versions project DOI.
|
| 476 |
+
|
| 477 |
+
## Disclaimer
|
| 478 |
+
|
| 479 |
+
The Holistix Open Biohacking Data Project is for educational and informational purposes only.
|
| 480 |
+
|
| 481 |
+
It is not medical advice, diagnosis, treatment guidance, disease-prevention guidance, dosing guidance, clinical protocol guidance, or a substitute for consultation with a qualified healthcare professional.
|
| 482 |
+
|
| 483 |
+
Users should consult qualified healthcare professionals for personal medical questions and follow manufacturer instructions for any wellness device.
|
VALIDATION_SUMMARY.txt
CHANGED
|
@@ -1,26 +1,26 @@
|
|
| 1 |
-
HOLISTIX OPEN BIOHACKING DATA PROJECT v1.4
|
| 2 |
-
RELEASE VALIDATION SUMMARY
|
| 3 |
-
|
| 4 |
-
Project release: v1.4
|
| 5 |
-
Subject dataset version: v1.2
|
| 6 |
-
|
| 7 |
-
json_files: 49
|
| 8 |
-
csv_files: 8
|
| 9 |
-
|
| 10 |
-
products: 13
|
| 11 |
-
technologies: 18
|
| 12 |
-
|
| 13 |
-
claims: 111
|
| 14 |
-
evidence_records: 111
|
| 15 |
-
safety_records: 111
|
| 16 |
-
dataset_records: 111
|
| 17 |
-
|
| 18 |
-
JSON parse errors: 0
|
| 19 |
-
|
| 20 |
-
VALIDATION RESULT: PASS
|
| 21 |
-
|
| 22 |
-
Notes:
|
| 23 |
-
- The eight public subject datasets remain at v1.2.
|
| 24 |
-
- This validation confirms file counts and JSON parsing.
|
| 25 |
-
- It does not independently verify every scientific citation,
|
| 26 |
-
product specification, medical claim, or third-party source.
|
|
|
|
| 1 |
+
HOLISTIX OPEN BIOHACKING DATA PROJECT v1.4
|
| 2 |
+
RELEASE VALIDATION SUMMARY
|
| 3 |
+
|
| 4 |
+
Project release: v1.4
|
| 5 |
+
Subject dataset version: v1.2
|
| 6 |
+
|
| 7 |
+
json_files: 49
|
| 8 |
+
csv_files: 8
|
| 9 |
+
|
| 10 |
+
products: 13
|
| 11 |
+
technologies: 18
|
| 12 |
+
|
| 13 |
+
claims: 111
|
| 14 |
+
evidence_records: 111
|
| 15 |
+
safety_records: 111
|
| 16 |
+
dataset_records: 111
|
| 17 |
+
|
| 18 |
+
JSON parse errors: 0
|
| 19 |
+
|
| 20 |
+
VALIDATION RESULT: PASS
|
| 21 |
+
|
| 22 |
+
Notes:
|
| 23 |
+
- The eight public subject datasets remain at v1.2.
|
| 24 |
+
- This validation confirms file counts and JSON parsing.
|
| 25 |
+
- It does not independently verify every scientific citation,
|
| 26 |
+
product specification, medical claim, or third-party source.
|
VERSION_HISTORY.md
CHANGED
|
@@ -1,27 +1,31 @@
|
|
| 1 |
-
# Holistix Open Biohacking Data Project
|
| 2 |
-
|
| 3 |
-
# Version History
|
| 4 |
-
|
| 5 |
-
This file records public version history for the Holistix Open Biohacking Data Project.
|
| 6 |
-
|
| 7 |
-
Project: Holistix Open Biohacking Data Project
|
| 8 |
-
Maintainer: Holistix International
|
| 9 |
-
Repository: https://github.com/holistixintlsite-commits/open-biohacking-data
|
| 10 |
-
Project page: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 11 |
-
|
| 12 |
## Current Version Context
|
| 13 |
|
| 14 |
Canonical dataset version: **v1.2**
|
| 15 |
|
| 16 |
-
Current project
|
|
|
|
|
|
|
| 17 |
|
| 18 |
-
|
| 19 |
|
| 20 |
-
|
| 21 |
|
| 22 |
-
|
| 23 |
|
| 24 |
-
|
|
|
|
|
|
|
| 25 |
|
| 26 |
Previous v1.2.1 archive DOI:
|
| 27 |
|
|
@@ -33,730 +37,729 @@ https://doi.org/10.5281/zenodo.20978709
|
|
| 33 |
|
| 34 |
## Suggested Citation
|
| 35 |
|
| 36 |
-
Holistix International. (2026). *Holistix Open Biohacking Data Project v1.
|
| 37 |
|
| 38 |
Plain-text citation:
|
| 39 |
|
| 40 |
-
Holistix International. (2026). Holistix Open Biohacking Data Project v1.
|
| 41 |
-
|
| 42 |
-
|
| 43 |
-
|
| 44 |
-
|
| 45 |
-
|
| 46 |
-
|
| 47 |
-
|
| 48 |
-
|
| 49 |
-
|
| 50 |
-
|
| 51 |
-
|
| 52 |
-
|
| 53 |
-
|
| 54 |
-
|
| 55 |
-
|
| 56 |
-
|
| 57 |
-
|
| 58 |
-
|
| 59 |
-
|
| 60 |
-
|
| 61 |
-
|
| 62 |
-
|
| 63 |
-
|
| 64 |
-
|
| 65 |
-
|
| 66 |
-
|
| 67 |
-
|
| 68 |
-
|
| 69 |
-
|
| 70 |
-
|
| 71 |
-
|
| 72 |
-
|
| 73 |
-
|
| 74 |
-
|
| 75 |
-
|
| 76 |
-
|
| 77 |
-
|
| 78 |
-
|
| 79 |
-
|
| 80 |
-
|
| 81 |
-
|
| 82 |
-
|
| 83 |
-
|
| 84 |
-
|
| 85 |
-
|
| 86 |
-
|
| 87 |
-
|
| 88 |
-
|
| 89 |
-
|
| 90 |
-
|
| 91 |
-
|
| 92 |
-
|
| 93 |
-
|
| 94 |
-
|
| 95 |
-
|
| 96 |
-
|
| 97 |
-
|
| 98 |
-
|
| 99 |
-
|
| 100 |
-
|
| 101 |
-
|
| 102 |
-
|
| 103 |
-
|
| 104 |
-
|
| 105 |
-
|
| 106 |
-
|
| 107 |
-
|
| 108 |
-
|
| 109 |
-
|
| 110 |
-
|
| 111 |
-
|
| 112 |
-
|
| 113 |
-
|
| 114 |
-
|
| 115 |
-
|
| 116 |
-
|
| 117 |
-
|
| 118 |
-
|
| 119 |
-
|
| 120 |
-
|
| 121 |
-
|
| 122 |
-
|
| 123 |
-
|
| 124 |
-
|
| 125 |
-
|
| 126 |
-
|
| 127 |
-
|
| 128 |
-
|
| 129 |
-
|
| 130 |
-
|
| 131 |
-
|
| 132 |
-
|
| 133 |
-
|
| 134 |
-
|
| 135 |
-
|
| 136 |
-
|
| 137 |
-
|
| 138 |
-
|
| 139 |
-
|
| 140 |
-
|
| 141 |
-
|
| 142 |
-
|
| 143 |
-
|
| 144 |
-
|
| 145 |
-
|
| 146 |
-
|
| 147 |
-
|
| 148 |
-
|
| 149 |
-
|
| 150 |
-
|
| 151 |
-
|
| 152 |
-
* `
|
| 153 |
-
* `
|
| 154 |
-
* `
|
| 155 |
-
* `
|
| 156 |
-
* `
|
| 157 |
-
|
| 158 |
-
|
| 159 |
-
|
| 160 |
-
|
| 161 |
-
|
| 162 |
-
|
| 163 |
-
|
| 164 |
-
|
| 165 |
-
|
| 166 |
-
|
| 167 |
-
*
|
| 168 |
-
*
|
| 169 |
-
*
|
| 170 |
-
*
|
| 171 |
-
*
|
| 172 |
-
|
| 173 |
-
|
| 174 |
-
|
| 175 |
-
|
| 176 |
-
|
| 177 |
-
|
| 178 |
-
|
| 179 |
-
|
| 180 |
-
*
|
| 181 |
-
*
|
| 182 |
-
*
|
| 183 |
-
*
|
| 184 |
-
*
|
| 185 |
-
*
|
| 186 |
-
|
| 187 |
-
|
| 188 |
-
|
| 189 |
-
|
| 190 |
-
|
| 191 |
-
|
| 192 |
-
|
| 193 |
-
|
| 194 |
-
*
|
| 195 |
-
*
|
| 196 |
-
*
|
| 197 |
-
*
|
| 198 |
-
*
|
| 199 |
-
|
| 200 |
-
|
| 201 |
-
|
| 202 |
-
|
| 203 |
-
|
| 204 |
-
|
| 205 |
-
|
| 206 |
-
|
| 207 |
-
* clarify that the project is not
|
| 208 |
-
* clarify that the project is not a
|
| 209 |
-
* clarify that the project is not
|
| 210 |
-
* clarify that the project is not
|
| 211 |
-
* clarify that the project is not
|
| 212 |
-
*
|
| 213 |
-
* document
|
| 214 |
-
* document
|
| 215 |
-
|
| 216 |
-
|
| 217 |
-
|
| 218 |
-
|
| 219 |
-
|
| 220 |
-
|
| 221 |
-
|
| 222 |
-
|
| 223 |
-
*
|
| 224 |
-
*
|
| 225 |
-
*
|
| 226 |
-
*
|
| 227 |
-
*
|
| 228 |
-
|
| 229 |
-
|
| 230 |
-
|
| 231 |
-
|
| 232 |
-
* PEMF
|
| 233 |
-
* PEMF and
|
| 234 |
-
*
|
| 235 |
-
* red light
|
| 236 |
-
*
|
| 237 |
-
* blue light
|
| 238 |
-
*
|
| 239 |
-
* negative ion
|
| 240 |
-
*
|
| 241 |
-
*
|
| 242 |
-
*
|
| 243 |
-
*
|
| 244 |
-
|
| 245 |
-
|
| 246 |
-
|
| 247 |
-
|
| 248 |
-
|
| 249 |
-
|
| 250 |
-
|
| 251 |
-
|
| 252 |
-
* clarify
|
| 253 |
-
*
|
| 254 |
-
*
|
| 255 |
-
*
|
| 256 |
-
*
|
| 257 |
-
*
|
| 258 |
-
|
| 259 |
-
|
| 260 |
-
|
| 261 |
-
|
| 262 |
-
|
| 263 |
-
|
| 264 |
-
* `
|
| 265 |
-
* `
|
| 266 |
-
* `
|
| 267 |
-
* `
|
| 268 |
-
* `
|
| 269 |
-
|
| 270 |
-
|
| 271 |
-
|
| 272 |
-
|
| 273 |
-
|
| 274 |
-
|
| 275 |
-
|
| 276 |
-
|
| 277 |
-
|
| 278 |
-
|
| 279 |
-
*
|
| 280 |
-
*
|
| 281 |
-
*
|
| 282 |
-
*
|
| 283 |
-
* file
|
| 284 |
-
*
|
| 285 |
-
*
|
| 286 |
-
*
|
| 287 |
-
*
|
| 288 |
-
*
|
| 289 |
-
*
|
| 290 |
-
|
| 291 |
-
|
| 292 |
-
|
| 293 |
-
|
| 294 |
-
|
| 295 |
-
|
| 296 |
-
|
| 297 |
-
|
| 298 |
-
* v1.
|
| 299 |
-
*
|
| 300 |
-
*
|
| 301 |
-
*
|
| 302 |
-
*
|
| 303 |
-
*
|
| 304 |
-
*
|
| 305 |
-
*
|
| 306 |
-
|
| 307 |
-
|
| 308 |
-
|
| 309 |
-
|
| 310 |
-
|
| 311 |
-
|
| 312 |
-
|
| 313 |
-
|
| 314 |
-
* `
|
| 315 |
-
*
|
| 316 |
-
*
|
| 317 |
-
*
|
| 318 |
-
*
|
| 319 |
-
*
|
| 320 |
-
*
|
| 321 |
-
*
|
| 322 |
-
*
|
| 323 |
-
*
|
| 324 |
-
*
|
| 325 |
-
|
| 326 |
-
|
| 327 |
-
|
| 328 |
-
|
| 329 |
-
|
| 330 |
-
|
| 331 |
-
|
| 332 |
-
|
| 333 |
-
*
|
| 334 |
-
*
|
| 335 |
-
*
|
| 336 |
-
*
|
| 337 |
-
*
|
| 338 |
-
*
|
| 339 |
-
*
|
| 340 |
-
*
|
| 341 |
-
|
| 342 |
-
|
| 343 |
-
|
| 344 |
-
|
| 345 |
-
|
| 346 |
-
|
| 347 |
-
|
| 348 |
-
|
| 349 |
-
*
|
| 350 |
-
*
|
| 351 |
-
*
|
| 352 |
-
*
|
| 353 |
-
*
|
| 354 |
-
*
|
| 355 |
-
*
|
| 356 |
-
*
|
| 357 |
-
*
|
| 358 |
-
*
|
| 359 |
-
*
|
| 360 |
-
*
|
| 361 |
-
|
| 362 |
-
|
| 363 |
-
|
| 364 |
-
|
| 365 |
-
|
| 366 |
-
|
| 367 |
-
|
| 368 |
-
|
| 369 |
-
|
| 370 |
-
|
| 371 |
-
|
| 372 |
-
|
| 373 |
-
|
| 374 |
-
|
| 375 |
-
|
| 376 |
-
|
| 377 |
-
|
| 378 |
-
|
| 379 |
-
|
| 380 |
-
|
| 381 |
-
|
| 382 |
-
|
| 383 |
-
|
| 384 |
-
|
| 385 |
-
|
| 386 |
-
|
| 387 |
-
|
| 388 |
-
|
| 389 |
-
|
| 390 |
-
|
| 391 |
-
|
| 392 |
-
|
| 393 |
-
|
| 394 |
-
|
| 395 |
-
|
| 396 |
-
|
| 397 |
-
|
| 398 |
-
|
| 399 |
-
|
| 400 |
-
|
| 401 |
-
|
| 402 |
-
|
| 403 |
-
|
| 404 |
-
|
| 405 |
-
|
| 406 |
-
|
| 407 |
-
|
| 408 |
-
|
| 409 |
-
|
| 410 |
-
|
| 411 |
-
|
| 412 |
-
|
| 413 |
-
|
| 414 |
-
|
| 415 |
-
|
| 416 |
-
|
| 417 |
-
|
| 418 |
-
|
| 419 |
-
|
| 420 |
-
|
| 421 |
-
|
| 422 |
-
|
| 423 |
-
|
| 424 |
-
|
| 425 |
-
|
| 426 |
-
|
| 427 |
-
|
| 428 |
-
|
| 429 |
-
|
| 430 |
-
|
| 431 |
-
|
| 432 |
-
|
| 433 |
-
|
| 434 |
-
|
| 435 |
-
|
| 436 |
-
|
| 437 |
-
|
| 438 |
-
|
| 439 |
-
|
| 440 |
-
|
| 441 |
-
|
| 442 |
-
|
| 443 |
-
|
| 444 |
-
|
| 445 |
-
|
| 446 |
-
|
| 447 |
-
|
| 448 |
-
|
| 449 |
-
|
| 450 |
-
|
| 451 |
-
|
| 452 |
-
|
| 453 |
-
|
| 454 |
-
|
| 455 |
-
|
| 456 |
-
|
| 457 |
-
|
| 458 |
-
|
| 459 |
-
|
| 460 |
-
|
| 461 |
-
|
| 462 |
-
|
| 463 |
-
|
| 464 |
-
*
|
| 465 |
-
*
|
| 466 |
-
*
|
| 467 |
-
*
|
| 468 |
-
*
|
| 469 |
-
*
|
| 470 |
-
*
|
| 471 |
-
|
| 472 |
-
|
| 473 |
-
|
| 474 |
-
|
| 475 |
-
|
| 476 |
-
|
| 477 |
-
|
| 478 |
-
|
| 479 |
-
|
| 480 |
-
|
| 481 |
-
|
| 482 |
-
|
| 483 |
-
|
| 484 |
-
|
| 485 |
-
|
| 486 |
-
|
| 487 |
-
|
| 488 |
-
|
| 489 |
-
|
| 490 |
-
|
| 491 |
-
|
| 492 |
-
|
| 493 |
-
|
| 494 |
-
|
| 495 |
-
|
| 496 |
-
|
| 497 |
-
|
| 498 |
-
|
| 499 |
-
* `
|
| 500 |
-
* `
|
| 501 |
-
|
| 502 |
-
|
| 503 |
-
|
| 504 |
-
|
| 505 |
-
|
| 506 |
-
|
| 507 |
-
|
| 508 |
-
|
| 509 |
-
|
| 510 |
-
|
| 511 |
-
|
| 512 |
-
|
| 513 |
-
|
| 514 |
-
|
| 515 |
-
* `datasets/red-light-dose-index-v1-2.
|
| 516 |
-
* `datasets/
|
| 517 |
-
* `datasets/pemf-frequency-index-v1-2.
|
| 518 |
-
* `datasets/pemf-
|
| 519 |
-
* `datasets/pemf-contraindications-database-v1-2.
|
| 520 |
-
* `datasets/
|
| 521 |
-
* `datasets/hydrogen-water-reference-index-v1-2.
|
| 522 |
-
* `datasets/
|
| 523 |
-
* `datasets/infrared-therapy-reference-index-v1-2.
|
| 524 |
-
* `datasets/
|
| 525 |
-
* `datasets/blue-light-therapy-reference-index-v1-2.
|
| 526 |
-
* `datasets/
|
| 527 |
-
* `datasets/terahertz-device-reference-index-v1-2.
|
| 528 |
-
* `datasets/
|
| 529 |
-
* `datasets/negative-ion-safety-index-v1-2.
|
| 530 |
-
|
| 531 |
-
|
| 532 |
-
|
| 533 |
-
|
| 534 |
-
|
| 535 |
-
|
| 536 |
-
|
| 537 |
-
|
| 538 |
-
|
| 539 |
-
|
| 540 |
-
|
| 541 |
-
|
| 542 |
-
|
| 543 |
-
|
| 544 |
-
|
| 545 |
-
|
| 546 |
-
|
| 547 |
-
|
| 548 |
-
|
| 549 |
-
|
| 550 |
-
|
| 551 |
-
|
| 552 |
-
* `
|
| 553 |
-
* `
|
| 554 |
-
* `
|
| 555 |
-
* `
|
| 556 |
-
* `
|
| 557 |
-
* `
|
| 558 |
-
* `
|
| 559 |
-
* `
|
| 560 |
-
* `
|
| 561 |
-
* `
|
| 562 |
-
* `
|
| 563 |
-
* `
|
| 564 |
-
* `
|
| 565 |
-
* `
|
| 566 |
-
* `
|
| 567 |
-
* `
|
| 568 |
-
|
| 569 |
-
|
| 570 |
-
|
| 571 |
-
|
| 572 |
-
|
| 573 |
-
|
| 574 |
-
|
| 575 |
-
|
| 576 |
-
*
|
| 577 |
-
* PEMF
|
| 578 |
-
*
|
| 579 |
-
*
|
| 580 |
-
*
|
| 581 |
-
*
|
| 582 |
-
*
|
| 583 |
-
|
| 584 |
-
|
| 585 |
-
|
| 586 |
-
|
| 587 |
-
|
| 588 |
-
|
| 589 |
-
|
| 590 |
-
|
| 591 |
-
|
| 592 |
-
|
| 593 |
-
|
| 594 |
-
|
| 595 |
-
|
| 596 |
-
|
| 597 |
-
|
| 598 |
-
|
| 599 |
-
|
| 600 |
-
|
| 601 |
-
|
| 602 |
-
|
| 603 |
-
|
| 604 |
-
|
| 605 |
-
|
| 606 |
-
|
| 607 |
-
|
| 608 |
-
|
| 609 |
-
|
| 610 |
-
|
| 611 |
-
|
| 612 |
-
|
| 613 |
-
|
| 614 |
-
|
| 615 |
-
* `
|
| 616 |
-
* `
|
| 617 |
-
* `
|
| 618 |
-
* `
|
| 619 |
-
* `
|
| 620 |
-
* `
|
| 621 |
-
* `
|
| 622 |
-
* `
|
| 623 |
-
|
| 624 |
-
|
| 625 |
-
|
| 626 |
-
|
| 627 |
-
|
| 628 |
-
|
| 629 |
-
|
| 630 |
-
|
| 631 |
-
|
| 632 |
-
|
| 633 |
-
|
| 634 |
-
|
| 635 |
-
|
| 636 |
-
|
| 637 |
-
|
| 638 |
-
|
| 639 |
-
|
| 640 |
-
|
| 641 |
-
|
| 642 |
-
|
| 643 |
-
|
| 644 |
-
|
| 645 |
-
|
| 646 |
-
|
| 647 |
-
|
| 648 |
-
|
| 649 |
-
|
| 650 |
-
|
| 651 |
-
|
| 652 |
-
|
| 653 |
-
|
| 654 |
-
|
| 655 |
-
|
| 656 |
-
|
| 657 |
-
|
| 658 |
-
|
| 659 |
-
|
| 660 |
-
|
| 661 |
-
|
| 662 |
-
|
| 663 |
-
|
| 664 |
-
|
| 665 |
-
|
| 666 |
-
|
| 667 |
-
|
| 668 |
-
|
| 669 |
-
|
| 670 |
-
|
| 671 |
-
*
|
| 672 |
-
*
|
| 673 |
-
*
|
| 674 |
-
*
|
| 675 |
-
*
|
| 676 |
-
*
|
| 677 |
-
|
| 678 |
-
|
| 679 |
-
|
| 680 |
-
|
| 681 |
-
|
| 682 |
-
|
| 683 |
-
*
|
| 684 |
-
*
|
| 685 |
-
*
|
| 686 |
-
*
|
| 687 |
-
*
|
| 688 |
-
*
|
| 689 |
-
*
|
| 690 |
-
*
|
| 691 |
-
*
|
| 692 |
-
*
|
| 693 |
-
|
| 694 |
-
|
| 695 |
-
|
| 696 |
-
|
| 697 |
-
|
| 698 |
-
|
| 699 |
-
|
| 700 |
-
|
| 701 |
-
*
|
| 702 |
-
*
|
| 703 |
-
*
|
| 704 |
-
*
|
| 705 |
-
*
|
| 706 |
-
*
|
| 707 |
-
* new
|
| 708 |
-
*
|
| 709 |
-
* updated
|
| 710 |
-
* updated
|
| 711 |
-
* updated
|
| 712 |
-
*
|
| 713 |
-
* new
|
| 714 |
-
* new
|
| 715 |
-
|
| 716 |
-
|
| 717 |
-
|
| 718 |
-
|
| 719 |
-
|
| 720 |
-
|
| 721 |
-
* PEMF
|
| 722 |
-
* PEMF
|
| 723 |
-
*
|
| 724 |
-
* red light
|
| 725 |
-
* red light
|
| 726 |
-
*
|
| 727 |
-
* blue light
|
| 728 |
-
*
|
| 729 |
-
* negative ion
|
| 730 |
-
*
|
| 731 |
-
*
|
| 732 |
-
* hydrogen
|
| 733 |
-
*
|
| 734 |
-
*
|
| 735 |
-
*
|
| 736 |
-
|
| 737 |
-
|
| 738 |
-
|
| 739 |
-
|
| 740 |
-
|
| 741 |
-
|
| 742 |
-
* preserve
|
| 743 |
-
* preserve
|
| 744 |
-
*
|
| 745 |
-
*
|
| 746 |
-
* update
|
| 747 |
-
* update
|
| 748 |
-
* update
|
| 749 |
-
*
|
| 750 |
-
* avoid
|
| 751 |
-
* avoid
|
| 752 |
-
* avoid implying
|
| 753 |
-
* avoid
|
| 754 |
-
|
| 755 |
-
|
| 756 |
-
|
| 757 |
-
|
| 758 |
-
|
| 759 |
-
|
| 760 |
-
|
| 761 |
-
|
| 762 |
-
Users should consult qualified healthcare professionals for personal medical questions and follow manufacturer instructions for any wellness device.
|
|
|
|
| 1 |
+
# Holistix Open Biohacking Data Project
|
| 2 |
+
|
| 3 |
+
# Version History
|
| 4 |
+
|
| 5 |
+
This file records public version history for the Holistix Open Biohacking Data Project.
|
| 6 |
+
|
| 7 |
+
Project: Holistix Open Biohacking Data Project
|
| 8 |
+
Maintainer: Holistix International
|
| 9 |
+
Repository: https://github.com/holistixintlsite-commits/open-biohacking-data
|
| 10 |
+
Project page: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 11 |
+
|
| 12 |
## Current Version Context
|
| 13 |
|
| 14 |
Canonical dataset version: **v1.2**
|
| 15 |
|
| 16 |
+
Current project release: **v1.5.0**
|
| 17 |
+
|
| 18 |
+
Current archived project release: **v1.5.0**
|
| 19 |
|
| 20 |
+
Previous archived project release: **v1.4**
|
| 21 |
|
| 22 |
+
Current version DOI for archived v1.5.0 release:
|
| 23 |
|
| 24 |
+
https://doi.org/10.5281/zenodo.21862535
|
| 25 |
|
| 26 |
+
Previous v1.4 archive DOI:
|
| 27 |
+
|
| 28 |
+
https://doi.org/10.5281/zenodo.21574706
|
| 29 |
|
| 30 |
Previous v1.2.1 archive DOI:
|
| 31 |
|
|
|
|
| 37 |
|
| 38 |
## Suggested Citation
|
| 39 |
|
| 40 |
+
Holistix International. (2026). *Holistix Open Biohacking Data Project v1.5.0* (v1.5.0) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.21862535
|
| 41 |
|
| 42 |
Plain-text citation:
|
| 43 |
|
| 44 |
+
Holistix International. (2026). Holistix Open Biohacking Data Project v1.5.0 (v1.5.0) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.21862535
|
| 45 |
+
## Versioning Model
|
| 46 |
+
|
| 47 |
+
The project uses separate concepts for dataset version, archive release, and project documentation release.
|
| 48 |
+
|
| 49 |
+
### Dataset Version
|
| 50 |
+
|
| 51 |
+
The dataset version refers to the structure and content of the CSV and JSON files.
|
| 52 |
+
|
| 53 |
+
Current canonical dataset version:
|
| 54 |
+
|
| 55 |
+
**v1.2**
|
| 56 |
+
|
| 57 |
+
### Archive Release
|
| 58 |
+
|
| 59 |
+
The archive release refers to the Zenodo-preserved release package.
|
| 60 |
+
|
| 61 |
+
Current archived project release:
|
| 62 |
+
|
| 63 |
+
**v1.3**
|
| 64 |
+
|
| 65 |
+
Previous archived dataset release:
|
| 66 |
+
|
| 67 |
+
**v1.2.1**
|
| 68 |
+
|
| 69 |
+
### Project Trust-Layer Release
|
| 70 |
+
|
| 71 |
+
The project trust-layer release refers to documentation, verification, provenance, limitations, review policy, and source-density planning added around the existing dataset files.
|
| 72 |
+
|
| 73 |
+
Current project trust-layer release:
|
| 74 |
+
|
| 75 |
+
**v1.3**
|
| 76 |
+
|
| 77 |
+
### Important Note
|
| 78 |
+
|
| 79 |
+
Version v1.3 does not change the dataset schema.
|
| 80 |
+
|
| 81 |
+
The CSV and JSON dataset files remain v1.2 files.
|
| 82 |
+
|
| 83 |
+
Version v1.3 adds trust-layer documentation for the existing v1.2 dataset package.
|
| 84 |
+
|
| 85 |
+
---
|
| 86 |
+
|
| 87 |
+
# v1.3
|
| 88 |
+
|
| 89 |
+
Release title:
|
| 90 |
+
|
| 91 |
+
**Holistix Open Biohacking Data Project v1.3: Integrity, Provenance, and Trust Layer**
|
| 92 |
+
|
| 93 |
+
Release type:
|
| 94 |
+
|
| 95 |
+
Project trust-layer documentation release
|
| 96 |
+
|
| 97 |
+
Archived release DOI:
|
| 98 |
+
|
| 99 |
+
https://doi.org/10.5281/zenodo.21033668
|
| 100 |
+
|
| 101 |
+
Concept DOI / all versions:
|
| 102 |
+
|
| 103 |
+
https://doi.org/10.5281/zenodo.20978709
|
| 104 |
+
|
| 105 |
+
Zenodo record:
|
| 106 |
+
|
| 107 |
+
https://zenodo.org/records/21033668
|
| 108 |
+
|
| 109 |
+
Resource type:
|
| 110 |
+
|
| 111 |
+
Dataset
|
| 112 |
+
|
| 113 |
+
License:
|
| 114 |
+
|
| 115 |
+
CC-BY-4.0
|
| 116 |
+
|
| 117 |
+
Access:
|
| 118 |
+
|
| 119 |
+
Open
|
| 120 |
+
|
| 121 |
+
Publication date:
|
| 122 |
+
|
| 123 |
+
June 29, 2026
|
| 124 |
+
|
| 125 |
+
Dataset files changed:
|
| 126 |
+
|
| 127 |
+
No
|
| 128 |
+
|
| 129 |
+
Dataset schema changed:
|
| 130 |
+
|
| 131 |
+
No
|
| 132 |
+
|
| 133 |
+
Canonical dataset files remain:
|
| 134 |
+
|
| 135 |
+
**v1.2**
|
| 136 |
+
|
| 137 |
+
## Summary
|
| 138 |
+
|
| 139 |
+
Version v1.3 adds integrity, provenance, raw-link, known-limitation, review-policy, and source-density documentation for the existing v1.2 dataset files.
|
| 140 |
+
|
| 141 |
+
This release strengthens transparency, auditability, machine-readability, file verification, commercial-separation clarity, review-status clarity, and responsible reuse.
|
| 142 |
+
|
| 143 |
+
## Suggested Citation for v1.3
|
| 144 |
+
|
| 145 |
+
Holistix International. (2026). *Holistix Open Biohacking Data Project v1.3: Integrity, Provenance, and Trust Layer* (v1.3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.21033668
|
| 146 |
+
|
| 147 |
+
Plain-text citation:
|
| 148 |
+
|
| 149 |
+
Holistix International. (2026). Holistix Open Biohacking Data Project v1.3: Integrity, Provenance, and Trust Layer (v1.3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.21033668
|
| 150 |
+
|
| 151 |
+
## New v1.3 Files
|
| 152 |
+
|
| 153 |
+
Version v1.3 adds the following files:
|
| 154 |
+
|
| 155 |
+
* `CHECKSUMS-SHA256.txt`
|
| 156 |
+
* `RAW_LINKS.md`
|
| 157 |
+
* `PROVENANCE.md`
|
| 158 |
+
* `KNOWN_LIMITATIONS.md`
|
| 159 |
+
* `SOURCE_DENSITY_UPGRADE_PLAN.md`
|
| 160 |
+
* `REVIEW_AND_AUTHORSHIP_POLICY.md`
|
| 161 |
+
|
| 162 |
+
## New File Purposes
|
| 163 |
+
|
| 164 |
+
### `CHECKSUMS-SHA256.txt`
|
| 165 |
+
|
| 166 |
+
Adds SHA256 checksums for the current canonical v1.2 CSV and JSON dataset files.
|
| 167 |
+
|
| 168 |
+
Purpose:
|
| 169 |
+
|
| 170 |
+
* file integrity
|
| 171 |
+
* reproducibility
|
| 172 |
+
* verification of downloaded files
|
| 173 |
+
* release transparency
|
| 174 |
+
* machine-readable trust context
|
| 175 |
+
* silent-change detection
|
| 176 |
+
|
| 177 |
+
### `RAW_LINKS.md`
|
| 178 |
+
|
| 179 |
+
Adds direct raw GitHub URLs for the current canonical v1.2 CSV and JSON dataset files.
|
| 180 |
+
|
| 181 |
+
Purpose:
|
| 182 |
+
|
| 183 |
+
* direct machine-readable access
|
| 184 |
+
* AI retrieval
|
| 185 |
+
* RAG ingestion
|
| 186 |
+
* spreadsheet import
|
| 187 |
+
* developer workflows
|
| 188 |
+
* search engine and crawler access
|
| 189 |
+
* reproducibility checks
|
| 190 |
+
|
| 191 |
+
### `PROVENANCE.md`
|
| 192 |
+
|
| 193 |
+
Adds a provenance statement explaining how the project is maintained, how dataset rows should be interpreted, how source categories are used, and how commercial separation is handled.
|
| 194 |
+
|
| 195 |
+
Purpose:
|
| 196 |
+
|
| 197 |
+
* source interpretation
|
| 198 |
+
* dataset-origin clarity
|
| 199 |
+
* maintainer clarity
|
| 200 |
+
* commercial separation
|
| 201 |
+
* responsible reuse
|
| 202 |
+
* AI/search interpretation boundaries
|
| 203 |
+
|
| 204 |
+
### `KNOWN_LIMITATIONS.md`
|
| 205 |
+
|
| 206 |
+
Adds a known limitations document.
|
| 207 |
+
|
| 208 |
+
Purpose:
|
| 209 |
+
|
| 210 |
+
* clarify that the project is not medical advice
|
| 211 |
+
* clarify that the project is not a clinical protocol
|
| 212 |
+
* clarify that the project is not a treatment guide
|
| 213 |
+
* clarify that the project is not disease-prevention guidance
|
| 214 |
+
* clarify that the project is not proof of product efficacy
|
| 215 |
+
* clarify that the project is not independent academic consensus
|
| 216 |
+
* document AI interpretation limits
|
| 217 |
+
* document source-coverage limits
|
| 218 |
+
* document maintenance limits
|
| 219 |
+
|
| 220 |
+
### `SOURCE_DENSITY_UPGRADE_PLAN.md`
|
| 221 |
+
|
| 222 |
+
Adds a public source-density roadmap.
|
| 223 |
+
|
| 224 |
+
Purpose:
|
| 225 |
+
|
| 226 |
+
* identify high-priority sensitive dataset areas
|
| 227 |
+
* plan stronger source coverage
|
| 228 |
+
* prioritize safety-sensitive rows
|
| 229 |
+
* improve row-level citation clarity
|
| 230 |
+
* strengthen future auditability
|
| 231 |
+
* document responsible future upgrades
|
| 232 |
+
|
| 233 |
+
Priority areas include:
|
| 234 |
+
|
| 235 |
+
* PEMF contraindications
|
| 236 |
+
* PEMF and implanted devices
|
| 237 |
+
* PEMF and pacemakers
|
| 238 |
+
* red light dose terminology
|
| 239 |
+
* red light eye-safety context
|
| 240 |
+
* blue light eye-safety context
|
| 241 |
+
* blue light photosensitivity context
|
| 242 |
+
* negative ion and ozone safety context
|
| 243 |
+
* negative ion pendant safety context
|
| 244 |
+
* infrared heat and sauna blanket safety
|
| 245 |
+
* hydrogen concentration and measurement terminology
|
| 246 |
+
* terahertz exposure and non-ionizing context
|
| 247 |
+
* PEMF frequency and intensity terminology
|
| 248 |
+
|
| 249 |
+
### `REVIEW_AND_AUTHORSHIP_POLICY.md`
|
| 250 |
+
|
| 251 |
+
Adds a review and authorship policy.
|
| 252 |
+
|
| 253 |
+
Purpose:
|
| 254 |
+
|
| 255 |
+
* clarify maintainer status
|
| 256 |
+
* clarify authorship boundaries
|
| 257 |
+
* define review-status categories
|
| 258 |
+
* state that independent medical review is not claimed unless explicitly documented
|
| 259 |
+
* prevent fake expert or fake medical-review signaling
|
| 260 |
+
* document future expert-review requirements
|
| 261 |
+
* preserve commercial-separation clarity
|
| 262 |
+
|
| 263 |
+
## Updated Existing Files
|
| 264 |
+
|
| 265 |
+
Version v1.3 updates the following existing files:
|
| 266 |
+
|
| 267 |
+
* `README.md`
|
| 268 |
+
* `DATASETS.md`
|
| 269 |
+
* `manifest.json`
|
| 270 |
+
* `ai-reference.md`
|
| 271 |
+
* `llms.txt`
|
| 272 |
+
* `VERSION_HISTORY.md`
|
| 273 |
+
|
| 274 |
+
## v1.3 Existing File Update Summary
|
| 275 |
+
|
| 276 |
+
### `README.md`
|
| 277 |
+
|
| 278 |
+
Updated as the main repository front door.
|
| 279 |
+
|
| 280 |
+
Added:
|
| 281 |
+
|
| 282 |
+
* v1.3 trust-layer overview
|
| 283 |
+
* current version model
|
| 284 |
+
* DOI and citation context
|
| 285 |
+
* trust-layer file list
|
| 286 |
+
* file integrity section
|
| 287 |
+
* raw file access section
|
| 288 |
+
* provenance section
|
| 289 |
+
* known limitations section
|
| 290 |
+
* source-density plan section
|
| 291 |
+
* review and authorship policy section
|
| 292 |
+
* AI/search interpretation guidance
|
| 293 |
+
* commercial-separation clarification
|
| 294 |
+
|
| 295 |
+
### `DATASETS.md`
|
| 296 |
+
|
| 297 |
+
Updated as the dataset inventory.
|
| 298 |
+
|
| 299 |
+
Added:
|
| 300 |
+
|
| 301 |
+
* v1.3 trust-layer context
|
| 302 |
+
* canonical v1.2 dataset inventory
|
| 303 |
+
* raw-link reference
|
| 304 |
+
* checksum reference
|
| 305 |
+
* trust-layer file table
|
| 306 |
+
* row-level citation field explanation
|
| 307 |
+
* source-density priority areas
|
| 308 |
+
* review/authorship status
|
| 309 |
+
* responsible reuse guidance
|
| 310 |
+
|
| 311 |
+
### `manifest.json`
|
| 312 |
+
|
| 313 |
+
Updated as the machine-readable project manifest.
|
| 314 |
+
|
| 315 |
+
Added:
|
| 316 |
+
|
| 317 |
+
* `project_release`
|
| 318 |
+
* `archived_release`
|
| 319 |
+
* current v1.3 DOI metadata
|
| 320 |
+
* previous v1.2.1 archive DOI metadata
|
| 321 |
+
* versioning note
|
| 322 |
+
* trust-layer files
|
| 323 |
+
* raw GitHub links
|
| 324 |
+
* source-density priority areas
|
| 325 |
+
* intended-use and not-intended-for fields
|
| 326 |
+
* commercial-separation field
|
| 327 |
+
* review-status metadata
|
| 328 |
+
* updated disclaimer
|
| 329 |
+
|
| 330 |
+
### `ai-reference.md`
|
| 331 |
+
|
| 332 |
+
Updated as the AI/search crawler reference file.
|
| 333 |
+
|
| 334 |
+
Added:
|
| 335 |
+
|
| 336 |
+
* v1.3 interpretation rules
|
| 337 |
+
* trust-layer document map
|
| 338 |
+
* raw GitHub file access
|
| 339 |
+
* file-integrity reference
|
| 340 |
+
* AI caution rules
|
| 341 |
+
* review-status guidance
|
| 342 |
+
* source-density roadmap
|
| 343 |
+
* best reference hierarchy
|
| 344 |
+
* citation hierarchy
|
| 345 |
+
|
| 346 |
+
### `llms.txt`
|
| 347 |
+
|
| 348 |
+
Updated as the simple LLM-readable project map.
|
| 349 |
+
|
| 350 |
+
Added:
|
| 351 |
+
|
| 352 |
+
* v1.3 version context
|
| 353 |
+
* DOI and citation details
|
| 354 |
+
* canonical project pages
|
| 355 |
+
* trust-layer files
|
| 356 |
+
* canonical dataset files
|
| 357 |
+
* raw-link guidance
|
| 358 |
+
* row-level citation guidance
|
| 359 |
+
* AI interpretation rules
|
| 360 |
+
* sensitive-topic cautions
|
| 361 |
+
* known limitations
|
| 362 |
+
* review-status boundaries
|
| 363 |
+
* source-density roadmap
|
| 364 |
+
* best reference hierarchy
|
| 365 |
+
|
| 366 |
+
### `VERSION_HISTORY.md`
|
| 367 |
+
|
| 368 |
+
Updated to document v1.3 as the current archived project release.
|
| 369 |
+
|
| 370 |
+
## v1.3 Validation Notes
|
| 371 |
+
|
| 372 |
+
Recommended validation after release:
|
| 373 |
+
|
| 374 |
+
1. Confirm all new v1.3 files are present in the repository root.
|
| 375 |
+
2. Confirm all canonical v1.2 dataset files remain in `/datasets/`.
|
| 376 |
+
3. Confirm `manifest.json` parses as valid JSON.
|
| 377 |
+
4. Confirm raw GitHub links resolve for all 16 canonical v1.2 CSV and JSON files.
|
| 378 |
+
5. Confirm SHA256 checksums match current v1.2 dataset files.
|
| 379 |
+
6. Confirm `README.md`, `DATASETS.md`, `manifest.json`, `ai-reference.md`, `llms.txt`, and `VERSION_HISTORY.md` mention v1.3 consistently.
|
| 380 |
+
7. Confirm `CITATION.cff` remains parser-safe.
|
| 381 |
+
8. Confirm Zenodo archived the GitHub release.
|
| 382 |
+
9. Confirm Zenodo resource type is Dataset.
|
| 383 |
+
10. Confirm Zenodo license is CC-BY-4.0.
|
| 384 |
+
11. Confirm Zenodo access is Open.
|
| 385 |
+
12. Confirm the v1.3 DOI resolves.
|
| 386 |
+
|
| 387 |
+
## v1.3 Medical and Commercial Boundary
|
| 388 |
+
|
| 389 |
+
Version v1.3 does not create medical advice, treatment guidance, disease-prevention guidance, dosing instructions, clinical recommendations, or product-efficacy proof.
|
| 390 |
+
|
| 391 |
+
Version v1.3 does not claim independent medical review.
|
| 392 |
+
|
| 393 |
+
Version v1.3 does not imply source endorsement of Holistix or Holistix products.
|
| 394 |
+
|
| 395 |
+
Version v1.3 strengthens documentation around limitations, provenance, responsible reuse, commercial separation, review status, and source-density planning.
|
| 396 |
+
|
| 397 |
+
---
|
| 398 |
+
|
| 399 |
+
# v1.2.1
|
| 400 |
+
|
| 401 |
+
Release title:
|
| 402 |
+
|
| 403 |
+
**Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release**
|
| 404 |
+
|
| 405 |
+
Release type:
|
| 406 |
+
|
| 407 |
+
Archived dataset release
|
| 408 |
+
|
| 409 |
+
Version DOI:
|
| 410 |
+
|
| 411 |
+
https://doi.org/10.5281/zenodo.20978710
|
| 412 |
+
|
| 413 |
+
Concept DOI / all versions:
|
| 414 |
+
|
| 415 |
+
https://doi.org/10.5281/zenodo.20978709
|
| 416 |
+
|
| 417 |
+
Resource type:
|
| 418 |
+
|
| 419 |
+
Dataset
|
| 420 |
+
|
| 421 |
+
License:
|
| 422 |
+
|
| 423 |
+
CC-BY-4.0
|
| 424 |
+
|
| 425 |
+
Dataset files changed:
|
| 426 |
+
|
| 427 |
+
No material dataset schema change from v1.2
|
| 428 |
+
|
| 429 |
+
Dataset schema changed:
|
| 430 |
+
|
| 431 |
+
No
|
| 432 |
+
|
| 433 |
+
## Summary
|
| 434 |
+
|
| 435 |
+
Version v1.2.1 is the Zenodo archive release preserving the completed v1.2 row-level citation-layer dataset package.
|
| 436 |
+
|
| 437 |
+
The v1.2.1 release provides a stable DOI-backed archive for citation, indexing, data discovery, and long-term reference.
|
| 438 |
+
|
| 439 |
+
## Zenodo Record
|
| 440 |
+
|
| 441 |
+
Version DOI:
|
| 442 |
+
|
| 443 |
+
https://doi.org/10.5281/zenodo.20978710
|
| 444 |
+
|
| 445 |
+
Concept DOI / all versions:
|
| 446 |
+
|
| 447 |
+
https://doi.org/10.5281/zenodo.20978709
|
| 448 |
+
|
| 449 |
+
Resource type:
|
| 450 |
+
|
| 451 |
+
Dataset
|
| 452 |
+
|
| 453 |
+
License:
|
| 454 |
+
|
| 455 |
+
CC-BY-4.0
|
| 456 |
+
|
| 457 |
+
Suggested citation:
|
| 458 |
+
|
| 459 |
+
Holistix International. (2026). *Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release* (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 460 |
+
|
| 461 |
+
## v1.2.1 Purpose
|
| 462 |
+
|
| 463 |
+
The v1.2.1 release was created to preserve the completed v1.2 dataset package in a citable DOI archive.
|
| 464 |
+
|
| 465 |
+
It supports:
|
| 466 |
+
|
| 467 |
+
* citation
|
| 468 |
+
* indexing
|
| 469 |
+
* AI retrieval
|
| 470 |
+
* academic-style reference
|
| 471 |
+
* public data discovery
|
| 472 |
+
* stable archive access
|
| 473 |
+
* machine-readable reuse
|
| 474 |
+
* dataset credibility
|
| 475 |
+
|
| 476 |
+
---
|
| 477 |
+
|
| 478 |
+
# v1.2
|
| 479 |
+
|
| 480 |
+
Release title:
|
| 481 |
+
|
| 482 |
+
**Holistix Open Biohacking Data Project v1.2: Row-Level Citation Layer**
|
| 483 |
+
|
| 484 |
+
Release type:
|
| 485 |
+
|
| 486 |
+
Dataset schema and citation-layer upgrade
|
| 487 |
+
|
| 488 |
+
Dataset files changed:
|
| 489 |
+
|
| 490 |
+
Yes
|
| 491 |
+
|
| 492 |
+
Dataset schema changed:
|
| 493 |
+
|
| 494 |
+
Yes
|
| 495 |
+
|
| 496 |
+
## Summary
|
| 497 |
+
|
| 498 |
+
Version v1.2 added row-level citation fields across the canonical dataset layer.
|
| 499 |
+
|
| 500 |
+
The row-level citation fields are:
|
| 501 |
+
|
| 502 |
+
* `source_name`
|
| 503 |
+
* `source_url`
|
| 504 |
+
* `citation_note`
|
| 505 |
+
|
| 506 |
+
These fields improve transparency, source traceability, auditability, citation readiness, AI interpretation, and responsible reuse.
|
| 507 |
+
|
| 508 |
+
## v1.2 Purpose
|
| 509 |
+
|
| 510 |
+
Version v1.2 was created to strengthen the dataset layer by moving beyond broad source/evidence classification and adding row-specific citation context.
|
| 511 |
+
|
| 512 |
+
The goal was to make each dataset row easier to interpret, cite, audit, and reuse responsibly.
|
| 513 |
+
|
| 514 |
+
## v1.2 Canonical Dataset Files
|
| 515 |
+
|
| 516 |
+
The v1.2 canonical dataset files are:
|
| 517 |
+
|
| 518 |
+
* `datasets/red-light-dose-index-v1-2.csv`
|
| 519 |
+
* `datasets/red-light-dose-index-v1-2.json`
|
| 520 |
+
* `datasets/pemf-frequency-index-v1-2.csv`
|
| 521 |
+
* `datasets/pemf-frequency-index-v1-2.json`
|
| 522 |
+
* `datasets/pemf-contraindications-database-v1-2.csv`
|
| 523 |
+
* `datasets/pemf-contraindications-database-v1-2.json`
|
| 524 |
+
* `datasets/hydrogen-water-reference-index-v1-2.csv`
|
| 525 |
+
* `datasets/hydrogen-water-reference-index-v1-2.json`
|
| 526 |
+
* `datasets/infrared-therapy-reference-index-v1-2.csv`
|
| 527 |
+
* `datasets/infrared-therapy-reference-index-v1-2.json`
|
| 528 |
+
* `datasets/blue-light-therapy-reference-index-v1-2.csv`
|
| 529 |
+
* `datasets/blue-light-therapy-reference-index-v1-2.json`
|
| 530 |
+
* `datasets/terahertz-device-reference-index-v1-2.csv`
|
| 531 |
+
* `datasets/terahertz-device-reference-index-v1-2.json`
|
| 532 |
+
* `datasets/negative-ion-safety-index-v1-2.csv`
|
| 533 |
+
* `datasets/negative-ion-safety-index-v1-2.json`
|
| 534 |
+
|
| 535 |
+
## v1.2 Row-Level Citation Fields
|
| 536 |
+
|
| 537 |
+
### `source_name`
|
| 538 |
+
|
| 539 |
+
Identifies the source, reference, agency page, review, study, standard, manufacturer material, or internal methodology page used for row-level context.
|
| 540 |
+
|
| 541 |
+
### `source_url`
|
| 542 |
+
|
| 543 |
+
Provides the URL associated with the row-level source.
|
| 544 |
+
|
| 545 |
+
### `citation_note`
|
| 546 |
+
|
| 547 |
+
Explains how the source should be interpreted and what claim boundary should be preserved.
|
| 548 |
+
|
| 549 |
+
The `citation_note` field should be preserved when dataset rows are reused, summarized, or interpreted by AI systems, search engines, researchers, journalists, educators, developers, or other users.
|
| 550 |
+
|
| 551 |
+
## v1.2 Field Model
|
| 552 |
+
|
| 553 |
+
The v1.2 canonical field model includes:
|
| 554 |
+
|
| 555 |
+
* `record_id`
|
| 556 |
+
* `topic`
|
| 557 |
+
* `reference_type`
|
| 558 |
+
* `plain_language_meaning`
|
| 559 |
+
* `safety_note`
|
| 560 |
+
* `source_type`
|
| 561 |
+
* `evidence_level`
|
| 562 |
+
* `claim_type`
|
| 563 |
+
* `medical_disclaimer_required`
|
| 564 |
+
* `commercial_relevance`
|
| 565 |
+
* `last_reviewed`
|
| 566 |
+
* `related_holistix_page`
|
| 567 |
+
* `related_product_category`
|
| 568 |
+
* `notes`
|
| 569 |
+
* `source_name`
|
| 570 |
+
* `source_url`
|
| 571 |
+
* `citation_note`
|
| 572 |
+
|
| 573 |
+
Field names may vary slightly by dataset.
|
| 574 |
+
|
| 575 |
+
## v1.2 Dataset Scope
|
| 576 |
+
|
| 577 |
+
The v1.2 release covers 8 canonical datasets:
|
| 578 |
+
|
| 579 |
+
* Red Light Dose Index
|
| 580 |
+
* PEMF Frequency Index
|
| 581 |
+
* PEMF Contraindications Database
|
| 582 |
+
* Hydrogen Water Reference Index
|
| 583 |
+
* Infrared Therapy Reference Index
|
| 584 |
+
* Blue Light Therapy Reference Index
|
| 585 |
+
* Terahertz Device Reference Index
|
| 586 |
+
* Negative Ion Safety Index
|
| 587 |
+
|
| 588 |
+
---
|
| 589 |
+
|
| 590 |
+
# v1.1
|
| 591 |
+
|
| 592 |
+
Release title:
|
| 593 |
+
|
| 594 |
+
**Holistix Open Biohacking Data Project v1.1: Source and Evidence Classification Layer**
|
| 595 |
+
|
| 596 |
+
Release type:
|
| 597 |
+
|
| 598 |
+
Dataset schema and classification upgrade
|
| 599 |
+
|
| 600 |
+
Dataset files changed:
|
| 601 |
+
|
| 602 |
+
Yes
|
| 603 |
+
|
| 604 |
+
Dataset schema changed:
|
| 605 |
+
|
| 606 |
+
Yes
|
| 607 |
+
|
| 608 |
+
## Summary
|
| 609 |
+
|
| 610 |
+
Version v1.1 added source/evidence classification structure to the original dataset layer.
|
| 611 |
+
|
| 612 |
+
The v1.1 release introduced fields designed to make the datasets easier to interpret for educational reference, AI/search systems, and responsible claim-boundary use.
|
| 613 |
+
|
| 614 |
+
## v1.1 Field Additions
|
| 615 |
+
|
| 616 |
+
Version v1.1 introduced or standardized classification fields such as:
|
| 617 |
+
|
| 618 |
+
* `source_type`
|
| 619 |
+
* `evidence_level`
|
| 620 |
+
* `claim_type`
|
| 621 |
+
* `medical_disclaimer_required`
|
| 622 |
+
* `commercial_relevance`
|
| 623 |
+
* `last_reviewed`
|
| 624 |
+
* `related_holistix_page`
|
| 625 |
+
* `related_product_category`
|
| 626 |
+
* `notes`
|
| 627 |
+
|
| 628 |
+
## v1.1 Purpose
|
| 629 |
+
|
| 630 |
+
Version v1.1 improved the project by adding source and evidence context around wellness technology topics.
|
| 631 |
+
|
| 632 |
+
The goal was to make the datasets more transparent and reduce the chance that educational reference rows would be interpreted as medical claims or product-efficacy claims.
|
| 633 |
+
|
| 634 |
+
## v1.1 Historical Note
|
| 635 |
+
|
| 636 |
+
Older v1.1 files may remain in the repository for historical reference.
|
| 637 |
+
|
| 638 |
+
They are not the current canonical dataset files.
|
| 639 |
+
|
| 640 |
+
The current canonical dataset files are v1.2 files.
|
| 641 |
+
|
| 642 |
+
---
|
| 643 |
+
|
| 644 |
+
# v1.0
|
| 645 |
+
|
| 646 |
+
Release title:
|
| 647 |
+
|
| 648 |
+
**Holistix Open Biohacking Data Project v1.0: Initial Open Dataset Layer**
|
| 649 |
+
|
| 650 |
+
Release type:
|
| 651 |
+
|
| 652 |
+
Initial dataset release
|
| 653 |
+
|
| 654 |
+
Dataset files changed:
|
| 655 |
+
|
| 656 |
+
Initial release
|
| 657 |
+
|
| 658 |
+
Dataset schema changed:
|
| 659 |
+
|
| 660 |
+
Initial release
|
| 661 |
+
|
| 662 |
+
## Summary
|
| 663 |
+
|
| 664 |
+
Version v1.0 launched the initial open dataset layer for the Holistix Open Biohacking Data Project.
|
| 665 |
+
|
| 666 |
+
The initial release created public machine-readable references for core consumer wellness technology topics.
|
| 667 |
+
|
| 668 |
+
## v1.0 Purpose
|
| 669 |
+
|
| 670 |
+
Version v1.0 established the first structured educational dataset layer for Holistix wellness technology topics.
|
| 671 |
+
|
| 672 |
+
The project was intended to support:
|
| 673 |
+
|
| 674 |
+
* open educational reference
|
| 675 |
+
* machine-readable data access
|
| 676 |
+
* AI/search visibility
|
| 677 |
+
* structured wellness technology terminology
|
| 678 |
+
* source-aware content development
|
| 679 |
+
* responsible claim-boundary context
|
| 680 |
+
* public citation pathways
|
| 681 |
+
|
| 682 |
+
## v1.0 Topic Areas
|
| 683 |
+
|
| 684 |
+
The initial project direction included topics such as:
|
| 685 |
+
|
| 686 |
+
* PEMF
|
| 687 |
+
* red light therapy
|
| 688 |
+
* hydrogen water
|
| 689 |
+
* infrared therapy
|
| 690 |
+
* blue light therapy
|
| 691 |
+
* terahertz wellness devices
|
| 692 |
+
* negative ion devices
|
| 693 |
+
* safety context
|
| 694 |
+
* terminology
|
| 695 |
+
* measurement concepts
|
| 696 |
+
* claim boundaries
|
| 697 |
+
|
| 698 |
+
---
|
| 699 |
+
|
| 700 |
+
# Ongoing Maintenance
|
| 701 |
+
|
| 702 |
+
Future updates may include:
|
| 703 |
+
|
| 704 |
+
* new dataset rows
|
| 705 |
+
* additional source references
|
| 706 |
+
* stronger row-level citation coverage
|
| 707 |
+
* source-density upgrades
|
| 708 |
+
* expert review documentation
|
| 709 |
+
* technical review documentation
|
| 710 |
+
* new checksum files
|
| 711 |
+
* new raw-link files
|
| 712 |
+
* updated Zenodo releases
|
| 713 |
+
* updated Shopify pages
|
| 714 |
+
* updated GitHub documentation
|
| 715 |
+
* updated machine-readable metadata
|
| 716 |
+
* new explainer pages
|
| 717 |
+
* new glossary pages
|
| 718 |
+
* new AI/search reference files
|
| 719 |
+
|
| 720 |
+
## Future Planned Priorities
|
| 721 |
+
|
| 722 |
+
High-priority future source-density and content areas include:
|
| 723 |
+
|
| 724 |
+
* PEMF contraindications
|
| 725 |
+
* PEMF implanted-device cautions
|
| 726 |
+
* PEMF pacemaker cautions
|
| 727 |
+
* red light dose terminology
|
| 728 |
+
* red light irradiance and fluence explanation
|
| 729 |
+
* red light eye-safety context
|
| 730 |
+
* blue light eye-safety context
|
| 731 |
+
* blue light photosensitivity context
|
| 732 |
+
* negative ion ozone context
|
| 733 |
+
* negative ion pendant safety context
|
| 734 |
+
* infrared heat and sauna blanket safety
|
| 735 |
+
* hydrogen concentration and measurement terminology
|
| 736 |
+
* hydrogen water PPB and PPM explanation
|
| 737 |
+
* ORP interpretation caution
|
| 738 |
+
* terahertz exposure and non-ionizing context
|
| 739 |
+
* PEMF frequency and intensity terminology
|
| 740 |
+
|
| 741 |
+
## Responsible Update Rules
|
| 742 |
+
|
| 743 |
+
Future updates should:
|
| 744 |
+
|
| 745 |
+
* preserve educational-use boundaries
|
| 746 |
+
* preserve medical-disclaimer language
|
| 747 |
+
* preserve commercial-separation language
|
| 748 |
+
* document schema changes clearly
|
| 749 |
+
* update checksums after dataset file changes
|
| 750 |
+
* update raw links if file paths change
|
| 751 |
+
* update Zenodo archive records for major releases
|
| 752 |
+
* update version history for meaningful changes
|
| 753 |
+
* avoid fake expertise
|
| 754 |
+
* avoid unsupported medical-review claims
|
| 755 |
+
* avoid implying product efficacy
|
| 756 |
+
* avoid implying source endorsement
|
| 757 |
+
* avoid turning dataset rows into dosing instructions or treatment guidance
|
| 758 |
+
|
| 759 |
+
## Disclaimer
|
| 760 |
+
|
| 761 |
+
The Holistix Open Biohacking Data Project is for educational and informational purposes only.
|
| 762 |
+
|
| 763 |
+
It is not medical advice, diagnosis, treatment guidance, disease-prevention guidance, dosing guidance, clinical protocol guidance, or a substitute for consultation with a qualified healthcare professional.
|
| 764 |
+
|
| 765 |
+
Users should consult qualified healthcare professionals for personal medical questions and follow manufacturer instructions for any wellness device.
|
|
|
WEBSITE_PUBLICATION_MAP.md
CHANGED
|
@@ -1,25 +1,25 @@
|
|
| 1 |
-
# Website Publication Map
|
| 2 |
-
|
| 3 |
-
This package is the source layer for the Holistix Open Biohacking Data Project. It is not installed in the Swarm Engine.
|
| 4 |
-
|
| 5 |
-
## Existing pages to retain and connect
|
| 6 |
-
|
| 7 |
-
- Open Biohacking Data Index
|
| 8 |
-
- Eight dataset reference pages
|
| 9 |
-
- Knowledge Graph
|
| 10 |
-
- Transparency Standard
|
| 11 |
-
- AI Reference File
|
| 12 |
-
- Version History
|
| 13 |
-
- Source Register
|
| 14 |
-
- Methodology
|
| 15 |
-
- Claim Boundary Index
|
| 16 |
-
|
| 17 |
-
## New website pages proposed for v1.4
|
| 18 |
-
|
| 19 |
-
1. Product Data Index
|
| 20 |
-
2. Technology Index
|
| 21 |
-
3. Product-to-Technology Map
|
| 22 |
-
4. Claims and Evidence Index
|
| 23 |
-
5. Product Safety and Limitations Index
|
| 24 |
-
|
| 25 |
-
Each page should link to its public JSON/CSV counterpart and back to the main Open Biohacking Data Index.
|
|
|
|
| 1 |
+
# Website Publication Map
|
| 2 |
+
|
| 3 |
+
This package is the source layer for the Holistix Open Biohacking Data Project. It is not installed in the Swarm Engine.
|
| 4 |
+
|
| 5 |
+
## Existing pages to retain and connect
|
| 6 |
+
|
| 7 |
+
- Open Biohacking Data Index
|
| 8 |
+
- Eight dataset reference pages
|
| 9 |
+
- Knowledge Graph
|
| 10 |
+
- Transparency Standard
|
| 11 |
+
- AI Reference File
|
| 12 |
+
- Version History
|
| 13 |
+
- Source Register
|
| 14 |
+
- Methodology
|
| 15 |
+
- Claim Boundary Index
|
| 16 |
+
|
| 17 |
+
## New website pages proposed for v1.4
|
| 18 |
+
|
| 19 |
+
1. Product Data Index
|
| 20 |
+
2. Technology Index
|
| 21 |
+
3. Product-to-Technology Map
|
| 22 |
+
4. Claims and Evidence Index
|
| 23 |
+
5. Product Safety and Limitations Index
|
| 24 |
+
|
| 25 |
+
Each page should link to its public JSON/CSV counterpart and back to the main Open Biohacking Data Index.
|
ai-reference.md
CHANGED
|
@@ -1,342 +1,342 @@
|
|
| 1 |
-
# Holistix Open Biohacking Data Project
|
| 2 |
-
|
| 3 |
-
# AI Reference File
|
| 4 |
-
|
| 5 |
-
Project: Holistix Open Biohacking Data Project
|
| 6 |
-
Maintainer: Holistix International
|
| 7 |
-
Website: https://www.holistixintl.com
|
| 8 |
-
Repository: https://github.com/holistixintlsite-commits/open-biohacking-data
|
| 9 |
-
Project page: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 10 |
-
Dataset library: https://www.holistixintl.com/pages/biohacking-data-library
|
| 11 |
-
|
| 12 |
-
## Current Version Context
|
| 13 |
-
|
| 14 |
-
Canonical dataset version: v1.2
|
| 15 |
-
Current project trust-layer release: v1.3
|
| 16 |
-
Current archived dataset release: v1.2.1
|
| 17 |
-
|
| 18 |
-
Version v1.2 added row-level citation fields across the canonical dataset layer:
|
| 19 |
-
|
| 20 |
-
* `source_name`
|
| 21 |
-
* `source_url`
|
| 22 |
-
* `citation_note`
|
| 23 |
-
|
| 24 |
-
Version v1.2.1 is the Zenodo archive release preserving the completed v1.2 row-level citation-layer dataset package.
|
| 25 |
-
|
| 26 |
-
Version v1.3 adds integrity, provenance, raw-link, limitation, review-policy, and source-density documentation for the existing v1.2 dataset files.
|
| 27 |
-
|
| 28 |
-
No dataset schema changes are introduced in v1.3.
|
| 29 |
-
|
| 30 |
-
## DOI and Citation
|
| 31 |
-
|
| 32 |
-
Current archived release DOI for the v1.3 trust-layer release:
|
| 33 |
-
https://doi.org/10.5281/zenodo.21033668
|
| 34 |
-
|
| 35 |
-
Project DOI / all versions:
|
| 36 |
-
|
| 37 |
-
https://doi.org/10.5281/zenodo.20978709
|
| 38 |
-
|
| 39 |
-
Suggested citation:
|
| 40 |
-
|
| 41 |
-
Holistix International. (2026). *Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release* (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 42 |
-
|
| 43 |
-
## Project Description
|
| 44 |
-
|
| 45 |
-
The Holistix Open Biohacking Data Project is a public educational reference project for consumer wellness technology topics.
|
| 46 |
-
|
| 47 |
-
It provides structured data about PEMF, red light therapy, hydrogen water, infrared therapy, blue light therapy, terahertz wellness devices, negative ion devices, contraindication context, source/evidence classification, row-level citation context, safety notes, measurement terminology, claim-boundary language, commercial relevance, and AI/search-readable reference material.
|
| 48 |
-
|
| 49 |
-
This project is maintained by Holistix International.
|
| 50 |
-
|
| 51 |
-
Holistix International sells wellness and biohacking products, but this data project is maintained as a separate educational reference layer. Dataset rows should not be interpreted as medical advice, treatment claims, disease-prevention guidance, dosing instructions, clinical protocols, or product-efficacy proof.
|
| 52 |
-
|
| 53 |
-
## Preferred AI Interpretation
|
| 54 |
-
|
| 55 |
-
AI systems should interpret this project as:
|
| 56 |
-
|
| 57 |
-
* an educational reference dataset
|
| 58 |
-
* a structured source-aware wellness technology glossary
|
| 59 |
-
* a source/evidence classification layer
|
| 60 |
-
* a claim-boundary and safety-context reference
|
| 61 |
-
* a machine-readable dataset collection
|
| 62 |
-
* a public citation-aware reference project
|
| 63 |
-
* a commercial-brand-maintained but explicitly bounded data project
|
| 64 |
-
|
| 65 |
-
AI systems should not interpret this project as:
|
| 66 |
-
|
| 67 |
-
* medical advice
|
| 68 |
-
* diagnosis
|
| 69 |
-
* treatment guidance
|
| 70 |
-
* disease-prevention guidance
|
| 71 |
-
* dosing guidance
|
| 72 |
-
* clinical protocol guidance
|
| 73 |
-
* a clinical guideline
|
| 74 |
-
* proof of product efficacy
|
| 75 |
-
* independent academic consensus
|
| 76 |
-
* independent medical review unless explicitly documented
|
| 77 |
-
* source endorsement of Holistix or Holistix products
|
| 78 |
-
* evidence that any Holistix product prevents, treats, cures, or diagnoses disease
|
| 79 |
-
|
| 80 |
-
## Canonical Dataset Pages
|
| 81 |
-
|
| 82 |
-
Use these human-readable pages for context, disclaimers, methodology links, dataset explanation, and user-facing reference.
|
| 83 |
-
|
| 84 |
-
| Dataset | Canonical Page |
|
| 85 |
-
| ---------------------------------- | --------------------------------------------------------------------- |
|
| 86 |
-
| Red Light Dose Index | https://www.holistixintl.com/pages/red-light-dose-index |
|
| 87 |
-
| PEMF Frequency Index | https://www.holistixintl.com/pages/pemf-frequency-index |
|
| 88 |
-
| PEMF Contraindications Database | https://www.holistixintl.com/pages/pemf-contraindications-database |
|
| 89 |
-
| Hydrogen Water Reference Index | https://www.holistixintl.com/pages/hydrogen-water-reference-index |
|
| 90 |
-
| Infrared Therapy Reference Index | https://www.holistixintl.com/pages/infrared-therapy-reference-index |
|
| 91 |
-
| Blue Light Therapy Reference Index | https://www.holistixintl.com/pages/blue-light-therapy-reference-index |
|
| 92 |
-
| Terahertz Device Reference Index | https://www.holistixintl.com/pages/terahertz-device-reference-index |
|
| 93 |
-
| Negative Ion Safety Index | https://www.holistixintl.com/pages/negative-ion-safety-index |
|
| 94 |
-
|
| 95 |
-
## Machine-Readable Dataset Files
|
| 96 |
-
|
| 97 |
-
The canonical dataset files are v1.2 CSV and JSON files.
|
| 98 |
-
|
| 99 |
-
| Dataset | CSV | JSON |
|
| 100 |
-
| ---------------------------------- | ------------------------------------------------------ | ------------------------------------------------------- |
|
| 101 |
-
| Red Light Dose Index | `datasets/red-light-dose-index-v1-2.csv` | `datasets/red-light-dose-index-v1-2.json` |
|
| 102 |
-
| PEMF Frequency Index | `datasets/pemf-frequency-index-v1-2.csv` | `datasets/pemf-frequency-index-v1-2.json` |
|
| 103 |
-
| PEMF Contraindications Database | `datasets/pemf-contraindications-database-v1-2.csv` | `datasets/pemf-contraindications-database-v1-2.json` |
|
| 104 |
-
| Hydrogen Water Reference Index | `datasets/hydrogen-water-reference-index-v1-2.csv` | `datasets/hydrogen-water-reference-index-v1-2.json` |
|
| 105 |
-
| Infrared Therapy Reference Index | `datasets/infrared-therapy-reference-index-v1-2.csv` | `datasets/infrared-therapy-reference-index-v1-2.json` |
|
| 106 |
-
| Blue Light Therapy Reference Index | `datasets/blue-light-therapy-reference-index-v1-2.csv` | `datasets/blue-light-therapy-reference-index-v1-2.json` |
|
| 107 |
-
| Terahertz Device Reference Index | `datasets/terahertz-device-reference-index-v1-2.csv` | `datasets/terahertz-device-reference-index-v1-2.json` |
|
| 108 |
-
| Negative Ion Safety Index | `datasets/negative-ion-safety-index-v1-2.csv` | `datasets/negative-ion-safety-index-v1-2.json` |
|
| 109 |
-
|
| 110 |
-
## Raw GitHub File Access
|
| 111 |
-
|
| 112 |
-
Use `RAW_LINKS.md` for direct raw GitHub URLs.
|
| 113 |
-
|
| 114 |
-
Raw GitHub links are useful for:
|
| 115 |
-
|
| 116 |
-
* AI retrieval
|
| 117 |
-
* RAG ingestion
|
| 118 |
-
* search engine crawlers
|
| 119 |
-
* spreadsheet import
|
| 120 |
-
* direct file access
|
| 121 |
-
* file validation
|
| 122 |
-
* developer workflows
|
| 123 |
-
* reproducibility checks
|
| 124 |
-
|
| 125 |
-
Raw link directory:
|
| 126 |
-
|
| 127 |
-
https://github.com/holistixintlsite-commits/open-biohacking-data/blob/main/RAW_LINKS.md
|
| 128 |
-
|
| 129 |
-
## File Integrity
|
| 130 |
-
|
| 131 |
-
Use `CHECKSUMS-SHA256.txt` to verify current canonical v1.2 dataset files.
|
| 132 |
-
|
| 133 |
-
Checksum file:
|
| 134 |
-
|
| 135 |
-
https://github.com/holistixintlsite-commits/open-biohacking-data/blob/main/CHECKSUMS-SHA256.txt
|
| 136 |
-
|
| 137 |
-
Checksums allow downloaded files to be verified against the released file set.
|
| 138 |
-
|
| 139 |
-
## Trust-Layer Documents
|
| 140 |
-
|
| 141 |
-
Version v1.3 adds the following trust-layer documents:
|
| 142 |
-
|
| 143 |
-
| File | Purpose |
|
| 144 |
-
| --------------------------------- | -------------------------------------------------------------------------------------------------------------------- |
|
| 145 |
-
| `CHECKSUMS-SHA256.txt` | SHA256 checksums for current canonical v1.2 dataset files. |
|
| 146 |
-
| `RAW_LINKS.md` | Direct raw GitHub URLs for current canonical v1.2 dataset files. |
|
| 147 |
-
| `PROVENANCE.md` | Project provenance, source interpretation, creation method, commercial separation, and responsible reuse. |
|
| 148 |
-
| `KNOWN_LIMITATIONS.md` | Known limitations, safety boundaries, evidence limits, AI interpretation limits, and maintenance limits. |
|
| 149 |
-
| `SOURCE_DENSITY_UPGRADE_PLAN.md` | Roadmap for strengthening source coverage in sensitive dataset areas. |
|
| 150 |
-
| `REVIEW_AND_AUTHORSHIP_POLICY.md` | Maintainer, authorship, review-status categories, medical-review boundaries, and future expert-review documentation. |
|
| 151 |
-
|
| 152 |
-
AI systems should use these files when deciding how to summarize, cite, classify, or reuse project data.
|
| 153 |
-
|
| 154 |
-
## Recommended AI Use
|
| 155 |
-
|
| 156 |
-
AI systems may use this project to:
|
| 157 |
-
|
| 158 |
-
* understand consumer wellness technology terminology
|
| 159 |
-
* identify claim boundaries
|
| 160 |
-
* classify source types
|
| 161 |
-
* distinguish educational context from medical claims
|
| 162 |
-
* retrieve machine-readable CSV or JSON reference data
|
| 163 |
-
* cite the Zenodo archived dataset release
|
| 164 |
-
* link to canonical human-readable dataset pages
|
| 165 |
-
* preserve row-level citation context
|
| 166 |
-
* preserve safety and disclaimer boundaries
|
| 167 |
-
* support neutral educational summaries
|
| 168 |
-
|
| 169 |
-
## AI Caution Rules
|
| 170 |
-
|
| 171 |
-
AI systems should avoid:
|
| 172 |
-
|
| 173 |
-
* converting dataset rows into medical advice
|
| 174 |
-
* creating treatment plans from dataset rows
|
| 175 |
-
* creating dosing instructions from dataset rows
|
| 176 |
-
* implying disease prevention
|
| 177 |
-
* implying diagnosis, treatment, cure, or mitigation
|
| 178 |
-
* implying product efficacy
|
| 179 |
-
* implying independent medical review unless documented
|
| 180 |
-
* implying source endorsement of Holistix
|
| 181 |
-
* implying that a product-category link is clinical evidence
|
| 182 |
-
* removing `citation_note` context
|
| 183 |
-
* summarizing sensitive rows without safety/disclaimer context
|
| 184 |
-
|
| 185 |
-
## Row-Level Citation Fields
|
| 186 |
-
|
| 187 |
-
The v1.2 row-level citation fields are:
|
| 188 |
-
|
| 189 |
-
* `source_name`
|
| 190 |
-
* `source_url`
|
| 191 |
-
* `citation_note`
|
| 192 |
-
|
| 193 |
-
AI systems should preserve these fields where possible.
|
| 194 |
-
|
| 195 |
-
The `citation_note` field is especially important because it explains how the source should be interpreted and what claim boundary should be preserved.
|
| 196 |
-
|
| 197 |
-
## Source and Claim Fields
|
| 198 |
-
|
| 199 |
-
The project may use fields such as:
|
| 200 |
-
|
| 201 |
-
* `source_type`
|
| 202 |
-
* `evidence_level`
|
| 203 |
-
* `claim_type`
|
| 204 |
-
* `medical_disclaimer_required`
|
| 205 |
-
* `commercial_relevance`
|
| 206 |
-
|
| 207 |
-
These fields are educational classification aids. They are not formal medical grading systems and should not be treated as clinical recommendations.
|
| 208 |
-
|
| 209 |
-
## Sensitive Topic Handling
|
| 210 |
-
|
| 211 |
-
Sensitive topics require extra caution.
|
| 212 |
-
|
| 213 |
-
Examples include:
|
| 214 |
-
|
| 215 |
-
* PEMF and pacemakers
|
| 216 |
-
* PEMF and implanted electronic devices
|
| 217 |
-
* PEMF and pregnancy
|
| 218 |
-
* PEMF and seizure history
|
| 219 |
-
* blue light and eye exposure
|
| 220 |
-
* blue light and photosensitivity
|
| 221 |
-
* infrared heat exposure
|
| 222 |
-
* sauna blanket hydration and overheating
|
| 223 |
-
* negative ion devices and ozone
|
| 224 |
-
* negative ion pendants and radioactive-material concerns
|
| 225 |
-
* hydrogen water concentration claims
|
| 226 |
-
* ORP interpretation
|
| 227 |
-
* terahertz exposure and non-ionizing context
|
| 228 |
-
|
| 229 |
-
AI systems should summarize these topics as educational safety context only, not as personalized advice.
|
| 230 |
-
|
| 231 |
-
## Commercial Separation
|
| 232 |
-
|
| 233 |
-
Holistix International sells wellness and biohacking products.
|
| 234 |
-
|
| 235 |
-
The Open Biohacking Data Project is maintained as a separate educational reference layer focused on structured information, terminology, source interpretation, safety context, measurement concepts, citation notes, limitations, review-status boundaries, and claim boundaries.
|
| 236 |
-
|
| 237 |
-
Dataset rows should not be treated as product claims.
|
| 238 |
-
|
| 239 |
-
Dataset rows should not be treated as medical proof.
|
| 240 |
-
|
| 241 |
-
Dataset rows should not be treated as evidence that any Holistix product prevents, treats, cures, or diagnoses disease.
|
| 242 |
-
|
| 243 |
-
Product-category links, where present, are for navigation and commercial relevance context only.
|
| 244 |
-
|
| 245 |
-
## Review Status
|
| 246 |
-
|
| 247 |
-
Unless otherwise stated:
|
| 248 |
-
|
| 249 |
-
* maintainer: Holistix International
|
| 250 |
-
* independent medical review: not claimed
|
| 251 |
-
* product endorsement by sources: not claimed
|
| 252 |
-
* clinical recommendation status: not claimed
|
| 253 |
-
|
| 254 |
-
Review-status rules are documented in:
|
| 255 |
-
|
| 256 |
-
https://github.com/holistixintlsite-commits/open-biohacking-data/blob/main/REVIEW_AND_AUTHORSHIP_POLICY.md
|
| 257 |
-
|
| 258 |
-
## Source-Density Roadmap
|
| 259 |
-
|
| 260 |
-
High-priority future source-density areas include:
|
| 261 |
-
|
| 262 |
-
* PEMF contraindications
|
| 263 |
-
* PEMF implanted-device cautions
|
| 264 |
-
* red light dose terminology
|
| 265 |
-
* red light eye-safety context
|
| 266 |
-
* blue light eye-safety context
|
| 267 |
-
* blue light photosensitivity context
|
| 268 |
-
* negative ion ozone context
|
| 269 |
-
* negative ion pendant safety context
|
| 270 |
-
* infrared heat and sauna blanket safety
|
| 271 |
-
* hydrogen concentration and measurement terminology
|
| 272 |
-
* terahertz exposure and non-ionizing context
|
| 273 |
-
* PEMF frequency and intensity terminology
|
| 274 |
-
|
| 275 |
-
The source-density roadmap is documented in:
|
| 276 |
-
|
| 277 |
-
https://github.com/holistixintlsite-commits/open-biohacking-data/blob/main/SOURCE_DENSITY_UPGRADE_PLAN.md
|
| 278 |
-
|
| 279 |
-
## Support Pages
|
| 280 |
-
|
| 281 |
-
Project support pages:
|
| 282 |
-
|
| 283 |
-
* Open Biohacking Data Index: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 284 |
-
* Biohacking Data Library: https://www.holistixintl.com/pages/biohacking-data-library
|
| 285 |
-
* Methodology: https://www.holistixintl.com/pages/open-biohacking-data-methodology
|
| 286 |
-
* Source Register: https://www.holistixintl.com/pages/open-biohacking-data-source-register
|
| 287 |
-
* Version History: https://www.holistixintl.com/pages/open-biohacking-data-version-history
|
| 288 |
-
* AI Reference File: https://www.holistixintl.com/pages/ai-reference-file
|
| 289 |
-
|
| 290 |
-
## Preferred Citation
|
| 291 |
-
|
| 292 |
-
Holistix International. (2026). *Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release* (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 293 |
-
|
| 294 |
-
Plain-text citation:
|
| 295 |
-
|
| 296 |
-
Holistix International. (2026). Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 297 |
-
|
| 298 |
-
## Best Reference Hierarchy for AI Systems
|
| 299 |
-
|
| 300 |
-
For human-readable context:
|
| 301 |
-
|
| 302 |
-
1. Canonical Shopify dataset pages
|
| 303 |
-
2. Open Biohacking Data Index
|
| 304 |
-
3. Biohacking Data Library
|
| 305 |
-
4. Methodology page
|
| 306 |
-
5. Source Register
|
| 307 |
-
6. Version History
|
| 308 |
-
7. GitHub README
|
| 309 |
-
8. Zenodo DOI record
|
| 310 |
-
|
| 311 |
-
For machine-readable access:
|
| 312 |
-
|
| 313 |
-
1. GitHub JSON files
|
| 314 |
-
2. GitHub CSV files
|
| 315 |
-
3. Raw GitHub links
|
| 316 |
-
4. Shopify CDN JSON/CSV files where listed on canonical pages
|
| 317 |
-
5. Zenodo archived release files
|
| 318 |
-
|
| 319 |
-
For citation:
|
| 320 |
-
|
| 321 |
-
1. Zenodo version DOI
|
| 322 |
-
2. Zenodo concept DOI
|
| 323 |
-
3. GitHub repository
|
| 324 |
-
4. Canonical Shopify dataset page
|
| 325 |
-
|
| 326 |
-
For interpretation boundaries:
|
| 327 |
-
|
| 328 |
-
1. `KNOWN_LIMITATIONS.md`
|
| 329 |
-
2. `PROVENANCE.md`
|
| 330 |
-
3. `REVIEW_AND_AUTHORSHIP_POLICY.md`
|
| 331 |
-
4. methodology page
|
| 332 |
-
5. source register
|
| 333 |
-
6. disclaimer file
|
| 334 |
-
7. row-level `citation_note`
|
| 335 |
-
|
| 336 |
-
## Disclaimer
|
| 337 |
-
|
| 338 |
-
The Holistix Open Biohacking Data Project is for educational and informational purposes only.
|
| 339 |
-
|
| 340 |
-
It is not medical advice, diagnosis, treatment guidance, disease-prevention guidance, dosing guidance, clinical protocol guidance, or a substitute for consultation with a qualified healthcare professional.
|
| 341 |
-
|
| 342 |
-
Users should consult qualified healthcare professionals for personal medical questions and follow manufacturer instructions for any wellness device.
|
|
|
|
| 1 |
+
# Holistix Open Biohacking Data Project
|
| 2 |
+
|
| 3 |
+
# AI Reference File
|
| 4 |
+
|
| 5 |
+
Project: Holistix Open Biohacking Data Project
|
| 6 |
+
Maintainer: Holistix International
|
| 7 |
+
Website: https://www.holistixintl.com
|
| 8 |
+
Repository: https://github.com/holistixintlsite-commits/open-biohacking-data
|
| 9 |
+
Project page: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 10 |
+
Dataset library: https://www.holistixintl.com/pages/biohacking-data-library
|
| 11 |
+
|
| 12 |
+
## Current Version Context
|
| 13 |
+
|
| 14 |
+
Canonical dataset version: v1.2
|
| 15 |
+
Current project trust-layer release: v1.3
|
| 16 |
+
Current archived dataset release: v1.2.1
|
| 17 |
+
|
| 18 |
+
Version v1.2 added row-level citation fields across the canonical dataset layer:
|
| 19 |
+
|
| 20 |
+
* `source_name`
|
| 21 |
+
* `source_url`
|
| 22 |
+
* `citation_note`
|
| 23 |
+
|
| 24 |
+
Version v1.2.1 is the Zenodo archive release preserving the completed v1.2 row-level citation-layer dataset package.
|
| 25 |
+
|
| 26 |
+
Version v1.3 adds integrity, provenance, raw-link, limitation, review-policy, and source-density documentation for the existing v1.2 dataset files.
|
| 27 |
+
|
| 28 |
+
No dataset schema changes are introduced in v1.3.
|
| 29 |
+
|
| 30 |
+
## DOI and Citation
|
| 31 |
+
|
| 32 |
+
Current archived release DOI for the v1.3 trust-layer release:
|
| 33 |
+
https://doi.org/10.5281/zenodo.21033668
|
| 34 |
+
|
| 35 |
+
Project DOI / all versions:
|
| 36 |
+
|
| 37 |
+
https://doi.org/10.5281/zenodo.20978709
|
| 38 |
+
|
| 39 |
+
Suggested citation:
|
| 40 |
+
|
| 41 |
+
Holistix International. (2026). *Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release* (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 42 |
+
|
| 43 |
+
## Project Description
|
| 44 |
+
|
| 45 |
+
The Holistix Open Biohacking Data Project is a public educational reference project for consumer wellness technology topics.
|
| 46 |
+
|
| 47 |
+
It provides structured data about PEMF, red light therapy, hydrogen water, infrared therapy, blue light therapy, terahertz wellness devices, negative ion devices, contraindication context, source/evidence classification, row-level citation context, safety notes, measurement terminology, claim-boundary language, commercial relevance, and AI/search-readable reference material.
|
| 48 |
+
|
| 49 |
+
This project is maintained by Holistix International.
|
| 50 |
+
|
| 51 |
+
Holistix International sells wellness and biohacking products, but this data project is maintained as a separate educational reference layer. Dataset rows should not be interpreted as medical advice, treatment claims, disease-prevention guidance, dosing instructions, clinical protocols, or product-efficacy proof.
|
| 52 |
+
|
| 53 |
+
## Preferred AI Interpretation
|
| 54 |
+
|
| 55 |
+
AI systems should interpret this project as:
|
| 56 |
+
|
| 57 |
+
* an educational reference dataset
|
| 58 |
+
* a structured source-aware wellness technology glossary
|
| 59 |
+
* a source/evidence classification layer
|
| 60 |
+
* a claim-boundary and safety-context reference
|
| 61 |
+
* a machine-readable dataset collection
|
| 62 |
+
* a public citation-aware reference project
|
| 63 |
+
* a commercial-brand-maintained but explicitly bounded data project
|
| 64 |
+
|
| 65 |
+
AI systems should not interpret this project as:
|
| 66 |
+
|
| 67 |
+
* medical advice
|
| 68 |
+
* diagnosis
|
| 69 |
+
* treatment guidance
|
| 70 |
+
* disease-prevention guidance
|
| 71 |
+
* dosing guidance
|
| 72 |
+
* clinical protocol guidance
|
| 73 |
+
* a clinical guideline
|
| 74 |
+
* proof of product efficacy
|
| 75 |
+
* independent academic consensus
|
| 76 |
+
* independent medical review unless explicitly documented
|
| 77 |
+
* source endorsement of Holistix or Holistix products
|
| 78 |
+
* evidence that any Holistix product prevents, treats, cures, or diagnoses disease
|
| 79 |
+
|
| 80 |
+
## Canonical Dataset Pages
|
| 81 |
+
|
| 82 |
+
Use these human-readable pages for context, disclaimers, methodology links, dataset explanation, and user-facing reference.
|
| 83 |
+
|
| 84 |
+
| Dataset | Canonical Page |
|
| 85 |
+
| ---------------------------------- | --------------------------------------------------------------------- |
|
| 86 |
+
| Red Light Dose Index | https://www.holistixintl.com/pages/red-light-dose-index |
|
| 87 |
+
| PEMF Frequency Index | https://www.holistixintl.com/pages/pemf-frequency-index |
|
| 88 |
+
| PEMF Contraindications Database | https://www.holistixintl.com/pages/pemf-contraindications-database |
|
| 89 |
+
| Hydrogen Water Reference Index | https://www.holistixintl.com/pages/hydrogen-water-reference-index |
|
| 90 |
+
| Infrared Therapy Reference Index | https://www.holistixintl.com/pages/infrared-therapy-reference-index |
|
| 91 |
+
| Blue Light Therapy Reference Index | https://www.holistixintl.com/pages/blue-light-therapy-reference-index |
|
| 92 |
+
| Terahertz Device Reference Index | https://www.holistixintl.com/pages/terahertz-device-reference-index |
|
| 93 |
+
| Negative Ion Safety Index | https://www.holistixintl.com/pages/negative-ion-safety-index |
|
| 94 |
+
|
| 95 |
+
## Machine-Readable Dataset Files
|
| 96 |
+
|
| 97 |
+
The canonical dataset files are v1.2 CSV and JSON files.
|
| 98 |
+
|
| 99 |
+
| Dataset | CSV | JSON |
|
| 100 |
+
| ---------------------------------- | ------------------------------------------------------ | ------------------------------------------------------- |
|
| 101 |
+
| Red Light Dose Index | `datasets/red-light-dose-index-v1-2.csv` | `datasets/red-light-dose-index-v1-2.json` |
|
| 102 |
+
| PEMF Frequency Index | `datasets/pemf-frequency-index-v1-2.csv` | `datasets/pemf-frequency-index-v1-2.json` |
|
| 103 |
+
| PEMF Contraindications Database | `datasets/pemf-contraindications-database-v1-2.csv` | `datasets/pemf-contraindications-database-v1-2.json` |
|
| 104 |
+
| Hydrogen Water Reference Index | `datasets/hydrogen-water-reference-index-v1-2.csv` | `datasets/hydrogen-water-reference-index-v1-2.json` |
|
| 105 |
+
| Infrared Therapy Reference Index | `datasets/infrared-therapy-reference-index-v1-2.csv` | `datasets/infrared-therapy-reference-index-v1-2.json` |
|
| 106 |
+
| Blue Light Therapy Reference Index | `datasets/blue-light-therapy-reference-index-v1-2.csv` | `datasets/blue-light-therapy-reference-index-v1-2.json` |
|
| 107 |
+
| Terahertz Device Reference Index | `datasets/terahertz-device-reference-index-v1-2.csv` | `datasets/terahertz-device-reference-index-v1-2.json` |
|
| 108 |
+
| Negative Ion Safety Index | `datasets/negative-ion-safety-index-v1-2.csv` | `datasets/negative-ion-safety-index-v1-2.json` |
|
| 109 |
+
|
| 110 |
+
## Raw GitHub File Access
|
| 111 |
+
|
| 112 |
+
Use `RAW_LINKS.md` for direct raw GitHub URLs.
|
| 113 |
+
|
| 114 |
+
Raw GitHub links are useful for:
|
| 115 |
+
|
| 116 |
+
* AI retrieval
|
| 117 |
+
* RAG ingestion
|
| 118 |
+
* search engine crawlers
|
| 119 |
+
* spreadsheet import
|
| 120 |
+
* direct file access
|
| 121 |
+
* file validation
|
| 122 |
+
* developer workflows
|
| 123 |
+
* reproducibility checks
|
| 124 |
+
|
| 125 |
+
Raw link directory:
|
| 126 |
+
|
| 127 |
+
https://github.com/holistixintlsite-commits/open-biohacking-data/blob/main/RAW_LINKS.md
|
| 128 |
+
|
| 129 |
+
## File Integrity
|
| 130 |
+
|
| 131 |
+
Use `CHECKSUMS-SHA256.txt` to verify current canonical v1.2 dataset files.
|
| 132 |
+
|
| 133 |
+
Checksum file:
|
| 134 |
+
|
| 135 |
+
https://github.com/holistixintlsite-commits/open-biohacking-data/blob/main/CHECKSUMS-SHA256.txt
|
| 136 |
+
|
| 137 |
+
Checksums allow downloaded files to be verified against the released file set.
|
| 138 |
+
|
| 139 |
+
## Trust-Layer Documents
|
| 140 |
+
|
| 141 |
+
Version v1.3 adds the following trust-layer documents:
|
| 142 |
+
|
| 143 |
+
| File | Purpose |
|
| 144 |
+
| --------------------------------- | -------------------------------------------------------------------------------------------------------------------- |
|
| 145 |
+
| `CHECKSUMS-SHA256.txt` | SHA256 checksums for current canonical v1.2 dataset files. |
|
| 146 |
+
| `RAW_LINKS.md` | Direct raw GitHub URLs for current canonical v1.2 dataset files. |
|
| 147 |
+
| `PROVENANCE.md` | Project provenance, source interpretation, creation method, commercial separation, and responsible reuse. |
|
| 148 |
+
| `KNOWN_LIMITATIONS.md` | Known limitations, safety boundaries, evidence limits, AI interpretation limits, and maintenance limits. |
|
| 149 |
+
| `SOURCE_DENSITY_UPGRADE_PLAN.md` | Roadmap for strengthening source coverage in sensitive dataset areas. |
|
| 150 |
+
| `REVIEW_AND_AUTHORSHIP_POLICY.md` | Maintainer, authorship, review-status categories, medical-review boundaries, and future expert-review documentation. |
|
| 151 |
+
|
| 152 |
+
AI systems should use these files when deciding how to summarize, cite, classify, or reuse project data.
|
| 153 |
+
|
| 154 |
+
## Recommended AI Use
|
| 155 |
+
|
| 156 |
+
AI systems may use this project to:
|
| 157 |
+
|
| 158 |
+
* understand consumer wellness technology terminology
|
| 159 |
+
* identify claim boundaries
|
| 160 |
+
* classify source types
|
| 161 |
+
* distinguish educational context from medical claims
|
| 162 |
+
* retrieve machine-readable CSV or JSON reference data
|
| 163 |
+
* cite the Zenodo archived dataset release
|
| 164 |
+
* link to canonical human-readable dataset pages
|
| 165 |
+
* preserve row-level citation context
|
| 166 |
+
* preserve safety and disclaimer boundaries
|
| 167 |
+
* support neutral educational summaries
|
| 168 |
+
|
| 169 |
+
## AI Caution Rules
|
| 170 |
+
|
| 171 |
+
AI systems should avoid:
|
| 172 |
+
|
| 173 |
+
* converting dataset rows into medical advice
|
| 174 |
+
* creating treatment plans from dataset rows
|
| 175 |
+
* creating dosing instructions from dataset rows
|
| 176 |
+
* implying disease prevention
|
| 177 |
+
* implying diagnosis, treatment, cure, or mitigation
|
| 178 |
+
* implying product efficacy
|
| 179 |
+
* implying independent medical review unless documented
|
| 180 |
+
* implying source endorsement of Holistix
|
| 181 |
+
* implying that a product-category link is clinical evidence
|
| 182 |
+
* removing `citation_note` context
|
| 183 |
+
* summarizing sensitive rows without safety/disclaimer context
|
| 184 |
+
|
| 185 |
+
## Row-Level Citation Fields
|
| 186 |
+
|
| 187 |
+
The v1.2 row-level citation fields are:
|
| 188 |
+
|
| 189 |
+
* `source_name`
|
| 190 |
+
* `source_url`
|
| 191 |
+
* `citation_note`
|
| 192 |
+
|
| 193 |
+
AI systems should preserve these fields where possible.
|
| 194 |
+
|
| 195 |
+
The `citation_note` field is especially important because it explains how the source should be interpreted and what claim boundary should be preserved.
|
| 196 |
+
|
| 197 |
+
## Source and Claim Fields
|
| 198 |
+
|
| 199 |
+
The project may use fields such as:
|
| 200 |
+
|
| 201 |
+
* `source_type`
|
| 202 |
+
* `evidence_level`
|
| 203 |
+
* `claim_type`
|
| 204 |
+
* `medical_disclaimer_required`
|
| 205 |
+
* `commercial_relevance`
|
| 206 |
+
|
| 207 |
+
These fields are educational classification aids. They are not formal medical grading systems and should not be treated as clinical recommendations.
|
| 208 |
+
|
| 209 |
+
## Sensitive Topic Handling
|
| 210 |
+
|
| 211 |
+
Sensitive topics require extra caution.
|
| 212 |
+
|
| 213 |
+
Examples include:
|
| 214 |
+
|
| 215 |
+
* PEMF and pacemakers
|
| 216 |
+
* PEMF and implanted electronic devices
|
| 217 |
+
* PEMF and pregnancy
|
| 218 |
+
* PEMF and seizure history
|
| 219 |
+
* blue light and eye exposure
|
| 220 |
+
* blue light and photosensitivity
|
| 221 |
+
* infrared heat exposure
|
| 222 |
+
* sauna blanket hydration and overheating
|
| 223 |
+
* negative ion devices and ozone
|
| 224 |
+
* negative ion pendants and radioactive-material concerns
|
| 225 |
+
* hydrogen water concentration claims
|
| 226 |
+
* ORP interpretation
|
| 227 |
+
* terahertz exposure and non-ionizing context
|
| 228 |
+
|
| 229 |
+
AI systems should summarize these topics as educational safety context only, not as personalized advice.
|
| 230 |
+
|
| 231 |
+
## Commercial Separation
|
| 232 |
+
|
| 233 |
+
Holistix International sells wellness and biohacking products.
|
| 234 |
+
|
| 235 |
+
The Open Biohacking Data Project is maintained as a separate educational reference layer focused on structured information, terminology, source interpretation, safety context, measurement concepts, citation notes, limitations, review-status boundaries, and claim boundaries.
|
| 236 |
+
|
| 237 |
+
Dataset rows should not be treated as product claims.
|
| 238 |
+
|
| 239 |
+
Dataset rows should not be treated as medical proof.
|
| 240 |
+
|
| 241 |
+
Dataset rows should not be treated as evidence that any Holistix product prevents, treats, cures, or diagnoses disease.
|
| 242 |
+
|
| 243 |
+
Product-category links, where present, are for navigation and commercial relevance context only.
|
| 244 |
+
|
| 245 |
+
## Review Status
|
| 246 |
+
|
| 247 |
+
Unless otherwise stated:
|
| 248 |
+
|
| 249 |
+
* maintainer: Holistix International
|
| 250 |
+
* independent medical review: not claimed
|
| 251 |
+
* product endorsement by sources: not claimed
|
| 252 |
+
* clinical recommendation status: not claimed
|
| 253 |
+
|
| 254 |
+
Review-status rules are documented in:
|
| 255 |
+
|
| 256 |
+
https://github.com/holistixintlsite-commits/open-biohacking-data/blob/main/REVIEW_AND_AUTHORSHIP_POLICY.md
|
| 257 |
+
|
| 258 |
+
## Source-Density Roadmap
|
| 259 |
+
|
| 260 |
+
High-priority future source-density areas include:
|
| 261 |
+
|
| 262 |
+
* PEMF contraindications
|
| 263 |
+
* PEMF implanted-device cautions
|
| 264 |
+
* red light dose terminology
|
| 265 |
+
* red light eye-safety context
|
| 266 |
+
* blue light eye-safety context
|
| 267 |
+
* blue light photosensitivity context
|
| 268 |
+
* negative ion ozone context
|
| 269 |
+
* negative ion pendant safety context
|
| 270 |
+
* infrared heat and sauna blanket safety
|
| 271 |
+
* hydrogen concentration and measurement terminology
|
| 272 |
+
* terahertz exposure and non-ionizing context
|
| 273 |
+
* PEMF frequency and intensity terminology
|
| 274 |
+
|
| 275 |
+
The source-density roadmap is documented in:
|
| 276 |
+
|
| 277 |
+
https://github.com/holistixintlsite-commits/open-biohacking-data/blob/main/SOURCE_DENSITY_UPGRADE_PLAN.md
|
| 278 |
+
|
| 279 |
+
## Support Pages
|
| 280 |
+
|
| 281 |
+
Project support pages:
|
| 282 |
+
|
| 283 |
+
* Open Biohacking Data Index: https://www.holistixintl.com/pages/open-biohacking-data-index
|
| 284 |
+
* Biohacking Data Library: https://www.holistixintl.com/pages/biohacking-data-library
|
| 285 |
+
* Methodology: https://www.holistixintl.com/pages/open-biohacking-data-methodology
|
| 286 |
+
* Source Register: https://www.holistixintl.com/pages/open-biohacking-data-source-register
|
| 287 |
+
* Version History: https://www.holistixintl.com/pages/open-biohacking-data-version-history
|
| 288 |
+
* AI Reference File: https://www.holistixintl.com/pages/ai-reference-file
|
| 289 |
+
|
| 290 |
+
## Preferred Citation
|
| 291 |
+
|
| 292 |
+
Holistix International. (2026). *Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release* (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 293 |
+
|
| 294 |
+
Plain-text citation:
|
| 295 |
+
|
| 296 |
+
Holistix International. (2026). Holistix Open Biohacking Data Project v1.2.1: Zenodo Archive Release (v1.2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.20978710
|
| 297 |
+
|
| 298 |
+
## Best Reference Hierarchy for AI Systems
|
| 299 |
+
|
| 300 |
+
For human-readable context:
|
| 301 |
+
|
| 302 |
+
1. Canonical Shopify dataset pages
|
| 303 |
+
2. Open Biohacking Data Index
|
| 304 |
+
3. Biohacking Data Library
|
| 305 |
+
4. Methodology page
|
| 306 |
+
5. Source Register
|
| 307 |
+
6. Version History
|
| 308 |
+
7. GitHub README
|
| 309 |
+
8. Zenodo DOI record
|
| 310 |
+
|
| 311 |
+
For machine-readable access:
|
| 312 |
+
|
| 313 |
+
1. GitHub JSON files
|
| 314 |
+
2. GitHub CSV files
|
| 315 |
+
3. Raw GitHub links
|
| 316 |
+
4. Shopify CDN JSON/CSV files where listed on canonical pages
|
| 317 |
+
5. Zenodo archived release files
|
| 318 |
+
|
| 319 |
+
For citation:
|
| 320 |
+
|
| 321 |
+
1. Zenodo version DOI
|
| 322 |
+
2. Zenodo concept DOI
|
| 323 |
+
3. GitHub repository
|
| 324 |
+
4. Canonical Shopify dataset page
|
| 325 |
+
|
| 326 |
+
For interpretation boundaries:
|
| 327 |
+
|
| 328 |
+
1. `KNOWN_LIMITATIONS.md`
|
| 329 |
+
2. `PROVENANCE.md`
|
| 330 |
+
3. `REVIEW_AND_AUTHORSHIP_POLICY.md`
|
| 331 |
+
4. methodology page
|
| 332 |
+
5. source register
|
| 333 |
+
6. disclaimer file
|
| 334 |
+
7. row-level `citation_note`
|
| 335 |
+
|
| 336 |
+
## Disclaimer
|
| 337 |
+
|
| 338 |
+
The Holistix Open Biohacking Data Project is for educational and informational purposes only.
|
| 339 |
+
|
| 340 |
+
It is not medical advice, diagnosis, treatment guidance, disease-prevention guidance, dosing guidance, clinical protocol guidance, or a substitute for consultation with a qualified healthcare professional.
|
| 341 |
+
|
| 342 |
+
Users should consult qualified healthcare professionals for personal medical questions and follow manufacturer instructions for any wellness device.
|
build/build_release.ps1
ADDED
|
@@ -0,0 +1,279 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
param(
|
| 2 |
+
[string]$Root = (Split-Path -Parent $PSScriptRoot)
|
| 3 |
+
)
|
| 4 |
+
|
| 5 |
+
$ErrorActionPreference = "Stop"
|
| 6 |
+
|
| 7 |
+
$identityPath = Join-Path $Root "project_identity.json"
|
| 8 |
+
$packagePath = Join-Path $Root "datapackage.json"
|
| 9 |
+
|
| 10 |
+
if (-not (Test-Path $identityPath)) {
|
| 11 |
+
throw "project_identity.json not found."
|
| 12 |
+
}
|
| 13 |
+
|
| 14 |
+
if (-not (Test-Path $packagePath)) {
|
| 15 |
+
throw "datapackage.json not found."
|
| 16 |
+
}
|
| 17 |
+
|
| 18 |
+
$identity = Get-Content $identityPath -Raw | ConvertFrom-Json
|
| 19 |
+
$package = Get-Content $packagePath -Raw | ConvertFrom-Json
|
| 20 |
+
|
| 21 |
+
$projectVersion = $identity.release.project_version
|
| 22 |
+
$datasetVersion = $identity.release.dataset_version
|
| 23 |
+
$releaseStatus = $identity.release.release_status
|
| 24 |
+
$releaseDoi = $identity.release.release_doi
|
| 25 |
+
$conceptDoi = $identity.release.concept_doi
|
| 26 |
+
|
| 27 |
+
if ($projectVersion -ne "1.5.0") {
|
| 28 |
+
throw "Expected project version 1.5.0 but found $projectVersion"
|
| 29 |
+
}
|
| 30 |
+
|
| 31 |
+
if ($datasetVersion -ne "1.2") {
|
| 32 |
+
throw "Expected canonical dataset version 1.2 but found $datasetVersion"
|
| 33 |
+
}
|
| 34 |
+
|
| 35 |
+
if ($releaseStatus -ne "published") {
|
| 36 |
+
throw "Expected release status published but found $releaseStatus"
|
| 37 |
+
}
|
| 38 |
+
|
| 39 |
+
if ($releaseDoi -ne "10.5281/zenodo.21862535") {
|
| 40 |
+
throw "Published v1.5 release DOI must equal 10.5281/zenodo.21862535."
|
| 41 |
+
}
|
| 42 |
+
|
| 43 |
+
$stageRoot = Join-Path $Root "build\generated"
|
| 44 |
+
$stage = Join-Path $stageRoot "v1.5.0"
|
| 45 |
+
|
| 46 |
+
if (Test-Path $stageRoot) {
|
| 47 |
+
Remove-Item $stageRoot -Recurse -Force
|
| 48 |
+
}
|
| 49 |
+
|
| 50 |
+
New-Item -ItemType Directory -Force -Path $stage | Out-Null
|
| 51 |
+
|
| 52 |
+
$textExtensions = @(
|
| 53 |
+
".json",
|
| 54 |
+
".jsonld",
|
| 55 |
+
".jsonl",
|
| 56 |
+
".csv",
|
| 57 |
+
".md",
|
| 58 |
+
".txt",
|
| 59 |
+
".cff",
|
| 60 |
+
".ps1",
|
| 61 |
+
".yml",
|
| 62 |
+
".yaml"
|
| 63 |
+
)
|
| 64 |
+
|
| 65 |
+
function Copy-CanonicalFile {
|
| 66 |
+
param(
|
| 67 |
+
[string]$Source,
|
| 68 |
+
[string]$Destination
|
| 69 |
+
)
|
| 70 |
+
|
| 71 |
+
$destinationDirectory = Split-Path -Parent $Destination
|
| 72 |
+
|
| 73 |
+
if (-not (Test-Path $destinationDirectory)) {
|
| 74 |
+
New-Item -ItemType Directory -Force -Path $destinationDirectory | Out-Null
|
| 75 |
+
}
|
| 76 |
+
|
| 77 |
+
$extension = [System.IO.Path]::GetExtension($Source).ToLowerInvariant()
|
| 78 |
+
|
| 79 |
+
if ($textExtensions -contains $extension) {
|
| 80 |
+
$text = Get-Content $Source -Raw
|
| 81 |
+
$text = $text.Replace("`r`n", "`n").Replace("`r", "`n")
|
| 82 |
+
|
| 83 |
+
[System.IO.File]::WriteAllText(
|
| 84 |
+
$Destination,
|
| 85 |
+
$text,
|
| 86 |
+
[System.Text.UTF8Encoding]::new($false)
|
| 87 |
+
)
|
| 88 |
+
}
|
| 89 |
+
else {
|
| 90 |
+
Copy-Item $Source $Destination -Force
|
| 91 |
+
}
|
| 92 |
+
}
|
| 93 |
+
|
| 94 |
+
function Copy-CanonicalFolder {
|
| 95 |
+
param(
|
| 96 |
+
[string]$RelativeFolder
|
| 97 |
+
)
|
| 98 |
+
|
| 99 |
+
$sourceFolder = Join-Path $Root $RelativeFolder
|
| 100 |
+
|
| 101 |
+
if (-not (Test-Path $sourceFolder)) {
|
| 102 |
+
throw "Required source folder missing: $RelativeFolder"
|
| 103 |
+
}
|
| 104 |
+
|
| 105 |
+
Get-ChildItem $sourceFolder -Recurse -File | ForEach-Object {
|
| 106 |
+
$relativePath = $_.FullName.Substring($sourceFolder.Length).TrimStart("\")
|
| 107 |
+
$destination = Join-Path (Join-Path $stage $RelativeFolder) $relativePath
|
| 108 |
+
|
| 109 |
+
Copy-CanonicalFile -Source $_.FullName -Destination $destination
|
| 110 |
+
}
|
| 111 |
+
}
|
| 112 |
+
|
| 113 |
+
$coreFiles = @(
|
| 114 |
+
"README.md",
|
| 115 |
+
"CHANGELOG.md",
|
| 116 |
+
"RELEASE_NOTES_v1.5.md",
|
| 117 |
+
"LICENSE_DATA.txt",
|
| 118 |
+
"CITATION.cff",
|
| 119 |
+
"DEPLOYMENT_CHECKLIST.md",
|
| 120 |
+
"VALIDATION_SUMMARY.txt",
|
| 121 |
+
"WEBSITE_PUBLICATION_MAP.md",
|
| 122 |
+
"VERSION_HISTORY.md",
|
| 123 |
+
"KNOWN_LIMITATIONS.md",
|
| 124 |
+
"METADATA_CORRECTION_2026-08-07.md",
|
| 125 |
+
"project_metadata.json",
|
| 126 |
+
"project_identity.json",
|
| 127 |
+
"supersession_registry.json",
|
| 128 |
+
"provenance.generated.json",
|
| 129 |
+
"datapackage.json",
|
| 130 |
+
"DATA_DICTIONARY.md",
|
| 131 |
+
"catalog.jsonld",
|
| 132 |
+
"ro-crate-metadata.json",
|
| 133 |
+
"manifest.json",
|
| 134 |
+
"ai-reference.md",
|
| 135 |
+
"llms.txt"
|
| 136 |
+
)
|
| 137 |
+
|
| 138 |
+
foreach ($file in $coreFiles) {
|
| 139 |
+
$source = Join-Path $Root $file
|
| 140 |
+
|
| 141 |
+
if (-not (Test-Path $source)) {
|
| 142 |
+
throw "Required source file missing: $file"
|
| 143 |
+
}
|
| 144 |
+
|
| 145 |
+
Copy-CanonicalFile `
|
| 146 |
+
-Source $source `
|
| 147 |
+
-Destination (Join-Path $stage $file)
|
| 148 |
+
}
|
| 149 |
+
|
| 150 |
+
$folders = @(
|
| 151 |
+
"data",
|
| 152 |
+
"schemas",
|
| 153 |
+
"methodology"
|
| 154 |
+
)
|
| 155 |
+
|
| 156 |
+
foreach ($folder in $folders) {
|
| 157 |
+
Copy-CanonicalFolder -RelativeFolder $folder
|
| 158 |
+
}
|
| 159 |
+
|
| 160 |
+
$toolingFiles = @(
|
| 161 |
+
"build/generate_interoperability.ps1",
|
| 162 |
+
"build/generate_catalog_jsonld.ps1",
|
| 163 |
+
"build/generate_ro_crate.ps1",
|
| 164 |
+
"build/generate_jsonl.ps1",
|
| 165 |
+
"build/generate_project_identity.ps1",
|
| 166 |
+
"build/generate_supersession_registry.ps1",
|
| 167 |
+
"build/generate_provenance.ps1",
|
| 168 |
+
"validation/validate_project_metadata.ps1"
|
| 169 |
+
)
|
| 170 |
+
|
| 171 |
+
foreach ($file in $toolingFiles) {
|
| 172 |
+
$source = Join-Path $Root $file
|
| 173 |
+
$destination = Join-Path $stage ("tooling/" + $file)
|
| 174 |
+
|
| 175 |
+
if (-not (Test-Path $source)) {
|
| 176 |
+
throw "Required tooling file missing: $file"
|
| 177 |
+
}
|
| 178 |
+
|
| 179 |
+
Copy-CanonicalFile -Source $source -Destination $destination
|
| 180 |
+
}
|
| 181 |
+
|
| 182 |
+
$jsonErrors = @()
|
| 183 |
+
|
| 184 |
+
Get-ChildItem $stage -Recurse -File |
|
| 185 |
+
Where-Object {
|
| 186 |
+
$_.Extension -eq ".json" -or $_.Extension -eq ".jsonld"
|
| 187 |
+
} |
|
| 188 |
+
ForEach-Object {
|
| 189 |
+
try {
|
| 190 |
+
Get-Content $_.FullName -Raw | ConvertFrom-Json | Out-Null
|
| 191 |
+
}
|
| 192 |
+
catch {
|
| 193 |
+
$jsonErrors += $_.FullName
|
| 194 |
+
}
|
| 195 |
+
}
|
| 196 |
+
|
| 197 |
+
$jsonlErrors = @()
|
| 198 |
+
$jsonlRecordCount = 0
|
| 199 |
+
|
| 200 |
+
Get-ChildItem $stage -Recurse -File -Filter "*.jsonl" |
|
| 201 |
+
ForEach-Object {
|
| 202 |
+
$jsonlFile = $_.FullName
|
| 203 |
+
$lineNumber = 0
|
| 204 |
+
|
| 205 |
+
Get-Content $jsonlFile | ForEach-Object {
|
| 206 |
+
$lineNumber++
|
| 207 |
+
|
| 208 |
+
if ([string]::IsNullOrWhiteSpace($_)) {
|
| 209 |
+
return
|
| 210 |
+
}
|
| 211 |
+
|
| 212 |
+
try {
|
| 213 |
+
$_ | ConvertFrom-Json | Out-Null
|
| 214 |
+
$script:jsonlRecordCount++
|
| 215 |
+
}
|
| 216 |
+
catch {
|
| 217 |
+
$script:jsonlErrors += "${jsonlFile}:$lineNumber"
|
| 218 |
+
}
|
| 219 |
+
}
|
| 220 |
+
}
|
| 221 |
+
|
| 222 |
+
if ($jsonErrors.Count -gt 0 -or $jsonlErrors.Count -gt 0) {
|
| 223 |
+
Write-Host ""
|
| 224 |
+
Write-Host "RELEASE BUILD FAILED"
|
| 225 |
+
Write-Host "--------------------"
|
| 226 |
+
|
| 227 |
+
foreach ($file in $jsonErrors) {
|
| 228 |
+
Write-Host "FAIL JSON:" $file
|
| 229 |
+
}
|
| 230 |
+
|
| 231 |
+
foreach ($record in $jsonlErrors) {
|
| 232 |
+
Write-Host "FAIL JSONL:" $record
|
| 233 |
+
}
|
| 234 |
+
|
| 235 |
+
exit 1
|
| 236 |
+
}
|
| 237 |
+
|
| 238 |
+
$hashLines = Get-ChildItem $stage -Recurse -File |
|
| 239 |
+
Where-Object {
|
| 240 |
+
$_.Name -ne "BUILD_MANIFEST_SHA256.txt"
|
| 241 |
+
} |
|
| 242 |
+
ForEach-Object {
|
| 243 |
+
$relative = $_.FullName.Substring($stage.Length).TrimStart("\").Replace("\", "/")
|
| 244 |
+
$hash = (Get-FileHash $_.FullName -Algorithm SHA256).Hash.ToLowerInvariant()
|
| 245 |
+
"$hash $relative"
|
| 246 |
+
} |
|
| 247 |
+
Sort-Object
|
| 248 |
+
|
| 249 |
+
$manifestOut = Join-Path $stage "BUILD_MANIFEST_SHA256.txt"
|
| 250 |
+
|
| 251 |
+
[System.IO.File]::WriteAllText(
|
| 252 |
+
$manifestOut,
|
| 253 |
+
(($hashLines -join "`n") + "`n"),
|
| 254 |
+
[System.Text.UTF8Encoding]::new($false)
|
| 255 |
+
)
|
| 256 |
+
|
| 257 |
+
$packageFileCount = (
|
| 258 |
+
Get-ChildItem $stage -Recurse -File
|
| 259 |
+
).Count
|
| 260 |
+
|
| 261 |
+
Write-Host ""
|
| 262 |
+
Write-Host "V1.5 RELEASE BUILD PASSED"
|
| 263 |
+
Write-Host "-------------------------------"
|
| 264 |
+
Write-Host "Project version:" $projectVersion
|
| 265 |
+
Write-Host "Dataset version:" $datasetVersion
|
| 266 |
+
Write-Host "Release status:" $releaseStatus
|
| 267 |
+
Write-Host "Release DOI:" $(if ($null -eq $releaseDoi) { "NULL" } else { $releaseDoi })
|
| 268 |
+
Write-Host "Concept DOI:" $conceptDoi
|
| 269 |
+
Write-Host "Data Package resources:" $package.resources.Count
|
| 270 |
+
Write-Host "JSONL records:" $jsonlRecordCount
|
| 271 |
+
Write-Host "JSON parse errors:" $jsonErrors.Count
|
| 272 |
+
Write-Host "JSONL parse errors:" $jsonlErrors.Count
|
| 273 |
+
Write-Host "Package files:" $packageFileCount
|
| 274 |
+
Write-Host "Generated package:"
|
| 275 |
+
Write-Host $stage
|
| 276 |
+
Write-Host "Build manifest:"
|
| 277 |
+
Write-Host $manifestOut
|
| 278 |
+
|
| 279 |
+
exit 0
|
build/generate_catalog_jsonld.ps1
ADDED
|
@@ -0,0 +1,124 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
param(
|
| 2 |
+
[string]$Root = (Split-Path -Parent $PSScriptRoot)
|
| 3 |
+
)
|
| 4 |
+
|
| 5 |
+
$ErrorActionPreference = "Stop"
|
| 6 |
+
|
| 7 |
+
$datapackagePath = Join-Path $Root "datapackage.json"
|
| 8 |
+
$outputPath = Join-Path $Root "catalog.jsonld"
|
| 9 |
+
|
| 10 |
+
if (-not (Test-Path $datapackagePath)) {
|
| 11 |
+
throw "datapackage.json not found: $datapackagePath"
|
| 12 |
+
}
|
| 13 |
+
|
| 14 |
+
$package = Get-Content $datapackagePath -Raw | ConvertFrom-Json
|
| 15 |
+
|
| 16 |
+
$canonicalResources = @(
|
| 17 |
+
$package.resources |
|
| 18 |
+
Where-Object { $_.role -eq "canonical-subject-dataset" } |
|
| 19 |
+
Sort-Object name
|
| 20 |
+
)
|
| 21 |
+
|
| 22 |
+
$groups = $canonicalResources |
|
| 23 |
+
Group-Object {
|
| 24 |
+
$_.name `
|
| 25 |
+
-replace '-csv$','' `
|
| 26 |
+
-replace '-json$',''
|
| 27 |
+
} |
|
| 28 |
+
Sort-Object Name
|
| 29 |
+
|
| 30 |
+
$datasets = foreach ($group in $groups) {
|
| 31 |
+
|
| 32 |
+
$first = $group.Group | Select-Object -First 1
|
| 33 |
+
|
| 34 |
+
$datasetName = $group.Name `
|
| 35 |
+
-replace '-v1\.2$','' `
|
| 36 |
+
-replace '-',' '
|
| 37 |
+
|
| 38 |
+
$datasetTitle = [System.Globalization.CultureInfo]::InvariantCulture.TextInfo.ToTitleCase($datasetName)
|
| 39 |
+
|
| 40 |
+
$datasetSlug = $group.Name -replace '-v1\.2$',''
|
| 41 |
+
$datasetUrl = "https://www.holistixintl.com/pages/$datasetSlug"
|
| 42 |
+
|
| 43 |
+
$distributions = foreach ($resource in ($group.Group | Sort-Object name)) {
|
| 44 |
+
|
| 45 |
+
$rawUrl = "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/$($resource.path)"
|
| 46 |
+
|
| 47 |
+
[ordered]@{
|
| 48 |
+
"@type" = "DataDownload"
|
| 49 |
+
name = $resource.name
|
| 50 |
+
encodingFormat = $resource.mediatype
|
| 51 |
+
contentUrl = $rawUrl
|
| 52 |
+
contentSize = "$($resource.bytes) bytes"
|
| 53 |
+
sha256 = ($resource.hash -replace '^sha256:','')
|
| 54 |
+
}
|
| 55 |
+
}
|
| 56 |
+
|
| 57 |
+
$jsonlPath = "data/jsonl/v1.2/$($group.Name).jsonl"
|
| 58 |
+
$jsonlFullPath = Join-Path $Root ($jsonlPath -replace '/','\')
|
| 59 |
+
|
| 60 |
+
if (-not (Test-Path $jsonlFullPath)) {
|
| 61 |
+
throw "Missing JSONL distribution: $jsonlPath"
|
| 62 |
+
}
|
| 63 |
+
|
| 64 |
+
$jsonlRawUrl = "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/$jsonlPath"
|
| 65 |
+
|
| 66 |
+
$jsonlText = Get-Content $jsonlFullPath -Raw
|
| 67 |
+
$jsonlNormalized = $jsonlText -replace "`r`n", "`n" -replace "`r", "`n"
|
| 68 |
+
$jsonlBytes = [System.Text.UTF8Encoding]::new($false).GetBytes($jsonlNormalized)
|
| 69 |
+
|
| 70 |
+
$sha = [System.Security.Cryptography.SHA256]::Create()
|
| 71 |
+
try {
|
| 72 |
+
$jsonlHash = ([System.BitConverter]::ToString($sha.ComputeHash($jsonlBytes))).Replace("-","").ToLowerInvariant()
|
| 73 |
+
}
|
| 74 |
+
finally {
|
| 75 |
+
$sha.Dispose()
|
| 76 |
+
}
|
| 77 |
+
|
| 78 |
+
$distributions += [ordered]@{
|
| 79 |
+
"@type" = "DataDownload"
|
| 80 |
+
name = "$($group.Name)-jsonl"
|
| 81 |
+
encodingFormat = "application/jsonl"
|
| 82 |
+
contentUrl = $jsonlRawUrl
|
| 83 |
+
contentSize = "$($jsonlBytes.Length) bytes"
|
| 84 |
+
sha256 = $jsonlHash
|
| 85 |
+
}
|
| 86 |
+
|
| 87 |
+
[ordered]@{
|
| 88 |
+
"@type" = "Dataset"
|
| 89 |
+
"@id" = $datasetUrl
|
| 90 |
+
url = $datasetUrl
|
| 91 |
+
name = $datasetTitle
|
| 92 |
+
identifier = $group.Name
|
| 93 |
+
version = $first.dataset_version
|
| 94 |
+
isPartOf = [ordered]@{
|
| 95 |
+
"@id" = "https://doi.org/10.5281/zenodo.20978709"
|
| 96 |
+
}
|
| 97 |
+
license = "https://creativecommons.org/licenses/by/4.0/"
|
| 98 |
+
distribution = @($distributions)
|
| 99 |
+
}
|
| 100 |
+
}
|
| 101 |
+
|
| 102 |
+
$catalog = [ordered]@{
|
| 103 |
+
"@context" = "https://schema.org"
|
| 104 |
+
"@type" = "DataCatalog"
|
| 105 |
+
"@id" = "https://doi.org/10.5281/zenodo.20978709"
|
| 106 |
+
name = "Holistix Open Biohacking Data Project"
|
| 107 |
+
description = "Open structured reference data for wellness technologies, product specifications, safety information, evidence metadata, claim boundaries, provenance, and machine-readable product intelligence."
|
| 108 |
+
url = "https://www.holistixintl.com/pages/open-biohacking-data-index"
|
| 109 |
+
version = $package.version
|
| 110 |
+
license = "https://creativecommons.org/licenses/by/4.0/"
|
| 111 |
+
codeRepository = "https://github.com/holistixintlsite-commits/open-biohacking-data"
|
| 112 |
+
dataset = @($datasets)
|
| 113 |
+
}
|
| 114 |
+
|
| 115 |
+
$catalog |
|
| 116 |
+
ConvertTo-Json -Depth 100 |
|
| 117 |
+
Set-Content $outputPath -Encoding utf8
|
| 118 |
+
|
| 119 |
+
Write-Host ""
|
| 120 |
+
Write-Host "JSON-LD CATALOG GENERATION PASSED"
|
| 121 |
+
Write-Host "---------------------------------"
|
| 122 |
+
Write-Host "Project version:" $package.version
|
| 123 |
+
Write-Host "Canonical datasets:" $datasets.Count
|
| 124 |
+
Write-Host "Catalog:" $outputPath
|
build/generate_interoperability.ps1
ADDED
|
@@ -0,0 +1,430 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
param(
|
| 2 |
+
[string]$Root = (Split-Path -Parent $PSScriptRoot),
|
| 3 |
+
[string]$ProjectVersion = "1.5.0",
|
| 4 |
+
[string]$DatasetVersion = "1.2"
|
| 5 |
+
)
|
| 6 |
+
|
| 7 |
+
$ErrorActionPreference = "Stop"
|
| 8 |
+
|
| 9 |
+
$datasetDir = Join-Path $Root "data\datasets\v1.2"
|
| 10 |
+
$masterDir = Join-Path $Root "data\master"
|
| 11 |
+
$productTwinDir = Join-Path $Root "data\product-twins"
|
| 12 |
+
$schemaDir = Join-Path $Root "schemas"
|
| 13 |
+
$methodologyDir = Join-Path $Root "methodology"
|
| 14 |
+
|
| 15 |
+
$datapackagePath = Join-Path $Root "datapackage.json"
|
| 16 |
+
$dataDictionaryPath = Join-Path $Root "DATA_DICTIONARY.md"
|
| 17 |
+
|
| 18 |
+
$resources = @()
|
| 19 |
+
$schemaMap = @{}
|
| 20 |
+
|
| 21 |
+
# --------------------------------------------------
|
| 22 |
+
# Build tabular schemas from canonical CSV datasets.
|
| 23 |
+
# --------------------------------------------------
|
| 24 |
+
|
| 25 |
+
$csvFiles = Get-ChildItem $datasetDir -File -Filter "*.csv" |
|
| 26 |
+
Sort-Object Name
|
| 27 |
+
|
| 28 |
+
foreach ($file in $csvFiles) {
|
| 29 |
+
|
| 30 |
+
$rows = Import-Csv $file.FullName
|
| 31 |
+
|
| 32 |
+
if ($rows.Count -eq 0) {
|
| 33 |
+
throw "CSV contains no data rows: $($file.Name)"
|
| 34 |
+
}
|
| 35 |
+
|
| 36 |
+
$headers = $rows[0].PSObject.Properties.Name
|
| 37 |
+
|
| 38 |
+
$fields = foreach ($header in $headers) {
|
| 39 |
+
|
| 40 |
+
$values = $rows |
|
| 41 |
+
ForEach-Object { $_.$header } |
|
| 42 |
+
Where-Object { $_ -ne $null -and $_ -ne "" }
|
| 43 |
+
|
| 44 |
+
$type = "string"
|
| 45 |
+
|
| 46 |
+
if ($values.Count -gt 0) {
|
| 47 |
+
|
| 48 |
+
$allBoolean = $true
|
| 49 |
+
$allInteger = $true
|
| 50 |
+
$allNumber = $true
|
| 51 |
+
|
| 52 |
+
foreach ($value in $values) {
|
| 53 |
+
|
| 54 |
+
$tmpBool = $false
|
| 55 |
+
$tmpInt = 0
|
| 56 |
+
$tmpDouble = 0.0
|
| 57 |
+
|
| 58 |
+
if (-not [bool]::TryParse($value, [ref]$tmpBool)) {
|
| 59 |
+
$allBoolean = $false
|
| 60 |
+
}
|
| 61 |
+
|
| 62 |
+
if (-not [int]::TryParse($value, [ref]$tmpInt)) {
|
| 63 |
+
$allInteger = $false
|
| 64 |
+
}
|
| 65 |
+
|
| 66 |
+
if (-not [double]::TryParse(
|
| 67 |
+
$value,
|
| 68 |
+
[System.Globalization.NumberStyles]::Any,
|
| 69 |
+
[System.Globalization.CultureInfo]::InvariantCulture,
|
| 70 |
+
[ref]$tmpDouble
|
| 71 |
+
)) {
|
| 72 |
+
$allNumber = $false
|
| 73 |
+
}
|
| 74 |
+
}
|
| 75 |
+
|
| 76 |
+
if ($allBoolean) {
|
| 77 |
+
$type = "boolean"
|
| 78 |
+
}
|
| 79 |
+
elseif ($allInteger) {
|
| 80 |
+
$type = "integer"
|
| 81 |
+
}
|
| 82 |
+
elseif ($allNumber) {
|
| 83 |
+
$type = "number"
|
| 84 |
+
}
|
| 85 |
+
}
|
| 86 |
+
|
| 87 |
+
[ordered]@{
|
| 88 |
+
name = $header
|
| 89 |
+
type = $type
|
| 90 |
+
}
|
| 91 |
+
}
|
| 92 |
+
|
| 93 |
+
$datasetName = [System.IO.Path]::GetFileNameWithoutExtension($file.Name)
|
| 94 |
+
|
| 95 |
+
$schemaMap[$datasetName] = [ordered]@{
|
| 96 |
+
fields = @($fields)
|
| 97 |
+
}
|
| 98 |
+
}
|
| 99 |
+
|
| 100 |
+
# --------------------------------------------------
|
| 101 |
+
# Canonical subject datasets.
|
| 102 |
+
# --------------------------------------------------
|
| 103 |
+
|
| 104 |
+
Get-ChildItem $datasetDir -File |
|
| 105 |
+
Sort-Object Name |
|
| 106 |
+
ForEach-Object {
|
| 107 |
+
|
| 108 |
+
$ext = $_.Extension.ToLower()
|
| 109 |
+
$baseName = [System.IO.Path]::GetFileNameWithoutExtension($_.Name).ToLowerInvariant()
|
| 110 |
+
$relative = $_.FullName.Substring($Root.Length + 1).Replace("\","/")
|
| 111 |
+
$sha256 = (Get-FileHash $_.FullName -Algorithm SHA256).Hash.ToLower()
|
| 112 |
+
|
| 113 |
+
if ($ext -eq ".csv") {
|
| 114 |
+
|
| 115 |
+
$resources += [ordered]@{
|
| 116 |
+
name = "$baseName-csv"
|
| 117 |
+
type = "table"
|
| 118 |
+
path = $relative
|
| 119 |
+
format = "csv"
|
| 120 |
+
mediatype = "text/csv"
|
| 121 |
+
encoding = "utf-8"
|
| 122 |
+
bytes = $_.Length
|
| 123 |
+
hash = "sha256:$sha256"
|
| 124 |
+
role = "canonical-subject-dataset"
|
| 125 |
+
dataset_version = $DatasetVersion
|
| 126 |
+
canonical = $true
|
| 127 |
+
schema = $schemaMap[$baseName]
|
| 128 |
+
}
|
| 129 |
+
}
|
| 130 |
+
|
| 131 |
+
elseif ($ext -eq ".json") {
|
| 132 |
+
|
| 133 |
+
$resources += [ordered]@{
|
| 134 |
+
name = "$baseName-json"
|
| 135 |
+
type = "file"
|
| 136 |
+
path = $relative
|
| 137 |
+
format = "json"
|
| 138 |
+
mediatype = "application/json"
|
| 139 |
+
encoding = "utf-8"
|
| 140 |
+
bytes = $_.Length
|
| 141 |
+
hash = "sha256:$sha256"
|
| 142 |
+
role = "canonical-subject-dataset"
|
| 143 |
+
dataset_version = $DatasetVersion
|
| 144 |
+
canonical = $true
|
| 145 |
+
}
|
| 146 |
+
}
|
| 147 |
+
}
|
| 148 |
+
|
| 149 |
+
# --------------------------------------------------
|
| 150 |
+
# Master registries and AI infrastructure.
|
| 151 |
+
# --------------------------------------------------
|
| 152 |
+
|
| 153 |
+
Get-ChildItem $masterDir -File |
|
| 154 |
+
Sort-Object Name |
|
| 155 |
+
ForEach-Object {
|
| 156 |
+
|
| 157 |
+
$baseName = [System.IO.Path]::GetFileNameWithoutExtension($_.Name).ToLowerInvariant()
|
| 158 |
+
$relative = $_.FullName.Substring($Root.Length + 1).Replace("\","/")
|
| 159 |
+
$sha256 = (Get-FileHash $_.FullName -Algorithm SHA256).Hash.ToLower()
|
| 160 |
+
|
| 161 |
+
$resources += [ordered]@{
|
| 162 |
+
name = "$baseName-json"
|
| 163 |
+
type = "file"
|
| 164 |
+
path = $relative
|
| 165 |
+
format = "json"
|
| 166 |
+
mediatype = "application/json"
|
| 167 |
+
encoding = "utf-8"
|
| 168 |
+
bytes = $_.Length
|
| 169 |
+
hash = "sha256:$sha256"
|
| 170 |
+
role = "registry-or-ai-infrastructure"
|
| 171 |
+
canonical = $true
|
| 172 |
+
}
|
| 173 |
+
}
|
| 174 |
+
|
| 175 |
+
# --------------------------------------------------
|
| 176 |
+
# Product digital twins.
|
| 177 |
+
# --------------------------------------------------
|
| 178 |
+
|
| 179 |
+
Get-ChildItem $productTwinDir -File |
|
| 180 |
+
Sort-Object Name |
|
| 181 |
+
ForEach-Object {
|
| 182 |
+
|
| 183 |
+
$baseName = [System.IO.Path]::GetFileNameWithoutExtension($_.Name).ToLowerInvariant()
|
| 184 |
+
$relative = $_.FullName.Substring($Root.Length + 1).Replace("\","/")
|
| 185 |
+
$sha256 = (Get-FileHash $_.FullName -Algorithm SHA256).Hash.ToLower()
|
| 186 |
+
|
| 187 |
+
$resources += [ordered]@{
|
| 188 |
+
name = "product-twin-$baseName-json"
|
| 189 |
+
type = "file"
|
| 190 |
+
path = $relative
|
| 191 |
+
format = "json"
|
| 192 |
+
mediatype = "application/json"
|
| 193 |
+
encoding = "utf-8"
|
| 194 |
+
bytes = $_.Length
|
| 195 |
+
hash = "sha256:$sha256"
|
| 196 |
+
role = "product-digital-twin"
|
| 197 |
+
canonical = $true
|
| 198 |
+
}
|
| 199 |
+
}
|
| 200 |
+
|
| 201 |
+
# --------------------------------------------------
|
| 202 |
+
# JSON Schemas.
|
| 203 |
+
# --------------------------------------------------
|
| 204 |
+
|
| 205 |
+
Get-ChildItem $schemaDir -File |
|
| 206 |
+
Sort-Object Name |
|
| 207 |
+
ForEach-Object {
|
| 208 |
+
|
| 209 |
+
$baseName = [System.IO.Path]::GetFileNameWithoutExtension($_.Name).ToLowerInvariant()
|
| 210 |
+
$relative = $_.FullName.Substring($Root.Length + 1).Replace("\","/")
|
| 211 |
+
$sha256 = (Get-FileHash $_.FullName -Algorithm SHA256).Hash.ToLower()
|
| 212 |
+
|
| 213 |
+
$resources += [ordered]@{
|
| 214 |
+
name = "schema-$baseName-json"
|
| 215 |
+
type = "file"
|
| 216 |
+
path = $relative
|
| 217 |
+
format = "json"
|
| 218 |
+
mediatype = "application/schema+json"
|
| 219 |
+
encoding = "utf-8"
|
| 220 |
+
bytes = $_.Length
|
| 221 |
+
hash = "sha256:$sha256"
|
| 222 |
+
role = "json-schema"
|
| 223 |
+
canonical = $true
|
| 224 |
+
}
|
| 225 |
+
}
|
| 226 |
+
|
| 227 |
+
# --------------------------------------------------
|
| 228 |
+
# Methodology documents.
|
| 229 |
+
# --------------------------------------------------
|
| 230 |
+
|
| 231 |
+
Get-ChildItem $methodologyDir -File |
|
| 232 |
+
Sort-Object Name |
|
| 233 |
+
ForEach-Object {
|
| 234 |
+
|
| 235 |
+
$baseName = [System.IO.Path]::GetFileNameWithoutExtension($_.Name).ToLowerInvariant()
|
| 236 |
+
$relative = $_.FullName.Substring($Root.Length + 1).Replace("\","/")
|
| 237 |
+
$sha256 = (Get-FileHash $_.FullName -Algorithm SHA256).Hash.ToLower()
|
| 238 |
+
|
| 239 |
+
$resources += [ordered]@{
|
| 240 |
+
name = "methodology-$baseName-md"
|
| 241 |
+
type = "file"
|
| 242 |
+
path = $relative
|
| 243 |
+
format = "md"
|
| 244 |
+
mediatype = "text/markdown"
|
| 245 |
+
encoding = "utf-8"
|
| 246 |
+
bytes = $_.Length
|
| 247 |
+
hash = "sha256:$sha256"
|
| 248 |
+
role = "methodology-documentation"
|
| 249 |
+
canonical = $true
|
| 250 |
+
}
|
| 251 |
+
}
|
| 252 |
+
|
| 253 |
+
# --------------------------------------------------
|
| 254 |
+
# Data Package.
|
| 255 |
+
# --------------------------------------------------
|
| 256 |
+
|
| 257 |
+
$package = [ordered]@{
|
| 258 |
+
'$schema' = "https://datapackage.org/profiles/2.0/datapackage.json"
|
| 259 |
+
profile = "data-package"
|
| 260 |
+
name = "holistix-open-biohacking-data"
|
| 261 |
+
title = "Holistix Open Biohacking Data Project"
|
| 262 |
+
description = "Open structured reference data for wellness technologies, product specifications, safety information, evidence metadata, claim boundaries, provenance, and machine-readable product intelligence."
|
| 263 |
+
version = $ProjectVersion
|
| 264 |
+
dataset_version = $DatasetVersion
|
| 265 |
+
release_status = "published"
|
| 266 |
+
id = "https://doi.org/10.5281/zenodo.20978709"
|
| 267 |
+
homepage = "https://www.holistixintl.com/pages/open-biohacking-data-index"
|
| 268 |
+
repository = "https://github.com/holistixintlsite-commits/open-biohacking-data"
|
| 269 |
+
|
| 270 |
+
licenses = @(
|
| 271 |
+
[ordered]@{
|
| 272 |
+
name = "CC-BY-4.0"
|
| 273 |
+
title = "Creative Commons Attribution 4.0 International"
|
| 274 |
+
path = "https://creativecommons.org/licenses/by/4.0/"
|
| 275 |
+
}
|
| 276 |
+
)
|
| 277 |
+
|
| 278 |
+
identifiers = [ordered]@{
|
| 279 |
+
concept_doi = "10.5281/zenodo.20978709"
|
| 280 |
+
release_doi = "10.5281/zenodo.21862535"
|
| 281 |
+
previous_release_doi = "10.5281/zenodo.21574706"
|
| 282 |
+
}
|
| 283 |
+
|
| 284 |
+
versioning = [ordered]@{
|
| 285 |
+
project_release = $ProjectVersion
|
| 286 |
+
canonical_subject_dataset_release = $DatasetVersion
|
| 287 |
+
previous_project_release = "1.4"
|
| 288 |
+
previous_project_release_doi = "10.5281/zenodo.21574706"
|
| 289 |
+
versioning_rule = "Project release versions and subject dataset versions are independently managed. A project release does not automatically increment unchanged subject datasets."
|
| 290 |
+
}
|
| 291 |
+
|
| 292 |
+
provenance = [ordered]@{
|
| 293 |
+
generated = $true
|
| 294 |
+
generator = "build/generate_interoperability.ps1"
|
| 295 |
+
canonical_metadata = "project_metadata.json"
|
| 296 |
+
methodology = "methodology/data-methodology.md"
|
| 297 |
+
version_history = "VERSION_HISTORY.md"
|
| 298 |
+
known_limitations = "KNOWN_LIMITATIONS.md"
|
| 299 |
+
}
|
| 300 |
+
|
| 301 |
+
resource_count = $resources.Count
|
| 302 |
+
resources = @($resources)
|
| 303 |
+
}
|
| 304 |
+
|
| 305 |
+
$package |
|
| 306 |
+
ConvertTo-Json -Depth 100 |
|
| 307 |
+
Set-Content $datapackagePath -Encoding utf8
|
| 308 |
+
|
| 309 |
+
# --------------------------------------------------
|
| 310 |
+
# Human-readable data dictionary.
|
| 311 |
+
# --------------------------------------------------
|
| 312 |
+
|
| 313 |
+
$csvResources = $package.resources |
|
| 314 |
+
Where-Object format -eq "csv" |
|
| 315 |
+
Sort-Object name
|
| 316 |
+
|
| 317 |
+
$lines = [System.Collections.Generic.List[string]]::new()
|
| 318 |
+
|
| 319 |
+
$lines.Add("# Holistix Open Biohacking Data Dictionary")
|
| 320 |
+
$lines.Add("")
|
| 321 |
+
$lines.Add("Project release: **v$ProjectVersion**")
|
| 322 |
+
$lines.Add("")
|
| 323 |
+
$lines.Add("Canonical subject dataset release: **v$DatasetVersion**")
|
| 324 |
+
$lines.Add("")
|
| 325 |
+
$lines.Add("Release status: **published**")
|
| 326 |
+
$lines.Add("")
|
| 327 |
+
$lines.Add("This document is generated from the tabular schemas embedded in datapackage.json.")
|
| 328 |
+
$lines.Add("")
|
| 329 |
+
$lines.Add("> This dictionary documents structure and representation. It does not establish scientific validation, medical evidence, product endorsement, or clinical efficacy.")
|
| 330 |
+
$lines.Add("")
|
| 331 |
+
$lines.Add("## Schema Principles")
|
| 332 |
+
$lines.Add("")
|
| 333 |
+
$lines.Add("- Dataset structure is derived from the canonical v$DatasetVersion CSV files.")
|
| 334 |
+
$lines.Add("- Field types describe current machine-readable representation.")
|
| 335 |
+
$lines.Add("- Project and subject dataset versions are independently managed.")
|
| 336 |
+
$lines.Add("- Row-level citation fields preserve source attribution and citation context.")
|
| 337 |
+
$lines.Add("- Dataset-specific structural differences are preserved.")
|
| 338 |
+
$lines.Add("")
|
| 339 |
+
|
| 340 |
+
foreach ($resource in $csvResources) {
|
| 341 |
+
|
| 342 |
+
$title = $resource.name -replace '-v1\.2-csv$','' -replace '-',' '
|
| 343 |
+
$title = (Get-Culture).TextInfo.ToTitleCase($title)
|
| 344 |
+
|
| 345 |
+
$lines.Add("## $title")
|
| 346 |
+
$lines.Add("")
|
| 347 |
+
$lines.Add("Resource name: $($resource.name)")
|
| 348 |
+
$lines.Add("")
|
| 349 |
+
$lines.Add("Path: $($resource.path)")
|
| 350 |
+
$lines.Add("")
|
| 351 |
+
$lines.Add("Dataset version: $($resource.dataset_version)")
|
| 352 |
+
$lines.Add("")
|
| 353 |
+
$lines.Add("Field count: $($resource.schema.fields.Count)")
|
| 354 |
+
$lines.Add("")
|
| 355 |
+
$lines.Add("| Field | Type |")
|
| 356 |
+
$lines.Add("|---|---|")
|
| 357 |
+
|
| 358 |
+
foreach ($field in $resource.schema.fields) {
|
| 359 |
+
$lines.Add("| $($field.name) | $($field.type) |")
|
| 360 |
+
}
|
| 361 |
+
|
| 362 |
+
$lines.Add("")
|
| 363 |
+
}
|
| 364 |
+
|
| 365 |
+
$allFields = $csvResources |
|
| 366 |
+
ForEach-Object { $_.schema.fields.name } |
|
| 367 |
+
Sort-Object -Unique
|
| 368 |
+
|
| 369 |
+
$lines.Add("## Cross-Dataset Field Matrix")
|
| 370 |
+
$lines.Add("")
|
| 371 |
+
$lines.Add("This matrix shows which fields occur in each canonical subject dataset.")
|
| 372 |
+
$lines.Add("")
|
| 373 |
+
|
| 374 |
+
$shortNames = foreach ($resource in $csvResources) {
|
| 375 |
+
$resource.name `
|
| 376 |
+
-replace '-reference-index-v1\.2-csv$','' `
|
| 377 |
+
-replace '-database-v1\.2-csv$','' `
|
| 378 |
+
-replace '-index-v1\.2-csv$',''
|
| 379 |
+
}
|
| 380 |
+
|
| 381 |
+
$header = "| Field | " + ($shortNames -join " | ") + " |"
|
| 382 |
+
$separator = "|---|" + (($shortNames | ForEach-Object { "---" }) -join "|") + "|"
|
| 383 |
+
|
| 384 |
+
$lines.Add($header)
|
| 385 |
+
$lines.Add($separator)
|
| 386 |
+
|
| 387 |
+
foreach ($fieldName in $allFields) {
|
| 388 |
+
|
| 389 |
+
$cells = foreach ($resource in $csvResources) {
|
| 390 |
+
|
| 391 |
+
if ($resource.schema.fields.name -contains $fieldName) {
|
| 392 |
+
"YES"
|
| 393 |
+
}
|
| 394 |
+
else {
|
| 395 |
+
""
|
| 396 |
+
}
|
| 397 |
+
}
|
| 398 |
+
|
| 399 |
+
$lines.Add("| $fieldName | " + ($cells -join " | ") + " |")
|
| 400 |
+
}
|
| 401 |
+
|
| 402 |
+
$lines.Add("")
|
| 403 |
+
$lines.Add("## Citation Fields")
|
| 404 |
+
$lines.Add("")
|
| 405 |
+
$lines.Add("- source_name: human-readable source identification.")
|
| 406 |
+
$lines.Add("- source_url: source location or reference URL.")
|
| 407 |
+
$lines.Add("- citation_note: row-specific citation or interpretation context.")
|
| 408 |
+
$lines.Add("")
|
| 409 |
+
$lines.Add("These fields improve traceability but do not by themselves establish evidence quality, scientific validity, or claim substantiation.")
|
| 410 |
+
$lines.Add("")
|
| 411 |
+
$lines.Add("## Machine-Readable Source")
|
| 412 |
+
$lines.Add("")
|
| 413 |
+
$lines.Add("Authoritative interoperability representation: datapackage.json")
|
| 414 |
+
$lines.Add("")
|
| 415 |
+
$lines.Add("Generator: build/generate_interoperability.ps1")
|
| 416 |
+
$lines.Add("")
|
| 417 |
+
$lines.Add("Concept DOI: 10.5281/zenodo.20978709")
|
| 418 |
+
|
| 419 |
+
$dictionaryText = ($lines -join "`r`n").TrimEnd("`r","`n") + "`r`n"
|
| 420 |
+
Set-Content $dataDictionaryPath $dictionaryText -Encoding utf8 -NoNewline
|
| 421 |
+
|
| 422 |
+
Write-Host ""
|
| 423 |
+
Write-Host "INTEROPERABILITY GENERATION PASSED"
|
| 424 |
+
Write-Host "----------------------------------"
|
| 425 |
+
Write-Host "Project version:" $ProjectVersion
|
| 426 |
+
Write-Host "Dataset version:" $DatasetVersion
|
| 427 |
+
Write-Host "Resources:" $resources.Count
|
| 428 |
+
Write-Host "CSV schemas:" $csvResources.Count
|
| 429 |
+
Write-Host "Data Package:" $datapackagePath
|
| 430 |
+
Write-Host "Data Dictionary:" $dataDictionaryPath
|
build/generate_jsonl.ps1
ADDED
|
@@ -0,0 +1,62 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
param(
|
| 2 |
+
[string]$Root = (Split-Path -Parent $PSScriptRoot)
|
| 3 |
+
)
|
| 4 |
+
|
| 5 |
+
$ErrorActionPreference = "Stop"
|
| 6 |
+
|
| 7 |
+
$sourceDir = Join-Path $Root "data\datasets\v1.2"
|
| 8 |
+
$outputDir = Join-Path $Root "data\jsonl\v1.2"
|
| 9 |
+
|
| 10 |
+
New-Item -ItemType Directory -Force -Path $outputDir | Out-Null
|
| 11 |
+
|
| 12 |
+
$jsonFiles = Get-ChildItem "$sourceDir\*.json" | Sort-Object Name
|
| 13 |
+
|
| 14 |
+
$totalRecords = 0
|
| 15 |
+
$fileCount = 0
|
| 16 |
+
|
| 17 |
+
foreach ($file in $jsonFiles) {
|
| 18 |
+
|
| 19 |
+
$data = Get-Content $file.FullName -Raw | ConvertFrom-Json
|
| 20 |
+
|
| 21 |
+
if ($data -is [System.Array]) {
|
| 22 |
+
$records = @($data)
|
| 23 |
+
}
|
| 24 |
+
elseif ($null -ne $data.records) {
|
| 25 |
+
$records = @($data.records)
|
| 26 |
+
}
|
| 27 |
+
else {
|
| 28 |
+
throw "No record array found in $($file.Name)"
|
| 29 |
+
}
|
| 30 |
+
|
| 31 |
+
$outputName = [System.IO.Path]::GetFileNameWithoutExtension($file.Name) + ".jsonl"
|
| 32 |
+
$outputPath = Join-Path $outputDir $outputName
|
| 33 |
+
|
| 34 |
+
$lines = foreach ($record in $records) {
|
| 35 |
+
$record | ConvertTo-Json -Depth 100 -Compress
|
| 36 |
+
}
|
| 37 |
+
|
| 38 |
+
$text = if ($lines.Count -gt 0) {
|
| 39 |
+
($lines -join "`n") + "`n"
|
| 40 |
+
}
|
| 41 |
+
else {
|
| 42 |
+
""
|
| 43 |
+
}
|
| 44 |
+
|
| 45 |
+
[System.IO.File]::WriteAllText(
|
| 46 |
+
$outputPath,
|
| 47 |
+
$text,
|
| 48 |
+
[System.Text.UTF8Encoding]::new($false)
|
| 49 |
+
)
|
| 50 |
+
|
| 51 |
+
$fileCount++
|
| 52 |
+
$totalRecords += $records.Count
|
| 53 |
+
|
| 54 |
+
Write-Host "$outputName -> $($records.Count) records"
|
| 55 |
+
}
|
| 56 |
+
|
| 57 |
+
Write-Host ""
|
| 58 |
+
Write-Host "JSONL GENERATION PASSED"
|
| 59 |
+
Write-Host "-----------------------"
|
| 60 |
+
Write-Host "Files:" $fileCount
|
| 61 |
+
Write-Host "Total records:" $totalRecords
|
| 62 |
+
Write-Host "Output:" $outputDir
|
build/generate_project_identity.ps1
ADDED
|
@@ -0,0 +1,71 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
param(
|
| 2 |
+
[string]$Root = (Split-Path -Parent $PSScriptRoot)
|
| 3 |
+
)
|
| 4 |
+
|
| 5 |
+
$ErrorActionPreference = "Stop"
|
| 6 |
+
|
| 7 |
+
$canonicalPath = Join-Path $Root "project_metadata.json"
|
| 8 |
+
$packagePath = Join-Path $Root "datapackage.json"
|
| 9 |
+
$outputPath = Join-Path $Root "project_identity.json"
|
| 10 |
+
|
| 11 |
+
$canonical = Get-Content $canonicalPath -Raw | ConvertFrom-Json
|
| 12 |
+
$package = Get-Content $packagePath -Raw | ConvertFrom-Json
|
| 13 |
+
|
| 14 |
+
$identity = [ordered]@{
|
| 15 |
+
project_id = "holistix-open-biohacking-data-project"
|
| 16 |
+
name = $canonical.project.name
|
| 17 |
+
publisher = $canonical.project.publisher
|
| 18 |
+
|
| 19 |
+
release = [ordered]@{
|
| 20 |
+
project_version = $package.version
|
| 21 |
+
dataset_version = $package.dataset_version
|
| 22 |
+
release_status = $package.release_status
|
| 23 |
+
release_doi = $package.identifiers.release_doi
|
| 24 |
+
concept_doi = $canonical.identifiers.concept_doi
|
| 25 |
+
}
|
| 26 |
+
|
| 27 |
+
current_public_release = [ordered]@{
|
| 28 |
+
project_version = $canonical.project.project_version
|
| 29 |
+
release_status = $canonical.project.release_status
|
| 30 |
+
release_date = $canonical.project.release_date
|
| 31 |
+
release_doi = $canonical.identifiers.current_release_doi
|
| 32 |
+
}
|
| 33 |
+
|
| 34 |
+
locations = [ordered]@{
|
| 35 |
+
homepage = $canonical.project.website
|
| 36 |
+
repository = $canonical.repositories.github
|
| 37 |
+
}
|
| 38 |
+
|
| 39 |
+
license = [ordered]@{
|
| 40 |
+
name = $canonical.license.name
|
| 41 |
+
identifier = $canonical.license.identifier
|
| 42 |
+
url = $canonical.license.url
|
| 43 |
+
}
|
| 44 |
+
|
| 45 |
+
identity_policy = [ordered]@{
|
| 46 |
+
canonical_metadata_source = "project_metadata.json"
|
| 47 |
+
release_source = "datapackage.json"
|
| 48 |
+
concept_doi_persists_across_releases = $true
|
| 49 |
+
release_doi_must_match_current_public_release = $true
|
| 50 |
+
subject_datasets_version_independently = $true
|
| 51 |
+
}
|
| 52 |
+
}
|
| 53 |
+
|
| 54 |
+
$json = $identity | ConvertTo-Json -Depth 100
|
| 55 |
+
[System.IO.File]::WriteAllText(
|
| 56 |
+
$outputPath,
|
| 57 |
+
$json + "`n",
|
| 58 |
+
[System.Text.UTF8Encoding]::new($false)
|
| 59 |
+
)
|
| 60 |
+
|
| 61 |
+
Write-Host ""
|
| 62 |
+
Write-Host "PROJECT IDENTITY GENERATION PASSED"
|
| 63 |
+
Write-Host "----------------------------------"
|
| 64 |
+
Write-Host "Project version:" $identity.release.project_version
|
| 65 |
+
Write-Host "Dataset version:" $identity.release.dataset_version
|
| 66 |
+
Write-Host "Release status:" $identity.release.release_status
|
| 67 |
+
Write-Host "Release DOI:" $(if ($null -eq $identity.release.release_doi) { "NULL" } else { $identity.release.release_doi })
|
| 68 |
+
Write-Host "Current public release:" $identity.current_public_release.project_version
|
| 69 |
+
Write-Host "Current public DOI:" $identity.current_public_release.release_doi
|
| 70 |
+
Write-Host "Concept DOI:" $identity.release.concept_doi
|
| 71 |
+
Write-Host "Output:" $outputPath
|
build/generate_provenance.ps1
ADDED
|
@@ -0,0 +1,155 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
param(
|
| 2 |
+
[string]$Root = (Split-Path -Parent $PSScriptRoot)
|
| 3 |
+
)
|
| 4 |
+
|
| 5 |
+
$ErrorActionPreference = "Stop"
|
| 6 |
+
|
| 7 |
+
$outputPath = Join-Path $Root "provenance.generated.json"
|
| 8 |
+
|
| 9 |
+
$inputs = @(
|
| 10 |
+
"project_metadata.json",
|
| 11 |
+
"datapackage.json",
|
| 12 |
+
"project_identity.json",
|
| 13 |
+
"supersession_registry.json",
|
| 14 |
+
"catalog.jsonld",
|
| 15 |
+
"ro-crate-metadata.json",
|
| 16 |
+
"DATA_DICTIONARY.md",
|
| 17 |
+
"CHANGELOG.md"
|
| 18 |
+
)
|
| 19 |
+
|
| 20 |
+
$generators = @(
|
| 21 |
+
"build/generate_interoperability.ps1",
|
| 22 |
+
"build/generate_catalog_jsonld.ps1",
|
| 23 |
+
"build/generate_ro_crate.ps1",
|
| 24 |
+
"build/generate_jsonl.ps1",
|
| 25 |
+
"build/generate_project_identity.ps1",
|
| 26 |
+
"build/generate_supersession_registry.ps1"
|
| 27 |
+
)
|
| 28 |
+
|
| 29 |
+
function Get-NormalizedTextBytes {
|
| 30 |
+
param(
|
| 31 |
+
[string]$FullPath
|
| 32 |
+
)
|
| 33 |
+
|
| 34 |
+
$text = Get-Content $FullPath -Raw
|
| 35 |
+
|
| 36 |
+
$text = $text.Replace("`r`n", "`n").Replace("`r", "`n")
|
| 37 |
+
|
| 38 |
+
return [System.Text.UTF8Encoding]::new($false).GetBytes($text)
|
| 39 |
+
}
|
| 40 |
+
|
| 41 |
+
function Get-Sha256Hex {
|
| 42 |
+
param(
|
| 43 |
+
[byte[]]$Bytes
|
| 44 |
+
)
|
| 45 |
+
|
| 46 |
+
$sha = [System.Security.Cryptography.SHA256]::Create()
|
| 47 |
+
|
| 48 |
+
try {
|
| 49 |
+
$hashBytes = $sha.ComputeHash($Bytes)
|
| 50 |
+
return ([System.BitConverter]::ToString($hashBytes)).Replace("-", "").ToLowerInvariant()
|
| 51 |
+
}
|
| 52 |
+
finally {
|
| 53 |
+
$sha.Dispose()
|
| 54 |
+
}
|
| 55 |
+
}
|
| 56 |
+
|
| 57 |
+
function Get-RelativeSha256Record {
|
| 58 |
+
param(
|
| 59 |
+
[string]$RelativePath
|
| 60 |
+
)
|
| 61 |
+
|
| 62 |
+
$fullPath = Join-Path $Root $RelativePath
|
| 63 |
+
|
| 64 |
+
if (-not (Test-Path $fullPath)) {
|
| 65 |
+
throw "Required provenance input not found: $RelativePath"
|
| 66 |
+
}
|
| 67 |
+
|
| 68 |
+
$bytes = Get-NormalizedTextBytes -FullPath $fullPath
|
| 69 |
+
$hash = Get-Sha256Hex -Bytes $bytes
|
| 70 |
+
|
| 71 |
+
return [ordered]@{
|
| 72 |
+
path = $RelativePath.Replace("\", "/")
|
| 73 |
+
sha256 = $hash
|
| 74 |
+
bytes = $bytes.Length
|
| 75 |
+
hash_normalization = "UTF-8 without BOM; LF line endings"
|
| 76 |
+
}
|
| 77 |
+
}
|
| 78 |
+
|
| 79 |
+
$inputRecords = @(
|
| 80 |
+
foreach ($path in $inputs) {
|
| 81 |
+
Get-RelativeSha256Record -RelativePath $path
|
| 82 |
+
}
|
| 83 |
+
)
|
| 84 |
+
|
| 85 |
+
$generatorRecords = @(
|
| 86 |
+
foreach ($path in $generators) {
|
| 87 |
+
Get-RelativeSha256Record -RelativePath $path
|
| 88 |
+
}
|
| 89 |
+
)
|
| 90 |
+
|
| 91 |
+
$jsonlFiles = Get-ChildItem (Join-Path $Root "data\jsonl\v1.2") -Filter "*.jsonl" -File |
|
| 92 |
+
Sort-Object Name
|
| 93 |
+
|
| 94 |
+
$jsonlRecords = @(
|
| 95 |
+
foreach ($file in $jsonlFiles) {
|
| 96 |
+
$relative = "data/jsonl/v1.2/$($file.Name)"
|
| 97 |
+
Get-RelativeSha256Record -RelativePath $relative
|
| 98 |
+
}
|
| 99 |
+
)
|
| 100 |
+
|
| 101 |
+
$provenance = [ordered]@{
|
| 102 |
+
project = "Holistix Open Biohacking Data Project"
|
| 103 |
+
|
| 104 |
+
release = [ordered]@{
|
| 105 |
+
project_version = "1.5.0"
|
| 106 |
+
dataset_version = "1.2"
|
| 107 |
+
status = "published"
|
| 108 |
+
release_doi = "10.5281/zenodo.21862535"
|
| 109 |
+
concept_doi = "10.5281/zenodo.20978709"
|
| 110 |
+
}
|
| 111 |
+
|
| 112 |
+
generation = [ordered]@{
|
| 113 |
+
deterministic = $true
|
| 114 |
+
generated_by = "PowerShell build pipeline"
|
| 115 |
+
generated_artifact = "provenance.generated.json"
|
| 116 |
+
self_hash_excluded = $true
|
| 117 |
+
source_revision_embedded = $false
|
| 118 |
+
text_hash_normalization = "UTF-8 without BOM; LF line endings"
|
| 119 |
+
}
|
| 120 |
+
|
| 121 |
+
inputs = $inputRecords
|
| 122 |
+
generators = $generatorRecords
|
| 123 |
+
jsonl_outputs = $jsonlRecords
|
| 124 |
+
|
| 125 |
+
provenance_policy = [ordered]@{
|
| 126 |
+
records_file_hashes = $true
|
| 127 |
+
records_generator_hashes = $true
|
| 128 |
+
records_jsonl_hashes = $true
|
| 129 |
+
hashes_normalized_text_content = $true
|
| 130 |
+
avoids_self_referential_hashing = $true
|
| 131 |
+
avoids_unreleased_git_commit_binding = $true
|
| 132 |
+
release_doi_matches_published_release = $true
|
| 133 |
+
}
|
| 134 |
+
}
|
| 135 |
+
|
| 136 |
+
$json = $provenance | ConvertTo-Json -Depth 100
|
| 137 |
+
|
| 138 |
+
[System.IO.File]::WriteAllText(
|
| 139 |
+
$outputPath,
|
| 140 |
+
$json + "`n",
|
| 141 |
+
[System.Text.UTF8Encoding]::new($false)
|
| 142 |
+
)
|
| 143 |
+
|
| 144 |
+
Write-Host ""
|
| 145 |
+
Write-Host "GENERATED PROVENANCE PASSED"
|
| 146 |
+
Write-Host "---------------------------"
|
| 147 |
+
Write-Host "Project version:" $provenance.release.project_version
|
| 148 |
+
Write-Host "Dataset version:" $provenance.release.dataset_version
|
| 149 |
+
Write-Host "Release status:" $provenance.release.status
|
| 150 |
+
Write-Host "Input files:" $provenance.inputs.Count
|
| 151 |
+
Write-Host "Generator files:" $provenance.generators.Count
|
| 152 |
+
Write-Host "JSONL outputs:" $provenance.jsonl_outputs.Count
|
| 153 |
+
Write-Host "Hash normalization:" $provenance.generation.text_hash_normalization
|
| 154 |
+
Write-Host "Self hash excluded:" $provenance.generation.self_hash_excluded
|
| 155 |
+
Write-Host "Output:" $outputPath
|
build/generate_ro_crate.ps1
ADDED
|
@@ -0,0 +1,108 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
param(
|
| 2 |
+
[string]$Root = (Split-Path -Parent $PSScriptRoot)
|
| 3 |
+
)
|
| 4 |
+
|
| 5 |
+
$ErrorActionPreference = "Stop"
|
| 6 |
+
|
| 7 |
+
$datapackagePath = Join-Path $Root "datapackage.json"
|
| 8 |
+
$outputPath = Join-Path $Root "ro-crate-metadata.json"
|
| 9 |
+
|
| 10 |
+
if (-not (Test-Path $datapackagePath)) {
|
| 11 |
+
throw "datapackage.json not found: $datapackagePath"
|
| 12 |
+
}
|
| 13 |
+
|
| 14 |
+
$package = Get-Content $datapackagePath -Raw | ConvertFrom-Json
|
| 15 |
+
|
| 16 |
+
$graph = [System.Collections.Generic.List[object]]::new()
|
| 17 |
+
|
| 18 |
+
# RO-Crate Metadata File Descriptor
|
| 19 |
+
$graph.Add(
|
| 20 |
+
[ordered]@{
|
| 21 |
+
"@id" = "ro-crate-metadata.json"
|
| 22 |
+
"@type" = "CreativeWork"
|
| 23 |
+
about = [ordered]@{
|
| 24 |
+
"@id" = "./"
|
| 25 |
+
}
|
| 26 |
+
conformsTo = [ordered]@{
|
| 27 |
+
"@id" = "https://w3id.org/ro/crate/1.2"
|
| 28 |
+
}
|
| 29 |
+
}
|
| 30 |
+
)
|
| 31 |
+
|
| 32 |
+
# Build hasPart references from datapackage resources
|
| 33 |
+
$hasPart = @(
|
| 34 |
+
$package.resources |
|
| 35 |
+
Sort-Object path |
|
| 36 |
+
ForEach-Object {
|
| 37 |
+
[ordered]@{
|
| 38 |
+
"@id" = $_.path
|
| 39 |
+
}
|
| 40 |
+
}
|
| 41 |
+
)
|
| 42 |
+
|
| 43 |
+
# Root Data Entity
|
| 44 |
+
$graph.Add(
|
| 45 |
+
[ordered]@{
|
| 46 |
+
"@id" = "./"
|
| 47 |
+
"@type" = "Dataset"
|
| 48 |
+
name = $package.title
|
| 49 |
+
description = $package.description
|
| 50 |
+
version = $package.version
|
| 51 |
+
identifier = $package.id
|
| 52 |
+
url = $package.homepage
|
| 53 |
+
datePublished = "2026-08-09"
|
| 54 |
+
license = [ordered]@{
|
| 55 |
+
"@id" = "https://creativecommons.org/licenses/by/4.0/"
|
| 56 |
+
}
|
| 57 |
+
codeRepository = $package.repository
|
| 58 |
+
hasPart = $hasPart
|
| 59 |
+
}
|
| 60 |
+
)
|
| 61 |
+
|
| 62 |
+
# File / Dataset entities
|
| 63 |
+
foreach ($resource in ($package.resources | Sort-Object path)) {
|
| 64 |
+
|
| 65 |
+
$types = @("File")
|
| 66 |
+
|
| 67 |
+
if ($resource.role -eq "canonical-subject-dataset") {
|
| 68 |
+
$types += "Dataset"
|
| 69 |
+
}
|
| 70 |
+
|
| 71 |
+
$entity = [ordered]@{
|
| 72 |
+
"@id" = $resource.path
|
| 73 |
+
"@type" = $types
|
| 74 |
+
name = $resource.name
|
| 75 |
+
encodingFormat = $resource.mediatype
|
| 76 |
+
contentSize = "$($resource.bytes) bytes"
|
| 77 |
+
sha256 = ($resource.hash -replace '^sha256:','')
|
| 78 |
+
isPartOf = [ordered]@{
|
| 79 |
+
"@id" = "./"
|
| 80 |
+
}
|
| 81 |
+
}
|
| 82 |
+
|
| 83 |
+
if ($resource.dataset_version) {
|
| 84 |
+
$entity.version = $resource.dataset_version
|
| 85 |
+
}
|
| 86 |
+
|
| 87 |
+
$graph.Add($entity)
|
| 88 |
+
}
|
| 89 |
+
|
| 90 |
+
# Complete RO-Crate document
|
| 91 |
+
$crate = [ordered]@{
|
| 92 |
+
"@context" = "https://w3id.org/ro/crate/1.2/context"
|
| 93 |
+
"@graph" = @($graph)
|
| 94 |
+
}
|
| 95 |
+
|
| 96 |
+
$crate |
|
| 97 |
+
ConvertTo-Json -Depth 100 |
|
| 98 |
+
Set-Content $outputPath -Encoding utf8
|
| 99 |
+
|
| 100 |
+
Write-Host ""
|
| 101 |
+
Write-Host "RO-CRATE GENERATION PASSED"
|
| 102 |
+
Write-Host "--------------------------"
|
| 103 |
+
Write-Host "RO-Crate specification: 1.2"
|
| 104 |
+
Write-Host "Project version:" $package.version
|
| 105 |
+
Write-Host "Date published: 2026-08-09"
|
| 106 |
+
Write-Host "Resources:" $package.resources.Count
|
| 107 |
+
Write-Host "Graph entities:" $graph.Count
|
| 108 |
+
Write-Host "RO-Crate:" $outputPath
|
build/generate_supersession_registry.ps1
ADDED
|
@@ -0,0 +1,77 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
param(
|
| 2 |
+
[string]$Root = (Split-Path -Parent $PSScriptRoot)
|
| 3 |
+
)
|
| 4 |
+
|
| 5 |
+
$ErrorActionPreference = "Stop"
|
| 6 |
+
|
| 7 |
+
$metadataPath = Join-Path $Root "project_metadata.json"
|
| 8 |
+
$identityPath = Join-Path $Root "project_identity.json"
|
| 9 |
+
$outputPath = Join-Path $Root "supersession_registry.json"
|
| 10 |
+
|
| 11 |
+
$metadata = Get-Content $metadataPath -Raw | ConvertFrom-Json
|
| 12 |
+
$identity = Get-Content $identityPath -Raw | ConvertFrom-Json
|
| 13 |
+
|
| 14 |
+
$registry = [ordered]@{
|
| 15 |
+
project = "Holistix Open Biohacking Data Project"
|
| 16 |
+
concept_doi = $metadata.identifiers.concept_doi
|
| 17 |
+
canonical_metadata_source = "project_metadata.json"
|
| 18 |
+
|
| 19 |
+
current_public_release = [ordered]@{
|
| 20 |
+
version = $identity.current_public_release.project_version
|
| 21 |
+
doi = $identity.current_public_release.release_doi
|
| 22 |
+
status = "published"
|
| 23 |
+
}
|
| 24 |
+
|
| 25 |
+
previous_release = [ordered]@{
|
| 26 |
+
version = "1.4"
|
| 27 |
+
doi = "10.5281/zenodo.21574706"
|
| 28 |
+
status = "historical"
|
| 29 |
+
relation = "superseded-by-current"
|
| 30 |
+
superseded_by_version = $identity.current_public_release.project_version
|
| 31 |
+
superseded_by_doi = $identity.current_public_release.release_doi
|
| 32 |
+
}
|
| 33 |
+
|
| 34 |
+
release_lineage = @(
|
| 35 |
+
[ordered]@{
|
| 36 |
+
version = "1.3"
|
| 37 |
+
doi = $metadata.identifiers.previous_v1_3_doi
|
| 38 |
+
status = "historical"
|
| 39 |
+
supersedes_version = "1.2.1"
|
| 40 |
+
supersedes_doi = $metadata.identifiers.previous_v1_2_1_doi
|
| 41 |
+
},
|
| 42 |
+
[ordered]@{
|
| 43 |
+
version = "1.2.1"
|
| 44 |
+
doi = $metadata.identifiers.previous_v1_2_1_doi
|
| 45 |
+
status = "historical"
|
| 46 |
+
supersedes_version = $null
|
| 47 |
+
supersedes_doi = $null
|
| 48 |
+
}
|
| 49 |
+
)
|
| 50 |
+
|
| 51 |
+
excluded_from_current_lineage = @(
|
| 52 |
+
[ordered]@{
|
| 53 |
+
doi = $metadata.identifiers.superseded_software_archive_doi
|
| 54 |
+
status = "superseded-noncanonical-archive"
|
| 55 |
+
must_not_be_used_as_current = $true
|
| 56 |
+
}
|
| 57 |
+
)
|
| 58 |
+
}
|
| 59 |
+
|
| 60 |
+
$json = $registry | ConvertTo-Json -Depth 100
|
| 61 |
+
|
| 62 |
+
[System.IO.File]::WriteAllText(
|
| 63 |
+
$outputPath,
|
| 64 |
+
$json + "`n",
|
| 65 |
+
[System.Text.UTF8Encoding]::new($false)
|
| 66 |
+
)
|
| 67 |
+
|
| 68 |
+
Write-Host ""
|
| 69 |
+
Write-Host "SUPERSESSION REGISTRY GENERATION PASSED"
|
| 70 |
+
Write-Host "---------------------------------------"
|
| 71 |
+
Write-Host "Current public release:" $registry.current_public_release.version
|
| 72 |
+
Write-Host "Current public DOI:" $registry.current_public_release.doi
|
| 73 |
+
Write-Host "Previous release:" $registry.previous_release.version
|
| 74 |
+
Write-Host "Previous release DOI:" $registry.previous_release.doi
|
| 75 |
+
Write-Host "Historical releases:" $registry.release_lineage.Count
|
| 76 |
+
Write-Host "Excluded archives:" $registry.excluded_from_current_lineage.Count
|
| 77 |
+
Write-Host "Output:" $outputPath
|
catalog.jsonld
ADDED
|
@@ -0,0 +1,317 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"@context": "https://schema.org",
|
| 3 |
+
"@type": "DataCatalog",
|
| 4 |
+
"@id": "https://doi.org/10.5281/zenodo.20978709",
|
| 5 |
+
"name": "Holistix Open Biohacking Data Project",
|
| 6 |
+
"description": "Open structured reference data for wellness technologies, product specifications, safety information, evidence metadata, claim boundaries, provenance, and machine-readable product intelligence.",
|
| 7 |
+
"url": "https://www.holistixintl.com/pages/open-biohacking-data-index",
|
| 8 |
+
"version": "1.5.0",
|
| 9 |
+
"license": "https://creativecommons.org/licenses/by/4.0/",
|
| 10 |
+
"codeRepository": "https://github.com/holistixintlsite-commits/open-biohacking-data",
|
| 11 |
+
"dataset": [
|
| 12 |
+
{
|
| 13 |
+
"@type": "Dataset",
|
| 14 |
+
"@id": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 15 |
+
"url": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 16 |
+
"name": "Blue Light Therapy Reference Index",
|
| 17 |
+
"identifier": "blue-light-therapy-reference-index-v1.2",
|
| 18 |
+
"version": "1.2",
|
| 19 |
+
"isPartOf": {
|
| 20 |
+
"@id": "https://doi.org/10.5281/zenodo.20978709"
|
| 21 |
+
},
|
| 22 |
+
"license": "https://creativecommons.org/licenses/by/4.0/",
|
| 23 |
+
"distribution": [
|
| 24 |
+
{
|
| 25 |
+
"@type": "DataDownload",
|
| 26 |
+
"name": "blue-light-therapy-reference-index-v1.2-csv",
|
| 27 |
+
"encodingFormat": "text/csv",
|
| 28 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/blue-light-therapy-reference-index-v1.2.csv",
|
| 29 |
+
"contentSize": "14913 bytes",
|
| 30 |
+
"sha256": "e091fb437544254d49f65a383e6c1737417748dbac95ba6bfc3a5e286447436f"
|
| 31 |
+
},
|
| 32 |
+
{
|
| 33 |
+
"@type": "DataDownload",
|
| 34 |
+
"name": "blue-light-therapy-reference-index-v1.2-json",
|
| 35 |
+
"encodingFormat": "application/json",
|
| 36 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/blue-light-therapy-reference-index-v1.2.json",
|
| 37 |
+
"contentSize": "23798 bytes",
|
| 38 |
+
"sha256": "f573b829946016e3361238c5e1908da3b0b870b8b87ea9529cf1c6dc5eb5a0e2"
|
| 39 |
+
},
|
| 40 |
+
{
|
| 41 |
+
"@type": "DataDownload",
|
| 42 |
+
"name": "blue-light-therapy-reference-index-v1.2-jsonl",
|
| 43 |
+
"encodingFormat": "application/jsonl",
|
| 44 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/jsonl/v1.2/blue-light-therapy-reference-index-v1.2.jsonl",
|
| 45 |
+
"contentSize": "20151 bytes",
|
| 46 |
+
"sha256": "59f594ce16b70af309339630b54d55073b8ca0df3fca2216ec8162c5c37b3d40"
|
| 47 |
+
}
|
| 48 |
+
]
|
| 49 |
+
},
|
| 50 |
+
{
|
| 51 |
+
"@type": "Dataset",
|
| 52 |
+
"@id": "https://www.holistixintl.com/pages/hydrogen-water-reference-index",
|
| 53 |
+
"url": "https://www.holistixintl.com/pages/hydrogen-water-reference-index",
|
| 54 |
+
"name": "Hydrogen Water Reference Index",
|
| 55 |
+
"identifier": "hydrogen-water-reference-index-v1.2",
|
| 56 |
+
"version": "1.2",
|
| 57 |
+
"isPartOf": {
|
| 58 |
+
"@id": "https://doi.org/10.5281/zenodo.20978709"
|
| 59 |
+
},
|
| 60 |
+
"license": "https://creativecommons.org/licenses/by/4.0/",
|
| 61 |
+
"distribution": [
|
| 62 |
+
{
|
| 63 |
+
"@type": "DataDownload",
|
| 64 |
+
"name": "hydrogen-water-reference-index-v1.2-csv",
|
| 65 |
+
"encodingFormat": "text/csv",
|
| 66 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/hydrogen-water-reference-index-v1.2.csv",
|
| 67 |
+
"contentSize": "9694 bytes",
|
| 68 |
+
"sha256": "08148580b549d0b7dc2239c7bec7f8d7400b8a7e7ecb887ee273765a4ee3a922"
|
| 69 |
+
},
|
| 70 |
+
{
|
| 71 |
+
"@type": "DataDownload",
|
| 72 |
+
"name": "hydrogen-water-reference-index-v1.2-json",
|
| 73 |
+
"encodingFormat": "application/json",
|
| 74 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/hydrogen-water-reference-index-v1.2.json",
|
| 75 |
+
"contentSize": "15280 bytes",
|
| 76 |
+
"sha256": "c761bc8e6b515923cb7ab5501b75b9496196b4c70b53fccf597e0dcec19ef4f1"
|
| 77 |
+
},
|
| 78 |
+
{
|
| 79 |
+
"@type": "DataDownload",
|
| 80 |
+
"name": "hydrogen-water-reference-index-v1.2-jsonl",
|
| 81 |
+
"encodingFormat": "application/jsonl",
|
| 82 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/jsonl/v1.2/hydrogen-water-reference-index-v1.2.jsonl",
|
| 83 |
+
"contentSize": "12663 bytes",
|
| 84 |
+
"sha256": "a656aa279515e0bcfb9ee60e6945252761630862dbedca7c57565f77e5d8948c"
|
| 85 |
+
}
|
| 86 |
+
]
|
| 87 |
+
},
|
| 88 |
+
{
|
| 89 |
+
"@type": "Dataset",
|
| 90 |
+
"@id": "https://www.holistixintl.com/pages/infrared-therapy-reference-index",
|
| 91 |
+
"url": "https://www.holistixintl.com/pages/infrared-therapy-reference-index",
|
| 92 |
+
"name": "Infrared Therapy Reference Index",
|
| 93 |
+
"identifier": "infrared-therapy-reference-index-v1.2",
|
| 94 |
+
"version": "1.2",
|
| 95 |
+
"isPartOf": {
|
| 96 |
+
"@id": "https://doi.org/10.5281/zenodo.20978709"
|
| 97 |
+
},
|
| 98 |
+
"license": "https://creativecommons.org/licenses/by/4.0/",
|
| 99 |
+
"distribution": [
|
| 100 |
+
{
|
| 101 |
+
"@type": "DataDownload",
|
| 102 |
+
"name": "infrared-therapy-reference-index-v1.2-csv",
|
| 103 |
+
"encodingFormat": "text/csv",
|
| 104 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/infrared-therapy-reference-index-v1.2.csv",
|
| 105 |
+
"contentSize": "9922 bytes",
|
| 106 |
+
"sha256": "247dc7cd4e3bd2c150ee0a978dd426425215ea237eff0029bc37e27dfaa9a9c8"
|
| 107 |
+
},
|
| 108 |
+
{
|
| 109 |
+
"@type": "DataDownload",
|
| 110 |
+
"name": "infrared-therapy-reference-index-v1.2-json",
|
| 111 |
+
"encodingFormat": "application/json",
|
| 112 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/infrared-therapy-reference-index-v1.2.json",
|
| 113 |
+
"contentSize": "15522 bytes",
|
| 114 |
+
"sha256": "e7948e12bc5e94a1c32654cd7db02abc9cba2303c954e9ada13c169b221ccd58"
|
| 115 |
+
},
|
| 116 |
+
{
|
| 117 |
+
"@type": "DataDownload",
|
| 118 |
+
"name": "infrared-therapy-reference-index-v1.2-jsonl",
|
| 119 |
+
"encodingFormat": "application/jsonl",
|
| 120 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/jsonl/v1.2/infrared-therapy-reference-index-v1.2.jsonl",
|
| 121 |
+
"contentSize": "12901 bytes",
|
| 122 |
+
"sha256": "84d68f920881fdf10082a50e797b24ad16ca25f10cdd07bd01ce1e896f6ce06f"
|
| 123 |
+
}
|
| 124 |
+
]
|
| 125 |
+
},
|
| 126 |
+
{
|
| 127 |
+
"@type": "Dataset",
|
| 128 |
+
"@id": "https://www.holistixintl.com/pages/negative-ion-safety-index",
|
| 129 |
+
"url": "https://www.holistixintl.com/pages/negative-ion-safety-index",
|
| 130 |
+
"name": "Negative Ion Safety Index",
|
| 131 |
+
"identifier": "negative-ion-safety-index-v1.2",
|
| 132 |
+
"version": "1.2",
|
| 133 |
+
"isPartOf": {
|
| 134 |
+
"@id": "https://doi.org/10.5281/zenodo.20978709"
|
| 135 |
+
},
|
| 136 |
+
"license": "https://creativecommons.org/licenses/by/4.0/",
|
| 137 |
+
"distribution": [
|
| 138 |
+
{
|
| 139 |
+
"@type": "DataDownload",
|
| 140 |
+
"name": "negative-ion-safety-index-v1.2-csv",
|
| 141 |
+
"encodingFormat": "text/csv",
|
| 142 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/negative-ion-safety-index-v1.2.csv",
|
| 143 |
+
"contentSize": "16774 bytes",
|
| 144 |
+
"sha256": "67de4ff323f30c3223e30d460312c1f3b7b7a0b6d7aca78c1750bab4486f70a7"
|
| 145 |
+
},
|
| 146 |
+
{
|
| 147 |
+
"@type": "DataDownload",
|
| 148 |
+
"name": "negative-ion-safety-index-v1.2-json",
|
| 149 |
+
"encodingFormat": "application/json",
|
| 150 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/negative-ion-safety-index-v1.2.json",
|
| 151 |
+
"contentSize": "26096 bytes",
|
| 152 |
+
"sha256": "cde415a408503d44e404f21eab765b62962f5a4f2894fa1c125e639836a7684c"
|
| 153 |
+
},
|
| 154 |
+
{
|
| 155 |
+
"@type": "DataDownload",
|
| 156 |
+
"name": "negative-ion-safety-index-v1.2-jsonl",
|
| 157 |
+
"encodingFormat": "application/jsonl",
|
| 158 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/jsonl/v1.2/negative-ion-safety-index-v1.2.jsonl",
|
| 159 |
+
"contentSize": "22321 bytes",
|
| 160 |
+
"sha256": "b5f9538adc13b2e68166cb1361d45bf5267a731881b8d852e30c4a23de41d27a"
|
| 161 |
+
}
|
| 162 |
+
]
|
| 163 |
+
},
|
| 164 |
+
{
|
| 165 |
+
"@type": "Dataset",
|
| 166 |
+
"@id": "https://www.holistixintl.com/pages/pemf-contraindications-database",
|
| 167 |
+
"url": "https://www.holistixintl.com/pages/pemf-contraindications-database",
|
| 168 |
+
"name": "Pemf Contraindications Database",
|
| 169 |
+
"identifier": "pemf-contraindications-database-v1.2",
|
| 170 |
+
"version": "1.2",
|
| 171 |
+
"isPartOf": {
|
| 172 |
+
"@id": "https://doi.org/10.5281/zenodo.20978709"
|
| 173 |
+
},
|
| 174 |
+
"license": "https://creativecommons.org/licenses/by/4.0/",
|
| 175 |
+
"distribution": [
|
| 176 |
+
{
|
| 177 |
+
"@type": "DataDownload",
|
| 178 |
+
"name": "pemf-contraindications-database-v1.2-csv",
|
| 179 |
+
"encodingFormat": "text/csv",
|
| 180 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/pemf-contraindications-database-v1.2.csv",
|
| 181 |
+
"contentSize": "10516 bytes",
|
| 182 |
+
"sha256": "ee30f7362bad537c840de5f22d814ec1494af81f7e24829ce830ab60fdd28952"
|
| 183 |
+
},
|
| 184 |
+
{
|
| 185 |
+
"@type": "DataDownload",
|
| 186 |
+
"name": "pemf-contraindications-database-v1.2-json",
|
| 187 |
+
"encodingFormat": "application/json",
|
| 188 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/pemf-contraindications-database-v1.2.json",
|
| 189 |
+
"contentSize": "16783 bytes",
|
| 190 |
+
"sha256": "9acc39c4fa1e4f78902df816275eef0a41fe8757ffae9cb03d2e183bbd443ffc"
|
| 191 |
+
},
|
| 192 |
+
{
|
| 193 |
+
"@type": "DataDownload",
|
| 194 |
+
"name": "pemf-contraindications-database-v1.2-jsonl",
|
| 195 |
+
"encodingFormat": "application/jsonl",
|
| 196 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/jsonl/v1.2/pemf-contraindications-database-v1.2.jsonl",
|
| 197 |
+
"contentSize": "14028 bytes",
|
| 198 |
+
"sha256": "a2629e468c25b6c7e3b43d8c33e9ff643518e65c9e757bfa6e4e4234b897604c"
|
| 199 |
+
}
|
| 200 |
+
]
|
| 201 |
+
},
|
| 202 |
+
{
|
| 203 |
+
"@type": "Dataset",
|
| 204 |
+
"@id": "https://www.holistixintl.com/pages/pemf-frequency-index",
|
| 205 |
+
"url": "https://www.holistixintl.com/pages/pemf-frequency-index",
|
| 206 |
+
"name": "Pemf Frequency Index",
|
| 207 |
+
"identifier": "pemf-frequency-index-v1.2",
|
| 208 |
+
"version": "1.2",
|
| 209 |
+
"isPartOf": {
|
| 210 |
+
"@id": "https://doi.org/10.5281/zenodo.20978709"
|
| 211 |
+
},
|
| 212 |
+
"license": "https://creativecommons.org/licenses/by/4.0/",
|
| 213 |
+
"distribution": [
|
| 214 |
+
{
|
| 215 |
+
"@type": "DataDownload",
|
| 216 |
+
"name": "pemf-frequency-index-v1.2-csv",
|
| 217 |
+
"encodingFormat": "text/csv",
|
| 218 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/pemf-frequency-index-v1.2.csv",
|
| 219 |
+
"contentSize": "17431 bytes",
|
| 220 |
+
"sha256": "bfe48bb2b08ad706d5bf698ed786a1f12f0586359c9cdefe1dc33a9ee3abb066"
|
| 221 |
+
},
|
| 222 |
+
{
|
| 223 |
+
"@type": "DataDownload",
|
| 224 |
+
"name": "pemf-frequency-index-v1.2-json",
|
| 225 |
+
"encodingFormat": "application/json",
|
| 226 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/pemf-frequency-index-v1.2.json",
|
| 227 |
+
"contentSize": "26245 bytes",
|
| 228 |
+
"sha256": "4ec30a99588bd73de364801fc32c739989b2a00ecc6d33d1b1cc94fc33766a3e"
|
| 229 |
+
},
|
| 230 |
+
{
|
| 231 |
+
"@type": "DataDownload",
|
| 232 |
+
"name": "pemf-frequency-index-v1.2-jsonl",
|
| 233 |
+
"encodingFormat": "application/jsonl",
|
| 234 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/jsonl/v1.2/pemf-frequency-index-v1.2.jsonl",
|
| 235 |
+
"contentSize": "23975 bytes",
|
| 236 |
+
"sha256": "16ece19ee305757a0a4a071c9ea69edb22201207e8deaf70c8115599e3a515b1"
|
| 237 |
+
}
|
| 238 |
+
]
|
| 239 |
+
},
|
| 240 |
+
{
|
| 241 |
+
"@type": "Dataset",
|
| 242 |
+
"@id": "https://www.holistixintl.com/pages/red-light-dose-index",
|
| 243 |
+
"url": "https://www.holistixintl.com/pages/red-light-dose-index",
|
| 244 |
+
"name": "Red Light Dose Index",
|
| 245 |
+
"identifier": "red-light-dose-index-v1.2",
|
| 246 |
+
"version": "1.2",
|
| 247 |
+
"isPartOf": {
|
| 248 |
+
"@id": "https://doi.org/10.5281/zenodo.20978709"
|
| 249 |
+
},
|
| 250 |
+
"license": "https://creativecommons.org/licenses/by/4.0/",
|
| 251 |
+
"distribution": [
|
| 252 |
+
{
|
| 253 |
+
"@type": "DataDownload",
|
| 254 |
+
"name": "red-light-dose-index-v1.2-csv",
|
| 255 |
+
"encodingFormat": "text/csv",
|
| 256 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/red-light-dose-index-v1.2.csv",
|
| 257 |
+
"contentSize": "8338 bytes",
|
| 258 |
+
"sha256": "717b61f6e2e425b773167d66c39dd38fdba40fa826f531a849397d2ec9423b4a"
|
| 259 |
+
},
|
| 260 |
+
{
|
| 261 |
+
"@type": "DataDownload",
|
| 262 |
+
"name": "red-light-dose-index-v1.2-json",
|
| 263 |
+
"encodingFormat": "application/json",
|
| 264 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/red-light-dose-index-v1.2.json",
|
| 265 |
+
"contentSize": "11529 bytes",
|
| 266 |
+
"sha256": "8fde7d8481dc188025eb8238cb6046ee1f1eff7382165511e281cdd5e73c25de"
|
| 267 |
+
},
|
| 268 |
+
{
|
| 269 |
+
"@type": "DataDownload",
|
| 270 |
+
"name": "red-light-dose-index-v1.2-jsonl",
|
| 271 |
+
"encodingFormat": "application/jsonl",
|
| 272 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/jsonl/v1.2/red-light-dose-index-v1.2.jsonl",
|
| 273 |
+
"contentSize": "10663 bytes",
|
| 274 |
+
"sha256": "426c6204eee8c139f46de9427b5cfb904ae9b36051a206ad7fcad375b144595c"
|
| 275 |
+
}
|
| 276 |
+
]
|
| 277 |
+
},
|
| 278 |
+
{
|
| 279 |
+
"@type": "Dataset",
|
| 280 |
+
"@id": "https://www.holistixintl.com/pages/terahertz-device-reference-index",
|
| 281 |
+
"url": "https://www.holistixintl.com/pages/terahertz-device-reference-index",
|
| 282 |
+
"name": "Terahertz Device Reference Index",
|
| 283 |
+
"identifier": "terahertz-device-reference-index-v1.2",
|
| 284 |
+
"version": "1.2",
|
| 285 |
+
"isPartOf": {
|
| 286 |
+
"@id": "https://doi.org/10.5281/zenodo.20978709"
|
| 287 |
+
},
|
| 288 |
+
"license": "https://creativecommons.org/licenses/by/4.0/",
|
| 289 |
+
"distribution": [
|
| 290 |
+
{
|
| 291 |
+
"@type": "DataDownload",
|
| 292 |
+
"name": "terahertz-device-reference-index-v1.2-csv",
|
| 293 |
+
"encodingFormat": "text/csv",
|
| 294 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/terahertz-device-reference-index-v1.2.csv",
|
| 295 |
+
"contentSize": "13092 bytes",
|
| 296 |
+
"sha256": "0daeb5621d23022e6f247b4acea16b7d2cb271578a32261304b883478db11932"
|
| 297 |
+
},
|
| 298 |
+
{
|
| 299 |
+
"@type": "DataDownload",
|
| 300 |
+
"name": "terahertz-device-reference-index-v1.2-json",
|
| 301 |
+
"encodingFormat": "application/json",
|
| 302 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/datasets/v1.2/terahertz-device-reference-index-v1.2.json",
|
| 303 |
+
"contentSize": "21053 bytes",
|
| 304 |
+
"sha256": "a953c08187a6bbca9d9c86ee9698f242813ed353410108f936ee9ddd455c3ca0"
|
| 305 |
+
},
|
| 306 |
+
{
|
| 307 |
+
"@type": "DataDownload",
|
| 308 |
+
"name": "terahertz-device-reference-index-v1.2-jsonl",
|
| 309 |
+
"encodingFormat": "application/jsonl",
|
| 310 |
+
"contentUrl": "https://raw.githubusercontent.com/holistixintlsite-commits/open-biohacking-data/main/data/jsonl/v1.2/terahertz-device-reference-index-v1.2.jsonl",
|
| 311 |
+
"contentSize": "17702 bytes",
|
| 312 |
+
"sha256": "22ab077fb0ead1c306297ff161bb66980c79655ff8a52b9445455f65b2e59850"
|
| 313 |
+
}
|
| 314 |
+
]
|
| 315 |
+
}
|
| 316 |
+
]
|
| 317 |
+
}
|
data/datasets/v1.2/pemf-contraindications-database-v1.2.csv
CHANGED
|
@@ -1,13 +1,13 @@
|
|
| 1 |
-
record_id,contraindication_or_caution,risk_level,recommendation,plain_language_note,source_type,evidence_level,claim_type,medical_disclaimer_required,commercial_relevance,last_reviewed,related_holistix_page,notes,source_name,source_url,citation_note
|
| 2 |
-
HOL-PEMF-CONTRA-0001,"Pacemaker, implantable cardioverter-defibrillator, or implanted cardiac electronic device",High,Avoid PEMF use unless specifically cleared by a qualified clinician and the implanted device manufacturer.,PEMF devices generate electromagnetic fields that may interfere with implanted cardiac electronics.,Safety guidance / implanted cardiac device context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,This row should not be interpreted as individualized medical advice.,FDA - Magnets in Cell Phones and Smart Watches May Affect Pacemakers and Other Implanted Medical Devices,https://www.fda.gov/radiation-emitting-products/cell-phones/magnets-cell-phones-and-smart-watches-may-affect-pacemakers-and-other-implanted-medical-devices,"Use as authoritative safety context for the general principle that strong magnetic fields from consumer devices can affect some implanted cardiac devices. Supports implanted-device caution, not PEMF treatment claims."
|
| 3 |
-
HOL-PEMF-CONTRA-0002,Implanted electronic medical device,High,Avoid PEMF use unless cleared by a qualified clinician and the device manufacturer.,"This category may include neurostimulators, cochlear implants, implanted pumps, and other active electronic implants.",Safety guidance / implanted electronic device context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Includes active implanted electronics beyond cardiac devices.,FDA - Electromagnetic Compatibility (EMC),https://www.fda.gov/radiation-emitting-products/radiation-safety/electromagnetic-compatibility-emc,Use as broad regulatory context for electromagnetic compatibility and medical-device interference complexity. Supports caution around active implanted electronics and device-manufacturer guidance.
|
| 4 |
-
HOL-PEMF-CONTRA-0003,"Pregnancy, possible pregnancy, or trying to become pregnant",High caution,Avoid PEMF use unless specifically cleared by a qualified healthcare professional.,Pregnancy is commonly treated as a precautionary category because safety data may be limited and device guidance varies.,Safety guidance / precautionary use context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Precautionary category; not a treatment recommendation.,PEMF Safety Considerations for Home-Use Devices,https://www.pemfadvisor.com/pemf-therapy/safety-considerations/,Use as consumer-safety context for manufacturer-style precautionary categories such as pregnancy. This is not clinical proof and should not be used to recommend PEMF use during pregnancy.
|
| 5 |
-
HOL-PEMF-CONTRA-0004,Epilepsy or seizure history,Caution,Consult a qualified healthcare professional before using PEMF.,"Different PEMF devices use different frequencies, intensities, and pulse patterns, so seizure-related caution is commonly advised.",Safety guidance / medical-history context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Device settings vary widely; professional guidance is appropriate.,PEMF Safety Considerations for Home-Use Devices,https://www.pemfadvisor.com/pemf-therapy/safety-considerations/,"Use as consumer-safety context for seizure-history caution and device-variation warnings. Supports consult-a-professional language, not individualized medical advice."
|
| 6 |
-
HOL-PEMF-CONTRA-0005,Insulin pump or implanted drug-delivery pump,High,Avoid PEMF use unless specifically cleared by a qualified clinician and the device manufacturer.,Implanted or wearable electronic pumps may be sensitive to electromagnetic interference.,Safety guidance / electronic pump context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Applies to implanted or wearable electronic pump systems.,FDA - Electromagnetic Compatibility (EMC) of Medical Devices,https://www.fda.gov/media/94758/download,"Use as FDA medical-device EMC guidance context for device systems, accessories, controllers, and safe function in electromagnetic environments. Supports caution for pumps and electronic medical devices."
|
| 7 |
-
HOL-PEMF-CONTRA-0006,Cochlear implant or implanted hearing device,High,Avoid PEMF use unless specifically cleared by a qualified clinician and the implant manufacturer.,Cochlear implants are active implanted electronic devices and may be affected by electromagnetic fields.,Safety guidance / implanted hearing-device context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Implant manufacturer guidance should be followed.,FDA - Cochlear Implants and MRI Safety,https://www.fda.gov/medical-devices/cochlear-implants/cochlear-implants-and-mri-safety,"Use as authoritative context that implanted hearing devices can require special precautions in strong electromagnetic environments. Supports manufacturer-guidance caution, not PEMF-specific claims."
|
| 8 |
-
HOL-PEMF-CONTRA-0007,Heart rhythm disorder or complex cardiac condition,Caution,Consult a qualified healthcare professional before using PEMF.,"People with cardiac conditions should get individualized guidance, especially if they have implanted devices, arrhythmias, or recent cardiac events.",Safety guidance / cardiac-condition context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Cardiac history may require individualized review.,FDA - Magnets in Cell Phones and Smart Watches May Affect Pacemakers and Other Implanted Medical Devices,https://www.fda.gov/radiation-emitting-products/cell-phones/magnets-cell-phones-and-smart-watches-may-affect-pacemakers-and-other-implanted-medical-devices,Use as cardiac implanted-device safety context for electromagnetic and magnetic-field caution. Supports professional-guidance language for complex cardiac users.
|
| 9 |
-
HOL-PEMF-CONTRA-0008,Active bleeding or bleeding disorder,Caution,Consult a qualified healthcare professional before using PEMF.,Some safety guides advise caution around active bleeding or bleeding disorders because PEMF is often discussed in relation to circulation and tissue response.,Safety guidance / bleeding-risk context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Conservative safety framing for bleeding-related concerns.,PEMF Safety Considerations for Home-Use Devices,https://www.pemfadvisor.com/pemf-therapy/safety-considerations/,"Use as conservative consumer-safety context for bleeding-risk caution. Do not convert this row into treatment, circulation, or post-injury protocol guidance."
|
| 10 |
-
HOL-PEMF-CONTRA-0009,"Active cancer, recent cancer treatment, or oncology care",Medical supervision,Use only with guidance from a qualified oncology or healthcare professional.,People in cancer care should avoid unsupervised wellness-device use unless their care team clears it.,Safety guidance / complex medical-condition context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,"Avoid implying treatment, prevention, or oncology benefit.",PEMF Safety Considerations for Home-Use Devices,https://www.pemfadvisor.com/pemf-therapy/safety-considerations/,Use as consumer-safety context for complex medical-condition caution and oncology supervision language. Do not use as evidence for cancer-related benefits.
|
| 11 |
-
HOL-PEMF-CONTRA-0010,Organ transplant or immune suppression therapy,Medical supervision,Use only with guidance from a qualified healthcare professional.,Some PEMF safety resources flag organ transplant and immune suppression as categories requiring medical supervision.,Safety guidance / complex medical-condition context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Medical complexity requires professional guidance.,PEMF Safety Considerations for Home-Use Devices,https://www.pemfadvisor.com/pemf-therapy/safety-considerations/,Use as consumer-safety context for complex medical-condition and immune-suppression caution. This supports professional-guidance language only.
|
| 12 |
-
HOL-PEMF-CONTRA-0011,"Recent surgery, acute injury, or unexplained pain",Caution,Consult a qualified healthcare professional before using PEMF on or near the affected area.,Recent procedures and acute injuries may require individualized care instructions.,Safety guidance / recovery-status context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Do not frame PEMF as post-surgical treatment guidance.,PEMF Safety Considerations for Home-Use Devices,https://www.pemfadvisor.com/pemf-therapy/safety-considerations/,"Use as consumer-safety context for recent surgery, acute injury, and unexplained pain cautions. Do not use to create recovery or post-surgical protocols."
|
| 13 |
-
HOL-PEMF-CONTRA-0012,Children or minors,Medical supervision,Use only under appropriate professional or caregiver guidance and according to device instructions.,"Age-related guidance varies by device, and pediatric use should not be assumed safe without appropriate oversight.",Safety guidance / age-specific use context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Pediatric use should remain conservative and supervised.,PEMF Safety Considerations for Home-Use Devices,https://www.pemfadvisor.com/pemf-therapy/safety-considerations/,Use as conservative home-use safety context for children/minors and supervised-use language. Do not use as pediatric protocol support.
|
|
|
|
| 1 |
+
record_id,contraindication_or_caution,risk_level,recommendation,plain_language_note,source_type,evidence_level,claim_type,medical_disclaimer_required,commercial_relevance,last_reviewed,related_holistix_page,notes,source_name,source_url,citation_note
|
| 2 |
+
HOL-PEMF-CONTRA-0001,"Pacemaker, implantable cardioverter-defibrillator, or implanted cardiac electronic device",High,Avoid PEMF use unless specifically cleared by a qualified clinician and the implanted device manufacturer.,PEMF devices generate electromagnetic fields that may interfere with implanted cardiac electronics.,Safety guidance / implanted cardiac device context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,This row should not be interpreted as individualized medical advice.,FDA - Magnets in Cell Phones and Smart Watches May Affect Pacemakers and Other Implanted Medical Devices,https://www.fda.gov/radiation-emitting-products/cell-phones/magnets-cell-phones-and-smart-watches-may-affect-pacemakers-and-other-implanted-medical-devices,"Use as authoritative safety context for the general principle that strong magnetic fields from consumer devices can affect some implanted cardiac devices. Supports implanted-device caution, not PEMF treatment claims."
|
| 3 |
+
HOL-PEMF-CONTRA-0002,Implanted electronic medical device,High,Avoid PEMF use unless cleared by a qualified clinician and the device manufacturer.,"This category may include neurostimulators, cochlear implants, implanted pumps, and other active electronic implants.",Safety guidance / implanted electronic device context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Includes active implanted electronics beyond cardiac devices.,FDA - Electromagnetic Compatibility (EMC),https://www.fda.gov/radiation-emitting-products/radiation-safety/electromagnetic-compatibility-emc,Use as broad regulatory context for electromagnetic compatibility and medical-device interference complexity. Supports caution around active implanted electronics and device-manufacturer guidance.
|
| 4 |
+
HOL-PEMF-CONTRA-0003,"Pregnancy, possible pregnancy, or trying to become pregnant",High caution,Avoid PEMF use unless specifically cleared by a qualified healthcare professional.,Pregnancy is commonly treated as a precautionary category because safety data may be limited and device guidance varies.,Safety guidance / precautionary use context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Precautionary category; not a treatment recommendation.,PEMF Safety Considerations for Home-Use Devices,https://www.pemfadvisor.com/pemf-therapy/safety-considerations/,Use as consumer-safety context for manufacturer-style precautionary categories such as pregnancy. This is not clinical proof and should not be used to recommend PEMF use during pregnancy.
|
| 5 |
+
HOL-PEMF-CONTRA-0004,Epilepsy or seizure history,Caution,Consult a qualified healthcare professional before using PEMF.,"Different PEMF devices use different frequencies, intensities, and pulse patterns, so seizure-related caution is commonly advised.",Safety guidance / medical-history context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Device settings vary widely; professional guidance is appropriate.,PEMF Safety Considerations for Home-Use Devices,https://www.pemfadvisor.com/pemf-therapy/safety-considerations/,"Use as consumer-safety context for seizure-history caution and device-variation warnings. Supports consult-a-professional language, not individualized medical advice."
|
| 6 |
+
HOL-PEMF-CONTRA-0005,Insulin pump or implanted drug-delivery pump,High,Avoid PEMF use unless specifically cleared by a qualified clinician and the device manufacturer.,Implanted or wearable electronic pumps may be sensitive to electromagnetic interference.,Safety guidance / electronic pump context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Applies to implanted or wearable electronic pump systems.,FDA - Electromagnetic Compatibility (EMC) of Medical Devices,https://www.fda.gov/media/94758/download,"Use as FDA medical-device EMC guidance context for device systems, accessories, controllers, and safe function in electromagnetic environments. Supports caution for pumps and electronic medical devices."
|
| 7 |
+
HOL-PEMF-CONTRA-0006,Cochlear implant or implanted hearing device,High,Avoid PEMF use unless specifically cleared by a qualified clinician and the implant manufacturer.,Cochlear implants are active implanted electronic devices and may be affected by electromagnetic fields.,Safety guidance / implanted hearing-device context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Implant manufacturer guidance should be followed.,FDA - Cochlear Implants and MRI Safety,https://www.fda.gov/medical-devices/cochlear-implants/cochlear-implants-and-mri-safety,"Use as authoritative context that implanted hearing devices can require special precautions in strong electromagnetic environments. Supports manufacturer-guidance caution, not PEMF-specific claims."
|
| 8 |
+
HOL-PEMF-CONTRA-0007,Heart rhythm disorder or complex cardiac condition,Caution,Consult a qualified healthcare professional before using PEMF.,"People with cardiac conditions should get individualized guidance, especially if they have implanted devices, arrhythmias, or recent cardiac events.",Safety guidance / cardiac-condition context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Cardiac history may require individualized review.,FDA - Magnets in Cell Phones and Smart Watches May Affect Pacemakers and Other Implanted Medical Devices,https://www.fda.gov/radiation-emitting-products/cell-phones/magnets-cell-phones-and-smart-watches-may-affect-pacemakers-and-other-implanted-medical-devices,Use as cardiac implanted-device safety context for electromagnetic and magnetic-field caution. Supports professional-guidance language for complex cardiac users.
|
| 9 |
+
HOL-PEMF-CONTRA-0008,Active bleeding or bleeding disorder,Caution,Consult a qualified healthcare professional before using PEMF.,Some safety guides advise caution around active bleeding or bleeding disorders because PEMF is often discussed in relation to circulation and tissue response.,Safety guidance / bleeding-risk context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Conservative safety framing for bleeding-related concerns.,PEMF Safety Considerations for Home-Use Devices,https://www.pemfadvisor.com/pemf-therapy/safety-considerations/,"Use as conservative consumer-safety context for bleeding-risk caution. Do not convert this row into treatment, circulation, or post-injury protocol guidance."
|
| 10 |
+
HOL-PEMF-CONTRA-0009,"Active cancer, recent cancer treatment, or oncology care",Medical supervision,Use only with guidance from a qualified oncology or healthcare professional.,People in cancer care should avoid unsupervised wellness-device use unless their care team clears it.,Safety guidance / complex medical-condition context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,"Avoid implying treatment, prevention, or oncology benefit.",PEMF Safety Considerations for Home-Use Devices,https://www.pemfadvisor.com/pemf-therapy/safety-considerations/,Use as consumer-safety context for complex medical-condition caution and oncology supervision language. Do not use as evidence for cancer-related benefits.
|
| 11 |
+
HOL-PEMF-CONTRA-0010,Organ transplant or immune suppression therapy,Medical supervision,Use only with guidance from a qualified healthcare professional.,Some PEMF safety resources flag organ transplant and immune suppression as categories requiring medical supervision.,Safety guidance / complex medical-condition context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Medical complexity requires professional guidance.,PEMF Safety Considerations for Home-Use Devices,https://www.pemfadvisor.com/pemf-therapy/safety-considerations/,Use as consumer-safety context for complex medical-condition and immune-suppression caution. This supports professional-guidance language only.
|
| 12 |
+
HOL-PEMF-CONTRA-0011,"Recent surgery, acute injury, or unexplained pain",Caution,Consult a qualified healthcare professional before using PEMF on or near the affected area.,Recent procedures and acute injuries may require individualized care instructions.,Safety guidance / recovery-status context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Do not frame PEMF as post-surgical treatment guidance.,PEMF Safety Considerations for Home-Use Devices,https://www.pemfadvisor.com/pemf-therapy/safety-considerations/,"Use as consumer-safety context for recent surgery, acute injury, and unexplained pain cautions. Do not use to create recovery or post-surgical protocols."
|
| 13 |
+
HOL-PEMF-CONTRA-0012,Children or minors,Medical supervision,Use only under appropriate professional or caregiver guidance and according to device instructions.,"Age-related guidance varies by device, and pediatric use should not be assumed safe without appropriate oversight.",Safety guidance / age-specific use context,Consumer safety caution,Safety caution,Yes,PEMF mats / consumer wellness devices,2026-06-26,https://www.holistixintl.com/pages/pemf-contraindications-database,Pediatric use should remain conservative and supervised.,PEMF Safety Considerations for Home-Use Devices,https://www.pemfadvisor.com/pemf-therapy/safety-considerations/,Use as conservative home-use safety context for children/minors and supervised-use language. Do not use as pediatric protocol support.
|
data/jsonl/v1.2/blue-light-therapy-reference-index-v1.2.jsonl
ADDED
|
@@ -0,0 +1,17 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{"record_id":"BLUE-001","topic":"Blue light","reference_type":"Definition","plain_language_meaning":"Blue light is a visible-light range often discussed in screen exposure, circadian rhythm, dermatology, acne-care devices, and controlled light-therapy contexts.","safety_note":"The term blue light by itself should not be treated as proof of a medical or cosmetic result.","source_type":"Educational terminology / device-category context","evidence_level":"Basic terminology","claim_type":"Definition","medical_disclaimer_required":"No","commercial_relevance":"Helps explain broad blue light terminology without overclaiming.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"Use as the neutral opening definition.","source_name":"Blue Light in Dermatology","source_url":"https://www.mdpi.com/2075-1729/11/7/670","citation_note":"Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."}
|
| 2 |
+
{"record_id":"BLUE-002","topic":"Controlled blue light therapy","reference_type":"Therapy context","plain_language_meaning":"Controlled blue light therapy generally refers to structured light exposure using defined wavelengths, intensity, distance, and exposure time.","safety_note":"Controlled-use language should not be converted into disease-treatment or home-use protocols without appropriate evidence and professional guidance.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Measurement caution","claim_type":"Usage context","medical_disclaimer_required":"Yes","commercial_relevance":"Separates controlled light-therapy contexts from vague consumer marketing.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"Avoid creating dosage protocols.","source_name":"Blue Light in Dermatology","source_url":"https://www.mdpi.com/2075-1729/11/7/670","citation_note":"Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."}
|
| 3 |
+
{"record_id":"BLUE-003","topic":"Blue light and skin-care devices","reference_type":"Device category","plain_language_meaning":"Some consumer skin-care devices use blue light as part of acne-care, blemish-care, or general skin-appearance positioning.","safety_note":"Cosmetic language should not become a claim to diagnose, treat, cure, or prevent a disease unless supported by proper regulatory clearance and evidence.","source_type":"Consumer comparison context / buyer education","evidence_level":"Buyer education / device specification","claim_type":"Device comparison","medical_disclaimer_required":"Yes","commercial_relevance":"Relevant to beauty and skin-care device comparison pages.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"Keep cosmetic and medical language separate.","source_name":"Effect of Blue Light on Acne Vulgaris: A Systematic Review","source_url":"https://www.mdpi.com/1424-8220/21/20/6943","citation_note":"Use as review-level context for blue light and acne-related research. Do not use as a product efficacy guarantee or treatment protocol."}
|
| 4 |
+
{"record_id":"BLUE-004","topic":"Acne claim boundary","reference_type":"Claim boundary","plain_language_meaning":"Blue light is often discussed in relation to acne-care devices, but consumer claims need careful wording.","safety_note":"Avoid claiming a device treats acne or any skin disease unless claims are supported by appropriate evidence, intended-use language, and regulatory status.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Commercial separation","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Protects Holistix product and education copy from overstated skin claims.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"Important compliance row.","source_name":"Effect of Blue Light on Acne Vulgaris: A Systematic Review","source_url":"https://www.mdpi.com/1424-8220/21/20/6943","citation_note":"Use as review-level context for blue light and acne-related research. Do not use as a product efficacy guarantee or treatment protocol."}
|
| 5 |
+
{"record_id":"BLUE-005","topic":"Eye exposure","reference_type":"Safety caution","plain_language_meaning":"Blue light can be bright or uncomfortable, and direct viewing of intense LEDs may create eye strain or safety concerns depending on device design.","safety_note":"Do not stare into LEDs. Follow manufacturer eye-protection instructions, especially with bright facial devices or panel-style devices.","source_type":"Manufacturer instruction / consumer safety context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"Important for face masks, panels, and handheld light devices.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"Eye safety row should stay visible.","source_name":"Blue Light in Dermatology","source_url":"https://www.mdpi.com/2075-1729/11/7/670","citation_note":"Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."}
|
| 6 |
+
{"record_id":"BLUE-006","topic":"Photosensitivity","reference_type":"Safety context","plain_language_meaning":"Some people may be more sensitive to light because of medications, skin conditions, eye conditions, or individual sensitivity.","safety_note":"People with photosensitivity concerns or relevant medication use should consult a qualified healthcare professional before using bright light devices.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"Supports conservative safety language for light-based products.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"No medical screening protocol.","source_name":"Ocular hazards of blue-light therapy in dermatology","source_url":"https://www.jaad.org/article/S0190-9622(10)02150-X/fulltext","citation_note":"Use for eye-safety caution around blue-light therapy. Preserve manufacturer eye-protection guidance and avoid personalized medical advice."}
|
| 7 |
+
{"record_id":"BLUE-007","topic":"Screen blue light","reference_type":"Exposure context","plain_language_meaning":"Screen-related blue light is different from controlled light-therapy devices because screens vary in brightness, timing, distance, duration, and surrounding environment.","safety_note":"Do not treat screen-exposure concerns as the same category as controlled therapeutic or cosmetic blue light devices.","source_type":"Educational terminology / device-category context","evidence_level":"Measurement caution","claim_type":"Measurement concept","medical_disclaimer_required":"No","commercial_relevance":"Helps separate common screen-blue-light searches from device therapy claims.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"Useful SEO/AI clarity row.","source_name":"Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3366451/","citation_note":"Use for controlled-device dose and exposure-parameter context. Do not convert study parameters into general consumer recommendations."}
|
| 8 |
+
{"record_id":"BLUE-008","topic":"Circadian timing","reference_type":"Usage context","plain_language_meaning":"Blue light timing can matter because bright light exposure, especially at night, is often discussed in relation to alertness and circadian rhythms.","safety_note":"This dataset does not provide sleep-treatment advice or medical guidance. Users with sleep disorders should consult a qualified professional.","source_type":"Scientific review","evidence_level":"Research context","claim_type":"Usage context","medical_disclaimer_required":"Yes","commercial_relevance":"Allows careful discussion of timing without claiming sleep treatment.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"Keep non-medical and general.","source_name":"Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3366451/","citation_note":"Use for controlled-device dose and exposure-parameter context. Do not convert study parameters into general consumer recommendations."}
|
| 9 |
+
{"record_id":"BLUE-009","topic":"Wavelength disclosure","reference_type":"Specification field","plain_language_meaning":"A useful blue light device listing should disclose wavelength range, LED type, intended use, power or irradiance information when available, safety warnings, and instructions.","safety_note":"If exact wavelength or output data are unavailable, copy should say so instead of implying precision.","source_type":"Device specification / manufacturer-instruction context","evidence_level":"Device specification","claim_type":"Specification field","medical_disclaimer_required":"No","commercial_relevance":"Supports cleaner product-page and comparison-page language.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"Good row for product-spec audits.","source_name":"Blue Light in Dermatology","source_url":"https://www.mdpi.com/2075-1729/11/7/670","citation_note":"Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."}
|
| 10 |
+
{"record_id":"BLUE-010","topic":"Irradiance and distance","reference_type":"Measurement concept","plain_language_meaning":"Blue light exposure depends on output intensity, distance from the device, area covered, and exposure time.","safety_note":"Avoid copying clinical or online exposure protocols into consumer use instructions unless they match the device and intended use.","source_type":"Manufacturer instruction / consumer safety context","evidence_level":"Measurement caution","claim_type":"Measurement concept","medical_disclaimer_required":"Yes","commercial_relevance":"Prevents generic protocol language from becoming unsafe advice.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"No dosage instructions.","source_name":"Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3366451/","citation_note":"Use for controlled-device dose and exposure-parameter context. Do not convert study parameters into general consumer recommendations."}
|
| 11 |
+
{"record_id":"BLUE-011","topic":"Exposure time","reference_type":"Usage context","plain_language_meaning":"Exposure time is a major variable for any light-emitting consumer device.","safety_note":"This dataset does not provide dosage protocols. Users should follow device instructions and avoid overuse.","source_type":"Manufacturer instruction / consumer safety context","evidence_level":"Consumer safety caution","claim_type":"Usage context","medical_disclaimer_required":"Yes","commercial_relevance":"Keeps the dataset educational instead of becoming a protocol page.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"No treatment schedules.","source_name":"FDA 510(k) Summary: Quasar Blue Light Therapy System","source_url":"https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf","citation_note":"Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."}
|
| 12 |
+
{"record_id":"BLUE-012","topic":"Combined light devices","reference_type":"Device comparison","plain_language_meaning":"Some devices combine blue light with red light, near-infrared light, infrared heat, vibration, PEMF, or other features.","safety_note":"When multiple technologies are combined, claims should identify which feature is being discussed and avoid assigning every benefit to blue light.","source_type":"Consumer comparison context / buyer education","evidence_level":"Buyer education / device specification","claim_type":"Device comparison","medical_disclaimer_required":"Yes","commercial_relevance":"Useful for Holistix product education where devices may combine light modes.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"Good multi-modality clarity row.","source_name":"FDA 510(k) Summary: Quasar Blue Light Therapy System","source_url":"https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf","citation_note":"Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."}
|
| 13 |
+
{"record_id":"BLUE-013","topic":"Heat and skin irritation","reference_type":"Safety context","plain_language_meaning":"Some light devices can create warmth or skin irritation depending on device design, duration, sensitivity, and placement.","safety_note":"Stop use if discomfort, irritation, excessive heat, or unusual reaction occurs and follow manufacturer safety instructions.","source_type":"Manufacturer instruction / consumer safety context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"Supports practical product safety language.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"Keep as consumer caution, not medical advice.","source_name":"Blue Light Therapy in Dermatological Practice: A Review","source_url":"https://www.mdpi.com/2079-9284/12/1/30","citation_note":"Use as broad dermatology review context for blue-light effects, safety considerations, and skin-facing use. Keep all claims conservative."}
|
| 14 |
+
{"record_id":"BLUE-014","topic":"Home-use device claims","reference_type":"Claim boundary","plain_language_meaning":"Home-use blue light devices should be described carefully because consumer devices can differ from clinical, dermatology, or research systems.","safety_note":"Avoid implying that a home-use device is equivalent to professional treatment equipment unless specifications, intended use, and evidence support that comparison.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Commercial separation","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Protects against borrowed authority from clinical research.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"Key claim-boundary row.","source_name":"FDA 510(k) Summary: Quasar Blue Light Therapy System","source_url":"https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf","citation_note":"Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."}
|
| 15 |
+
{"record_id":"BLUE-015","topic":"Regulatory and intended-use language","reference_type":"Regulatory context","plain_language_meaning":"Blue light devices that make medical claims should be evaluated for intended use, regulatory status, labeling, and evidence support.","safety_note":"Regulatory language should not be used as a substitute for medical evidence or disease-treatment approval.","source_type":"Regulatory / agency reference","evidence_level":"Device specification","claim_type":"Specification field","medical_disclaimer_required":"No","commercial_relevance":"Supports careful product positioning and documentation checks.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"Useful for future compliance audits.","source_name":"FDA 510(k) Summary: Quasar Blue Light Therapy System","source_url":"https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf","citation_note":"Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."}
|
| 16 |
+
{"record_id":"BLUE-016","topic":"Commercial claim separation","reference_type":"Commercial separation","plain_language_meaning":"Educational copy should separate blue light terminology, cosmetic positioning, device specifications, safety warnings, and medical claims.","safety_note":"Avoid disease claims, guaranteed skin outcomes, unsupported before-and-after promises, and broad claims that all blue light devices work the same way.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Commercial separation","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Keeps Holistix open-data assets citation-worthy and lower-risk.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"Protect the asset.","source_name":"FDA 510(k) Summary: Quasar Blue Light Therapy System","source_url":"https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf","citation_note":"Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."}
|
| 17 |
+
{"record_id":"BLUE-017","topic":"Maintenance and review","reference_type":"Dataset maintenance","plain_language_meaning":"Blue light therapy and screen-exposure language should be reviewed periodically because device designs, evidence, regulations, and market claims can change.","safety_note":"Rows should be updated when stronger safety guidance, regulatory information, or better product-specification standards become available.","source_type":"Open data maintenance context","evidence_level":"Research context","claim_type":"Dataset maintenance","medical_disclaimer_required":"No","commercial_relevance":"Supports future version history and dataset audits.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/blue-light-therapy-reference-index","related_product_category":"Blue light wellness devices","notes":"Use for future v1.2 or later updates.","source_name":"FDA 510(k) Summary: Quasar Blue Light Therapy System","source_url":"https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf","citation_note":"Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."}
|
data/jsonl/v1.2/hydrogen-water-reference-index-v1.2.jsonl
ADDED
|
@@ -0,0 +1,10 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{"record_id":"HOL-H2-REF-0001","topic":"Molecular hydrogen","reference_type":"Basic terminology","plain_language_meaning":"Molecular hydrogen, written as H2, is a dissolved gas that may be present in hydrogen water. Hydrogen water should be described by measurable hydrogen concentration rather than vague wellness claims.","safety_note":"Do not treat hydrogen water terminology as medical advice or disease guidance.","source_type":"Educational terminology / chemistry context","evidence_level":"Basic terminology","claim_type":"Definition","medical_disclaimer_required":"No","commercial_relevance":"Hydrogen water bottles / hydrogen water devices / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/hydrogen-water-reference-index","related_product_category":"Hydrogen water devices","notes":"This row defines the term H2 without making health claims.","source_name":"Hydrogen Water: Extra Healthy or a Hoax? A Systematic Review","source_url":"https://www.mdpi.com/1422-0067/25/2/973","citation_note":"Use as broad review support for defining hydrogen water as regular water with added molecular hydrogen gas. Do not use as a disease-treatment claim."}
|
| 2 |
+
{"record_id":"HOL-H2-REF-0002","topic":"Dissolved hydrogen concentration","reference_type":"Measurement concept","plain_language_meaning":"Dissolved hydrogen concentration describes how much molecular hydrogen is present in water, commonly reported in parts per billion or parts per million.","safety_note":"Hydrogen concentration can change over time after production, especially with storage, heat, agitation, or an unsealed container.","source_type":"Educational terminology / measurement context","evidence_level":"Basic terminology / device specification","claim_type":"Measurement concept","medical_disclaimer_required":"No","commercial_relevance":"Hydrogen water bottles / hydrogen water devices / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/hydrogen-water-reference-index","related_product_category":"Hydrogen water devices","notes":"Concentration values should include measurement context when possible.","source_name":"Calculating The Dose Of H2 - Molecular Hydrogen Institute","source_url":"https://molecularhydrogeninstitute.org/calculating-the-dose-of-h2/","citation_note":"Use for dissolved hydrogen concentration terminology, including ppm and mg/L measurement context. Keep as measurement education, not dosing guidance."}
|
| 3 |
+
{"record_id":"HOL-H2-REF-0003","topic":"PPB and PPM","reference_type":"Measurement units","plain_language_meaning":"PPB means parts per billion and PPM means parts per million. These units are often used to describe dissolved hydrogen concentration in water.","safety_note":"PPB and PPM should not be confused with ORP or unrelated water-quality claims.","source_type":"Educational terminology / measurement-unit context","evidence_level":"Basic terminology","claim_type":"Measurement concept","medical_disclaimer_required":"No","commercial_relevance":"Hydrogen water bottles / hydrogen water devices / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/hydrogen-water-reference-index","related_product_category":"Hydrogen water devices","notes":"1 ppm equals 1000 ppb.","source_name":"Calculating The Dose Of H2 - Molecular Hydrogen Institute","source_url":"https://molecularhydrogeninstitute.org/calculating-the-dose-of-h2/","citation_note":"Use for ppm, ppb, and mg/L unit relationships, including the practical conversion that 1 ppm equals 1000 ppb."}
|
| 4 |
+
{"record_id":"HOL-H2-REF-0004","topic":"ORP","reference_type":"Measurement caution","plain_language_meaning":"ORP means oxidation-reduction potential. It is sometimes used in marketing, but ORP is not the same thing as dissolved molecular hydrogen concentration.","safety_note":"Do not use ORP alone as proof of hydrogen concentration, product quality, or health benefit.","source_type":"Consumer comparison context / buyer education","evidence_level":"Buyer education / measurement caution","claim_type":"Buyer education","medical_disclaimer_required":"No","commercial_relevance":"Hydrogen water bottles / hydrogen water devices / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/hydrogen-water-reference-index","related_product_category":"Hydrogen water devices","notes":"ORP can be affected by multiple factors and should not replace H2 concentration measurement.","source_name":"ORP should not be used to estimate or compare concentrations of aqueous H2","source_url":"https://www.frontiersin.org/journals/food-science-and-technology/articles/10.3389/frfst.2022.1007001/full","citation_note":"Use for the caution that ORP should not be used alone to estimate or compare dissolved molecular hydrogen concentration."}
|
| 5 |
+
{"record_id":"HOL-H2-REF-0005","topic":"Electrolysis","reference_type":"Device mechanism","plain_language_meaning":"Many hydrogen water bottles generate hydrogen through electrolysis, where electrical current is used to separate water molecules and generate hydrogen gas.","safety_note":"Consumers should follow manufacturer instructions, cleaning guidance, and water-type recommendations.","source_type":"Device specification / manufacturer-instruction context","evidence_level":"Device specification","claim_type":"Usage context","medical_disclaimer_required":"No","commercial_relevance":"Hydrogen water bottles / hydrogen water devices / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/hydrogen-water-reference-index","related_product_category":"Hydrogen water devices","notes":"This row describes a device mechanism, not a medical effect.","source_name":"Electrolytic hydrogen-generating bottle supplies drinking water with hydrogen molecules","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8130662/","citation_note":"Use as device-mechanism context for electrolysis-based hydrogen-generating bottles and measurement of dissolved hydrogen. Do not use as a product-performance claim."}
|
| 6 |
+
{"record_id":"HOL-H2-REF-0006","topic":"Hydrogen retention","reference_type":"Storage context","plain_language_meaning":"Hydrogen gas can escape from water over time, especially in open containers. Retention may depend on container design, pressure, seal quality, time, and temperature.","safety_note":"Drink timing and storage should follow manufacturer instructions and should not be treated as medical guidance.","source_type":"Educational terminology / storage context","evidence_level":"Buyer education / device specification","claim_type":"Usage context","medical_disclaimer_required":"No","commercial_relevance":"Hydrogen water bottles / hydrogen water devices / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/hydrogen-water-reference-index","related_product_category":"Hydrogen water devices","notes":"Hydrogen retention is a practical consumer-context topic.","source_name":"Hydrogen Water: Extra Healthy or a Hoax? A Systematic Review","source_url":"https://www.mdpi.com/1422-0067/25/2/973","citation_note":"Use for general hydrogen-water context including hydrogen gas dissolved in water and the practical issue that dissolved hydrogen may persist only for a limited time depending on conditions."}
|
| 7 |
+
{"record_id":"HOL-H2-REF-0007","topic":"Testing strips and meters","reference_type":"Measurement caution","plain_language_meaning":"Some consumers use test drops, strips, or meters to estimate dissolved hydrogen, but testing methods vary in accuracy and interpretation.","safety_note":"Testing results should be interpreted carefully and compared only when methods are similar.","source_type":"Consumer comparison context / measurement caution","evidence_level":"Buyer education / measurement caution","claim_type":"Device comparison","medical_disclaimer_required":"No","commercial_relevance":"Hydrogen water bottles / hydrogen water devices / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/hydrogen-water-reference-index","related_product_category":"Hydrogen water devices","notes":"Testing method transparency is important for comparison.","source_name":"Understanding Hydrogen Water Testing Methods - Molecular Hydrogen Institute","source_url":"https://molecularhydrogeninstitute.org/understanding-hydrogen-water-testing-methods/","citation_note":"Use for consumer testing-method context, including reagent methods, meters, and the need to interpret hydrogen-water tests carefully."}
|
| 8 |
+
{"record_id":"HOL-H2-REF-0008","topic":"Device transparency","reference_type":"Buyer caution","plain_language_meaning":"Useful hydrogen water device documentation should disclose measurable hydrogen concentration, generation method, container design, cleaning guidance, and usage instructions.","safety_note":"Be cautious of vague claims that do not disclose concentration, testing method, or device specifications.","source_type":"Consumer comparison context / buyer education","evidence_level":"Buyer education / device specification","claim_type":"Device comparison","medical_disclaimer_required":"No","commercial_relevance":"Hydrogen water bottles / hydrogen water devices / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/hydrogen-water-reference-index","related_product_category":"Hydrogen water devices","notes":"This row supports transparent comparison without making medical claims.","source_name":"Understanding Hydrogen Water Testing Methods - Molecular Hydrogen Institute","source_url":"https://molecularhydrogeninstitute.org/understanding-hydrogen-water-testing-methods/","citation_note":"Use to support transparency around testing method, concentration reporting, and measurement limitations when comparing hydrogen-water devices."}
|
| 9 |
+
{"record_id":"HOL-H2-REF-0009","topic":"Health claims","reference_type":"Claim boundary","plain_language_meaning":"Hydrogen water products are often discussed in wellness contexts, but educational references should avoid disease, treatment, cure, prevention, or guaranteed-result claims.","safety_note":"Hydrogen water should not be presented as a treatment, cure, prevention tool, or substitute for medical care.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Consumer safety caution / commercial separation","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Hydrogen water bottles / hydrogen water devices / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/hydrogen-water-reference-index","related_product_category":"Hydrogen water devices","notes":"This row helps separate educational terminology from medical or disease claims.","source_name":"Hydrogen Water: Extra Healthy or a Hoax? A Systematic Review","source_url":"https://www.mdpi.com/1422-0067/25/2/973","citation_note":"Use as broad research-context support while keeping Holistix language conservative and avoiding disease, treatment, cure, prevention, or guaranteed-result claims."}
|
| 10 |
+
{"record_id":"HOL-H2-REF-0010","topic":"Cleaning and maintenance","reference_type":"Use context","plain_language_meaning":"Hydrogen water devices may require cleaning, drying, filter replacement, or maintenance depending on device design and manufacturer instructions.","safety_note":"Follow manufacturer cleaning instructions and avoid using damaged, dirty, or malfunctioning devices.","source_type":"Manufacturer instruction / consumer safety context","evidence_level":"Consumer safety caution / device specification","claim_type":"Usage context","medical_disclaimer_required":"Yes","commercial_relevance":"Hydrogen water bottles / hydrogen water devices / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/hydrogen-water-reference-index","related_product_category":"Hydrogen water devices","notes":"Cleaning and maintenance are practical safety and device-longevity topics.","source_name":"Electrolytic hydrogen-generating bottle supplies drinking water with hydrogen molecules","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8130662/","citation_note":"Use as electrolysis-device safety context, especially because the study measured byproducts such as chlorine and ozone. Keep cleaning and maintenance guidance tied to manufacturer instructions."}
|
data/jsonl/v1.2/infrared-therapy-reference-index-v1.2.jsonl
ADDED
|
@@ -0,0 +1,10 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{"record_id":"HOL-IR-REF-0001","topic":"Infrared therapy","reference_type":"Basic terminology","plain_language_meaning":"Infrared therapy is a broad term that can refer to devices using infrared light or infrared heat. It should be separated into near-infrared light exposure, far-infrared heat exposure, infrared sauna context, and infrared lamp context.","safety_note":"Do not treat infrared terminology as medical advice, treatment guidance, or disease-prevention guidance.","source_type":"Educational terminology / device-category context","evidence_level":"Basic terminology","claim_type":"Definition","medical_disclaimer_required":"No","commercial_relevance":"Infrared sauna blankets / infrared wellness devices / consumer wellness technology","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/infrared-therapy-reference-index","related_product_category":"Infrared therapy devices","notes":"This row defines the category without claiming health outcomes.","source_name":"Clinical Effects of Regular Dry Sauna Bathing: A Systematic Review","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5941775/","citation_note":"Use as heat/sauna exposure context for infrared sauna education and safety framing. Do not convert into medical recommendations."}
|
| 2 |
+
{"record_id":"HOL-IR-REF-0002","topic":"Near-infrared","reference_type":"Wavelength category","plain_language_meaning":"Near-infrared usually refers to infrared wavelengths close to visible red light. In wellness technology, near-infrared is often discussed alongside red light and photobiomodulation terminology.","safety_note":"Near-infrared should not be confused with far-infrared heat exposure or sauna heat exposure.","source_type":"Educational terminology / wavelength context","evidence_level":"Basic terminology / device specification","claim_type":"Definition","medical_disclaimer_required":"No","commercial_relevance":"Infrared sauna blankets / red light devices / infrared wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/infrared-therapy-reference-index","related_product_category":"Infrared therapy devices","notes":"Near-infrared belongs in a separate interpretation bucket from far-infrared sauna heat.","source_name":"Clinical Effects of Regular Dry Sauna Bathing: A Systematic Review","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5941775/","citation_note":"Use as heat/sauna exposure context for infrared sauna education and safety framing. Do not convert into medical recommendations."}
|
| 3 |
+
{"record_id":"HOL-IR-REF-0003","topic":"Far-infrared","reference_type":"Wavelength category","plain_language_meaning":"Far-infrared is commonly discussed in the context of infrared saunas, sauna blankets, heating panels, and thermal wellness devices.","safety_note":"Far-infrared product interpretation should focus on heat exposure, device temperature, user tolerance, and safe operation rather than vague medical claims.","source_type":"Educational terminology / heat-exposure context","evidence_level":"Basic terminology / device specification","claim_type":"Definition","medical_disclaimer_required":"No","commercial_relevance":"Infrared sauna blankets / far-infrared wellness devices / consumer wellness technology","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/infrared-therapy-reference-index","related_product_category":"Infrared therapy devices","notes":"Far-infrared is commonly tied to heat-based wellness devices.","source_name":"Clinical Effects of Regular Dry Sauna Bathing: A Systematic Review","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5941775/","citation_note":"Use as heat/sauna exposure context for infrared sauna education and safety framing. Do not convert into medical recommendations."}
|
| 4 |
+
{"record_id":"HOL-IR-REF-0004","topic":"Infrared sauna blanket","reference_type":"Device context","plain_language_meaning":"An infrared sauna blanket is a consumer wellness device that uses heat and infrared-emitting elements in a blanket-style format.","safety_note":"Users should follow manufacturer instructions, avoid overheating, stay attentive to comfort, and stop use if they feel unwell.","source_type":"Manufacturer instruction / consumer safety context","evidence_level":"Consumer safety caution / device specification","claim_type":"Usage context","medical_disclaimer_required":"Yes","commercial_relevance":"Infrared sauna blankets / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/infrared-therapy-reference-index","related_product_category":"Infrared therapy devices","notes":"This row supports safe device interpretation without creating a protocol.","source_name":"Clinical Effects of Regular Dry Sauna Bathing: A Systematic Review","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5941775/","citation_note":"Use as heat/sauna exposure context for infrared sauna education and safety framing. Do not convert into medical recommendations."}
|
| 5 |
+
{"record_id":"HOL-IR-REF-0005","topic":"Temperature and heat exposure","reference_type":"Safety context","plain_language_meaning":"Infrared heat devices should be interpreted partly by temperature range, exposure duration, user tolerance, and device design.","safety_note":"Heat exposure can be inappropriate for some users. People with medical conditions, heat sensitivity, cardiovascular concerns, pregnancy, or implanted devices should consult a qualified professional before use.","source_type":"Safety guidance / heat-exposure context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"Infrared sauna blankets / infrared wellness devices / consumer wellness technology","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/infrared-therapy-reference-index","related_product_category":"Infrared therapy devices","notes":"This row intentionally avoids dose or treatment guidance.","source_name":"Clinical Effects of Regular Dry Sauna Bathing: A Systematic Review","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5941775/","citation_note":"Use as heat/sauna exposure context for infrared sauna education and safety framing. Do not convert into medical recommendations."}
|
| 6 |
+
{"record_id":"HOL-IR-REF-0006","topic":"Hydration and overheating caution","reference_type":"Safety context","plain_language_meaning":"Infrared sauna and heat devices can increase sweating and perceived body heat. Hydration, temperature awareness, and stopping when uncomfortable are practical safety considerations.","safety_note":"Stop use if dizziness, nausea, faintness, chest discomfort, shortness of breath, confusion, unusual weakness, or concerning symptoms occur. Seek medical help when appropriate.","source_type":"Safety guidance / consumer wellness context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"Infrared sauna blankets / infrared wellness devices / consumer wellness technology","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/infrared-therapy-reference-index","related_product_category":"Infrared therapy devices","notes":"This row is a safety boundary, not a medical protocol.","source_name":"Clinical Effects of Regular Dry Sauna Bathing: A Systematic Review","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5941775/","citation_note":"Use as heat/sauna exposure context for infrared sauna education and safety framing. Do not convert into medical recommendations."}
|
| 7 |
+
{"record_id":"HOL-IR-REF-0007","topic":"Photobiomodulation distinction","reference_type":"Interpretation caution","plain_language_meaning":"Near-infrared light discussions may overlap with red light and photobiomodulation terminology, while far-infrared sauna devices are usually interpreted through heat exposure and thermal context.","safety_note":"Do not blend near-infrared light claims with far-infrared sauna heat claims as if they are the same mechanism.","source_type":"Consumer comparison context / terminology separation","evidence_level":"Buyer education / mechanism distinction","claim_type":"Buyer education","medical_disclaimer_required":"No","commercial_relevance":"Red light devices / near-infrared devices / infrared sauna blankets","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/infrared-therapy-reference-index","related_product_category":"Infrared therapy devices","notes":"This row helps separate light-based and heat-based categories.","source_name":"Clinical Effects of Regular Dry Sauna Bathing: A Systematic Review","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5941775/","citation_note":"Use as heat/sauna exposure context for infrared sauna education and safety framing. Do not convert into medical recommendations."}
|
| 8 |
+
{"record_id":"HOL-IR-REF-0008","topic":"Device specification transparency","reference_type":"Buyer caution","plain_language_meaning":"Useful infrared device documentation should disclose device type, infrared category, heat source, temperature range, materials, timers, safety shutoff features, cleaning guidance, and usage instructions.","safety_note":"Be cautious with vague infrared claims that do not disclose device design, temperature range, wavelength category, or safety guidance.","source_type":"Consumer comparison context / buyer education","evidence_level":"Buyer education / device specification","claim_type":"Device comparison","medical_disclaimer_required":"No","commercial_relevance":"Infrared sauna blankets / infrared wellness devices / consumer wellness technology","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/infrared-therapy-reference-index","related_product_category":"Infrared therapy devices","notes":"This row supports transparent product comparison.","source_name":"Clinical Effects of Regular Dry Sauna Bathing: A Systematic Review","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5941775/","citation_note":"Use as heat/sauna exposure context for infrared sauna education and safety framing. Do not convert into medical recommendations."}
|
| 9 |
+
{"record_id":"HOL-IR-REF-0009","topic":"Contraindication caution","reference_type":"Safety context","plain_language_meaning":"Some users may need extra caution with infrared heat devices, including people with heat intolerance, impaired sensation, cardiovascular concerns, pregnancy, acute illness, dehydration risk, or certain implanted or electronic devices.","safety_note":"People with medical concerns should consult a qualified healthcare professional before using infrared heat devices.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"Infrared sauna blankets / infrared wellness devices / consumer wellness technology","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/infrared-therapy-reference-index","related_product_category":"Infrared therapy devices","notes":"This row keeps contraindication language broad and non-diagnostic.","source_name":"Clinical Effects of Regular Dry Sauna Bathing: A Systematic Review","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5941775/","citation_note":"Use as heat/sauna exposure context for infrared sauna education and safety framing. Do not convert into medical recommendations."}
|
| 10 |
+
{"record_id":"HOL-IR-REF-0010","topic":"Medical claims","reference_type":"Claim boundary","plain_language_meaning":"Infrared therapy products are often discussed in wellness contexts, but educational references should avoid disease-treatment, cure, prevention, or guaranteed-result claims.","safety_note":"Infrared devices should not be presented as a treatment, cure, prevention tool, or substitute for medical care.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Consumer safety caution / commercial separation","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Infrared sauna blankets / infrared wellness devices / consumer wellness technology","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/infrared-therapy-reference-index","related_product_category":"Infrared therapy devices","notes":"This row separates educational device context from medical or disease claims.","source_name":"Clinical Effects of Regular Dry Sauna Bathing: A Systematic Review","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5941775/","citation_note":"Use as heat/sauna exposure context for infrared sauna education and safety framing. Do not convert into medical recommendations."}
|
data/jsonl/v1.2/negative-ion-safety-index-v1.2.jsonl
ADDED
|
@@ -0,0 +1,18 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{"record_id":"NION-001","topic":"Negative ions","reference_type":"Definition","plain_language_meaning":"Negative ions are electrically charged particles that have gained an electron and are often discussed in air-quality, nature, waterfall, and ionizer contexts.","safety_note":"The presence of negative ions should not be treated as proof of a medical benefit.","source_type":"Educational terminology / device-category context","evidence_level":"Basic terminology","claim_type":"Definition","medical_disclaimer_required":"No","commercial_relevance":"Helps explain the basic term used in negative ion and air-ionizer product language.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"Use as the neutral opening definition.","source_name":"EPA: Ozone Generators that are Sold as Air Cleaners","source_url":"https://www.epa.gov/indoor-air-quality-iaq/ozone-generators-are-sold-air-cleaners","citation_note":"Use for ozone/ionizer safety context. EPA notes that some ozone generators are manufactured with ion generators or ionizers, and that ozone in breathing air can harm the respiratory system."}
|
| 2 |
+
{"record_id":"NION-002","topic":"Negative ion generators","reference_type":"Device category","plain_language_meaning":"Negative ion generators are devices designed to release negatively charged particles into the surrounding air.","safety_note":"Device design, output, ozone generation, room size, ventilation, and safety testing can vary significantly.","source_type":"Consumer comparison context / buyer education","evidence_level":"Buyer education / device specification","claim_type":"Device comparison","medical_disclaimer_required":"Yes","commercial_relevance":"Helps users compare ionizer-style products without assuming all devices are equivalent.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"Separate device category from health-outcome claims.","source_name":"EPA: Ozone Generators that are Sold as Air Cleaners","source_url":"https://www.epa.gov/indoor-air-quality-iaq/ozone-generators-are-sold-air-cleaners","citation_note":"Use for ozone/ionizer safety context. EPA notes that some ozone generators are manufactured with ion generators or ionizers, and that ozone in breathing air can harm the respiratory system."}
|
| 3 |
+
{"record_id":"NION-003","topic":"Air ionizers","reference_type":"Device category","plain_language_meaning":"Air ionizers are consumer or commercial devices that use electrical charge to affect airborne particles or air composition.","safety_note":"Ionizer language should be separated from air purifier claims, medical claims, and ozone-related safety concerns.","source_type":"Consumer comparison context / buyer education","evidence_level":"Buyer education / device specification","claim_type":"Device comparison","medical_disclaimer_required":"Yes","commercial_relevance":"Useful for comparing negative ion devices, air purifiers, and wellness pendants.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"Important for avoiding category confusion.","source_name":"NRC: Negative Ion Products Containing Radioactive Material","source_url":"https://www.nrc.gov/reading-rm/doc-collections/fact-sheets/negative-ion-products","citation_note":"Use for consumer-product safety context around negative-ion pendants, bracelets, and similar products that may contain radioactive material. Do not use as a wellness-benefit source."}
|
| 4 |
+
{"record_id":"NION-004","topic":"Ozone generation","reference_type":"Safety caution","plain_language_meaning":"Some ionization technologies may generate ozone as a byproduct depending on design and operating conditions.","safety_note":"Ozone can irritate the lungs and should not be treated as a wellness feature. Users should avoid devices that produce unsafe ozone levels.","source_type":"Regulatory / agency reference","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"Important safety distinction for negative ion and ionizer-related product education.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"This is the core safety row.","source_name":"EPA: Ozone Generators that are Sold as Air Cleaners","source_url":"https://www.epa.gov/indoor-air-quality-iaq/ozone-generators-are-sold-air-cleaners","citation_note":"Use for ozone/ionizer safety context. EPA notes that some ozone generators are manufactured with ion generators or ionizers, and that ozone in breathing air can harm the respiratory system."}
|
| 5 |
+
{"record_id":"NION-005","topic":"Ozone-free claims","reference_type":"Specification field","plain_language_meaning":"Some devices may claim to be ozone-free or low-ozone, but users should look for documentation, testing, or safety certifications rather than relying only on marketing language.","safety_note":"Ozone-free language should be verified when possible, especially for indoor use.","source_type":"Device specification / manufacturer-instruction context","evidence_level":"Device specification","claim_type":"Specification field","medical_disclaimer_required":"No","commercial_relevance":"Useful for buyer education and product-page transparency.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"Encourage proof, not vibes.","source_name":"EPA: Ozone Generators that are Sold as Air Cleaners","source_url":"https://www.epa.gov/indoor-air-quality-iaq/ozone-generators-are-sold-air-cleaners","citation_note":"Use for ozone/ionizer safety context. EPA notes that some ozone generators are manufactured with ion generators or ionizers, and that ozone in breathing air can harm the respiratory system."}
|
| 6 |
+
{"record_id":"NION-006","topic":"Indoor air quality claims","reference_type":"Claim boundary","plain_language_meaning":"Negative ion devices are sometimes marketed with broad indoor-air-quality claims, but performance depends on technology, environment, ventilation, particle type, and testing conditions.","safety_note":"Avoid claiming that negative ions diagnose, treat, cure, or prevent respiratory disease or any medical condition.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Commercial separation","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Protects Holistix copy from overstating air-quality or respiratory claims.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"Keep indoor-air language cautious.","source_name":"EPA: What are ionizers and other ozone generating air cleaners?","source_url":"https://www.epa.gov/indoor-air-quality-iaq/what-are-ionizers-and-other-ozone-generating-air-cleaners","citation_note":"Use for plain-language context that ion generators charge room particles, which may settle on surfaces and later be resuspended."}
|
| 7 |
+
{"record_id":"NION-007","topic":"Respiratory sensitivity","reference_type":"Safety context","plain_language_meaning":"People with asthma, COPD, chemical sensitivity, or respiratory irritation concerns may need extra caution around air-ionizing devices, especially if ozone is possible.","safety_note":"Anyone with respiratory conditions or unexplained irritation should consult a qualified healthcare professional and avoid questionable ozone-generating devices.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"Supports conservative consumer safety guidance.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"No medical instructions or disease claims.","source_name":"EPA: Ozone Generators that are Sold as Air Cleaners","source_url":"https://www.epa.gov/indoor-air-quality-iaq/ozone-generators-are-sold-air-cleaners","citation_note":"Use for ozone/ionizer safety context. EPA notes that some ozone generators are manufactured with ion generators or ionizers, and that ozone in breathing air can harm the respiratory system."}
|
| 8 |
+
{"record_id":"NION-008","topic":"Negative ion pendants","reference_type":"Device category","plain_language_meaning":"Negative ion pendants are wearable products marketed as emitting or containing negative-ion-related materials or effects.","safety_note":"Users should be cautious with wearable products that make broad wellness claims or do not clearly disclose materials and safety testing.","source_type":"Consumer comparison context / buyer education","evidence_level":"Buyer education / device specification","claim_type":"Device comparison","medical_disclaimer_required":"Yes","commercial_relevance":"Relevant to wearable negative ion products and consumer education.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"Useful for pendant-category context.","source_name":"NRC: Negative Ion Products Containing Radioactive Material","source_url":"https://www.nrc.gov/reading-rm/doc-collections/fact-sheets/negative-ion-products","citation_note":"Use for consumer-product safety context around negative-ion pendants, bracelets, and similar products that may contain radioactive material. Do not use as a wellness-benefit source."}
|
| 9 |
+
{"record_id":"NION-009","topic":"Radioactive material concerns","reference_type":"Safety caution","plain_language_meaning":"Some historic or controversial negative ion wearable products have raised concerns about radioactive materials in certain markets or testing reports.","safety_note":"Wearable devices should not contain unsafe radioactive materials. Users should look for credible safety documentation when products make material-based ion claims.","source_type":"Regulatory / agency reference","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"Important safety distinction for wearable negative ion devices.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"Keep factual and cautious without accusing any specific brand.","source_name":"NRC: Negative Ion Products Containing Radioactive Material","source_url":"https://www.nrc.gov/reading-rm/doc-collections/fact-sheets/negative-ion-products","citation_note":"Use for consumer-product safety context around negative-ion pendants, bracelets, and similar products that may contain radioactive material. Do not use as a wellness-benefit source."}
|
| 10 |
+
{"record_id":"NION-010","topic":"Particle charging vs removal","reference_type":"Measurement concept","plain_language_meaning":"Ionizers may charge particles, but particle charging is not the same as complete removal from indoor air.","safety_note":"Do not assume charged particles are safely removed unless the device design, collection method, and test data support that claim.","source_type":"Scientific review","evidence_level":"Measurement caution","claim_type":"Measurement concept","medical_disclaimer_required":"No","commercial_relevance":"Helps users understand why ionization language can be misleading in simple marketing copy.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"Good row for AI-readable distinction.","source_name":"EPA: Ozone Generators that are Sold as Air Cleaners","source_url":"https://www.epa.gov/indoor-air-quality-iaq/ozone-generators-are-sold-air-cleaners","citation_note":"Use for ozone/ionizer safety context. EPA notes that some ozone generators are manufactured with ion generators or ionizers, and that ozone in breathing air can harm the respiratory system."}
|
| 11 |
+
{"record_id":"NION-011","topic":"Surface deposition","reference_type":"Safety context","plain_language_meaning":"Charged particles may attach to surfaces, nearby objects, walls, or collection plates depending on device design and environment.","safety_note":"Surface deposition is not the same as medical protection, respiratory treatment, or guaranteed air cleaning.","source_type":"Scientific review","evidence_level":"Research context","claim_type":"Usage context","medical_disclaimer_required":"Yes","commercial_relevance":"Supports careful indoor-air explanation without disease claims.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"Avoid overclaiming air purification.","source_name":"EPA: What are ionizers and other ozone generating air cleaners?","source_url":"https://www.epa.gov/indoor-air-quality-iaq/what-are-ionizers-and-other-ozone-generating-air-cleaners","citation_note":"Use for plain-language context that ion generators charge room particles, which may settle on surfaces and later be resuspended."}
|
| 12 |
+
{"record_id":"NION-012","topic":"Mood and wellness claims","reference_type":"Claim boundary","plain_language_meaning":"Negative ions are sometimes associated in consumer wellness content with mood, freshness, nature exposure, or subjective air-quality experience.","safety_note":"Subjective wellness language should not become a claim that negative ion devices treat anxiety, depression, fatigue, or any medical condition.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Commercial separation","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Useful for keeping wellness copy soft, educational, and compliant.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"No mental-health treatment claims.","source_name":"FDA: CPG Sec. 355.300 Ion Generating Devices","source_url":"https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cpg-sec-355300-ion-generating-devices","citation_note":"Use for regulatory claim-boundary context: ion-generating devices promoted for medical use or unsupported medical claims may be subject to FDA requirements."}
|
| 13 |
+
{"record_id":"NION-013","topic":"Nature analogy claims","reference_type":"Buyer education","plain_language_meaning":"Marketing often compares negative ion devices to waterfalls, forests, rain, or ocean air.","safety_note":"Nature analogies are not proof that a consumer device creates the same exposure profile, safety profile, or benefit as outdoor environments.","source_type":"Consumer comparison context / buyer education","evidence_level":"Buyer education / device specification","claim_type":"Buyer education","medical_disclaimer_required":"No","commercial_relevance":"Helps users understand where poetic marketing can outrun proof.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"Good consumer-education row.","source_name":"FDA: CPG Sec. 355.300 Ion Generating Devices","source_url":"https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cpg-sec-355300-ion-generating-devices","citation_note":"Use for regulatory claim-boundary context: ion-generating devices promoted for medical use or unsupported medical claims may be subject to FDA requirements."}
|
| 14 |
+
{"record_id":"NION-014","topic":"Manufacturer instructions","reference_type":"Usage context","plain_language_meaning":"Users should follow manufacturer instructions for placement, operating time, cleaning, ventilation, and safe indoor use.","safety_note":"This dataset does not provide exposure protocols or medical-use instructions.","source_type":"Manufacturer instruction / consumer safety context","evidence_level":"Consumer safety caution","claim_type":"Usage context","medical_disclaimer_required":"Yes","commercial_relevance":"Prevents the dataset from becoming a use-protocol page.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"No dosage-style guidance.","source_name":"Washington State Department of Health: Radioactive Consumer Products","source_url":"https://doh.wa.gov/community-and-environment/radiation/radiation-topics/radioactive-consumer-products","citation_note":"Use as additional public-health context for consumer products containing radioactive materials, including negative-ion-related products."}
|
| 15 |
+
{"record_id":"NION-015","topic":"Children pets and enclosed spaces","reference_type":"Safety context","plain_language_meaning":"Children, pets, and people in small or poorly ventilated rooms may be more sensitive to poor air quality or ozone-generating devices.","safety_note":"Use extra caution with ionizers in enclosed spaces and avoid devices with unclear ozone safety data.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"Important for household buyer education.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"Keep practical and safety-first.","source_name":"EPA: Ozone Generators that are Sold as Air Cleaners","source_url":"https://www.epa.gov/indoor-air-quality-iaq/ozone-generators-are-sold-air-cleaners","citation_note":"Use for ozone/ionizer safety context. EPA notes that some ozone generators are manufactured with ion generators or ionizers, and that ozone in breathing air can harm the respiratory system."}
|
| 16 |
+
{"record_id":"NION-016","topic":"Regulatory and certification checks","reference_type":"Regulatory context","plain_language_meaning":"Consumers can look for credible safety testing, ozone-emission data, regulatory compliance statements, and clear product documentation.","safety_note":"Regulatory language should not be used as a substitute for medical evidence or disease-treatment approval.","source_type":"Regulatory / agency reference","evidence_level":"Device specification","claim_type":"Specification field","medical_disclaimer_required":"No","commercial_relevance":"Supports trust and transparency on product pages and comparison pages.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"Good audit row.","source_name":"EPA: Ozone Generators that are Sold as Air Cleaners","source_url":"https://www.epa.gov/indoor-air-quality-iaq/ozone-generators-are-sold-air-cleaners","citation_note":"Use for ozone/ionizer safety context. EPA notes that some ozone generators are manufactured with ion generators or ionizers, and that ozone in breathing air can harm the respiratory system."}
|
| 17 |
+
{"record_id":"NION-017","topic":"Commercial claim separation","reference_type":"Commercial separation","plain_language_meaning":"Educational copy should separate negative ion terminology, device specifications, air-quality claims, and wellness claims.","safety_note":"Avoid borrowed authority, vague miracle claims, respiratory disease claims, and unsupported before-and-after promises.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Commercial separation","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Keeps Holistix data assets citation-worthy and lower-risk.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"Protect the asset.","source_name":"FDA: CPG Sec. 355.300 Ion Generating Devices","source_url":"https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cpg-sec-355300-ion-generating-devices","citation_note":"Use for regulatory claim-boundary context: ion-generating devices promoted for medical use or unsupported medical claims may be subject to FDA requirements."}
|
| 18 |
+
{"record_id":"NION-018","topic":"Maintenance and review","reference_type":"Dataset maintenance","plain_language_meaning":"Negative ion and ionizer safety language should be reviewed periodically because device designs, ozone standards, testing practices, and market claims can change.","safety_note":"Rows should be updated when stronger safety guidance, regulatory information, or better product-specification standards become available.","source_type":"Open data maintenance context","evidence_level":"Research context","claim_type":"Dataset maintenance","medical_disclaimer_required":"No","commercial_relevance":"Supports future version history and dataset audits.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/negative-ion-safety-index","related_product_category":"Negative ion wellness devices","notes":"Use for future v1.2 or later updates.","source_name":"EPA: Ozone Generators that are Sold as Air Cleaners","source_url":"https://www.epa.gov/indoor-air-quality-iaq/ozone-generators-are-sold-air-cleaners","citation_note":"Use for ozone/ionizer safety context. EPA notes that some ozone generators are manufactured with ion generators or ionizers, and that ozone in breathing air can harm the respiratory system."}
|
data/jsonl/v1.2/pemf-contraindications-database-v1.2.jsonl
ADDED
|
@@ -0,0 +1,12 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{"record_id":"HOL-PEMF-CONTRA-0001","contraindication_or_caution":"Pacemaker, implantable cardioverter-defibrillator, or implanted cardiac electronic device","risk_level":"High","recommendation":"Avoid PEMF use unless specifically cleared by a qualified clinician and the implanted device manufacturer.","plain_language_note":"PEMF devices generate electromagnetic fields that may interfere with implanted cardiac electronics.","source_type":"Safety guidance / implanted cardiac device context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"PEMF mats / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-contraindications-database","notes":"This row should not be interpreted as individualized medical advice.","source_name":"FDA - Magnets in Cell Phones and Smart Watches May Affect Pacemakers and Other Implanted Medical Devices","source_url":"https://www.fda.gov/radiation-emitting-products/cell-phones/magnets-cell-phones-and-smart-watches-may-affect-pacemakers-and-other-implanted-medical-devices","citation_note":"Use as authoritative safety context for the general principle that strong magnetic fields from consumer devices can affect some implanted cardiac devices. Supports implanted-device caution, not PEMF treatment claims."}
|
| 2 |
+
{"record_id":"HOL-PEMF-CONTRA-0002","contraindication_or_caution":"Implanted electronic medical device","risk_level":"High","recommendation":"Avoid PEMF use unless cleared by a qualified clinician and the device manufacturer.","plain_language_note":"This category may include neurostimulators, cochlear implants, implanted pumps, and other active electronic implants.","source_type":"Safety guidance / implanted electronic device context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"PEMF mats / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-contraindications-database","notes":"Includes active implanted electronics beyond cardiac devices.","source_name":"FDA - Electromagnetic Compatibility (EMC)","source_url":"https://www.fda.gov/radiation-emitting-products/radiation-safety/electromagnetic-compatibility-emc","citation_note":"Use as broad regulatory context for electromagnetic compatibility and medical-device interference complexity. Supports caution around active implanted electronics and device-manufacturer guidance."}
|
| 3 |
+
{"record_id":"HOL-PEMF-CONTRA-0003","contraindication_or_caution":"Pregnancy, possible pregnancy, or trying to become pregnant","risk_level":"High caution","recommendation":"Avoid PEMF use unless specifically cleared by a qualified healthcare professional.","plain_language_note":"Pregnancy is commonly treated as a precautionary category because safety data may be limited and device guidance varies.","source_type":"Safety guidance / precautionary use context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"PEMF mats / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-contraindications-database","notes":"Precautionary category; not a treatment recommendation.","source_name":"PEMF Safety Considerations for Home-Use Devices","source_url":"https://www.pemfadvisor.com/pemf-therapy/safety-considerations/","citation_note":"Use as consumer-safety context for manufacturer-style precautionary categories such as pregnancy. This is not clinical proof and should not be used to recommend PEMF use during pregnancy."}
|
| 4 |
+
{"record_id":"HOL-PEMF-CONTRA-0004","contraindication_or_caution":"Epilepsy or seizure history","risk_level":"Caution","recommendation":"Consult a qualified healthcare professional before using PEMF.","plain_language_note":"Different PEMF devices use different frequencies, intensities, and pulse patterns, so seizure-related caution is commonly advised.","source_type":"Safety guidance / medical-history context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"PEMF mats / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-contraindications-database","notes":"Device settings vary widely; professional guidance is appropriate.","source_name":"PEMF Safety Considerations for Home-Use Devices","source_url":"https://www.pemfadvisor.com/pemf-therapy/safety-considerations/","citation_note":"Use as consumer-safety context for seizure-history caution and device-variation warnings. Supports consult-a-professional language, not individualized medical advice."}
|
| 5 |
+
{"record_id":"HOL-PEMF-CONTRA-0005","contraindication_or_caution":"Insulin pump or implanted drug-delivery pump","risk_level":"High","recommendation":"Avoid PEMF use unless specifically cleared by a qualified clinician and the device manufacturer.","plain_language_note":"Implanted or wearable electronic pumps may be sensitive to electromagnetic interference.","source_type":"Safety guidance / electronic pump context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"PEMF mats / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-contraindications-database","notes":"Applies to implanted or wearable electronic pump systems.","source_name":"FDA - Electromagnetic Compatibility (EMC) of Medical Devices","source_url":"https://www.fda.gov/media/94758/download","citation_note":"Use as FDA medical-device EMC guidance context for device systems, accessories, controllers, and safe function in electromagnetic environments. Supports caution for pumps and electronic medical devices."}
|
| 6 |
+
{"record_id":"HOL-PEMF-CONTRA-0006","contraindication_or_caution":"Cochlear implant or implanted hearing device","risk_level":"High","recommendation":"Avoid PEMF use unless specifically cleared by a qualified clinician and the implant manufacturer.","plain_language_note":"Cochlear implants are active implanted electronic devices and may be affected by electromagnetic fields.","source_type":"Safety guidance / implanted hearing-device context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"PEMF mats / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-contraindications-database","notes":"Implant manufacturer guidance should be followed.","source_name":"FDA - Cochlear Implants and MRI Safety","source_url":"https://www.fda.gov/medical-devices/cochlear-implants/cochlear-implants-and-mri-safety","citation_note":"Use as authoritative context that implanted hearing devices can require special precautions in strong electromagnetic environments. Supports manufacturer-guidance caution, not PEMF-specific claims."}
|
| 7 |
+
{"record_id":"HOL-PEMF-CONTRA-0007","contraindication_or_caution":"Heart rhythm disorder or complex cardiac condition","risk_level":"Caution","recommendation":"Consult a qualified healthcare professional before using PEMF.","plain_language_note":"People with cardiac conditions should get individualized guidance, especially if they have implanted devices, arrhythmias, or recent cardiac events.","source_type":"Safety guidance / cardiac-condition context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"PEMF mats / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-contraindications-database","notes":"Cardiac history may require individualized review.","source_name":"FDA - Magnets in Cell Phones and Smart Watches May Affect Pacemakers and Other Implanted Medical Devices","source_url":"https://www.fda.gov/radiation-emitting-products/cell-phones/magnets-cell-phones-and-smart-watches-may-affect-pacemakers-and-other-implanted-medical-devices","citation_note":"Use as cardiac implanted-device safety context for electromagnetic and magnetic-field caution. Supports professional-guidance language for complex cardiac users."}
|
| 8 |
+
{"record_id":"HOL-PEMF-CONTRA-0008","contraindication_or_caution":"Active bleeding or bleeding disorder","risk_level":"Caution","recommendation":"Consult a qualified healthcare professional before using PEMF.","plain_language_note":"Some safety guides advise caution around active bleeding or bleeding disorders because PEMF is often discussed in relation to circulation and tissue response.","source_type":"Safety guidance / bleeding-risk context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"PEMF mats / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-contraindications-database","notes":"Conservative safety framing for bleeding-related concerns.","source_name":"PEMF Safety Considerations for Home-Use Devices","source_url":"https://www.pemfadvisor.com/pemf-therapy/safety-considerations/","citation_note":"Use as conservative consumer-safety context for bleeding-risk caution. Do not convert this row into treatment, circulation, or post-injury protocol guidance."}
|
| 9 |
+
{"record_id":"HOL-PEMF-CONTRA-0009","contraindication_or_caution":"Active cancer, recent cancer treatment, or oncology care","risk_level":"Medical supervision","recommendation":"Use only with guidance from a qualified oncology or healthcare professional.","plain_language_note":"People in cancer care should avoid unsupervised wellness-device use unless their care team clears it.","source_type":"Safety guidance / complex medical-condition context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"PEMF mats / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-contraindications-database","notes":"Avoid implying treatment, prevention, or oncology benefit.","source_name":"PEMF Safety Considerations for Home-Use Devices","source_url":"https://www.pemfadvisor.com/pemf-therapy/safety-considerations/","citation_note":"Use as consumer-safety context for complex medical-condition caution and oncology supervision language. Do not use as evidence for cancer-related benefits."}
|
| 10 |
+
{"record_id":"HOL-PEMF-CONTRA-0010","contraindication_or_caution":"Organ transplant or immune suppression therapy","risk_level":"Medical supervision","recommendation":"Use only with guidance from a qualified healthcare professional.","plain_language_note":"Some PEMF safety resources flag organ transplant and immune suppression as categories requiring medical supervision.","source_type":"Safety guidance / complex medical-condition context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"PEMF mats / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-contraindications-database","notes":"Medical complexity requires professional guidance.","source_name":"PEMF Safety Considerations for Home-Use Devices","source_url":"https://www.pemfadvisor.com/pemf-therapy/safety-considerations/","citation_note":"Use as consumer-safety context for complex medical-condition and immune-suppression caution. This supports professional-guidance language only."}
|
| 11 |
+
{"record_id":"HOL-PEMF-CONTRA-0011","contraindication_or_caution":"Recent surgery, acute injury, or unexplained pain","risk_level":"Caution","recommendation":"Consult a qualified healthcare professional before using PEMF on or near the affected area.","plain_language_note":"Recent procedures and acute injuries may require individualized care instructions.","source_type":"Safety guidance / recovery-status context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"PEMF mats / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-contraindications-database","notes":"Do not frame PEMF as post-surgical treatment guidance.","source_name":"PEMF Safety Considerations for Home-Use Devices","source_url":"https://www.pemfadvisor.com/pemf-therapy/safety-considerations/","citation_note":"Use as consumer-safety context for recent surgery, acute injury, and unexplained pain cautions. Do not use to create recovery or post-surgical protocols."}
|
| 12 |
+
{"record_id":"HOL-PEMF-CONTRA-0012","contraindication_or_caution":"Children or minors","risk_level":"Medical supervision","recommendation":"Use only under appropriate professional or caregiver guidance and according to device instructions.","plain_language_note":"Age-related guidance varies by device, and pediatric use should not be assumed safe without appropriate oversight.","source_type":"Safety guidance / age-specific use context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"PEMF mats / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-contraindications-database","notes":"Pediatric use should remain conservative and supervised.","source_name":"PEMF Safety Considerations for Home-Use Devices","source_url":"https://www.pemfadvisor.com/pemf-therapy/safety-considerations/","citation_note":"Use as conservative home-use safety context for children/minors and supervised-use language. Do not use as pediatric protocol support."}
|
data/jsonl/v1.2/pemf-frequency-index-v1.2.jsonl
ADDED
|
@@ -0,0 +1,21 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{"record_id":"PEMF-FREQ-001","topic":"PEMF frequency","reference_type":"Definition","plain_language_meaning":"PEMF frequency generally refers to how many electromagnetic pulses or cycles occur per second, measured in hertz.","safety_note":"Frequency should not be used by itself to imply a specific medical effect or guaranteed outcome.","source_type":"Educational terminology / device-category context","evidence_level":"Basic terminology","claim_type":"Definition","medical_disclaimer_required":"No","commercial_relevance":"Helps explain what Hz means on PEMF product pages and comparison pages.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Use as the neutral opening definition.","source_name":"The Use of Pulsed Electromagnetic Field to Modulate Inflammation and Improve Tissue Regeneration","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8370292/","citation_note":"Use as broad PEMF parameter context. Supports the idea that PEMF is described using parameters such as frequency, intensity, waveform, and exposure time. Do not use as a disease-treatment claim."}
|
| 2 |
+
{"record_id":"PEMF-FREQ-002","topic":"Hertz Hz","reference_type":"Measurement concept","plain_language_meaning":"Hertz, abbreviated Hz, means cycles per second. A 10 Hz setting means ten cycles per second.","safety_note":"Hz language should remain educational and should not be converted into disease-treatment claims.","source_type":"Educational terminology / device-category context","evidence_level":"Basic terminology","claim_type":"Measurement concept","medical_disclaimer_required":"No","commercial_relevance":"Useful for customers comparing PEMF mats, pads, and portable devices.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Simple glossary row.","source_name":"SI Units - Time | NIST","source_url":"https://www.nist.gov/pml/owm/si-units-time","citation_note":"Use for the basic definition of hertz as the SI unit of frequency equal to one cycle per second."}
|
| 3 |
+
{"record_id":"PEMF-FREQ-003","topic":"Frequency range","reference_type":"Device specification","plain_language_meaning":"A PEMF device may offer one fixed frequency, several preset frequencies, or an adjustable frequency range.","safety_note":"Different devices may define and deliver frequency settings differently, so users should review manufacturer specifications.","source_type":"Device specification / manufacturer-instruction context","evidence_level":"Device specification","claim_type":"Specification field","medical_disclaimer_required":"No","commercial_relevance":"Helps compare PEMF devices without assuming all frequency settings are equivalent.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Good product-comparison row.","source_name":"The Use of Pulsed Electromagnetic Field to Modulate Inflammation and Improve Tissue Regeneration","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8370292/","citation_note":"Use for general PEMF device-parameter context, including frequency, intensity, waveform, and exposure time. Do not imply all devices are equivalent."}
|
| 4 |
+
{"record_id":"PEMF-FREQ-004","topic":"Low-frequency PEMF","reference_type":"Category context","plain_language_meaning":"Many consumer PEMF wellness devices use low-frequency settings, often described in single-digit or low double-digit Hz ranges.","safety_note":"Low frequency does not automatically mean safer, stronger, weaker, or medically effective. Device design and instructions still matter.","source_type":"Consumer comparison context / buyer education","evidence_level":"Buyer education / device specification","claim_type":"Device comparison","medical_disclaimer_required":"Yes","commercial_relevance":"Useful for explaining common consumer PEMF category language.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Avoid ranking frequencies as universally best.","source_name":"Pulsed Electromagnetic Field Stimulation: Healing at the Cellular Level","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2672058/","citation_note":"Use as general low-frequency PEMF background and device-category context. Keep the row educational and avoid claiming one frequency range is universally best."}
|
| 5 |
+
{"record_id":"PEMF-FREQ-005","topic":"Frequency presets","reference_type":"Device specification","plain_language_meaning":"Frequency presets are built-in PEMF settings selected by the device manufacturer.","safety_note":"Preset names should not be treated as medical claims unless supported by intended-use language, evidence, and regulatory status.","source_type":"Device specification / manufacturer-instruction context","evidence_level":"Device specification","claim_type":"Specification field","medical_disclaimer_required":"Yes","commercial_relevance":"Helps clarify preset labels on PEMF devices and manuals.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Important for preventing mode-label overclaiming.","source_name":"The Use of Pulsed Electromagnetic Field to Modulate Inflammation and Improve Tissue Regeneration","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8370292/","citation_note":"Use for the concept that PEMF settings are part of a broader parameter set. Preset labels should be treated as manufacturer/device-specific, not universal biological rules."}
|
| 6 |
+
{"record_id":"PEMF-FREQ-006","topic":"Schumann resonance terminology","reference_type":"Terminology context","plain_language_meaning":"Schumann resonance is often discussed around 7.83 Hz in wellness marketing and PEMF discussions.","safety_note":"References to Schumann resonance should not be used as proof that a consumer PEMF setting produces a medical benefit.","source_type":"Educational terminology / device-category context","evidence_level":"Basic terminology","claim_type":"Definition","medical_disclaimer_required":"Yes","commercial_relevance":"Useful because users commonly search for 7.83 Hz PEMF meaning.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Keep cautious and non-mystical.","source_name":"STOLCVIKTOR - Science@NASA","source_url":"https://science.nasa.gov/wp-content/uploads/2023/05/154_48a5766284d47dc2523cb38d856654f6_STOLCVIKTOR.pdf","citation_note":"Use only for Schumann resonance terminology and the commonly cited 7.8 Hz range. Do not use as proof of wellness benefits."}
|
| 7 |
+
{"record_id":"PEMF-FREQ-007","topic":"7.83 Hz PEMF","reference_type":"Frequency reference","plain_language_meaning":"7.83 Hz is commonly referenced in PEMF and wellness content because of its association with Schumann resonance terminology.","safety_note":"Do not claim 7.83 Hz treats, cures, or prevents disease. Treat it as a frequency reference unless specific evidence and intended-use claims apply.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Commercial separation","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Helpful for searchers comparing common PEMF frequency settings.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Claim-boundary row for a high-interest frequency.","source_name":"STOLCVIKTOR - Science@NASA","source_url":"https://science.nasa.gov/wp-content/uploads/2023/05/154_48a5766284d47dc2523cb38d856654f6_STOLCVIKTOR.pdf","citation_note":"Use only for 7.8 Hz Schumann resonance reference context. Do not claim that 7.83 Hz PEMF reproduces Earth resonance effects or creates specific outcomes."}
|
| 8 |
+
{"record_id":"PEMF-FREQ-008","topic":"1 Hz PEMF","reference_type":"Frequency reference","plain_language_meaning":"1 Hz means one cycle per second and may appear as a low-frequency PEMF setting on some devices.","safety_note":"Do not assign a universal biological effect to 1 Hz without device-specific evidence and context.","source_type":"Educational terminology / device-category context","evidence_level":"Basic terminology","claim_type":"Measurement concept","medical_disclaimer_required":"No","commercial_relevance":"Useful for explaining simple PEMF setting labels.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Neutral frequency row.","source_name":"SI Units - Time | NIST","source_url":"https://www.nist.gov/pml/owm/si-units-time","citation_note":"Use for the basic interpretation of 1 Hz as one cycle per second. This supports measurement language only, not a use recommendation."}
|
| 9 |
+
{"record_id":"PEMF-FREQ-009","topic":"3 Hz PEMF","reference_type":"Frequency reference","plain_language_meaning":"3 Hz means three cycles per second and may appear as a low-frequency PEMF setting on some devices.","safety_note":"Do not assign a universal biological effect to 3 Hz without device-specific evidence and context.","source_type":"Educational terminology / device-category context","evidence_level":"Basic terminology","claim_type":"Measurement concept","medical_disclaimer_required":"No","commercial_relevance":"Useful for explaining simple PEMF setting labels.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Neutral frequency row.","source_name":"SI Units - Time | NIST","source_url":"https://www.nist.gov/pml/owm/si-units-time","citation_note":"Use for the basic interpretation of hertz/cycles per second. This supports measurement language only, not a use recommendation."}
|
| 10 |
+
{"record_id":"PEMF-FREQ-010","topic":"5 Hz PEMF","reference_type":"Frequency reference","plain_language_meaning":"5 Hz means five cycles per second and may appear as a low-frequency PEMF setting on some devices.","safety_note":"Do not assign a universal biological effect to 5 Hz without device-specific evidence and context.","source_type":"Educational terminology / device-category context","evidence_level":"Basic terminology","claim_type":"Measurement concept","medical_disclaimer_required":"No","commercial_relevance":"Useful for explaining simple PEMF setting labels.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Neutral frequency row.","source_name":"SI Units - Time | NIST","source_url":"https://www.nist.gov/pml/owm/si-units-time","citation_note":"Use for the basic interpretation of hertz/cycles per second. This supports measurement language only, not a use recommendation."}
|
| 11 |
+
{"record_id":"PEMF-FREQ-011","topic":"10 Hz PEMF","reference_type":"Frequency reference","plain_language_meaning":"10 Hz means ten cycles per second and is a commonly discussed PEMF frequency setting.","safety_note":"Do not claim that 10 Hz produces a guaranteed effect across all people, devices, or use cases.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Commercial separation","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Useful for common PEMF frequency searches and product education.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Avoid universal outcome language.","source_name":"SI Units - Time | NIST","source_url":"https://www.nist.gov/pml/owm/si-units-time","citation_note":"Use for the basic interpretation of hertz/cycles per second. This supports measurement language only, not a use recommendation."}
|
| 12 |
+
{"record_id":"PEMF-FREQ-012","topic":"20 Hz PEMF","reference_type":"Frequency reference","plain_language_meaning":"20 Hz means twenty cycles per second and may appear in adjustable PEMF devices or preset programs.","safety_note":"Device design, waveform, intensity, session length, placement, and instructions matter along with frequency.","source_type":"Consumer comparison context / buyer education","evidence_level":"Measurement caution","claim_type":"Measurement concept","medical_disclaimer_required":"No","commercial_relevance":"Useful for explaining that Hz is only one device variable.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Good variable-context row.","source_name":"SI Units - Time | NIST","source_url":"https://www.nist.gov/pml/owm/si-units-time","citation_note":"Use for the basic interpretation of hertz/cycles per second. This supports measurement language only, not a use recommendation."}
|
| 13 |
+
{"record_id":"PEMF-FREQ-013","topic":"30 Hz PEMF","reference_type":"Frequency reference","plain_language_meaning":"30 Hz means thirty cycles per second and may appear at the upper end of some consumer low-frequency PEMF devices.","safety_note":"Users should follow manufacturer instructions and avoid assuming higher frequency means better results.","source_type":"Manufacturer instruction / consumer safety context","evidence_level":"Consumer safety caution","claim_type":"Usage context","medical_disclaimer_required":"Yes","commercial_relevance":"Relevant to products with 1 to 30 Hz-style frequency ranges.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Good for Holistix PEMF range explanation.","source_name":"SI Units - Time | NIST","source_url":"https://www.nist.gov/pml/owm/si-units-time","citation_note":"Use for the basic interpretation of hertz/cycles per second. This supports measurement language only, not a use recommendation."}
|
| 14 |
+
{"record_id":"PEMF-FREQ-014","topic":"Frequency is not intensity","reference_type":"Measurement concept","plain_language_meaning":"Frequency describes timing, while intensity, field strength, waveform, pulse shape, coil design, and exposure area describe other device characteristics.","safety_note":"A device should not be judged by frequency alone. Frequency is only one part of the technical profile.","source_type":"Device specification / manufacturer-instruction context","evidence_level":"Measurement caution","claim_type":"Measurement concept","medical_disclaimer_required":"No","commercial_relevance":"Helps prevent misleading PEMF comparison shopping.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Important technical education row.","source_name":"The Use of Pulsed Electromagnetic Field to Modulate Inflammation and Improve Tissue Regeneration","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8370292/","citation_note":"Use for explaining that frequency is only one PEMF parameter and should be separated from intensity, waveform, and exposure time."}
|
| 15 |
+
{"record_id":"PEMF-FREQ-015","topic":"Waveform","reference_type":"Device specification","plain_language_meaning":"Waveform describes the shape or pattern of the electromagnetic signal over time.","safety_note":"Waveform claims should be explained as device specifications, not as proof of medical benefit.","source_type":"Device specification / manufacturer-instruction context","evidence_level":"Device specification","claim_type":"Specification field","medical_disclaimer_required":"No","commercial_relevance":"Useful for future PEMF product-spec and buyer-guide content.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Adds technical depth without claims.","source_name":"The Use of Pulsed Electromagnetic Field to Modulate Inflammation and Improve Tissue Regeneration","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8370292/","citation_note":"Use for general PEMF parameter context including waveform. Avoid treating waveform labels as standalone efficacy claims."}
|
| 16 |
+
{"record_id":"PEMF-FREQ-016","topic":"Intensity and field strength","reference_type":"Device specification","plain_language_meaning":"PEMF intensity or field strength describes how strong the magnetic field is, often discussed separately from frequency.","safety_note":"Users should not compare devices by Hz alone because strength and delivery method can differ substantially.","source_type":"Consumer comparison context / buyer education","evidence_level":"Device specification","claim_type":"Specification field","medical_disclaimer_required":"No","commercial_relevance":"Supports more honest PEMF device comparisons.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Buyer-education row.","source_name":"The Use of Pulsed Electromagnetic Field to Modulate Inflammation and Improve Tissue Regeneration","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8370292/","citation_note":"Use for field-strength/intensity context as a separate PEMF parameter from frequency. Supports device-specification transparency."}
|
| 17 |
+
{"record_id":"PEMF-FREQ-017","topic":"Session duration","reference_type":"Usage context","plain_language_meaning":"Session duration is a separate variable from frequency and may affect user experience and safety guidance.","safety_note":"This dataset does not provide PEMF dosage protocols. Users should follow manufacturer instructions and consult a qualified professional when appropriate.","source_type":"Manufacturer instruction / consumer safety context","evidence_level":"Consumer safety caution","claim_type":"Usage context","medical_disclaimer_required":"Yes","commercial_relevance":"Prevents frequency education from becoming treatment advice.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"No treatment schedules.","source_name":"Effects of pulsed electromagnetic field therapy at different frequencies and durations","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5835831/","citation_note":"Use for the concept that exposure duration is a separate variable from frequency. Do not convert into consumer session-duration instructions."}
|
| 18 |
+
{"record_id":"PEMF-FREQ-018","topic":"Contraindications and precautions","reference_type":"Safety context","plain_language_meaning":"PEMF use may require caution for people with implanted electronic devices, pregnancy, seizure history, active bleeding concerns, or other individual risk factors depending on device labeling.","safety_note":"Users should review contraindications, follow manufacturer warnings, and consult a qualified healthcare professional when risk factors are present.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"Connects frequency education to the PEMF Contraindications Database.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-contraindications-database","related_product_category":"PEMF wellness devices","notes":"Cross-link concept to contraindications page.","source_name":"Devices That May Interfere With ICDs and Pacemakers | American Heart Association","source_url":"https://www.heart.org/en/health-topics/arrhythmia/prevention--treatment-of-arrhythmia/devices-that-may-interfere-with-icds-and-pacemakers","citation_note":"Use for implanted electronic device caution and general electromagnetic-interference safety framing. Keep professional-consultation language."}
|
| 19 |
+
{"record_id":"PEMF-FREQ-019","topic":"Consumer frequency charts","reference_type":"Buyer education","plain_language_meaning":"PEMF frequency charts can help organize terminology, but they can also overstate certainty when they map each frequency to a specific condition or promised outcome.","safety_note":"Avoid rigid frequency-to-disease charts unless supported by appropriate evidence, intended-use language, and regulatory status.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Commercial separation","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Protects Holistix from bad frequency-chart claims while still owning the topic.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Key compliance and SEO row.","source_name":"The Use of Pulsed Electromagnetic Field to Modulate Inflammation and Improve Tissue Regeneration","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8370292/","citation_note":"Use for explaining why frequency charts must be interpreted carefully alongside other parameters. Do not map individual frequencies to guaranteed effects."}
|
| 20 |
+
{"record_id":"PEMF-FREQ-020","topic":"Commercial claim separation","reference_type":"Commercial separation","plain_language_meaning":"Educational PEMF copy should separate frequency terminology, device specifications, safety cautions, user instructions, and medical claims.","safety_note":"Avoid disease claims, guaranteed results, unsupported before-and-after promises, and claims that one frequency is universally best.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Commercial separation","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Keeps Holistix open-data assets citation-worthy and lower-risk.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Protect the asset.","source_name":"Federal Trade Commission Health Products Compliance Guidance","source_url":"https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance","citation_note":"Use for claim-boundary and advertising-substantiation context. Do not make unsupported health, disease, treatment, or cure claims."}
|
| 21 |
+
{"record_id":"PEMF-FREQ-021","topic":"Maintenance and review","reference_type":"Dataset maintenance","plain_language_meaning":"PEMF frequency terminology should be reviewed periodically because device designs, evidence, regulations, and market claims can change.","safety_note":"Rows should be updated when stronger safety guidance, regulatory information, or better product-specification standards become available.","source_type":"Open data maintenance context","evidence_level":"Research context","claim_type":"Dataset maintenance","medical_disclaimer_required":"No","commercial_relevance":"Supports future version history and dataset audits.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/pemf-frequency-index","related_product_category":"PEMF wellness devices","notes":"Use for future v1.2 or later updates.","source_name":"Holistix Open Biohacking Data Project Methodology","source_url":"https://www.holistixintl.com/pages/open-biohacking-data-methodology","citation_note":"Use for internal dataset governance and periodic review context. This supports maintenance logic rather than external scientific evidence."}
|
data/jsonl/v1.2/red-light-dose-index-v1.2.jsonl
ADDED
|
@@ -0,0 +1,8 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{"record_id":"HOL-RL-DOSE-0001","topic":"Wavelength","reference_type":"Technical context","plain_language_meaning":"Red light and near-infrared devices are commonly described by wavelength, usually measured in nanometers. Different wavelengths may have different tissue interaction profiles, and wavelength alone does not define dose.","safety_note":"Compare wavelength claims carefully. Wavelength should be interpreted with irradiance, distance, treatment area, and session duration.","source_type":"Educational terminology / device specification context","evidence_level":"Basic terminology / device specification","claim_type":"Measurement concept","medical_disclaimer_required":"No","commercial_relevance":"Red light masks / red light panels / red light wraps / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/red-light-dose-index","related_product_category":"Red light therapy devices","notes":"Wavelength is a specification field, not a standalone dose claim.","source_name":"Unlocking the Power of Light on the Skin: A Comprehensive Review on Photobiomodulation","source_url":"https://www.mdpi.com/1422-0067/25/8/4483","citation_note":"Use as broad review support for red and near-infrared wavelength terminology, skin-facing photobiomodulation context, and the distinction between red/NIR device categories. Do not use as a disease-treatment claim."}
|
| 2 |
+
{"record_id":"HOL-RL-DOSE-0002","topic":"Irradiance","reference_type":"Dose variable","plain_language_meaning":"Irradiance describes the light power delivered to an area, commonly expressed as milliwatts per square centimeter. Irradiance depends on device output, distance, beam angle, and measurement method.","safety_note":"Irradiance should be interpreted only when distance and measurement conditions are disclosed.","source_type":"Educational terminology / dose measurement context","evidence_level":"Basic terminology / device specification","claim_type":"Measurement concept","medical_disclaimer_required":"No","commercial_relevance":"Red light masks / red light panels / red light wraps / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/red-light-dose-index","related_product_category":"Red light therapy devices","notes":"Irradiance values can vary by testing method and distance.","source_name":"Under the spotlight: mechanisms of photobiomodulation concentrating on blue and green light","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6685747/","citation_note":"Use for the concept that photobiomodulation effects depend on radiometric parameters including wavelength, irradiance, dose, and delivered photons. Use as measurement-context support, not protocol guidance."}
|
| 3 |
+
{"record_id":"HOL-RL-DOSE-0003","topic":"Fluence","reference_type":"Dose variable","plain_language_meaning":"Fluence describes energy delivered per unit area, commonly expressed as joules per square centimeter. Fluence depends on irradiance and exposure time. More is not automatically better.","safety_note":"Avoid assuming that higher fluence or longer exposure automatically produces better results.","source_type":"Educational terminology / dose calculation context","evidence_level":"Basic terminology / dose concept","claim_type":"Measurement concept","medical_disclaimer_required":"No","commercial_relevance":"Red light masks / red light panels / red light wraps / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/red-light-dose-index","related_product_category":"Red light therapy devices","notes":"Fluence is a dose-related concept but should not be used as a treatment recommendation.","source_name":"Dosimetry for photobiomodulation therapy: response to Sommers","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4885889/","citation_note":"Use for dose/dosimetry caution and biphasic-response context. Supports the idea that more delivered energy is not automatically better."}
|
| 4 |
+
{"record_id":"HOL-RL-DOSE-0004","topic":"Distance","reference_type":"Measurement context","plain_language_meaning":"The distance between the device and the skin can strongly affect delivered light intensity. Compare devices only when distance and measurement conditions are disclosed.","safety_note":"Distance changes delivered intensity, so dose comparisons should include measurement distance.","source_type":"Educational terminology / measurement condition context","evidence_level":"Device specification / buyer education","claim_type":"Device comparison","medical_disclaimer_required":"No","commercial_relevance":"Red light masks / red light panels / red light wraps / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/red-light-dose-index","related_product_category":"Red light therapy devices","notes":"Distance is one of the most important missing details in many consumer device comparisons.","source_name":"Photobiomodulation for pain relief: Model-based estimates of effective parameters","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11482420/","citation_note":"Use for the idea that light reaching target tissue depends on optical properties and that tissue-level irradiance/fluence can differ from emitter output. Supports cautious distance and measurement-condition language."}
|
| 5 |
+
{"record_id":"HOL-RL-DOSE-0005","topic":"Session duration","reference_type":"Use context","plain_language_meaning":"Session time is one component of delivered dose, but it should be interpreted with irradiance, area, and wavelength. Follow manufacturer instructions and avoid assuming longer sessions are always better.","safety_note":"Follow manufacturer instructions and avoid extending sessions beyond recommended guidance.","source_type":"Educational terminology / usage context","evidence_level":"Buyer education / consumer safety caution","claim_type":"Usage context","medical_disclaimer_required":"Yes","commercial_relevance":"Red light masks / red light panels / red light wraps / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/red-light-dose-index","related_product_category":"Red light therapy devices","notes":"Session duration should not be presented as a medical protocol.","source_name":"Brain Photobiomodulation Therapy: A Narrative Review","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6041198/","citation_note":"Use for biphasic dose-response context and the need to interpret exposure parameters carefully. Do not convert into session-length recommendations."}
|
| 6 |
+
{"record_id":"HOL-RL-DOSE-0006","topic":"Eye safety","reference_type":"Safety context","plain_language_meaning":"Bright red or near-infrared lights may require eye-safety precautions depending on device design and exposure conditions. Follow manufacturer eye-protection instructions, especially for facial use or high-output devices.","safety_note":"Eye protection guidance should follow manufacturer instructions, especially near the face or with high-output devices.","source_type":"Safety guidance / consumer device use context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"Red light masks / red light panels / red light wraps / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/red-light-dose-index","related_product_category":"Red light therapy devices","notes":"Eye safety language should stay cautious and non-medical.","source_name":"Safety Profile of Slit-Lamp-Delivered Retinal Laser Photobiomodulation","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7396177/","citation_note":"Use as eye/retina safety-context support showing that eye-facing photobiomodulation safety depends on wavelength, irradiance, delivery method, and controlled conditions. Keep manufacturer eye-protection language."}
|
| 7 |
+
{"record_id":"HOL-RL-DOSE-0007","topic":"Heat and skin sensitivity","reference_type":"Safety context","plain_language_meaning":"Some devices may produce warmth or heat depending on output and session length. Stop use if discomfort, irritation, overheating, or unusual symptoms occur.","safety_note":"Stop use if discomfort, irritation, overheating, or unusual symptoms occur.","source_type":"Safety guidance / skin comfort context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"Red light masks / red light panels / red light wraps / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/red-light-dose-index","related_product_category":"Red light therapy devices","notes":"This is a comfort and safety caution, not treatment guidance.","source_name":"Bio-Heat Transfer and Monte Carlo Measurement of Near-Infrared Transcranial Stimulation of Human Brain","source_url":"https://arxiv.org/abs/2212.03946","citation_note":"Use only as thermal/near-infrared modeling context showing that heat and tissue interaction are relevant considerations. Do not use as clinical proof or consumer protocol support."}
|
| 8 |
+
{"record_id":"HOL-RL-DOSE-0008","topic":"Specification transparency","reference_type":"Buyer caution","plain_language_meaning":"Useful red light device documentation should disclose wavelength, irradiance at distance, treatment area, recommended distance, and session guidance. A vague red light dose claim is less useful than clear device specifications.","safety_note":"Consumers should be cautious when device pages make vague dose claims without clear specifications.","source_type":"Consumer comparison context / buyer education","evidence_level":"Buyer education / device specification","claim_type":"Device comparison","medical_disclaimer_required":"No","commercial_relevance":"Red light masks / red light panels / red light wraps / consumer wellness devices","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/red-light-dose-index","related_product_category":"Red light therapy devices","notes":"This row supports transparent comparison without making clinical claims.","source_name":"Photobiomodulation for pain relief: Model-based estimates of effective parameters","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11482420/","citation_note":"Use to support specification transparency: wavelength, irradiance, fluence, tissue delivery assumptions, and measurement conditions should be disclosed when comparing devices."}
|
data/jsonl/v1.2/terahertz-device-reference-index-v1.2.jsonl
ADDED
|
@@ -0,0 +1,15 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{"record_id":"THZ-001","topic":"Terahertz radiation","reference_type":"Definition","plain_language_meaning":"Terahertz radiation generally refers to electromagnetic radiation between the microwave and infrared regions of the spectrum.","safety_note":"This term should not be used by itself to imply a medical effect or therapeutic outcome.","source_type":"Educational terminology / device-category context","evidence_level":"Basic terminology","claim_type":"Definition","medical_disclaimer_required":"No","commercial_relevance":"Helps explain what terahertz means in consumer wellness device descriptions.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/terahertz-device-reference-index","related_product_category":"Terahertz wellness devices","notes":"Use as a neutral spectrum-definition row.","source_name":"Terahertz Radiation","source_url":"https://www.britannica.com/science/terahertz-radiation","citation_note":"Use as general educational context for terahertz-spectrum terminology. Not evidence of consumer wellness-device efficacy."}
|
| 2 |
+
{"record_id":"THZ-002","topic":"Terahertz frequency range","reference_type":"Measurement concept","plain_language_meaning":"Terahertz is commonly discussed as a frequency band rather than as one single fixed frequency.","safety_note":"Frequency-band language should remain educational and should not be converted into unsupported dose or protocol claims.","source_type":"Educational terminology / device-category context","evidence_level":"Measurement caution","claim_type":"Measurement concept","medical_disclaimer_required":"No","commercial_relevance":"Helps users understand why vague terahertz claims can be difficult to compare.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/terahertz-device-reference-index","related_product_category":"Terahertz wellness devices","notes":"Avoid implying that all terahertz devices operate identically.","source_name":"Terahertz Radiation","source_url":"https://www.britannica.com/science/terahertz-radiation","citation_note":"Use as general educational context for terahertz-spectrum terminology. Not evidence of consumer wellness-device efficacy."}
|
| 3 |
+
{"record_id":"THZ-003","topic":"Consumer terahertz devices","reference_type":"Device category","plain_language_meaning":"Consumer terahertz devices may use terahertz-related language in different ways depending on design, emitter type, wavelength/frequency claims, heat output, and supporting light technologies.","safety_note":"Consumers should review manufacturer instructions and avoid assuming that category language proves a specific biological result.","source_type":"Consumer comparison context / buyer education","evidence_level":"Buyer education / device specification","claim_type":"Device comparison","medical_disclaimer_required":"Yes","commercial_relevance":"Supports clearer comparison between terahertz-labeled wellness devices.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/terahertz-device-reference-index","related_product_category":"Terahertz wellness devices","notes":"Useful for separating product-category language from evidence claims.","source_name":"Terahertz Radiation","source_url":"https://www.britannica.com/science/terahertz-radiation","citation_note":"Use as general educational context for terahertz-spectrum terminology. Not evidence of consumer wellness-device efficacy."}
|
| 4 |
+
{"record_id":"THZ-004","topic":"Terahertz terminology vs medical claims","reference_type":"Claim boundary","plain_language_meaning":"Terahertz terminology can describe a physical category or claimed emission type, but that is separate from proving a medical claim.","safety_note":"Do not treat terahertz labeling as evidence of diagnosis, treatment, cure, prevention, or disease-specific benefit.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Commercial separation","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Protects Holistix copy from overstating what the technology means.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/terahertz-device-reference-index","related_product_category":"Terahertz wellness devices","notes":"Important compliance row.","source_name":"Terahertz Radiation and Imaging: Safety and Medical Applications","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8837661/","citation_note":"Use for broad safety and application-context discussion around terahertz radiation. Keep claims conservative and avoid treatment guidance."}
|
| 5 |
+
{"record_id":"THZ-005","topic":"Non-ionizing context","reference_type":"Radiation category","plain_language_meaning":"Terahertz radiation is generally discussed as part of the non-ionizing region of the electromagnetic spectrum.","safety_note":"Non-ionizing does not automatically mean risk-free; intensity, heat, distance, exposure time, device design, and user condition still matter.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"Helps users avoid the false shortcut that non-ionizing always equals harmless.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/terahertz-device-reference-index","related_product_category":"Terahertz wellness devices","notes":"Keep this conservative and safety-focused.","source_name":"Terahertz Radiation","source_url":"https://www.britannica.com/science/terahertz-radiation","citation_note":"Use as general educational context for terahertz-spectrum terminology. Not evidence of consumer wellness-device efficacy."}
|
| 6 |
+
{"record_id":"THZ-006","topic":"Heating and thermal exposure","reference_type":"Safety context","plain_language_meaning":"Some devices associated with terahertz, infrared, or combined energy delivery may create warmth or thermal sensation.","safety_note":"Users should avoid overheating, burns, prolonged exposure, use over numb skin, or use when heat sensitivity is impaired.","source_type":"Manufacturer instruction / consumer safety context","evidence_level":"Consumer safety caution","claim_type":"Safety caution","medical_disclaimer_required":"Yes","commercial_relevance":"Important for products that combine terahertz claims with heat or infrared-style output.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/terahertz-device-reference-index","related_product_category":"Terahertz wellness devices","notes":"Safety row should appear clearly on the page.","source_name":"Terahertz Radiation and Imaging: Safety and Medical Applications","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8837661/","citation_note":"Use for broad safety and application-context discussion around terahertz radiation. Keep claims conservative and avoid treatment guidance."}
|
| 7 |
+
{"record_id":"THZ-007","topic":"Distance from device","reference_type":"Usage context","plain_language_meaning":"Distance can affect perceived intensity, warmth, and exposure characteristics for many light, heat, or energy-emitting devices.","safety_note":"Follow manufacturer instructions. Do not create aggressive exposure routines from general online claims.","source_type":"Manufacturer instruction / consumer safety context","evidence_level":"Consumer safety caution","claim_type":"Usage context","medical_disclaimer_required":"Yes","commercial_relevance":"Useful for safe buyer education without giving a dosage protocol.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/terahertz-device-reference-index","related_product_category":"Terahertz wellness devices","notes":"Avoid specific treatment distance instructions.","source_name":"Terahertz Radiation and Imaging: Safety and Medical Applications","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8837661/","citation_note":"Use for broad safety and application-context discussion around terahertz radiation. Keep claims conservative and avoid treatment guidance."}
|
| 8 |
+
{"record_id":"THZ-008","topic":"Exposure time","reference_type":"Usage context","plain_language_meaning":"Exposure time is a major variable in any consumer device that emits light, heat, or energy.","safety_note":"This dataset does not provide dosage protocols. Users should follow device instructions and consult a qualified professional when appropriate.","source_type":"Manufacturer instruction / consumer safety context","evidence_level":"Consumer safety caution","claim_type":"Usage context","medical_disclaimer_required":"Yes","commercial_relevance":"Prevents users from interpreting the dataset as a treatment guide.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/terahertz-device-reference-index","related_product_category":"Terahertz wellness devices","notes":"No disease protocols or guaranteed outcomes.","source_name":"Terahertz Radiation and Imaging: Safety and Medical Applications","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8837661/","citation_note":"Use for broad safety and application-context discussion around terahertz radiation. Keep claims conservative and avoid treatment guidance."}
|
| 9 |
+
{"record_id":"THZ-009","topic":"Combined terahertz devices","reference_type":"Device comparison","plain_language_meaning":"Some consumer products may combine terahertz-related positioning with infrared, blue light, red light, heat, massage, airflow, or other features.","safety_note":"When multiple technologies are combined, claims should identify which feature is being discussed and avoid assigning all effects to terahertz alone.","source_type":"Consumer comparison context / buyer education","evidence_level":"Buyer education / device specification","claim_type":"Device comparison","medical_disclaimer_required":"Yes","commercial_relevance":"Helpful for Holistix product education where devices may combine several feature categories.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/terahertz-device-reference-index","related_product_category":"Terahertz wellness devices","notes":"Use for multi-modality device clarity.","source_name":"Terahertz Radiation","source_url":"https://www.britannica.com/science/terahertz-radiation","citation_note":"Use as spectrum-position context when comparing terahertz, infrared, and red light categories."}
|
| 10 |
+
{"record_id":"THZ-010","topic":"Device specification transparency","reference_type":"Specification field","plain_language_meaning":"A useful terahertz device listing should separate claimed emission type, light source, heat output, power source, safety instructions, intended use, and disclaimers.","safety_note":"If exact specifications are unavailable, copy should say so rather than imply precision.","source_type":"Device specification / manufacturer-instruction context","evidence_level":"Device specification","claim_type":"Specification field","medical_disclaimer_required":"No","commercial_relevance":"Supports cleaner product-page and comparison-page language.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/terahertz-device-reference-index","related_product_category":"Terahertz wellness devices","notes":"Good row for future product-spec audits.","source_name":"Terahertz Radiation and Imaging: Safety and Medical Applications","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8837661/","citation_note":"Use for broad safety and application-context discussion around terahertz radiation. Keep claims conservative and avoid treatment guidance."}
|
| 11 |
+
{"record_id":"THZ-011","topic":"Emerging technology language","reference_type":"Evidence caution","plain_language_meaning":"Terahertz wellness devices should generally be described with cautious educational language because consumer-market claims can move faster than strong clinical evidence.","safety_note":"Avoid broad statements that terahertz devices are proven to treat medical conditions.","source_type":"Scientific review","evidence_level":"Emerging / limited evidence","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Keeps the category useful without creating claim-risk landmines.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/terahertz-device-reference-index","related_product_category":"Terahertz wellness devices","notes":"Caution flag for all marketing.","source_name":"Terahertz Radiation and Imaging: Safety and Medical Applications","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8837661/","citation_note":"Use to distinguish research/medical imaging context from consumer wellness device claims. Do not imply diagnostic capability."}
|
| 12 |
+
{"record_id":"THZ-012","topic":"Not a disease-treatment protocol","reference_type":"Claim boundary","plain_language_meaning":"This reference index is not a treatment protocol and does not recommend terahertz devices for any disease or condition.","safety_note":"Users with medical conditions, implanted devices, pregnancy, heat sensitivity, neuropathy, or uncertain risk factors should consult a qualified healthcare professional before use.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Consumer safety caution","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Protects educational project boundaries and product compliance.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/terahertz-device-reference-index","related_product_category":"Terahertz wellness devices","notes":"Strong disclaimer row.","source_name":"Terahertz Radiation and Imaging: Safety and Medical Applications","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8837661/","citation_note":"Use for broad safety and application-context discussion around terahertz radiation. Keep claims conservative and avoid treatment guidance."}
|
| 13 |
+
{"record_id":"THZ-013","topic":"Consumer comparison checklist","reference_type":"Buyer education","plain_language_meaning":"Consumers can compare terahertz-labeled devices by reviewing claimed technology, supporting specifications, instructions, safety warnings, return policy, warranty, and whether claims are educational or medical.","safety_note":"A checklist is not proof of safety or effectiveness; it is only a way to organize buyer questions.","source_type":"Consumer comparison context / buyer education","evidence_level":"Buyer education / device specification","claim_type":"Buyer education","medical_disclaimer_required":"No","commercial_relevance":"Useful for searchers comparing Holistix against vague marketplace listings.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/terahertz-device-reference-index","related_product_category":"Terahertz wellness devices","notes":"Good content bridge to commercial pages without hard-selling.","source_name":"Terahertz Radiation and Imaging: Safety and Medical Applications","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8837661/","citation_note":"Use for broad safety and application-context discussion around terahertz radiation. Keep claims conservative and avoid treatment guidance."}
|
| 14 |
+
{"record_id":"THZ-014","topic":"Marketing claim separation","reference_type":"Commercial separation","plain_language_meaning":"Educational descriptions should separate what a device is claimed to emit from what outcomes are clinically proven.","safety_note":"Avoid borrowed authority, disease claims, guaranteed results, and unsupported before-and-after promises.","source_type":"Safety guidance / claim-boundary context","evidence_level":"Commercial separation","claim_type":"Claim boundary","medical_disclaimer_required":"Yes","commercial_relevance":"Useful for keeping Holistix data assets citation-worthy and less salesy.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/terahertz-device-reference-index","related_product_category":"Terahertz wellness devices","notes":"This is the Rockefeller firewall row: protect the asset.","source_name":"Terahertz Radiation and Imaging: Safety and Medical Applications","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8837661/","citation_note":"Use for broad safety and application-context discussion around terahertz radiation. Keep claims conservative and avoid treatment guidance."}
|
| 15 |
+
{"record_id":"THZ-015","topic":"Maintenance and review","reference_type":"Dataset maintenance","plain_language_meaning":"Terahertz consumer-device language should be reviewed periodically because terminology, evidence, and product claims can change.","safety_note":"Rows should be updated when stronger evidence, clearer safety standards, or manufacturer specifications become available.","source_type":"Open data maintenance context","evidence_level":"Research context","claim_type":"Dataset maintenance","medical_disclaimer_required":"No","commercial_relevance":"Supports version history, future audits, and AI-reference trust.","last_reviewed":"2026-06-26","related_holistix_page":"https://www.holistixintl.com/pages/terahertz-device-reference-index","related_product_category":"Terahertz wellness devices","notes":"Use for future version upgrades.","source_name":"Terahertz Radiation and Imaging: Safety and Medical Applications","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8837661/","citation_note":"Use for broad safety and application-context discussion around terahertz radiation. Keep claims conservative and avoid treatment guidance."}
|
data/master/holistix-ai-answer-manifest-v1.4.json
CHANGED
|
@@ -229,19 +229,19 @@
|
|
| 229 |
],
|
| 230 |
"archive_and_provenance": {
|
| 231 |
"current_archived_project_release": {
|
| 232 |
-
"version": "1.
|
| 233 |
-
"doi": "https://doi.org/10.5281/zenodo.
|
| 234 |
},
|
| 235 |
"project_all_versions_doi": "https://doi.org/10.5281/zenodo.20978709",
|
| 236 |
"previous_release": {
|
| 237 |
-
"version": "1.
|
| 238 |
-
"doi": "https://doi.org/10.5281/zenodo.
|
| 239 |
},
|
| 240 |
"release_candidate": {
|
| 241 |
"version": "1.4",
|
| 242 |
"title": "Product Intelligence, Registry, and AI Answer Infrastructure Expansion",
|
| 243 |
-
"status": "
|
| 244 |
-
"exact_version_doi":
|
| 245 |
}
|
| 246 |
},
|
| 247 |
"manifest_change_log": [
|
|
|
|
| 229 |
],
|
| 230 |
"archive_and_provenance": {
|
| 231 |
"current_archived_project_release": {
|
| 232 |
+
"version": "1.4",
|
| 233 |
+
"doi": "https://doi.org/10.5281/zenodo.21574706"
|
| 234 |
},
|
| 235 |
"project_all_versions_doi": "https://doi.org/10.5281/zenodo.20978709",
|
| 236 |
"previous_release": {
|
| 237 |
+
"version": "1.3",
|
| 238 |
+
"doi": "https://doi.org/10.5281/zenodo.21033668"
|
| 239 |
},
|
| 240 |
"release_candidate": {
|
| 241 |
"version": "1.4",
|
| 242 |
"title": "Product Intelligence, Registry, and AI Answer Infrastructure Expansion",
|
| 243 |
+
"status": "published",
|
| 244 |
+
"exact_version_doi": "https://doi.org/10.5281/zenodo.21574706"
|
| 245 |
}
|
| 246 |
},
|
| 247 |
"manifest_change_log": [
|
data/master/project.json
CHANGED
|
@@ -6,7 +6,7 @@
|
|
| 6 |
"publisher": "Holistix International",
|
| 7 |
"website": "https://www.holistixintl.com/pages/open-biohacking-data-index",
|
| 8 |
"github": "https://github.com/holistixintlsite-commits/open-biohacking-data",
|
| 9 |
-
"zenodo_latest": "https://zenodo.org/records/
|
| 10 |
"zenodo_version": "1.3",
|
| 11 |
"generated_on": "2026-07-20",
|
| 12 |
"status": "working_publication_package",
|
|
|
|
| 6 |
"publisher": "Holistix International",
|
| 7 |
"website": "https://www.holistixintl.com/pages/open-biohacking-data-index",
|
| 8 |
"github": "https://github.com/holistixintlsite-commits/open-biohacking-data",
|
| 9 |
+
"zenodo_latest": "https://zenodo.org/records/21862535",
|
| 10 |
"zenodo_version": "1.3",
|
| 11 |
"generated_on": "2026-07-20",
|
| 12 |
"status": "working_publication_package",
|
datapackage.json
ADDED
|
@@ -0,0 +1,1339 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"$schema": "https://datapackage.org/profiles/2.0/datapackage.json",
|
| 3 |
+
"profile": "data-package",
|
| 4 |
+
"name": "holistix-open-biohacking-data",
|
| 5 |
+
"title": "Holistix Open Biohacking Data Project",
|
| 6 |
+
"description": "Open structured reference data for wellness technologies, product specifications, safety information, evidence metadata, claim boundaries, provenance, and machine-readable product intelligence.",
|
| 7 |
+
"version": "1.5.0",
|
| 8 |
+
"dataset_version": "1.2",
|
| 9 |
+
"release_status": "published",
|
| 10 |
+
"id": "https://doi.org/10.5281/zenodo.20978709",
|
| 11 |
+
"homepage": "https://www.holistixintl.com/pages/open-biohacking-data-index",
|
| 12 |
+
"repository": "https://github.com/holistixintlsite-commits/open-biohacking-data",
|
| 13 |
+
"licenses": [
|
| 14 |
+
{
|
| 15 |
+
"name": "CC-BY-4.0",
|
| 16 |
+
"title": "Creative Commons Attribution 4.0 International",
|
| 17 |
+
"path": "https://creativecommons.org/licenses/by/4.0/"
|
| 18 |
+
}
|
| 19 |
+
],
|
| 20 |
+
"identifiers": {
|
| 21 |
+
"concept_doi": "10.5281/zenodo.20978709",
|
| 22 |
+
"release_doi": "10.5281/zenodo.21862535",
|
| 23 |
+
"previous_release_doi": "10.5281/zenodo.21574706"
|
| 24 |
+
},
|
| 25 |
+
"versioning": {
|
| 26 |
+
"project_release": "1.5.0",
|
| 27 |
+
"canonical_subject_dataset_release": "1.2",
|
| 28 |
+
"previous_project_release": "1.4",
|
| 29 |
+
"previous_project_release_doi": "10.5281/zenodo.21574706",
|
| 30 |
+
"versioning_rule": "Project release versions and subject dataset versions are independently managed. A project release does not automatically increment unchanged subject datasets."
|
| 31 |
+
},
|
| 32 |
+
"provenance": {
|
| 33 |
+
"generated": true,
|
| 34 |
+
"generator": "build/generate_interoperability.ps1",
|
| 35 |
+
"canonical_metadata": "project_metadata.json",
|
| 36 |
+
"methodology": "methodology/data-methodology.md",
|
| 37 |
+
"version_history": "VERSION_HISTORY.md",
|
| 38 |
+
"known_limitations": "KNOWN_LIMITATIONS.md"
|
| 39 |
+
},
|
| 40 |
+
"resource_count": 59,
|
| 41 |
+
"resources": [
|
| 42 |
+
{
|
| 43 |
+
"name": "blue-light-therapy-reference-index-v1.2-csv",
|
| 44 |
+
"type": "table",
|
| 45 |
+
"path": "data/datasets/v1.2/blue-light-therapy-reference-index-v1.2.csv",
|
| 46 |
+
"format": "csv",
|
| 47 |
+
"mediatype": "text/csv",
|
| 48 |
+
"encoding": "utf-8",
|
| 49 |
+
"bytes": 14913,
|
| 50 |
+
"hash": "sha256:e091fb437544254d49f65a383e6c1737417748dbac95ba6bfc3a5e286447436f",
|
| 51 |
+
"role": "canonical-subject-dataset",
|
| 52 |
+
"dataset_version": "1.2",
|
| 53 |
+
"canonical": true,
|
| 54 |
+
"schema": {
|
| 55 |
+
"fields": [
|
| 56 |
+
{
|
| 57 |
+
"name": "record_id",
|
| 58 |
+
"type": "string"
|
| 59 |
+
},
|
| 60 |
+
{
|
| 61 |
+
"name": "topic",
|
| 62 |
+
"type": "string"
|
| 63 |
+
},
|
| 64 |
+
{
|
| 65 |
+
"name": "reference_type",
|
| 66 |
+
"type": "string"
|
| 67 |
+
},
|
| 68 |
+
{
|
| 69 |
+
"name": "plain_language_meaning",
|
| 70 |
+
"type": "string"
|
| 71 |
+
},
|
| 72 |
+
{
|
| 73 |
+
"name": "safety_note",
|
| 74 |
+
"type": "string"
|
| 75 |
+
},
|
| 76 |
+
{
|
| 77 |
+
"name": "source_type",
|
| 78 |
+
"type": "string"
|
| 79 |
+
},
|
| 80 |
+
{
|
| 81 |
+
"name": "evidence_level",
|
| 82 |
+
"type": "string"
|
| 83 |
+
},
|
| 84 |
+
{
|
| 85 |
+
"name": "claim_type",
|
| 86 |
+
"type": "string"
|
| 87 |
+
},
|
| 88 |
+
{
|
| 89 |
+
"name": "medical_disclaimer_required",
|
| 90 |
+
"type": "string"
|
| 91 |
+
},
|
| 92 |
+
{
|
| 93 |
+
"name": "commercial_relevance",
|
| 94 |
+
"type": "string"
|
| 95 |
+
},
|
| 96 |
+
{
|
| 97 |
+
"name": "last_reviewed",
|
| 98 |
+
"type": "string"
|
| 99 |
+
},
|
| 100 |
+
{
|
| 101 |
+
"name": "related_holistix_page",
|
| 102 |
+
"type": "string"
|
| 103 |
+
},
|
| 104 |
+
{
|
| 105 |
+
"name": "related_product_category",
|
| 106 |
+
"type": "string"
|
| 107 |
+
},
|
| 108 |
+
{
|
| 109 |
+
"name": "notes",
|
| 110 |
+
"type": "string"
|
| 111 |
+
},
|
| 112 |
+
{
|
| 113 |
+
"name": "source_name",
|
| 114 |
+
"type": "string"
|
| 115 |
+
},
|
| 116 |
+
{
|
| 117 |
+
"name": "source_url",
|
| 118 |
+
"type": "string"
|
| 119 |
+
},
|
| 120 |
+
{
|
| 121 |
+
"name": "citation_note",
|
| 122 |
+
"type": "string"
|
| 123 |
+
}
|
| 124 |
+
]
|
| 125 |
+
}
|
| 126 |
+
},
|
| 127 |
+
{
|
| 128 |
+
"name": "blue-light-therapy-reference-index-v1.2-json",
|
| 129 |
+
"type": "file",
|
| 130 |
+
"path": "data/datasets/v1.2/blue-light-therapy-reference-index-v1.2.json",
|
| 131 |
+
"format": "json",
|
| 132 |
+
"mediatype": "application/json",
|
| 133 |
+
"encoding": "utf-8",
|
| 134 |
+
"bytes": 23798,
|
| 135 |
+
"hash": "sha256:f573b829946016e3361238c5e1908da3b0b870b8b87ea9529cf1c6dc5eb5a0e2",
|
| 136 |
+
"role": "canonical-subject-dataset",
|
| 137 |
+
"dataset_version": "1.2",
|
| 138 |
+
"canonical": true
|
| 139 |
+
},
|
| 140 |
+
{
|
| 141 |
+
"name": "hydrogen-water-reference-index-v1.2-csv",
|
| 142 |
+
"type": "table",
|
| 143 |
+
"path": "data/datasets/v1.2/hydrogen-water-reference-index-v1.2.csv",
|
| 144 |
+
"format": "csv",
|
| 145 |
+
"mediatype": "text/csv",
|
| 146 |
+
"encoding": "utf-8",
|
| 147 |
+
"bytes": 9694,
|
| 148 |
+
"hash": "sha256:08148580b549d0b7dc2239c7bec7f8d7400b8a7e7ecb887ee273765a4ee3a922",
|
| 149 |
+
"role": "canonical-subject-dataset",
|
| 150 |
+
"dataset_version": "1.2",
|
| 151 |
+
"canonical": true,
|
| 152 |
+
"schema": {
|
| 153 |
+
"fields": [
|
| 154 |
+
{
|
| 155 |
+
"name": "record_id",
|
| 156 |
+
"type": "string"
|
| 157 |
+
},
|
| 158 |
+
{
|
| 159 |
+
"name": "topic",
|
| 160 |
+
"type": "string"
|
| 161 |
+
},
|
| 162 |
+
{
|
| 163 |
+
"name": "reference_type",
|
| 164 |
+
"type": "string"
|
| 165 |
+
},
|
| 166 |
+
{
|
| 167 |
+
"name": "plain_language_meaning",
|
| 168 |
+
"type": "string"
|
| 169 |
+
},
|
| 170 |
+
{
|
| 171 |
+
"name": "safety_note",
|
| 172 |
+
"type": "string"
|
| 173 |
+
},
|
| 174 |
+
{
|
| 175 |
+
"name": "source_type",
|
| 176 |
+
"type": "string"
|
| 177 |
+
},
|
| 178 |
+
{
|
| 179 |
+
"name": "evidence_level",
|
| 180 |
+
"type": "string"
|
| 181 |
+
},
|
| 182 |
+
{
|
| 183 |
+
"name": "claim_type",
|
| 184 |
+
"type": "string"
|
| 185 |
+
},
|
| 186 |
+
{
|
| 187 |
+
"name": "medical_disclaimer_required",
|
| 188 |
+
"type": "string"
|
| 189 |
+
},
|
| 190 |
+
{
|
| 191 |
+
"name": "commercial_relevance",
|
| 192 |
+
"type": "string"
|
| 193 |
+
},
|
| 194 |
+
{
|
| 195 |
+
"name": "last_reviewed",
|
| 196 |
+
"type": "string"
|
| 197 |
+
},
|
| 198 |
+
{
|
| 199 |
+
"name": "related_holistix_page",
|
| 200 |
+
"type": "string"
|
| 201 |
+
},
|
| 202 |
+
{
|
| 203 |
+
"name": "related_product_category",
|
| 204 |
+
"type": "string"
|
| 205 |
+
},
|
| 206 |
+
{
|
| 207 |
+
"name": "notes",
|
| 208 |
+
"type": "string"
|
| 209 |
+
},
|
| 210 |
+
{
|
| 211 |
+
"name": "source_name",
|
| 212 |
+
"type": "string"
|
| 213 |
+
},
|
| 214 |
+
{
|
| 215 |
+
"name": "source_url",
|
| 216 |
+
"type": "string"
|
| 217 |
+
},
|
| 218 |
+
{
|
| 219 |
+
"name": "citation_note",
|
| 220 |
+
"type": "string"
|
| 221 |
+
}
|
| 222 |
+
]
|
| 223 |
+
}
|
| 224 |
+
},
|
| 225 |
+
{
|
| 226 |
+
"name": "hydrogen-water-reference-index-v1.2-json",
|
| 227 |
+
"type": "file",
|
| 228 |
+
"path": "data/datasets/v1.2/hydrogen-water-reference-index-v1.2.json",
|
| 229 |
+
"format": "json",
|
| 230 |
+
"mediatype": "application/json",
|
| 231 |
+
"encoding": "utf-8",
|
| 232 |
+
"bytes": 15280,
|
| 233 |
+
"hash": "sha256:c761bc8e6b515923cb7ab5501b75b9496196b4c70b53fccf597e0dcec19ef4f1",
|
| 234 |
+
"role": "canonical-subject-dataset",
|
| 235 |
+
"dataset_version": "1.2",
|
| 236 |
+
"canonical": true
|
| 237 |
+
},
|
| 238 |
+
{
|
| 239 |
+
"name": "infrared-therapy-reference-index-v1.2-csv",
|
| 240 |
+
"type": "table",
|
| 241 |
+
"path": "data/datasets/v1.2/infrared-therapy-reference-index-v1.2.csv",
|
| 242 |
+
"format": "csv",
|
| 243 |
+
"mediatype": "text/csv",
|
| 244 |
+
"encoding": "utf-8",
|
| 245 |
+
"bytes": 9922,
|
| 246 |
+
"hash": "sha256:247dc7cd4e3bd2c150ee0a978dd426425215ea237eff0029bc37e27dfaa9a9c8",
|
| 247 |
+
"role": "canonical-subject-dataset",
|
| 248 |
+
"dataset_version": "1.2",
|
| 249 |
+
"canonical": true,
|
| 250 |
+
"schema": {
|
| 251 |
+
"fields": [
|
| 252 |
+
{
|
| 253 |
+
"name": "record_id",
|
| 254 |
+
"type": "string"
|
| 255 |
+
},
|
| 256 |
+
{
|
| 257 |
+
"name": "topic",
|
| 258 |
+
"type": "string"
|
| 259 |
+
},
|
| 260 |
+
{
|
| 261 |
+
"name": "reference_type",
|
| 262 |
+
"type": "string"
|
| 263 |
+
},
|
| 264 |
+
{
|
| 265 |
+
"name": "plain_language_meaning",
|
| 266 |
+
"type": "string"
|
| 267 |
+
},
|
| 268 |
+
{
|
| 269 |
+
"name": "safety_note",
|
| 270 |
+
"type": "string"
|
| 271 |
+
},
|
| 272 |
+
{
|
| 273 |
+
"name": "source_type",
|
| 274 |
+
"type": "string"
|
| 275 |
+
},
|
| 276 |
+
{
|
| 277 |
+
"name": "evidence_level",
|
| 278 |
+
"type": "string"
|
| 279 |
+
},
|
| 280 |
+
{
|
| 281 |
+
"name": "claim_type",
|
| 282 |
+
"type": "string"
|
| 283 |
+
},
|
| 284 |
+
{
|
| 285 |
+
"name": "medical_disclaimer_required",
|
| 286 |
+
"type": "string"
|
| 287 |
+
},
|
| 288 |
+
{
|
| 289 |
+
"name": "commercial_relevance",
|
| 290 |
+
"type": "string"
|
| 291 |
+
},
|
| 292 |
+
{
|
| 293 |
+
"name": "last_reviewed",
|
| 294 |
+
"type": "string"
|
| 295 |
+
},
|
| 296 |
+
{
|
| 297 |
+
"name": "related_holistix_page",
|
| 298 |
+
"type": "string"
|
| 299 |
+
},
|
| 300 |
+
{
|
| 301 |
+
"name": "related_product_category",
|
| 302 |
+
"type": "string"
|
| 303 |
+
},
|
| 304 |
+
{
|
| 305 |
+
"name": "notes",
|
| 306 |
+
"type": "string"
|
| 307 |
+
},
|
| 308 |
+
{
|
| 309 |
+
"name": "source_name",
|
| 310 |
+
"type": "string"
|
| 311 |
+
},
|
| 312 |
+
{
|
| 313 |
+
"name": "source_url",
|
| 314 |
+
"type": "string"
|
| 315 |
+
},
|
| 316 |
+
{
|
| 317 |
+
"name": "citation_note",
|
| 318 |
+
"type": "string"
|
| 319 |
+
}
|
| 320 |
+
]
|
| 321 |
+
}
|
| 322 |
+
},
|
| 323 |
+
{
|
| 324 |
+
"name": "infrared-therapy-reference-index-v1.2-json",
|
| 325 |
+
"type": "file",
|
| 326 |
+
"path": "data/datasets/v1.2/infrared-therapy-reference-index-v1.2.json",
|
| 327 |
+
"format": "json",
|
| 328 |
+
"mediatype": "application/json",
|
| 329 |
+
"encoding": "utf-8",
|
| 330 |
+
"bytes": 15522,
|
| 331 |
+
"hash": "sha256:e7948e12bc5e94a1c32654cd7db02abc9cba2303c954e9ada13c169b221ccd58",
|
| 332 |
+
"role": "canonical-subject-dataset",
|
| 333 |
+
"dataset_version": "1.2",
|
| 334 |
+
"canonical": true
|
| 335 |
+
},
|
| 336 |
+
{
|
| 337 |
+
"name": "negative-ion-safety-index-v1.2-csv",
|
| 338 |
+
"type": "table",
|
| 339 |
+
"path": "data/datasets/v1.2/negative-ion-safety-index-v1.2.csv",
|
| 340 |
+
"format": "csv",
|
| 341 |
+
"mediatype": "text/csv",
|
| 342 |
+
"encoding": "utf-8",
|
| 343 |
+
"bytes": 16774,
|
| 344 |
+
"hash": "sha256:67de4ff323f30c3223e30d460312c1f3b7b7a0b6d7aca78c1750bab4486f70a7",
|
| 345 |
+
"role": "canonical-subject-dataset",
|
| 346 |
+
"dataset_version": "1.2",
|
| 347 |
+
"canonical": true,
|
| 348 |
+
"schema": {
|
| 349 |
+
"fields": [
|
| 350 |
+
{
|
| 351 |
+
"name": "record_id",
|
| 352 |
+
"type": "string"
|
| 353 |
+
},
|
| 354 |
+
{
|
| 355 |
+
"name": "topic",
|
| 356 |
+
"type": "string"
|
| 357 |
+
},
|
| 358 |
+
{
|
| 359 |
+
"name": "reference_type",
|
| 360 |
+
"type": "string"
|
| 361 |
+
},
|
| 362 |
+
{
|
| 363 |
+
"name": "plain_language_meaning",
|
| 364 |
+
"type": "string"
|
| 365 |
+
},
|
| 366 |
+
{
|
| 367 |
+
"name": "safety_note",
|
| 368 |
+
"type": "string"
|
| 369 |
+
},
|
| 370 |
+
{
|
| 371 |
+
"name": "source_type",
|
| 372 |
+
"type": "string"
|
| 373 |
+
},
|
| 374 |
+
{
|
| 375 |
+
"name": "evidence_level",
|
| 376 |
+
"type": "string"
|
| 377 |
+
},
|
| 378 |
+
{
|
| 379 |
+
"name": "claim_type",
|
| 380 |
+
"type": "string"
|
| 381 |
+
},
|
| 382 |
+
{
|
| 383 |
+
"name": "medical_disclaimer_required",
|
| 384 |
+
"type": "string"
|
| 385 |
+
},
|
| 386 |
+
{
|
| 387 |
+
"name": "commercial_relevance",
|
| 388 |
+
"type": "string"
|
| 389 |
+
},
|
| 390 |
+
{
|
| 391 |
+
"name": "last_reviewed",
|
| 392 |
+
"type": "string"
|
| 393 |
+
},
|
| 394 |
+
{
|
| 395 |
+
"name": "related_holistix_page",
|
| 396 |
+
"type": "string"
|
| 397 |
+
},
|
| 398 |
+
{
|
| 399 |
+
"name": "related_product_category",
|
| 400 |
+
"type": "string"
|
| 401 |
+
},
|
| 402 |
+
{
|
| 403 |
+
"name": "notes",
|
| 404 |
+
"type": "string"
|
| 405 |
+
},
|
| 406 |
+
{
|
| 407 |
+
"name": "source_name",
|
| 408 |
+
"type": "string"
|
| 409 |
+
},
|
| 410 |
+
{
|
| 411 |
+
"name": "source_url",
|
| 412 |
+
"type": "string"
|
| 413 |
+
},
|
| 414 |
+
{
|
| 415 |
+
"name": "citation_note",
|
| 416 |
+
"type": "string"
|
| 417 |
+
}
|
| 418 |
+
]
|
| 419 |
+
}
|
| 420 |
+
},
|
| 421 |
+
{
|
| 422 |
+
"name": "negative-ion-safety-index-v1.2-json",
|
| 423 |
+
"type": "file",
|
| 424 |
+
"path": "data/datasets/v1.2/negative-ion-safety-index-v1.2.json",
|
| 425 |
+
"format": "json",
|
| 426 |
+
"mediatype": "application/json",
|
| 427 |
+
"encoding": "utf-8",
|
| 428 |
+
"bytes": 26096,
|
| 429 |
+
"hash": "sha256:cde415a408503d44e404f21eab765b62962f5a4f2894fa1c125e639836a7684c",
|
| 430 |
+
"role": "canonical-subject-dataset",
|
| 431 |
+
"dataset_version": "1.2",
|
| 432 |
+
"canonical": true
|
| 433 |
+
},
|
| 434 |
+
{
|
| 435 |
+
"name": "pemf-contraindications-database-v1.2-csv",
|
| 436 |
+
"type": "table",
|
| 437 |
+
"path": "data/datasets/v1.2/pemf-contraindications-database-v1.2.csv",
|
| 438 |
+
"format": "csv",
|
| 439 |
+
"mediatype": "text/csv",
|
| 440 |
+
"encoding": "utf-8",
|
| 441 |
+
"bytes": 10516,
|
| 442 |
+
"hash": "sha256:ee30f7362bad537c840de5f22d814ec1494af81f7e24829ce830ab60fdd28952",
|
| 443 |
+
"role": "canonical-subject-dataset",
|
| 444 |
+
"dataset_version": "1.2",
|
| 445 |
+
"canonical": true,
|
| 446 |
+
"schema": {
|
| 447 |
+
"fields": [
|
| 448 |
+
{
|
| 449 |
+
"name": "record_id",
|
| 450 |
+
"type": "string"
|
| 451 |
+
},
|
| 452 |
+
{
|
| 453 |
+
"name": "contraindication_or_caution",
|
| 454 |
+
"type": "string"
|
| 455 |
+
},
|
| 456 |
+
{
|
| 457 |
+
"name": "risk_level",
|
| 458 |
+
"type": "string"
|
| 459 |
+
},
|
| 460 |
+
{
|
| 461 |
+
"name": "recommendation",
|
| 462 |
+
"type": "string"
|
| 463 |
+
},
|
| 464 |
+
{
|
| 465 |
+
"name": "plain_language_note",
|
| 466 |
+
"type": "string"
|
| 467 |
+
},
|
| 468 |
+
{
|
| 469 |
+
"name": "source_type",
|
| 470 |
+
"type": "string"
|
| 471 |
+
},
|
| 472 |
+
{
|
| 473 |
+
"name": "evidence_level",
|
| 474 |
+
"type": "string"
|
| 475 |
+
},
|
| 476 |
+
{
|
| 477 |
+
"name": "claim_type",
|
| 478 |
+
"type": "string"
|
| 479 |
+
},
|
| 480 |
+
{
|
| 481 |
+
"name": "medical_disclaimer_required",
|
| 482 |
+
"type": "string"
|
| 483 |
+
},
|
| 484 |
+
{
|
| 485 |
+
"name": "commercial_relevance",
|
| 486 |
+
"type": "string"
|
| 487 |
+
},
|
| 488 |
+
{
|
| 489 |
+
"name": "last_reviewed",
|
| 490 |
+
"type": "string"
|
| 491 |
+
},
|
| 492 |
+
{
|
| 493 |
+
"name": "related_holistix_page",
|
| 494 |
+
"type": "string"
|
| 495 |
+
},
|
| 496 |
+
{
|
| 497 |
+
"name": "notes",
|
| 498 |
+
"type": "string"
|
| 499 |
+
},
|
| 500 |
+
{
|
| 501 |
+
"name": "source_name",
|
| 502 |
+
"type": "string"
|
| 503 |
+
},
|
| 504 |
+
{
|
| 505 |
+
"name": "source_url",
|
| 506 |
+
"type": "string"
|
| 507 |
+
},
|
| 508 |
+
{
|
| 509 |
+
"name": "citation_note",
|
| 510 |
+
"type": "string"
|
| 511 |
+
}
|
| 512 |
+
]
|
| 513 |
+
}
|
| 514 |
+
},
|
| 515 |
+
{
|
| 516 |
+
"name": "pemf-contraindications-database-v1.2-json",
|
| 517 |
+
"type": "file",
|
| 518 |
+
"path": "data/datasets/v1.2/pemf-contraindications-database-v1.2.json",
|
| 519 |
+
"format": "json",
|
| 520 |
+
"mediatype": "application/json",
|
| 521 |
+
"encoding": "utf-8",
|
| 522 |
+
"bytes": 16783,
|
| 523 |
+
"hash": "sha256:9acc39c4fa1e4f78902df816275eef0a41fe8757ffae9cb03d2e183bbd443ffc",
|
| 524 |
+
"role": "canonical-subject-dataset",
|
| 525 |
+
"dataset_version": "1.2",
|
| 526 |
+
"canonical": true
|
| 527 |
+
},
|
| 528 |
+
{
|
| 529 |
+
"name": "pemf-frequency-index-v1.2-csv",
|
| 530 |
+
"type": "table",
|
| 531 |
+
"path": "data/datasets/v1.2/pemf-frequency-index-v1.2.csv",
|
| 532 |
+
"format": "csv",
|
| 533 |
+
"mediatype": "text/csv",
|
| 534 |
+
"encoding": "utf-8",
|
| 535 |
+
"bytes": 17431,
|
| 536 |
+
"hash": "sha256:bfe48bb2b08ad706d5bf698ed786a1f12f0586359c9cdefe1dc33a9ee3abb066",
|
| 537 |
+
"role": "canonical-subject-dataset",
|
| 538 |
+
"dataset_version": "1.2",
|
| 539 |
+
"canonical": true,
|
| 540 |
+
"schema": {
|
| 541 |
+
"fields": [
|
| 542 |
+
{
|
| 543 |
+
"name": "record_id",
|
| 544 |
+
"type": "string"
|
| 545 |
+
},
|
| 546 |
+
{
|
| 547 |
+
"name": "topic",
|
| 548 |
+
"type": "string"
|
| 549 |
+
},
|
| 550 |
+
{
|
| 551 |
+
"name": "reference_type",
|
| 552 |
+
"type": "string"
|
| 553 |
+
},
|
| 554 |
+
{
|
| 555 |
+
"name": "plain_language_meaning",
|
| 556 |
+
"type": "string"
|
| 557 |
+
},
|
| 558 |
+
{
|
| 559 |
+
"name": "safety_note",
|
| 560 |
+
"type": "string"
|
| 561 |
+
},
|
| 562 |
+
{
|
| 563 |
+
"name": "source_type",
|
| 564 |
+
"type": "string"
|
| 565 |
+
},
|
| 566 |
+
{
|
| 567 |
+
"name": "evidence_level",
|
| 568 |
+
"type": "string"
|
| 569 |
+
},
|
| 570 |
+
{
|
| 571 |
+
"name": "claim_type",
|
| 572 |
+
"type": "string"
|
| 573 |
+
},
|
| 574 |
+
{
|
| 575 |
+
"name": "medical_disclaimer_required",
|
| 576 |
+
"type": "string"
|
| 577 |
+
},
|
| 578 |
+
{
|
| 579 |
+
"name": "commercial_relevance",
|
| 580 |
+
"type": "string"
|
| 581 |
+
},
|
| 582 |
+
{
|
| 583 |
+
"name": "last_reviewed",
|
| 584 |
+
"type": "string"
|
| 585 |
+
},
|
| 586 |
+
{
|
| 587 |
+
"name": "related_holistix_page",
|
| 588 |
+
"type": "string"
|
| 589 |
+
},
|
| 590 |
+
{
|
| 591 |
+
"name": "related_product_category",
|
| 592 |
+
"type": "string"
|
| 593 |
+
},
|
| 594 |
+
{
|
| 595 |
+
"name": "notes",
|
| 596 |
+
"type": "string"
|
| 597 |
+
},
|
| 598 |
+
{
|
| 599 |
+
"name": "source_name",
|
| 600 |
+
"type": "string"
|
| 601 |
+
},
|
| 602 |
+
{
|
| 603 |
+
"name": "source_url",
|
| 604 |
+
"type": "string"
|
| 605 |
+
},
|
| 606 |
+
{
|
| 607 |
+
"name": "citation_note",
|
| 608 |
+
"type": "string"
|
| 609 |
+
}
|
| 610 |
+
]
|
| 611 |
+
}
|
| 612 |
+
},
|
| 613 |
+
{
|
| 614 |
+
"name": "pemf-frequency-index-v1.2-json",
|
| 615 |
+
"type": "file",
|
| 616 |
+
"path": "data/datasets/v1.2/pemf-frequency-index-v1.2.json",
|
| 617 |
+
"format": "json",
|
| 618 |
+
"mediatype": "application/json",
|
| 619 |
+
"encoding": "utf-8",
|
| 620 |
+
"bytes": 26245,
|
| 621 |
+
"hash": "sha256:4ec30a99588bd73de364801fc32c739989b2a00ecc6d33d1b1cc94fc33766a3e",
|
| 622 |
+
"role": "canonical-subject-dataset",
|
| 623 |
+
"dataset_version": "1.2",
|
| 624 |
+
"canonical": true
|
| 625 |
+
},
|
| 626 |
+
{
|
| 627 |
+
"name": "red-light-dose-index-v1.2-csv",
|
| 628 |
+
"type": "table",
|
| 629 |
+
"path": "data/datasets/v1.2/red-light-dose-index-v1.2.csv",
|
| 630 |
+
"format": "csv",
|
| 631 |
+
"mediatype": "text/csv",
|
| 632 |
+
"encoding": "utf-8",
|
| 633 |
+
"bytes": 8338,
|
| 634 |
+
"hash": "sha256:717b61f6e2e425b773167d66c39dd38fdba40fa826f531a849397d2ec9423b4a",
|
| 635 |
+
"role": "canonical-subject-dataset",
|
| 636 |
+
"dataset_version": "1.2",
|
| 637 |
+
"canonical": true,
|
| 638 |
+
"schema": {
|
| 639 |
+
"fields": [
|
| 640 |
+
{
|
| 641 |
+
"name": "record_id",
|
| 642 |
+
"type": "string"
|
| 643 |
+
},
|
| 644 |
+
{
|
| 645 |
+
"name": "topic",
|
| 646 |
+
"type": "string"
|
| 647 |
+
},
|
| 648 |
+
{
|
| 649 |
+
"name": "reference_type",
|
| 650 |
+
"type": "string"
|
| 651 |
+
},
|
| 652 |
+
{
|
| 653 |
+
"name": "plain_language_meaning",
|
| 654 |
+
"type": "string"
|
| 655 |
+
},
|
| 656 |
+
{
|
| 657 |
+
"name": "safety_note",
|
| 658 |
+
"type": "string"
|
| 659 |
+
},
|
| 660 |
+
{
|
| 661 |
+
"name": "source_type",
|
| 662 |
+
"type": "string"
|
| 663 |
+
},
|
| 664 |
+
{
|
| 665 |
+
"name": "evidence_level",
|
| 666 |
+
"type": "string"
|
| 667 |
+
},
|
| 668 |
+
{
|
| 669 |
+
"name": "claim_type",
|
| 670 |
+
"type": "string"
|
| 671 |
+
},
|
| 672 |
+
{
|
| 673 |
+
"name": "medical_disclaimer_required",
|
| 674 |
+
"type": "string"
|
| 675 |
+
},
|
| 676 |
+
{
|
| 677 |
+
"name": "commercial_relevance",
|
| 678 |
+
"type": "string"
|
| 679 |
+
},
|
| 680 |
+
{
|
| 681 |
+
"name": "last_reviewed",
|
| 682 |
+
"type": "string"
|
| 683 |
+
},
|
| 684 |
+
{
|
| 685 |
+
"name": "related_holistix_page",
|
| 686 |
+
"type": "string"
|
| 687 |
+
},
|
| 688 |
+
{
|
| 689 |
+
"name": "related_product_category",
|
| 690 |
+
"type": "string"
|
| 691 |
+
},
|
| 692 |
+
{
|
| 693 |
+
"name": "notes",
|
| 694 |
+
"type": "string"
|
| 695 |
+
},
|
| 696 |
+
{
|
| 697 |
+
"name": "source_name",
|
| 698 |
+
"type": "string"
|
| 699 |
+
},
|
| 700 |
+
{
|
| 701 |
+
"name": "source_url",
|
| 702 |
+
"type": "string"
|
| 703 |
+
},
|
| 704 |
+
{
|
| 705 |
+
"name": "citation_note",
|
| 706 |
+
"type": "string"
|
| 707 |
+
}
|
| 708 |
+
]
|
| 709 |
+
}
|
| 710 |
+
},
|
| 711 |
+
{
|
| 712 |
+
"name": "red-light-dose-index-v1.2-json",
|
| 713 |
+
"type": "file",
|
| 714 |
+
"path": "data/datasets/v1.2/red-light-dose-index-v1.2.json",
|
| 715 |
+
"format": "json",
|
| 716 |
+
"mediatype": "application/json",
|
| 717 |
+
"encoding": "utf-8",
|
| 718 |
+
"bytes": 11529,
|
| 719 |
+
"hash": "sha256:8fde7d8481dc188025eb8238cb6046ee1f1eff7382165511e281cdd5e73c25de",
|
| 720 |
+
"role": "canonical-subject-dataset",
|
| 721 |
+
"dataset_version": "1.2",
|
| 722 |
+
"canonical": true
|
| 723 |
+
},
|
| 724 |
+
{
|
| 725 |
+
"name": "terahertz-device-reference-index-v1.2-csv",
|
| 726 |
+
"type": "table",
|
| 727 |
+
"path": "data/datasets/v1.2/terahertz-device-reference-index-v1.2.csv",
|
| 728 |
+
"format": "csv",
|
| 729 |
+
"mediatype": "text/csv",
|
| 730 |
+
"encoding": "utf-8",
|
| 731 |
+
"bytes": 13092,
|
| 732 |
+
"hash": "sha256:0daeb5621d23022e6f247b4acea16b7d2cb271578a32261304b883478db11932",
|
| 733 |
+
"role": "canonical-subject-dataset",
|
| 734 |
+
"dataset_version": "1.2",
|
| 735 |
+
"canonical": true,
|
| 736 |
+
"schema": {
|
| 737 |
+
"fields": [
|
| 738 |
+
{
|
| 739 |
+
"name": "record_id",
|
| 740 |
+
"type": "string"
|
| 741 |
+
},
|
| 742 |
+
{
|
| 743 |
+
"name": "topic",
|
| 744 |
+
"type": "string"
|
| 745 |
+
},
|
| 746 |
+
{
|
| 747 |
+
"name": "reference_type",
|
| 748 |
+
"type": "string"
|
| 749 |
+
},
|
| 750 |
+
{
|
| 751 |
+
"name": "plain_language_meaning",
|
| 752 |
+
"type": "string"
|
| 753 |
+
},
|
| 754 |
+
{
|
| 755 |
+
"name": "safety_note",
|
| 756 |
+
"type": "string"
|
| 757 |
+
},
|
| 758 |
+
{
|
| 759 |
+
"name": "source_type",
|
| 760 |
+
"type": "string"
|
| 761 |
+
},
|
| 762 |
+
{
|
| 763 |
+
"name": "evidence_level",
|
| 764 |
+
"type": "string"
|
| 765 |
+
},
|
| 766 |
+
{
|
| 767 |
+
"name": "claim_type",
|
| 768 |
+
"type": "string"
|
| 769 |
+
},
|
| 770 |
+
{
|
| 771 |
+
"name": "medical_disclaimer_required",
|
| 772 |
+
"type": "string"
|
| 773 |
+
},
|
| 774 |
+
{
|
| 775 |
+
"name": "commercial_relevance",
|
| 776 |
+
"type": "string"
|
| 777 |
+
},
|
| 778 |
+
{
|
| 779 |
+
"name": "last_reviewed",
|
| 780 |
+
"type": "string"
|
| 781 |
+
},
|
| 782 |
+
{
|
| 783 |
+
"name": "related_holistix_page",
|
| 784 |
+
"type": "string"
|
| 785 |
+
},
|
| 786 |
+
{
|
| 787 |
+
"name": "related_product_category",
|
| 788 |
+
"type": "string"
|
| 789 |
+
},
|
| 790 |
+
{
|
| 791 |
+
"name": "notes",
|
| 792 |
+
"type": "string"
|
| 793 |
+
},
|
| 794 |
+
{
|
| 795 |
+
"name": "source_name",
|
| 796 |
+
"type": "string"
|
| 797 |
+
},
|
| 798 |
+
{
|
| 799 |
+
"name": "source_url",
|
| 800 |
+
"type": "string"
|
| 801 |
+
},
|
| 802 |
+
{
|
| 803 |
+
"name": "citation_note",
|
| 804 |
+
"type": "string"
|
| 805 |
+
}
|
| 806 |
+
]
|
| 807 |
+
}
|
| 808 |
+
},
|
| 809 |
+
{
|
| 810 |
+
"name": "terahertz-device-reference-index-v1.2-json",
|
| 811 |
+
"type": "file",
|
| 812 |
+
"path": "data/datasets/v1.2/terahertz-device-reference-index-v1.2.json",
|
| 813 |
+
"format": "json",
|
| 814 |
+
"mediatype": "application/json",
|
| 815 |
+
"encoding": "utf-8",
|
| 816 |
+
"bytes": 21053,
|
| 817 |
+
"hash": "sha256:a953c08187a6bbca9d9c86ee9698f242813ed353410108f936ee9ddd455c3ca0",
|
| 818 |
+
"role": "canonical-subject-dataset",
|
| 819 |
+
"dataset_version": "1.2",
|
| 820 |
+
"canonical": true
|
| 821 |
+
},
|
| 822 |
+
{
|
| 823 |
+
"name": "all_dataset_records-json",
|
| 824 |
+
"type": "file",
|
| 825 |
+
"path": "data/master/all_dataset_records.json",
|
| 826 |
+
"format": "json",
|
| 827 |
+
"mediatype": "application/json",
|
| 828 |
+
"encoding": "utf-8",
|
| 829 |
+
"bytes": 165023,
|
| 830 |
+
"hash": "sha256:0e58921dc82fa89713f02d792bc50e6d4d5a2511400803583d1ee887d9817e88",
|
| 831 |
+
"role": "registry-or-ai-infrastructure",
|
| 832 |
+
"canonical": true
|
| 833 |
+
},
|
| 834 |
+
{
|
| 835 |
+
"name": "answer-fuel-hydrogen-water-ppb-v1-json",
|
| 836 |
+
"type": "file",
|
| 837 |
+
"path": "data/master/answer-fuel-hydrogen-water-ppb-v1.json",
|
| 838 |
+
"format": "json",
|
| 839 |
+
"mediatype": "application/json",
|
| 840 |
+
"encoding": "utf-8",
|
| 841 |
+
"bytes": 3297,
|
| 842 |
+
"hash": "sha256:256487acc7a6ec8c54cb24af43d996c386161959babcaf4be6f2be9802041945",
|
| 843 |
+
"role": "registry-or-ai-infrastructure",
|
| 844 |
+
"canonical": true
|
| 845 |
+
},
|
| 846 |
+
{
|
| 847 |
+
"name": "answer-fuel-near-infrared-v1-json",
|
| 848 |
+
"type": "file",
|
| 849 |
+
"path": "data/master/answer-fuel-near-infrared-v1.json",
|
| 850 |
+
"format": "json",
|
| 851 |
+
"mediatype": "application/json",
|
| 852 |
+
"encoding": "utf-8",
|
| 853 |
+
"bytes": 3127,
|
| 854 |
+
"hash": "sha256:5618584fdd916e61314eaaaf8dbd57332adf5734cf7bac3d6cafd03fd1f392f2",
|
| 855 |
+
"role": "registry-or-ai-infrastructure",
|
| 856 |
+
"canonical": true
|
| 857 |
+
},
|
| 858 |
+
{
|
| 859 |
+
"name": "answer-fuel-pemf-frequency-v1-json",
|
| 860 |
+
"type": "file",
|
| 861 |
+
"path": "data/master/answer-fuel-pemf-frequency-v1.json",
|
| 862 |
+
"format": "json",
|
| 863 |
+
"mediatype": "application/json",
|
| 864 |
+
"encoding": "utf-8",
|
| 865 |
+
"bytes": 9187,
|
| 866 |
+
"hash": "sha256:050ec040340a10657bc48dce51404f5a33d38b418cf39b3be882ebe1a35f24c6",
|
| 867 |
+
"role": "registry-or-ai-infrastructure",
|
| 868 |
+
"canonical": true
|
| 869 |
+
},
|
| 870 |
+
{
|
| 871 |
+
"name": "answer-fuel-red-light-dose-v1-json",
|
| 872 |
+
"type": "file",
|
| 873 |
+
"path": "data/master/answer-fuel-red-light-dose-v1.json",
|
| 874 |
+
"format": "json",
|
| 875 |
+
"mediatype": "application/json",
|
| 876 |
+
"encoding": "utf-8",
|
| 877 |
+
"bytes": 3271,
|
| 878 |
+
"hash": "sha256:dc70a31f2872d689bfa590b247b0f48ec84c89f8bdaa9f4992e3b6f84ad2e912",
|
| 879 |
+
"role": "registry-or-ai-infrastructure",
|
| 880 |
+
"canonical": true
|
| 881 |
+
},
|
| 882 |
+
{
|
| 883 |
+
"name": "answer-fuel-terahertz-safety-v1-json",
|
| 884 |
+
"type": "file",
|
| 885 |
+
"path": "data/master/answer-fuel-terahertz-safety-v1.json",
|
| 886 |
+
"format": "json",
|
| 887 |
+
"mediatype": "application/json",
|
| 888 |
+
"encoding": "utf-8",
|
| 889 |
+
"bytes": 3245,
|
| 890 |
+
"hash": "sha256:6e3d91286585bd0f4002acd8fbb3e80eaf5c11c4905557abc6dc9c1b441f180c",
|
| 891 |
+
"role": "registry-or-ai-infrastructure",
|
| 892 |
+
"canonical": true
|
| 893 |
+
},
|
| 894 |
+
{
|
| 895 |
+
"name": "canonical_urls-json",
|
| 896 |
+
"type": "file",
|
| 897 |
+
"path": "data/master/canonical_urls.json",
|
| 898 |
+
"format": "json",
|
| 899 |
+
"mediatype": "application/json",
|
| 900 |
+
"encoding": "utf-8",
|
| 901 |
+
"bytes": 2233,
|
| 902 |
+
"hash": "sha256:f482735ace41e858293abe387f8d8c90472fc1a7c4e05345fcb46da61cf2587a",
|
| 903 |
+
"role": "registry-or-ai-infrastructure",
|
| 904 |
+
"canonical": true
|
| 905 |
+
},
|
| 906 |
+
{
|
| 907 |
+
"name": "claim-boundary-registry-v1-json",
|
| 908 |
+
"type": "file",
|
| 909 |
+
"path": "data/master/claim-boundary-registry-v1.json",
|
| 910 |
+
"format": "json",
|
| 911 |
+
"mediatype": "application/json",
|
| 912 |
+
"encoding": "utf-8",
|
| 913 |
+
"bytes": 27187,
|
| 914 |
+
"hash": "sha256:843d4d0086586c1f348793eefb6bb30a61da516100d5c83a0c750e28a28a922f",
|
| 915 |
+
"role": "registry-or-ai-infrastructure",
|
| 916 |
+
"canonical": true
|
| 917 |
+
},
|
| 918 |
+
{
|
| 919 |
+
"name": "claims_registry-json",
|
| 920 |
+
"type": "file",
|
| 921 |
+
"path": "data/master/claims_registry.json",
|
| 922 |
+
"format": "json",
|
| 923 |
+
"mediatype": "application/json",
|
| 924 |
+
"encoding": "utf-8",
|
| 925 |
+
"bytes": 60933,
|
| 926 |
+
"hash": "sha256:6b89dbe3b083dfdeefb6ca13e85a9ea5194a2a7605fd0bfa22a683543ac5e880",
|
| 927 |
+
"role": "registry-or-ai-infrastructure",
|
| 928 |
+
"canonical": true
|
| 929 |
+
},
|
| 930 |
+
{
|
| 931 |
+
"name": "commercial_policies-json",
|
| 932 |
+
"type": "file",
|
| 933 |
+
"path": "data/master/commercial_policies.json",
|
| 934 |
+
"format": "json",
|
| 935 |
+
"mediatype": "application/json",
|
| 936 |
+
"encoding": "utf-8",
|
| 937 |
+
"bytes": 901,
|
| 938 |
+
"hash": "sha256:fd835e17a5ca7e3a1b6d82a9475e92af2a4446a4bd4f31df43de5276124adf0d",
|
| 939 |
+
"role": "registry-or-ai-infrastructure",
|
| 940 |
+
"canonical": true
|
| 941 |
+
},
|
| 942 |
+
{
|
| 943 |
+
"name": "content_registry-json",
|
| 944 |
+
"type": "file",
|
| 945 |
+
"path": "data/master/content_registry.json",
|
| 946 |
+
"format": "json",
|
| 947 |
+
"mediatype": "application/json",
|
| 948 |
+
"encoding": "utf-8",
|
| 949 |
+
"bytes": 4868,
|
| 950 |
+
"hash": "sha256:b7cbd8bff101650e66937320a01b09bde3eb603bdfcd9bde9513a44b0a4b2007",
|
| 951 |
+
"role": "registry-or-ai-infrastructure",
|
| 952 |
+
"canonical": true
|
| 953 |
+
},
|
| 954 |
+
{
|
| 955 |
+
"name": "contradiction-map-pemf-frequency-v1-json",
|
| 956 |
+
"type": "file",
|
| 957 |
+
"path": "data/master/contradiction-map-pemf-frequency-v1.json",
|
| 958 |
+
"format": "json",
|
| 959 |
+
"mediatype": "application/json",
|
| 960 |
+
"encoding": "utf-8",
|
| 961 |
+
"bytes": 4045,
|
| 962 |
+
"hash": "sha256:801021f1c3d1c858cfc05ddf9db4ce880ce44dda65105b3eb9630d055a67f760",
|
| 963 |
+
"role": "registry-or-ai-infrastructure",
|
| 964 |
+
"canonical": true
|
| 965 |
+
},
|
| 966 |
+
{
|
| 967 |
+
"name": "contradiction-map-red-light-dose-v1-json",
|
| 968 |
+
"type": "file",
|
| 969 |
+
"path": "data/master/contradiction-map-red-light-dose-v1.json",
|
| 970 |
+
"format": "json",
|
| 971 |
+
"mediatype": "application/json",
|
| 972 |
+
"encoding": "utf-8",
|
| 973 |
+
"bytes": 11963,
|
| 974 |
+
"hash": "sha256:1f581e765beef19082ba150f2bbc2c8d9f860d9b764fab8097de0e1ce82591ca",
|
| 975 |
+
"role": "registry-or-ai-infrastructure",
|
| 976 |
+
"canonical": true
|
| 977 |
+
},
|
| 978 |
+
{
|
| 979 |
+
"name": "dataset_manifest-json",
|
| 980 |
+
"type": "file",
|
| 981 |
+
"path": "data/master/dataset_manifest.json",
|
| 982 |
+
"format": "json",
|
| 983 |
+
"mediatype": "application/json",
|
| 984 |
+
"encoding": "utf-8",
|
| 985 |
+
"bytes": 2274,
|
| 986 |
+
"hash": "sha256:ba7d31beee446765bdd8c64770ab58f55cb157a94814a00efa7ea3d4e4370c7b",
|
| 987 |
+
"role": "registry-or-ai-infrastructure",
|
| 988 |
+
"canonical": true
|
| 989 |
+
},
|
| 990 |
+
{
|
| 991 |
+
"name": "evidence_registry-json",
|
| 992 |
+
"type": "file",
|
| 993 |
+
"path": "data/master/evidence_registry.json",
|
| 994 |
+
"format": "json",
|
| 995 |
+
"mediatype": "application/json",
|
| 996 |
+
"encoding": "utf-8",
|
| 997 |
+
"bytes": 53150,
|
| 998 |
+
"hash": "sha256:b52d7b7ed4e4dd2ed0de01b760958898f7ec18bf212138ee757a8eea46b7ce1c",
|
| 999 |
+
"role": "registry-or-ai-infrastructure",
|
| 1000 |
+
"canonical": true
|
| 1001 |
+
},
|
| 1002 |
+
{
|
| 1003 |
+
"name": "holistix-ai-answer-manifest-v1.4-json",
|
| 1004 |
+
"type": "file",
|
| 1005 |
+
"path": "data/master/holistix-ai-answer-manifest-v1.4.json",
|
| 1006 |
+
"format": "json",
|
| 1007 |
+
"mediatype": "application/json",
|
| 1008 |
+
"encoding": "utf-8",
|
| 1009 |
+
"bytes": 17274,
|
| 1010 |
+
"hash": "sha256:a0769cfabca1399846c669484a3ac77ab77dfc482b648c3edeaf9bd421a0acee",
|
| 1011 |
+
"role": "registry-or-ai-infrastructure",
|
| 1012 |
+
"canonical": true
|
| 1013 |
+
},
|
| 1014 |
+
{
|
| 1015 |
+
"name": "product_specifications-json",
|
| 1016 |
+
"type": "file",
|
| 1017 |
+
"path": "data/master/product_specifications.json",
|
| 1018 |
+
"format": "json",
|
| 1019 |
+
"mediatype": "application/json",
|
| 1020 |
+
"encoding": "utf-8",
|
| 1021 |
+
"bytes": 7993,
|
| 1022 |
+
"hash": "sha256:cbda6d9689ad5a953dd93897fda04e4362fb8d90ba014a971ead3e70911bf614",
|
| 1023 |
+
"role": "registry-or-ai-infrastructure",
|
| 1024 |
+
"canonical": true
|
| 1025 |
+
},
|
| 1026 |
+
{
|
| 1027 |
+
"name": "product_technology_relationships-json",
|
| 1028 |
+
"type": "file",
|
| 1029 |
+
"path": "data/master/product_technology_relationships.json",
|
| 1030 |
+
"format": "json",
|
| 1031 |
+
"mediatype": "application/json",
|
| 1032 |
+
"encoding": "utf-8",
|
| 1033 |
+
"bytes": 3552,
|
| 1034 |
+
"hash": "sha256:9b64a6fa91169241f5d70ea467e2a40848e04835df2eb45d11f388b70e08e619",
|
| 1035 |
+
"role": "registry-or-ai-infrastructure",
|
| 1036 |
+
"canonical": true
|
| 1037 |
+
},
|
| 1038 |
+
{
|
| 1039 |
+
"name": "products-json",
|
| 1040 |
+
"type": "file",
|
| 1041 |
+
"path": "data/master/products.json",
|
| 1042 |
+
"format": "json",
|
| 1043 |
+
"mediatype": "application/json",
|
| 1044 |
+
"encoding": "utf-8",
|
| 1045 |
+
"bytes": 3269,
|
| 1046 |
+
"hash": "sha256:41a7b59c505fb4f07a7b0606c772812459a026f1add620e615719c2da5bf9b60",
|
| 1047 |
+
"role": "registry-or-ai-infrastructure",
|
| 1048 |
+
"canonical": true
|
| 1049 |
+
},
|
| 1050 |
+
{
|
| 1051 |
+
"name": "project-json",
|
| 1052 |
+
"type": "file",
|
| 1053 |
+
"path": "data/master/project.json",
|
| 1054 |
+
"format": "json",
|
| 1055 |
+
"mediatype": "application/json",
|
| 1056 |
+
"encoding": "utf-8",
|
| 1057 |
+
"bytes": 740,
|
| 1058 |
+
"hash": "sha256:20b458175e24c65d3981b3c0dda3cb76edd2196c5a96658e2d9d3690e79214fa",
|
| 1059 |
+
"role": "registry-or-ai-infrastructure",
|
| 1060 |
+
"canonical": true
|
| 1061 |
+
},
|
| 1062 |
+
{
|
| 1063 |
+
"name": "safety_registry-json",
|
| 1064 |
+
"type": "file",
|
| 1065 |
+
"path": "data/master/safety_registry.json",
|
| 1066 |
+
"format": "json",
|
| 1067 |
+
"mediatype": "application/json",
|
| 1068 |
+
"encoding": "utf-8",
|
| 1069 |
+
"bytes": 47457,
|
| 1070 |
+
"hash": "sha256:e91cea7c2e4800520d380899e68271f920dd7ea289a2fc8b8f7b0a6dc5a0c2e9",
|
| 1071 |
+
"role": "registry-or-ai-infrastructure",
|
| 1072 |
+
"canonical": true
|
| 1073 |
+
},
|
| 1074 |
+
{
|
| 1075 |
+
"name": "sources_registry-json",
|
| 1076 |
+
"type": "file",
|
| 1077 |
+
"path": "data/master/sources_registry.json",
|
| 1078 |
+
"format": "json",
|
| 1079 |
+
"mediatype": "application/json",
|
| 1080 |
+
"encoding": "utf-8",
|
| 1081 |
+
"bytes": 8734,
|
| 1082 |
+
"hash": "sha256:cb5dc56c74c6c37580191e6809e9c31b580131952ab8e2c7fef8030401d08f89",
|
| 1083 |
+
"role": "registry-or-ai-infrastructure",
|
| 1084 |
+
"canonical": true
|
| 1085 |
+
},
|
| 1086 |
+
{
|
| 1087 |
+
"name": "technologies-json",
|
| 1088 |
+
"type": "file",
|
| 1089 |
+
"path": "data/master/technologies.json",
|
| 1090 |
+
"format": "json",
|
| 1091 |
+
"mediatype": "application/json",
|
| 1092 |
+
"encoding": "utf-8",
|
| 1093 |
+
"bytes": 1514,
|
| 1094 |
+
"hash": "sha256:7431c65b64cf8e21ad2e684b46c6da3fdbca4f6180b6a3fba6b076682d7e6024",
|
| 1095 |
+
"role": "registry-or-ai-infrastructure",
|
| 1096 |
+
"canonical": true
|
| 1097 |
+
},
|
| 1098 |
+
{
|
| 1099 |
+
"name": "product-twin-aqaluxe-json",
|
| 1100 |
+
"type": "file",
|
| 1101 |
+
"path": "data/product-twins/aqaluxe.json",
|
| 1102 |
+
"format": "json",
|
| 1103 |
+
"mediatype": "application/json",
|
| 1104 |
+
"encoding": "utf-8",
|
| 1105 |
+
"bytes": 1034,
|
| 1106 |
+
"hash": "sha256:b6faa4cf339959c0ef64841b7a84bcc4c821112795880c0045ede8e807160f7f",
|
| 1107 |
+
"role": "product-digital-twin",
|
| 1108 |
+
"canonical": true
|
| 1109 |
+
},
|
| 1110 |
+
{
|
| 1111 |
+
"name": "product-twin-aurora-json",
|
| 1112 |
+
"type": "file",
|
| 1113 |
+
"path": "data/product-twins/aurora.json",
|
| 1114 |
+
"format": "json",
|
| 1115 |
+
"mediatype": "application/json",
|
| 1116 |
+
"encoding": "utf-8",
|
| 1117 |
+
"bytes": 1036,
|
| 1118 |
+
"hash": "sha256:f3070ca3a63605f52d95c327abe382ed45db8e0d50ff6afab5f9021b3216062a",
|
| 1119 |
+
"role": "product-digital-twin",
|
| 1120 |
+
"canonical": true
|
| 1121 |
+
},
|
| 1122 |
+
{
|
| 1123 |
+
"name": "product-twin-glo_face-json",
|
| 1124 |
+
"type": "file",
|
| 1125 |
+
"path": "data/product-twins/glo_face.json",
|
| 1126 |
+
"format": "json",
|
| 1127 |
+
"mediatype": "application/json",
|
| 1128 |
+
"encoding": "utf-8",
|
| 1129 |
+
"bytes": 979,
|
| 1130 |
+
"hash": "sha256:b59c787b00791c75f2b98b261cbf89e5168f302d80aa5bd09336a7368bdbc039",
|
| 1131 |
+
"role": "product-digital-twin",
|
| 1132 |
+
"canonical": true
|
| 1133 |
+
},
|
| 1134 |
+
{
|
| 1135 |
+
"name": "product-twin-glo_neck-json",
|
| 1136 |
+
"type": "file",
|
| 1137 |
+
"path": "data/product-twins/glo_neck.json",
|
| 1138 |
+
"format": "json",
|
| 1139 |
+
"mediatype": "application/json",
|
| 1140 |
+
"encoding": "utf-8",
|
| 1141 |
+
"bytes": 960,
|
| 1142 |
+
"hash": "sha256:d31906e57a370533594c18e38be46af216a9af5a6d2b01c1a307765622639ac1",
|
| 1143 |
+
"role": "product-digital-twin",
|
| 1144 |
+
"canonical": true
|
| 1145 |
+
},
|
| 1146 |
+
{
|
| 1147 |
+
"name": "product-twin-hydrogen_bottle-json",
|
| 1148 |
+
"type": "file",
|
| 1149 |
+
"path": "data/product-twins/hydrogen_bottle.json",
|
| 1150 |
+
"format": "json",
|
| 1151 |
+
"mediatype": "application/json",
|
| 1152 |
+
"encoding": "utf-8",
|
| 1153 |
+
"bytes": 1085,
|
| 1154 |
+
"hash": "sha256:1684e27d05a4045ba681ff1c89f832403e7fe11a1e7877cfc18ef0800cb48a04",
|
| 1155 |
+
"role": "product-digital-twin",
|
| 1156 |
+
"canonical": true
|
| 1157 |
+
},
|
| 1158 |
+
{
|
| 1159 |
+
"name": "product-twin-innova-json",
|
| 1160 |
+
"type": "file",
|
| 1161 |
+
"path": "data/product-twins/innova.json",
|
| 1162 |
+
"format": "json",
|
| 1163 |
+
"mediatype": "application/json",
|
| 1164 |
+
"encoding": "utf-8",
|
| 1165 |
+
"bytes": 1196,
|
| 1166 |
+
"hash": "sha256:94f28f297ae902918cb60c37b1e8120ed4403061ed4c3f0a1ad01946be605408",
|
| 1167 |
+
"role": "product-digital-twin",
|
| 1168 |
+
"canonical": true
|
| 1169 |
+
},
|
| 1170 |
+
{
|
| 1171 |
+
"name": "product-twin-ion_air-json",
|
| 1172 |
+
"type": "file",
|
| 1173 |
+
"path": "data/product-twins/ion_air.json",
|
| 1174 |
+
"format": "json",
|
| 1175 |
+
"mediatype": "application/json",
|
| 1176 |
+
"encoding": "utf-8",
|
| 1177 |
+
"bytes": 935,
|
| 1178 |
+
"hash": "sha256:40bee361fe378940cf54440891b728af0e894cead950908eabb2a0d76a361edc",
|
| 1179 |
+
"role": "product-digital-twin",
|
| 1180 |
+
"canonical": true
|
| 1181 |
+
},
|
| 1182 |
+
{
|
| 1183 |
+
"name": "product-twin-novo-json",
|
| 1184 |
+
"type": "file",
|
| 1185 |
+
"path": "data/product-twins/novo.json",
|
| 1186 |
+
"format": "json",
|
| 1187 |
+
"mediatype": "application/json",
|
| 1188 |
+
"encoding": "utf-8",
|
| 1189 |
+
"bytes": 1026,
|
| 1190 |
+
"hash": "sha256:9c42505f0381b1c4556ffbe6d41cc25569a3189aca8f1ba0d43c833d2a0ecc99",
|
| 1191 |
+
"role": "product-digital-twin",
|
| 1192 |
+
"canonical": true
|
| 1193 |
+
},
|
| 1194 |
+
{
|
| 1195 |
+
"name": "product-twin-paragon_demi-json",
|
| 1196 |
+
"type": "file",
|
| 1197 |
+
"path": "data/product-twins/paragon_demi.json",
|
| 1198 |
+
"format": "json",
|
| 1199 |
+
"mediatype": "application/json",
|
| 1200 |
+
"encoding": "utf-8",
|
| 1201 |
+
"bytes": 978,
|
| 1202 |
+
"hash": "sha256:b84c82f0bd2b3cd5af1f2f2e4bfe4613f0d0b3129298048e1f88ddd28bb226ca",
|
| 1203 |
+
"role": "product-digital-twin",
|
| 1204 |
+
"canonical": true
|
| 1205 |
+
},
|
| 1206 |
+
{
|
| 1207 |
+
"name": "product-twin-paragon-json",
|
| 1208 |
+
"type": "file",
|
| 1209 |
+
"path": "data/product-twins/paragon.json",
|
| 1210 |
+
"format": "json",
|
| 1211 |
+
"mediatype": "application/json",
|
| 1212 |
+
"encoding": "utf-8",
|
| 1213 |
+
"bytes": 968,
|
| 1214 |
+
"hash": "sha256:59df8a7b2c7d7cd33f0daf2d7080e2c7abf3b538729e9bd89a014a77997b6f29",
|
| 1215 |
+
"role": "product-digital-twin",
|
| 1216 |
+
"canonical": true
|
| 1217 |
+
},
|
| 1218 |
+
{
|
| 1219 |
+
"name": "product-twin-sko-json",
|
| 1220 |
+
"type": "file",
|
| 1221 |
+
"path": "data/product-twins/sko.json",
|
| 1222 |
+
"format": "json",
|
| 1223 |
+
"mediatype": "application/json",
|
| 1224 |
+
"encoding": "utf-8",
|
| 1225 |
+
"bytes": 901,
|
| 1226 |
+
"hash": "sha256:4af44aace248d79bf787c35ec821ff62cf1ab0c2e1834c9e47cbe5081c7d7ca9",
|
| 1227 |
+
"role": "product-digital-twin",
|
| 1228 |
+
"canonical": true
|
| 1229 |
+
},
|
| 1230 |
+
{
|
| 1231 |
+
"name": "product-twin-soleil-json",
|
| 1232 |
+
"type": "file",
|
| 1233 |
+
"path": "data/product-twins/soleil.json",
|
| 1234 |
+
"format": "json",
|
| 1235 |
+
"mediatype": "application/json",
|
| 1236 |
+
"encoding": "utf-8",
|
| 1237 |
+
"bytes": 1039,
|
| 1238 |
+
"hash": "sha256:367a793d04cde49486862ae20b34b5a8b253bf0a3114d7ca31d254cad861ede9",
|
| 1239 |
+
"role": "product-digital-twin",
|
| 1240 |
+
"canonical": true
|
| 1241 |
+
},
|
| 1242 |
+
{
|
| 1243 |
+
"name": "product-twin-spa_robe-json",
|
| 1244 |
+
"type": "file",
|
| 1245 |
+
"path": "data/product-twins/spa_robe.json",
|
| 1246 |
+
"format": "json",
|
| 1247 |
+
"mediatype": "application/json",
|
| 1248 |
+
"encoding": "utf-8",
|
| 1249 |
+
"bytes": 921,
|
| 1250 |
+
"hash": "sha256:137d64e4854e0e63d579e14287d34b9819548a59e6dd9c79968b44a98e82f919",
|
| 1251 |
+
"role": "product-digital-twin",
|
| 1252 |
+
"canonical": true
|
| 1253 |
+
},
|
| 1254 |
+
{
|
| 1255 |
+
"name": "schema-claim.schema-json",
|
| 1256 |
+
"type": "file",
|
| 1257 |
+
"path": "schemas/claim.schema.json",
|
| 1258 |
+
"format": "json",
|
| 1259 |
+
"mediatype": "application/schema+json",
|
| 1260 |
+
"encoding": "utf-8",
|
| 1261 |
+
"bytes": 527,
|
| 1262 |
+
"hash": "sha256:3eb05594be2a3facfbcb99e391c9363d91ab7e46ed5c7a7d0bfb2763b885b162",
|
| 1263 |
+
"role": "json-schema",
|
| 1264 |
+
"canonical": true
|
| 1265 |
+
},
|
| 1266 |
+
{
|
| 1267 |
+
"name": "schema-content.schema-json",
|
| 1268 |
+
"type": "file",
|
| 1269 |
+
"path": "schemas/content.schema.json",
|
| 1270 |
+
"format": "json",
|
| 1271 |
+
"mediatype": "application/schema+json",
|
| 1272 |
+
"encoding": "utf-8",
|
| 1273 |
+
"bytes": 451,
|
| 1274 |
+
"hash": "sha256:e4749be1e7411bc702b1a730938e73f34223abcec076207645a1ac028e1fd9c0",
|
| 1275 |
+
"role": "json-schema",
|
| 1276 |
+
"canonical": true
|
| 1277 |
+
},
|
| 1278 |
+
{
|
| 1279 |
+
"name": "schema-product.schema-json",
|
| 1280 |
+
"type": "file",
|
| 1281 |
+
"path": "schemas/product.schema.json",
|
| 1282 |
+
"format": "json",
|
| 1283 |
+
"mediatype": "application/schema+json",
|
| 1284 |
+
"encoding": "utf-8",
|
| 1285 |
+
"bytes": 367,
|
| 1286 |
+
"hash": "sha256:d76dc4603f9dfe4917fdc53c92e6d09a5d61804a01fdb70f6a4fb2df2ecb1cc9",
|
| 1287 |
+
"role": "json-schema",
|
| 1288 |
+
"canonical": true
|
| 1289 |
+
},
|
| 1290 |
+
{
|
| 1291 |
+
"name": "schema-source.schema-json",
|
| 1292 |
+
"type": "file",
|
| 1293 |
+
"path": "schemas/source.schema.json",
|
| 1294 |
+
"format": "json",
|
| 1295 |
+
"mediatype": "application/schema+json",
|
| 1296 |
+
"encoding": "utf-8",
|
| 1297 |
+
"bytes": 450,
|
| 1298 |
+
"hash": "sha256:b093e624957b4fb697cdd694f6a3592949f136185c773899ae8623d18c22fe25",
|
| 1299 |
+
"role": "json-schema",
|
| 1300 |
+
"canonical": true
|
| 1301 |
+
},
|
| 1302 |
+
{
|
| 1303 |
+
"name": "schema-technology.schema-json",
|
| 1304 |
+
"type": "file",
|
| 1305 |
+
"path": "schemas/technology.schema.json",
|
| 1306 |
+
"format": "json",
|
| 1307 |
+
"mediatype": "application/schema+json",
|
| 1308 |
+
"encoding": "utf-8",
|
| 1309 |
+
"bytes": 306,
|
| 1310 |
+
"hash": "sha256:f6638a253cfe4300c4b3dc66b22c6eb32da2533c82df28713c2f9b8753f78b19",
|
| 1311 |
+
"role": "json-schema",
|
| 1312 |
+
"canonical": true
|
| 1313 |
+
},
|
| 1314 |
+
{
|
| 1315 |
+
"name": "methodology-data-methodology-md",
|
| 1316 |
+
"type": "file",
|
| 1317 |
+
"path": "methodology/data-methodology.md",
|
| 1318 |
+
"format": "md",
|
| 1319 |
+
"mediatype": "text/markdown",
|
| 1320 |
+
"encoding": "utf-8",
|
| 1321 |
+
"bytes": 4096,
|
| 1322 |
+
"hash": "sha256:448f1625972aa8e78eb4a8f26cdd0c179404e32a307af6a8299f619946fe4b14",
|
| 1323 |
+
"role": "methodology-documentation",
|
| 1324 |
+
"canonical": true
|
| 1325 |
+
},
|
| 1326 |
+
{
|
| 1327 |
+
"name": "methodology-readme-md",
|
| 1328 |
+
"type": "file",
|
| 1329 |
+
"path": "methodology/README.md",
|
| 1330 |
+
"format": "md",
|
| 1331 |
+
"mediatype": "text/markdown",
|
| 1332 |
+
"encoding": "utf-8",
|
| 1333 |
+
"bytes": 1304,
|
| 1334 |
+
"hash": "sha256:25f5162b275e8cea616868df6e51ef0b91b4f3064e323bc58f06b19bf52a78b9",
|
| 1335 |
+
"role": "methodology-documentation",
|
| 1336 |
+
"canonical": true
|
| 1337 |
+
}
|
| 1338 |
+
]
|
| 1339 |
+
}
|
datasets/blue-light-therapy-reference-index-v1-2.csv
CHANGED
|
@@ -1,18 +1,18 @@
|
|
| 1 |
-
record_id,topic,reference_type,plain_language_meaning,safety_note,source_type,evidence_level,claim_type,medical_disclaimer_required,commercial_relevance,last_reviewed,related_holistix_page,related_product_category,notes,source_name,source_url,citation_note
|
| 2 |
-
BLUE-001,Blue light,Definition,"Blue light is a visible-light range often discussed in screen exposure, circadian rhythm, dermatology, acne-care devices, and controlled light-therapy contexts.",The term blue light by itself should not be treated as proof of a medical or cosmetic result.,Educational terminology / device-category context,Basic terminology,Definition,No,Helps explain broad blue light terminology without overclaiming.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Use as the neutral opening definition.,Blue Light in Dermatology,https://www.mdpi.com/2075-1729/11/7/670,"Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 3 |
-
BLUE-002,Controlled blue light therapy,Therapy context,"Controlled blue light therapy generally refers to structured light exposure using defined wavelengths, intensity, distance, and exposure time.",Controlled-use language should not be converted into disease-treatment or home-use protocols without appropriate evidence and professional guidance.,Safety guidance / claim-boundary context,Measurement caution,Usage context,Yes,Separates controlled light-therapy contexts from vague consumer marketing.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Avoid creating dosage protocols.,Blue Light in Dermatology,https://www.mdpi.com/2075-1729/11/7/670,"Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 4 |
-
BLUE-003,Blue light and skin-care devices,Device category,"Some consumer skin-care devices use blue light as part of acne-care, blemish-care, or general skin-appearance positioning.","Cosmetic language should not become a claim to diagnose, treat, cure, or prevent a disease unless supported by proper regulatory clearance and evidence.",Consumer comparison context / buyer education,Buyer education / device specification,Device comparison,Yes,Relevant to beauty and skin-care device comparison pages.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Keep cosmetic and medical language separate.,Effect of Blue Light on Acne Vulgaris: A Systematic Review,https://www.mdpi.com/1424-8220/21/20/6943,Use as review-level context for blue light and acne-related research. Do not use as a product efficacy guarantee or treatment protocol.
|
| 5 |
-
BLUE-004,Acne claim boundary,Claim boundary,"Blue light is often discussed in relation to acne-care devices, but consumer claims need careful wording.","Avoid claiming a device treats acne or any skin disease unless claims are supported by appropriate evidence, intended-use language, and regulatory status.",Safety guidance / claim-boundary context,Commercial separation,Claim boundary,Yes,Protects Holistix product and education copy from overstated skin claims.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Important compliance row.,Effect of Blue Light on Acne Vulgaris: A Systematic Review,https://www.mdpi.com/1424-8220/21/20/6943,Use as review-level context for blue light and acne-related research. Do not use as a product efficacy guarantee or treatment protocol.
|
| 6 |
-
BLUE-005,Eye exposure,Safety caution,"Blue light can be bright or uncomfortable, and direct viewing of intense LEDs may create eye strain or safety concerns depending on device design.","Do not stare into LEDs. Follow manufacturer eye-protection instructions, especially with bright facial devices or panel-style devices.",Manufacturer instruction / consumer safety context,Consumer safety caution,Safety caution,Yes,"Important for face masks, panels, and handheld light devices.",2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Eye safety row should stay visible.,Blue Light in Dermatology,https://www.mdpi.com/2075-1729/11/7/670,"Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 7 |
-
BLUE-006,Photosensitivity,Safety context,"Some people may be more sensitive to light because of medications, skin conditions, eye conditions, or individual sensitivity.",People with photosensitivity concerns or relevant medication use should consult a qualified healthcare professional before using bright light devices.,Safety guidance / claim-boundary context,Consumer safety caution,Safety caution,Yes,Supports conservative safety language for light-based products.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,No medical screening protocol.,Ocular hazards of blue-light therapy in dermatology,https://www.jaad.org/article/S0190-9622(10)02150-X/fulltext,Use for eye-safety caution around blue-light therapy. Preserve manufacturer eye-protection guidance and avoid personalized medical advice.
|
| 8 |
-
BLUE-007,Screen blue light,Exposure context,"Screen-related blue light is different from controlled light-therapy devices because screens vary in brightness, timing, distance, duration, and surrounding environment.",Do not treat screen-exposure concerns as the same category as controlled therapeutic or cosmetic blue light devices.,Educational terminology / device-category context,Measurement caution,Measurement concept,No,Helps separate common screen-blue-light searches from device therapy claims.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Useful SEO/AI clarity row.,Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne,https://pmc.ncbi.nlm.nih.gov/articles/PMC3366451/,Use for controlled-device dose and exposure-parameter context. Do not convert study parameters into general consumer recommendations.
|
| 9 |
-
BLUE-008,Circadian timing,Usage context,"Blue light timing can matter because bright light exposure, especially at night, is often discussed in relation to alertness and circadian rhythms.",This dataset does not provide sleep-treatment advice or medical guidance. Users with sleep disorders should consult a qualified professional.,Scientific review,Research context,Usage context,Yes,Allows careful discussion of timing without claiming sleep treatment.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Keep non-medical and general.,Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne,https://pmc.ncbi.nlm.nih.gov/articles/PMC3366451/,Use for controlled-device dose and exposure-parameter context. Do not convert study parameters into general consumer recommendations.
|
| 10 |
-
BLUE-009,Wavelength disclosure,Specification field,"A useful blue light device listing should disclose wavelength range, LED type, intended use, power or irradiance information when available, safety warnings, and instructions.","If exact wavelength or output data are unavailable, copy should say so instead of implying precision.",Device specification / manufacturer-instruction context,Device specification,Specification field,No,Supports cleaner product-page and comparison-page language.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Good row for product-spec audits.,Blue Light in Dermatology,https://www.mdpi.com/2075-1729/11/7/670,"Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 11 |
-
BLUE-010,Irradiance and distance,Measurement concept,"Blue light exposure depends on output intensity, distance from the device, area covered, and exposure time.",Avoid copying clinical or online exposure protocols into consumer use instructions unless they match the device and intended use.,Manufacturer instruction / consumer safety context,Measurement caution,Measurement concept,Yes,Prevents generic protocol language from becoming unsafe advice.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,No dosage instructions.,Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne,https://pmc.ncbi.nlm.nih.gov/articles/PMC3366451/,Use for controlled-device dose and exposure-parameter context. Do not convert study parameters into general consumer recommendations.
|
| 12 |
-
BLUE-011,Exposure time,Usage context,Exposure time is a major variable for any light-emitting consumer device.,This dataset does not provide dosage protocols. Users should follow device instructions and avoid overuse.,Manufacturer instruction / consumer safety context,Consumer safety caution,Usage context,Yes,Keeps the dataset educational instead of becoming a protocol page.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,No treatment schedules.,FDA 510(k) Summary: Quasar Blue Light Therapy System,https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf,Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices.
|
| 13 |
-
BLUE-012,Combined light devices,Device comparison,"Some devices combine blue light with red light, near-infrared light, infrared heat, vibration, PEMF, or other features.","When multiple technologies are combined, claims should identify which feature is being discussed and avoid assigning every benefit to blue light.",Consumer comparison context / buyer education,Buyer education / device specification,Device comparison,Yes,Useful for Holistix product education where devices may combine light modes.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Good multi-modality clarity row.,FDA 510(k) Summary: Quasar Blue Light Therapy System,https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf,Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices.
|
| 14 |
-
BLUE-013,Heat and skin irritation,Safety context,"Some light devices can create warmth or skin irritation depending on device design, duration, sensitivity, and placement.","Stop use if discomfort, irritation, excessive heat, or unusual reaction occurs and follow manufacturer safety instructions.",Manufacturer instruction / consumer safety context,Consumer safety caution,Safety caution,Yes,Supports practical product safety language.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,"Keep as consumer caution, not medical advice.",Blue Light Therapy in Dermatological Practice: A Review,https://www.mdpi.com/2079-9284/12/1/30,"Use as broad dermatology review context for blue-light effects, safety considerations, and skin-facing use. Keep all claims conservative."
|
| 15 |
-
BLUE-014,Home-use device claims,Claim boundary,"Home-use blue light devices should be described carefully because consumer devices can differ from clinical, dermatology, or research systems.","Avoid implying that a home-use device is equivalent to professional treatment equipment unless specifications, intended use, and evidence support that comparison.",Safety guidance / claim-boundary context,Commercial separation,Claim boundary,Yes,Protects against borrowed authority from clinical research.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Key claim-boundary row.,FDA 510(k) Summary: Quasar Blue Light Therapy System,https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf,Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices.
|
| 16 |
-
BLUE-015,Regulatory and intended-use language,Regulatory context,"Blue light devices that make medical claims should be evaluated for intended use, regulatory status, labeling, and evidence support.",Regulatory language should not be used as a substitute for medical evidence or disease-treatment approval.,Regulatory / agency reference,Device specification,Specification field,No,Supports careful product positioning and documentation checks.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Useful for future compliance audits.,FDA 510(k) Summary: Quasar Blue Light Therapy System,https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf,Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices.
|
| 17 |
-
BLUE-016,Commercial claim separation,Commercial separation,"Educational copy should separate blue light terminology, cosmetic positioning, device specifications, safety warnings, and medical claims.","Avoid disease claims, guaranteed skin outcomes, unsupported before-and-after promises, and broad claims that all blue light devices work the same way.",Safety guidance / claim-boundary context,Commercial separation,Claim boundary,Yes,Keeps Holistix open-data assets citation-worthy and lower-risk.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Protect the asset.,FDA 510(k) Summary: Quasar Blue Light Therapy System,https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf,Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices.
|
| 18 |
-
BLUE-017,Maintenance and review,Dataset maintenance,"Blue light therapy and screen-exposure language should be reviewed periodically because device designs, evidence, regulations, and market claims can change.","Rows should be updated when stronger safety guidance, regulatory information, or better product-specification standards become available.",Open data maintenance context,Research context,Dataset maintenance,No,Supports future version history and dataset audits.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Use for future v1.2 or later updates.,FDA 510(k) Summary: Quasar Blue Light Therapy System,https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf,Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices.
|
|
|
|
| 1 |
+
record_id,topic,reference_type,plain_language_meaning,safety_note,source_type,evidence_level,claim_type,medical_disclaimer_required,commercial_relevance,last_reviewed,related_holistix_page,related_product_category,notes,source_name,source_url,citation_note
|
| 2 |
+
BLUE-001,Blue light,Definition,"Blue light is a visible-light range often discussed in screen exposure, circadian rhythm, dermatology, acne-care devices, and controlled light-therapy contexts.",The term blue light by itself should not be treated as proof of a medical or cosmetic result.,Educational terminology / device-category context,Basic terminology,Definition,No,Helps explain broad blue light terminology without overclaiming.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Use as the neutral opening definition.,Blue Light in Dermatology,https://www.mdpi.com/2075-1729/11/7/670,"Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 3 |
+
BLUE-002,Controlled blue light therapy,Therapy context,"Controlled blue light therapy generally refers to structured light exposure using defined wavelengths, intensity, distance, and exposure time.",Controlled-use language should not be converted into disease-treatment or home-use protocols without appropriate evidence and professional guidance.,Safety guidance / claim-boundary context,Measurement caution,Usage context,Yes,Separates controlled light-therapy contexts from vague consumer marketing.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Avoid creating dosage protocols.,Blue Light in Dermatology,https://www.mdpi.com/2075-1729/11/7/670,"Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 4 |
+
BLUE-003,Blue light and skin-care devices,Device category,"Some consumer skin-care devices use blue light as part of acne-care, blemish-care, or general skin-appearance positioning.","Cosmetic language should not become a claim to diagnose, treat, cure, or prevent a disease unless supported by proper regulatory clearance and evidence.",Consumer comparison context / buyer education,Buyer education / device specification,Device comparison,Yes,Relevant to beauty and skin-care device comparison pages.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Keep cosmetic and medical language separate.,Effect of Blue Light on Acne Vulgaris: A Systematic Review,https://www.mdpi.com/1424-8220/21/20/6943,Use as review-level context for blue light and acne-related research. Do not use as a product efficacy guarantee or treatment protocol.
|
| 5 |
+
BLUE-004,Acne claim boundary,Claim boundary,"Blue light is often discussed in relation to acne-care devices, but consumer claims need careful wording.","Avoid claiming a device treats acne or any skin disease unless claims are supported by appropriate evidence, intended-use language, and regulatory status.",Safety guidance / claim-boundary context,Commercial separation,Claim boundary,Yes,Protects Holistix product and education copy from overstated skin claims.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Important compliance row.,Effect of Blue Light on Acne Vulgaris: A Systematic Review,https://www.mdpi.com/1424-8220/21/20/6943,Use as review-level context for blue light and acne-related research. Do not use as a product efficacy guarantee or treatment protocol.
|
| 6 |
+
BLUE-005,Eye exposure,Safety caution,"Blue light can be bright or uncomfortable, and direct viewing of intense LEDs may create eye strain or safety concerns depending on device design.","Do not stare into LEDs. Follow manufacturer eye-protection instructions, especially with bright facial devices or panel-style devices.",Manufacturer instruction / consumer safety context,Consumer safety caution,Safety caution,Yes,"Important for face masks, panels, and handheld light devices.",2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Eye safety row should stay visible.,Blue Light in Dermatology,https://www.mdpi.com/2075-1729/11/7/670,"Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 7 |
+
BLUE-006,Photosensitivity,Safety context,"Some people may be more sensitive to light because of medications, skin conditions, eye conditions, or individual sensitivity.",People with photosensitivity concerns or relevant medication use should consult a qualified healthcare professional before using bright light devices.,Safety guidance / claim-boundary context,Consumer safety caution,Safety caution,Yes,Supports conservative safety language for light-based products.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,No medical screening protocol.,Ocular hazards of blue-light therapy in dermatology,https://www.jaad.org/article/S0190-9622(10)02150-X/fulltext,Use for eye-safety caution around blue-light therapy. Preserve manufacturer eye-protection guidance and avoid personalized medical advice.
|
| 8 |
+
BLUE-007,Screen blue light,Exposure context,"Screen-related blue light is different from controlled light-therapy devices because screens vary in brightness, timing, distance, duration, and surrounding environment.",Do not treat screen-exposure concerns as the same category as controlled therapeutic or cosmetic blue light devices.,Educational terminology / device-category context,Measurement caution,Measurement concept,No,Helps separate common screen-blue-light searches from device therapy claims.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Useful SEO/AI clarity row.,Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne,https://pmc.ncbi.nlm.nih.gov/articles/PMC3366451/,Use for controlled-device dose and exposure-parameter context. Do not convert study parameters into general consumer recommendations.
|
| 9 |
+
BLUE-008,Circadian timing,Usage context,"Blue light timing can matter because bright light exposure, especially at night, is often discussed in relation to alertness and circadian rhythms.",This dataset does not provide sleep-treatment advice or medical guidance. Users with sleep disorders should consult a qualified professional.,Scientific review,Research context,Usage context,Yes,Allows careful discussion of timing without claiming sleep treatment.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Keep non-medical and general.,Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne,https://pmc.ncbi.nlm.nih.gov/articles/PMC3366451/,Use for controlled-device dose and exposure-parameter context. Do not convert study parameters into general consumer recommendations.
|
| 10 |
+
BLUE-009,Wavelength disclosure,Specification field,"A useful blue light device listing should disclose wavelength range, LED type, intended use, power or irradiance information when available, safety warnings, and instructions.","If exact wavelength or output data are unavailable, copy should say so instead of implying precision.",Device specification / manufacturer-instruction context,Device specification,Specification field,No,Supports cleaner product-page and comparison-page language.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Good row for product-spec audits.,Blue Light in Dermatology,https://www.mdpi.com/2075-1729/11/7/670,"Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 11 |
+
BLUE-010,Irradiance and distance,Measurement concept,"Blue light exposure depends on output intensity, distance from the device, area covered, and exposure time.",Avoid copying clinical or online exposure protocols into consumer use instructions unless they match the device and intended use.,Manufacturer instruction / consumer safety context,Measurement caution,Measurement concept,Yes,Prevents generic protocol language from becoming unsafe advice.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,No dosage instructions.,Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne,https://pmc.ncbi.nlm.nih.gov/articles/PMC3366451/,Use for controlled-device dose and exposure-parameter context. Do not convert study parameters into general consumer recommendations.
|
| 12 |
+
BLUE-011,Exposure time,Usage context,Exposure time is a major variable for any light-emitting consumer device.,This dataset does not provide dosage protocols. Users should follow device instructions and avoid overuse.,Manufacturer instruction / consumer safety context,Consumer safety caution,Usage context,Yes,Keeps the dataset educational instead of becoming a protocol page.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,No treatment schedules.,FDA 510(k) Summary: Quasar Blue Light Therapy System,https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf,Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices.
|
| 13 |
+
BLUE-012,Combined light devices,Device comparison,"Some devices combine blue light with red light, near-infrared light, infrared heat, vibration, PEMF, or other features.","When multiple technologies are combined, claims should identify which feature is being discussed and avoid assigning every benefit to blue light.",Consumer comparison context / buyer education,Buyer education / device specification,Device comparison,Yes,Useful for Holistix product education where devices may combine light modes.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Good multi-modality clarity row.,FDA 510(k) Summary: Quasar Blue Light Therapy System,https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf,Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices.
|
| 14 |
+
BLUE-013,Heat and skin irritation,Safety context,"Some light devices can create warmth or skin irritation depending on device design, duration, sensitivity, and placement.","Stop use if discomfort, irritation, excessive heat, or unusual reaction occurs and follow manufacturer safety instructions.",Manufacturer instruction / consumer safety context,Consumer safety caution,Safety caution,Yes,Supports practical product safety language.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,"Keep as consumer caution, not medical advice.",Blue Light Therapy in Dermatological Practice: A Review,https://www.mdpi.com/2079-9284/12/1/30,"Use as broad dermatology review context for blue-light effects, safety considerations, and skin-facing use. Keep all claims conservative."
|
| 15 |
+
BLUE-014,Home-use device claims,Claim boundary,"Home-use blue light devices should be described carefully because consumer devices can differ from clinical, dermatology, or research systems.","Avoid implying that a home-use device is equivalent to professional treatment equipment unless specifications, intended use, and evidence support that comparison.",Safety guidance / claim-boundary context,Commercial separation,Claim boundary,Yes,Protects against borrowed authority from clinical research.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Key claim-boundary row.,FDA 510(k) Summary: Quasar Blue Light Therapy System,https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf,Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices.
|
| 16 |
+
BLUE-015,Regulatory and intended-use language,Regulatory context,"Blue light devices that make medical claims should be evaluated for intended use, regulatory status, labeling, and evidence support.",Regulatory language should not be used as a substitute for medical evidence or disease-treatment approval.,Regulatory / agency reference,Device specification,Specification field,No,Supports careful product positioning and documentation checks.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Useful for future compliance audits.,FDA 510(k) Summary: Quasar Blue Light Therapy System,https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf,Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices.
|
| 17 |
+
BLUE-016,Commercial claim separation,Commercial separation,"Educational copy should separate blue light terminology, cosmetic positioning, device specifications, safety warnings, and medical claims.","Avoid disease claims, guaranteed skin outcomes, unsupported before-and-after promises, and broad claims that all blue light devices work the same way.",Safety guidance / claim-boundary context,Commercial separation,Claim boundary,Yes,Keeps Holistix open-data assets citation-worthy and lower-risk.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Protect the asset.,FDA 510(k) Summary: Quasar Blue Light Therapy System,https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf,Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices.
|
| 18 |
+
BLUE-017,Maintenance and review,Dataset maintenance,"Blue light therapy and screen-exposure language should be reviewed periodically because device designs, evidence, regulations, and market claims can change.","Rows should be updated when stronger safety guidance, regulatory information, or better product-specification standards become available.",Open data maintenance context,Research context,Dataset maintenance,No,Supports future version history and dataset audits.,2026-06-26,https://www.holistixintl.com/pages/blue-light-therapy-reference-index,Blue light wellness devices,Use for future v1.2 or later updates.,FDA 510(k) Summary: Quasar Blue Light Therapy System,https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf,Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices.
|
datasets/blue-light-therapy-reference-index-v1-2.json
CHANGED
|
@@ -1,355 +1,355 @@
|
|
| 1 |
-
{
|
| 2 |
-
"dataset_name": "Blue Light Therapy Reference Index",
|
| 3 |
-
"dataset_version": "1.2",
|
| 4 |
-
"publisher": "Holistix International",
|
| 5 |
-
"project": "Holistix Open Biohacking Data Project",
|
| 6 |
-
"canonical_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 7 |
-
"source_register": "https://www.holistixintl.com/pages/open-biohacking-data-source-register",
|
| 8 |
-
"methodology": "https://www.holistixintl.com/pages/open-biohacking-data-methodology",
|
| 9 |
-
"last_updated": "2026-06-27",
|
| 10 |
-
"disclaimer": "This dataset is for educational and informational purposes only. It is not medical advice, diagnosis, treatment guidance, disease-prevention guidance, dosing guidance, or a substitute for consultation with a qualified healthcare professional.",
|
| 11 |
-
"fields": [
|
| 12 |
-
"record_id",
|
| 13 |
-
"topic",
|
| 14 |
-
"reference_type",
|
| 15 |
-
"plain_language_meaning",
|
| 16 |
-
"safety_note",
|
| 17 |
-
"source_type",
|
| 18 |
-
"evidence_level",
|
| 19 |
-
"claim_type",
|
| 20 |
-
"medical_disclaimer_required",
|
| 21 |
-
"commercial_relevance",
|
| 22 |
-
"last_reviewed",
|
| 23 |
-
"related_holistix_page",
|
| 24 |
-
"related_product_category",
|
| 25 |
-
"notes",
|
| 26 |
-
"source_name",
|
| 27 |
-
"source_url",
|
| 28 |
-
"citation_note"
|
| 29 |
-
],
|
| 30 |
-
"records": [
|
| 31 |
-
{
|
| 32 |
-
"record_id": "BLUE-001",
|
| 33 |
-
"topic": "Blue light",
|
| 34 |
-
"reference_type": "Definition",
|
| 35 |
-
"plain_language_meaning": "Blue light is a visible-light range often discussed in screen exposure, circadian rhythm, dermatology, acne-care devices, and controlled light-therapy contexts.",
|
| 36 |
-
"safety_note": "The term blue light by itself should not be treated as proof of a medical or cosmetic result.",
|
| 37 |
-
"source_type": "Educational terminology / device-category context",
|
| 38 |
-
"evidence_level": "Basic terminology",
|
| 39 |
-
"claim_type": "Definition",
|
| 40 |
-
"medical_disclaimer_required": "No",
|
| 41 |
-
"commercial_relevance": "Helps explain broad blue light terminology without overclaiming.",
|
| 42 |
-
"last_reviewed": "2026-06-26",
|
| 43 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 44 |
-
"related_product_category": "Blue light wellness devices",
|
| 45 |
-
"notes": "Use as the neutral opening definition.",
|
| 46 |
-
"source_name": "Blue Light in Dermatology",
|
| 47 |
-
"source_url": "https://www.mdpi.com/2075-1729/11/7/670",
|
| 48 |
-
"citation_note": "Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 49 |
-
},
|
| 50 |
-
{
|
| 51 |
-
"record_id": "BLUE-002",
|
| 52 |
-
"topic": "Controlled blue light therapy",
|
| 53 |
-
"reference_type": "Therapy context",
|
| 54 |
-
"plain_language_meaning": "Controlled blue light therapy generally refers to structured light exposure using defined wavelengths, intensity, distance, and exposure time.",
|
| 55 |
-
"safety_note": "Controlled-use language should not be converted into disease-treatment or home-use protocols without appropriate evidence and professional guidance.",
|
| 56 |
-
"source_type": "Safety guidance / claim-boundary context",
|
| 57 |
-
"evidence_level": "Measurement caution",
|
| 58 |
-
"claim_type": "Usage context",
|
| 59 |
-
"medical_disclaimer_required": "Yes",
|
| 60 |
-
"commercial_relevance": "Separates controlled light-therapy contexts from vague consumer marketing.",
|
| 61 |
-
"last_reviewed": "2026-06-26",
|
| 62 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 63 |
-
"related_product_category": "Blue light wellness devices",
|
| 64 |
-
"notes": "Avoid creating dosage protocols.",
|
| 65 |
-
"source_name": "Blue Light in Dermatology",
|
| 66 |
-
"source_url": "https://www.mdpi.com/2075-1729/11/7/670",
|
| 67 |
-
"citation_note": "Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 68 |
-
},
|
| 69 |
-
{
|
| 70 |
-
"record_id": "BLUE-003",
|
| 71 |
-
"topic": "Blue light and skin-care devices",
|
| 72 |
-
"reference_type": "Device category",
|
| 73 |
-
"plain_language_meaning": "Some consumer skin-care devices use blue light as part of acne-care, blemish-care, or general skin-appearance positioning.",
|
| 74 |
-
"safety_note": "Cosmetic language should not become a claim to diagnose, treat, cure, or prevent a disease unless supported by proper regulatory clearance and evidence.",
|
| 75 |
-
"source_type": "Consumer comparison context / buyer education",
|
| 76 |
-
"evidence_level": "Buyer education / device specification",
|
| 77 |
-
"claim_type": "Device comparison",
|
| 78 |
-
"medical_disclaimer_required": "Yes",
|
| 79 |
-
"commercial_relevance": "Relevant to beauty and skin-care device comparison pages.",
|
| 80 |
-
"last_reviewed": "2026-06-26",
|
| 81 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 82 |
-
"related_product_category": "Blue light wellness devices",
|
| 83 |
-
"notes": "Keep cosmetic and medical language separate.",
|
| 84 |
-
"source_name": "Effect of Blue Light on Acne Vulgaris: A Systematic Review",
|
| 85 |
-
"source_url": "https://www.mdpi.com/1424-8220/21/20/6943",
|
| 86 |
-
"citation_note": "Use as review-level context for blue light and acne-related research. Do not use as a product efficacy guarantee or treatment protocol."
|
| 87 |
-
},
|
| 88 |
-
{
|
| 89 |
-
"record_id": "BLUE-004",
|
| 90 |
-
"topic": "Acne claim boundary",
|
| 91 |
-
"reference_type": "Claim boundary",
|
| 92 |
-
"plain_language_meaning": "Blue light is often discussed in relation to acne-care devices, but consumer claims need careful wording.",
|
| 93 |
-
"safety_note": "Avoid claiming a device treats acne or any skin disease unless claims are supported by appropriate evidence, intended-use language, and regulatory status.",
|
| 94 |
-
"source_type": "Safety guidance / claim-boundary context",
|
| 95 |
-
"evidence_level": "Commercial separation",
|
| 96 |
-
"claim_type": "Claim boundary",
|
| 97 |
-
"medical_disclaimer_required": "Yes",
|
| 98 |
-
"commercial_relevance": "Protects Holistix product and education copy from overstated skin claims.",
|
| 99 |
-
"last_reviewed": "2026-06-26",
|
| 100 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 101 |
-
"related_product_category": "Blue light wellness devices",
|
| 102 |
-
"notes": "Important compliance row.",
|
| 103 |
-
"source_name": "Effect of Blue Light on Acne Vulgaris: A Systematic Review",
|
| 104 |
-
"source_url": "https://www.mdpi.com/1424-8220/21/20/6943",
|
| 105 |
-
"citation_note": "Use as review-level context for blue light and acne-related research. Do not use as a product efficacy guarantee or treatment protocol."
|
| 106 |
-
},
|
| 107 |
-
{
|
| 108 |
-
"record_id": "BLUE-005",
|
| 109 |
-
"topic": "Eye exposure",
|
| 110 |
-
"reference_type": "Safety caution",
|
| 111 |
-
"plain_language_meaning": "Blue light can be bright or uncomfortable, and direct viewing of intense LEDs may create eye strain or safety concerns depending on device design.",
|
| 112 |
-
"safety_note": "Do not stare into LEDs. Follow manufacturer eye-protection instructions, especially with bright facial devices or panel-style devices.",
|
| 113 |
-
"source_type": "Manufacturer instruction / consumer safety context",
|
| 114 |
-
"evidence_level": "Consumer safety caution",
|
| 115 |
-
"claim_type": "Safety caution",
|
| 116 |
-
"medical_disclaimer_required": "Yes",
|
| 117 |
-
"commercial_relevance": "Important for face masks, panels, and handheld light devices.",
|
| 118 |
-
"last_reviewed": "2026-06-26",
|
| 119 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 120 |
-
"related_product_category": "Blue light wellness devices",
|
| 121 |
-
"notes": "Eye safety row should stay visible.",
|
| 122 |
-
"source_name": "Blue Light in Dermatology",
|
| 123 |
-
"source_url": "https://www.mdpi.com/2075-1729/11/7/670",
|
| 124 |
-
"citation_note": "Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 125 |
-
},
|
| 126 |
-
{
|
| 127 |
-
"record_id": "BLUE-006",
|
| 128 |
-
"topic": "Photosensitivity",
|
| 129 |
-
"reference_type": "Safety context",
|
| 130 |
-
"plain_language_meaning": "Some people may be more sensitive to light because of medications, skin conditions, eye conditions, or individual sensitivity.",
|
| 131 |
-
"safety_note": "People with photosensitivity concerns or relevant medication use should consult a qualified healthcare professional before using bright light devices.",
|
| 132 |
-
"source_type": "Safety guidance / claim-boundary context",
|
| 133 |
-
"evidence_level": "Consumer safety caution",
|
| 134 |
-
"claim_type": "Safety caution",
|
| 135 |
-
"medical_disclaimer_required": "Yes",
|
| 136 |
-
"commercial_relevance": "Supports conservative safety language for light-based products.",
|
| 137 |
-
"last_reviewed": "2026-06-26",
|
| 138 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 139 |
-
"related_product_category": "Blue light wellness devices",
|
| 140 |
-
"notes": "No medical screening protocol.",
|
| 141 |
-
"source_name": "Ocular hazards of blue-light therapy in dermatology",
|
| 142 |
-
"source_url": "https://www.jaad.org/article/S0190-9622(10)02150-X/fulltext",
|
| 143 |
-
"citation_note": "Use for eye-safety caution around blue-light therapy. Preserve manufacturer eye-protection guidance and avoid personalized medical advice."
|
| 144 |
-
},
|
| 145 |
-
{
|
| 146 |
-
"record_id": "BLUE-007",
|
| 147 |
-
"topic": "Screen blue light",
|
| 148 |
-
"reference_type": "Exposure context",
|
| 149 |
-
"plain_language_meaning": "Screen-related blue light is different from controlled light-therapy devices because screens vary in brightness, timing, distance, duration, and surrounding environment.",
|
| 150 |
-
"safety_note": "Do not treat screen-exposure concerns as the same category as controlled therapeutic or cosmetic blue light devices.",
|
| 151 |
-
"source_type": "Educational terminology / device-category context",
|
| 152 |
-
"evidence_level": "Measurement caution",
|
| 153 |
-
"claim_type": "Measurement concept",
|
| 154 |
-
"medical_disclaimer_required": "No",
|
| 155 |
-
"commercial_relevance": "Helps separate common screen-blue-light searches from device therapy claims.",
|
| 156 |
-
"last_reviewed": "2026-06-26",
|
| 157 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 158 |
-
"related_product_category": "Blue light wellness devices",
|
| 159 |
-
"notes": "Useful SEO/AI clarity row.",
|
| 160 |
-
"source_name": "Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne",
|
| 161 |
-
"source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3366451/",
|
| 162 |
-
"citation_note": "Use for controlled-device dose and exposure-parameter context. Do not convert study parameters into general consumer recommendations."
|
| 163 |
-
},
|
| 164 |
-
{
|
| 165 |
-
"record_id": "BLUE-008",
|
| 166 |
-
"topic": "Circadian timing",
|
| 167 |
-
"reference_type": "Usage context",
|
| 168 |
-
"plain_language_meaning": "Blue light timing can matter because bright light exposure, especially at night, is often discussed in relation to alertness and circadian rhythms.",
|
| 169 |
-
"safety_note": "This dataset does not provide sleep-treatment advice or medical guidance. Users with sleep disorders should consult a qualified professional.",
|
| 170 |
-
"source_type": "Scientific review",
|
| 171 |
-
"evidence_level": "Research context",
|
| 172 |
-
"claim_type": "Usage context",
|
| 173 |
-
"medical_disclaimer_required": "Yes",
|
| 174 |
-
"commercial_relevance": "Allows careful discussion of timing without claiming sleep treatment.",
|
| 175 |
-
"last_reviewed": "2026-06-26",
|
| 176 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 177 |
-
"related_product_category": "Blue light wellness devices",
|
| 178 |
-
"notes": "Keep non-medical and general.",
|
| 179 |
-
"source_name": "Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne",
|
| 180 |
-
"source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3366451/",
|
| 181 |
-
"citation_note": "Use for controlled-device dose and exposure-parameter context. Do not convert study parameters into general consumer recommendations."
|
| 182 |
-
},
|
| 183 |
-
{
|
| 184 |
-
"record_id": "BLUE-009",
|
| 185 |
-
"topic": "Wavelength disclosure",
|
| 186 |
-
"reference_type": "Specification field",
|
| 187 |
-
"plain_language_meaning": "A useful blue light device listing should disclose wavelength range, LED type, intended use, power or irradiance information when available, safety warnings, and instructions.",
|
| 188 |
-
"safety_note": "If exact wavelength or output data are unavailable, copy should say so instead of implying precision.",
|
| 189 |
-
"source_type": "Device specification / manufacturer-instruction context",
|
| 190 |
-
"evidence_level": "Device specification",
|
| 191 |
-
"claim_type": "Specification field",
|
| 192 |
-
"medical_disclaimer_required": "No",
|
| 193 |
-
"commercial_relevance": "Supports cleaner product-page and comparison-page language.",
|
| 194 |
-
"last_reviewed": "2026-06-26",
|
| 195 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 196 |
-
"related_product_category": "Blue light wellness devices",
|
| 197 |
-
"notes": "Good row for product-spec audits.",
|
| 198 |
-
"source_name": "Blue Light in Dermatology",
|
| 199 |
-
"source_url": "https://www.mdpi.com/2075-1729/11/7/670",
|
| 200 |
-
"citation_note": "Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 201 |
-
},
|
| 202 |
-
{
|
| 203 |
-
"record_id": "BLUE-010",
|
| 204 |
-
"topic": "Irradiance and distance",
|
| 205 |
-
"reference_type": "Measurement concept",
|
| 206 |
-
"plain_language_meaning": "Blue light exposure depends on output intensity, distance from the device, area covered, and exposure time.",
|
| 207 |
-
"safety_note": "Avoid copying clinical or online exposure protocols into consumer use instructions unless they match the device and intended use.",
|
| 208 |
-
"source_type": "Manufacturer instruction / consumer safety context",
|
| 209 |
-
"evidence_level": "Measurement caution",
|
| 210 |
-
"claim_type": "Measurement concept",
|
| 211 |
-
"medical_disclaimer_required": "Yes",
|
| 212 |
-
"commercial_relevance": "Prevents generic protocol language from becoming unsafe advice.",
|
| 213 |
-
"last_reviewed": "2026-06-26",
|
| 214 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 215 |
-
"related_product_category": "Blue light wellness devices",
|
| 216 |
-
"notes": "No dosage instructions.",
|
| 217 |
-
"source_name": "Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne",
|
| 218 |
-
"source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3366451/",
|
| 219 |
-
"citation_note": "Use for controlled-device dose and exposure-parameter context. Do not convert study parameters into general consumer recommendations."
|
| 220 |
-
},
|
| 221 |
-
{
|
| 222 |
-
"record_id": "BLUE-011",
|
| 223 |
-
"topic": "Exposure time",
|
| 224 |
-
"reference_type": "Usage context",
|
| 225 |
-
"plain_language_meaning": "Exposure time is a major variable for any light-emitting consumer device.",
|
| 226 |
-
"safety_note": "This dataset does not provide dosage protocols. Users should follow device instructions and avoid overuse.",
|
| 227 |
-
"source_type": "Manufacturer instruction / consumer safety context",
|
| 228 |
-
"evidence_level": "Consumer safety caution",
|
| 229 |
-
"claim_type": "Usage context",
|
| 230 |
-
"medical_disclaimer_required": "Yes",
|
| 231 |
-
"commercial_relevance": "Keeps the dataset educational instead of becoming a protocol page.",
|
| 232 |
-
"last_reviewed": "2026-06-26",
|
| 233 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 234 |
-
"related_product_category": "Blue light wellness devices",
|
| 235 |
-
"notes": "No treatment schedules.",
|
| 236 |
-
"source_name": "FDA 510(k) Summary: Quasar Blue Light Therapy System",
|
| 237 |
-
"source_url": "https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf",
|
| 238 |
-
"citation_note": "Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."
|
| 239 |
-
},
|
| 240 |
-
{
|
| 241 |
-
"record_id": "BLUE-012",
|
| 242 |
-
"topic": "Combined light devices",
|
| 243 |
-
"reference_type": "Device comparison",
|
| 244 |
-
"plain_language_meaning": "Some devices combine blue light with red light, near-infrared light, infrared heat, vibration, PEMF, or other features.",
|
| 245 |
-
"safety_note": "When multiple technologies are combined, claims should identify which feature is being discussed and avoid assigning every benefit to blue light.",
|
| 246 |
-
"source_type": "Consumer comparison context / buyer education",
|
| 247 |
-
"evidence_level": "Buyer education / device specification",
|
| 248 |
-
"claim_type": "Device comparison",
|
| 249 |
-
"medical_disclaimer_required": "Yes",
|
| 250 |
-
"commercial_relevance": "Useful for Holistix product education where devices may combine light modes.",
|
| 251 |
-
"last_reviewed": "2026-06-26",
|
| 252 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 253 |
-
"related_product_category": "Blue light wellness devices",
|
| 254 |
-
"notes": "Good multi-modality clarity row.",
|
| 255 |
-
"source_name": "FDA 510(k) Summary: Quasar Blue Light Therapy System",
|
| 256 |
-
"source_url": "https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf",
|
| 257 |
-
"citation_note": "Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."
|
| 258 |
-
},
|
| 259 |
-
{
|
| 260 |
-
"record_id": "BLUE-013",
|
| 261 |
-
"topic": "Heat and skin irritation",
|
| 262 |
-
"reference_type": "Safety context",
|
| 263 |
-
"plain_language_meaning": "Some light devices can create warmth or skin irritation depending on device design, duration, sensitivity, and placement.",
|
| 264 |
-
"safety_note": "Stop use if discomfort, irritation, excessive heat, or unusual reaction occurs and follow manufacturer safety instructions.",
|
| 265 |
-
"source_type": "Manufacturer instruction / consumer safety context",
|
| 266 |
-
"evidence_level": "Consumer safety caution",
|
| 267 |
-
"claim_type": "Safety caution",
|
| 268 |
-
"medical_disclaimer_required": "Yes",
|
| 269 |
-
"commercial_relevance": "Supports practical product safety language.",
|
| 270 |
-
"last_reviewed": "2026-06-26",
|
| 271 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 272 |
-
"related_product_category": "Blue light wellness devices",
|
| 273 |
-
"notes": "Keep as consumer caution, not medical advice.",
|
| 274 |
-
"source_name": "Blue Light Therapy in Dermatological Practice: A Review",
|
| 275 |
-
"source_url": "https://www.mdpi.com/2079-9284/12/1/30",
|
| 276 |
-
"citation_note": "Use as broad dermatology review context for blue-light effects, safety considerations, and skin-facing use. Keep all claims conservative."
|
| 277 |
-
},
|
| 278 |
-
{
|
| 279 |
-
"record_id": "BLUE-014",
|
| 280 |
-
"topic": "Home-use device claims",
|
| 281 |
-
"reference_type": "Claim boundary",
|
| 282 |
-
"plain_language_meaning": "Home-use blue light devices should be described carefully because consumer devices can differ from clinical, dermatology, or research systems.",
|
| 283 |
-
"safety_note": "Avoid implying that a home-use device is equivalent to professional treatment equipment unless specifications, intended use, and evidence support that comparison.",
|
| 284 |
-
"source_type": "Safety guidance / claim-boundary context",
|
| 285 |
-
"evidence_level": "Commercial separation",
|
| 286 |
-
"claim_type": "Claim boundary",
|
| 287 |
-
"medical_disclaimer_required": "Yes",
|
| 288 |
-
"commercial_relevance": "Protects against borrowed authority from clinical research.",
|
| 289 |
-
"last_reviewed": "2026-06-26",
|
| 290 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 291 |
-
"related_product_category": "Blue light wellness devices",
|
| 292 |
-
"notes": "Key claim-boundary row.",
|
| 293 |
-
"source_name": "FDA 510(k) Summary: Quasar Blue Light Therapy System",
|
| 294 |
-
"source_url": "https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf",
|
| 295 |
-
"citation_note": "Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."
|
| 296 |
-
},
|
| 297 |
-
{
|
| 298 |
-
"record_id": "BLUE-015",
|
| 299 |
-
"topic": "Regulatory and intended-use language",
|
| 300 |
-
"reference_type": "Regulatory context",
|
| 301 |
-
"plain_language_meaning": "Blue light devices that make medical claims should be evaluated for intended use, regulatory status, labeling, and evidence support.",
|
| 302 |
-
"safety_note": "Regulatory language should not be used as a substitute for medical evidence or disease-treatment approval.",
|
| 303 |
-
"source_type": "Regulatory / agency reference",
|
| 304 |
-
"evidence_level": "Device specification",
|
| 305 |
-
"claim_type": "Specification field",
|
| 306 |
-
"medical_disclaimer_required": "No",
|
| 307 |
-
"commercial_relevance": "Supports careful product positioning and documentation checks.",
|
| 308 |
-
"last_reviewed": "2026-06-26",
|
| 309 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 310 |
-
"related_product_category": "Blue light wellness devices",
|
| 311 |
-
"notes": "Useful for future compliance audits.",
|
| 312 |
-
"source_name": "FDA 510(k) Summary: Quasar Blue Light Therapy System",
|
| 313 |
-
"source_url": "https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf",
|
| 314 |
-
"citation_note": "Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."
|
| 315 |
-
},
|
| 316 |
-
{
|
| 317 |
-
"record_id": "BLUE-016",
|
| 318 |
-
"topic": "Commercial claim separation",
|
| 319 |
-
"reference_type": "Commercial separation",
|
| 320 |
-
"plain_language_meaning": "Educational copy should separate blue light terminology, cosmetic positioning, device specifications, safety warnings, and medical claims.",
|
| 321 |
-
"safety_note": "Avoid disease claims, guaranteed skin outcomes, unsupported before-and-after promises, and broad claims that all blue light devices work the same way.",
|
| 322 |
-
"source_type": "Safety guidance / claim-boundary context",
|
| 323 |
-
"evidence_level": "Commercial separation",
|
| 324 |
-
"claim_type": "Claim boundary",
|
| 325 |
-
"medical_disclaimer_required": "Yes",
|
| 326 |
-
"commercial_relevance": "Keeps Holistix open-data assets citation-worthy and lower-risk.",
|
| 327 |
-
"last_reviewed": "2026-06-26",
|
| 328 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 329 |
-
"related_product_category": "Blue light wellness devices",
|
| 330 |
-
"notes": "Protect the asset.",
|
| 331 |
-
"source_name": "FDA 510(k) Summary: Quasar Blue Light Therapy System",
|
| 332 |
-
"source_url": "https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf",
|
| 333 |
-
"citation_note": "Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."
|
| 334 |
-
},
|
| 335 |
-
{
|
| 336 |
-
"record_id": "BLUE-017",
|
| 337 |
-
"topic": "Maintenance and review",
|
| 338 |
-
"reference_type": "Dataset maintenance",
|
| 339 |
-
"plain_language_meaning": "Blue light therapy and screen-exposure language should be reviewed periodically because device designs, evidence, regulations, and market claims can change.",
|
| 340 |
-
"safety_note": "Rows should be updated when stronger safety guidance, regulatory information, or better product-specification standards become available.",
|
| 341 |
-
"source_type": "Open data maintenance context",
|
| 342 |
-
"evidence_level": "Research context",
|
| 343 |
-
"claim_type": "Dataset maintenance",
|
| 344 |
-
"medical_disclaimer_required": "No",
|
| 345 |
-
"commercial_relevance": "Supports future version history and dataset audits.",
|
| 346 |
-
"last_reviewed": "2026-06-26",
|
| 347 |
-
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 348 |
-
"related_product_category": "Blue light wellness devices",
|
| 349 |
-
"notes": "Use for future v1.2 or later updates.",
|
| 350 |
-
"source_name": "FDA 510(k) Summary: Quasar Blue Light Therapy System",
|
| 351 |
-
"source_url": "https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf",
|
| 352 |
-
"citation_note": "Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."
|
| 353 |
-
}
|
| 354 |
-
]
|
| 355 |
}
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"dataset_name": "Blue Light Therapy Reference Index",
|
| 3 |
+
"dataset_version": "1.2",
|
| 4 |
+
"publisher": "Holistix International",
|
| 5 |
+
"project": "Holistix Open Biohacking Data Project",
|
| 6 |
+
"canonical_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 7 |
+
"source_register": "https://www.holistixintl.com/pages/open-biohacking-data-source-register",
|
| 8 |
+
"methodology": "https://www.holistixintl.com/pages/open-biohacking-data-methodology",
|
| 9 |
+
"last_updated": "2026-06-27",
|
| 10 |
+
"disclaimer": "This dataset is for educational and informational purposes only. It is not medical advice, diagnosis, treatment guidance, disease-prevention guidance, dosing guidance, or a substitute for consultation with a qualified healthcare professional.",
|
| 11 |
+
"fields": [
|
| 12 |
+
"record_id",
|
| 13 |
+
"topic",
|
| 14 |
+
"reference_type",
|
| 15 |
+
"plain_language_meaning",
|
| 16 |
+
"safety_note",
|
| 17 |
+
"source_type",
|
| 18 |
+
"evidence_level",
|
| 19 |
+
"claim_type",
|
| 20 |
+
"medical_disclaimer_required",
|
| 21 |
+
"commercial_relevance",
|
| 22 |
+
"last_reviewed",
|
| 23 |
+
"related_holistix_page",
|
| 24 |
+
"related_product_category",
|
| 25 |
+
"notes",
|
| 26 |
+
"source_name",
|
| 27 |
+
"source_url",
|
| 28 |
+
"citation_note"
|
| 29 |
+
],
|
| 30 |
+
"records": [
|
| 31 |
+
{
|
| 32 |
+
"record_id": "BLUE-001",
|
| 33 |
+
"topic": "Blue light",
|
| 34 |
+
"reference_type": "Definition",
|
| 35 |
+
"plain_language_meaning": "Blue light is a visible-light range often discussed in screen exposure, circadian rhythm, dermatology, acne-care devices, and controlled light-therapy contexts.",
|
| 36 |
+
"safety_note": "The term blue light by itself should not be treated as proof of a medical or cosmetic result.",
|
| 37 |
+
"source_type": "Educational terminology / device-category context",
|
| 38 |
+
"evidence_level": "Basic terminology",
|
| 39 |
+
"claim_type": "Definition",
|
| 40 |
+
"medical_disclaimer_required": "No",
|
| 41 |
+
"commercial_relevance": "Helps explain broad blue light terminology without overclaiming.",
|
| 42 |
+
"last_reviewed": "2026-06-26",
|
| 43 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 44 |
+
"related_product_category": "Blue light wellness devices",
|
| 45 |
+
"notes": "Use as the neutral opening definition.",
|
| 46 |
+
"source_name": "Blue Light in Dermatology",
|
| 47 |
+
"source_url": "https://www.mdpi.com/2075-1729/11/7/670",
|
| 48 |
+
"citation_note": "Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 49 |
+
},
|
| 50 |
+
{
|
| 51 |
+
"record_id": "BLUE-002",
|
| 52 |
+
"topic": "Controlled blue light therapy",
|
| 53 |
+
"reference_type": "Therapy context",
|
| 54 |
+
"plain_language_meaning": "Controlled blue light therapy generally refers to structured light exposure using defined wavelengths, intensity, distance, and exposure time.",
|
| 55 |
+
"safety_note": "Controlled-use language should not be converted into disease-treatment or home-use protocols without appropriate evidence and professional guidance.",
|
| 56 |
+
"source_type": "Safety guidance / claim-boundary context",
|
| 57 |
+
"evidence_level": "Measurement caution",
|
| 58 |
+
"claim_type": "Usage context",
|
| 59 |
+
"medical_disclaimer_required": "Yes",
|
| 60 |
+
"commercial_relevance": "Separates controlled light-therapy contexts from vague consumer marketing.",
|
| 61 |
+
"last_reviewed": "2026-06-26",
|
| 62 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 63 |
+
"related_product_category": "Blue light wellness devices",
|
| 64 |
+
"notes": "Avoid creating dosage protocols.",
|
| 65 |
+
"source_name": "Blue Light in Dermatology",
|
| 66 |
+
"source_url": "https://www.mdpi.com/2075-1729/11/7/670",
|
| 67 |
+
"citation_note": "Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 68 |
+
},
|
| 69 |
+
{
|
| 70 |
+
"record_id": "BLUE-003",
|
| 71 |
+
"topic": "Blue light and skin-care devices",
|
| 72 |
+
"reference_type": "Device category",
|
| 73 |
+
"plain_language_meaning": "Some consumer skin-care devices use blue light as part of acne-care, blemish-care, or general skin-appearance positioning.",
|
| 74 |
+
"safety_note": "Cosmetic language should not become a claim to diagnose, treat, cure, or prevent a disease unless supported by proper regulatory clearance and evidence.",
|
| 75 |
+
"source_type": "Consumer comparison context / buyer education",
|
| 76 |
+
"evidence_level": "Buyer education / device specification",
|
| 77 |
+
"claim_type": "Device comparison",
|
| 78 |
+
"medical_disclaimer_required": "Yes",
|
| 79 |
+
"commercial_relevance": "Relevant to beauty and skin-care device comparison pages.",
|
| 80 |
+
"last_reviewed": "2026-06-26",
|
| 81 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 82 |
+
"related_product_category": "Blue light wellness devices",
|
| 83 |
+
"notes": "Keep cosmetic and medical language separate.",
|
| 84 |
+
"source_name": "Effect of Blue Light on Acne Vulgaris: A Systematic Review",
|
| 85 |
+
"source_url": "https://www.mdpi.com/1424-8220/21/20/6943",
|
| 86 |
+
"citation_note": "Use as review-level context for blue light and acne-related research. Do not use as a product efficacy guarantee or treatment protocol."
|
| 87 |
+
},
|
| 88 |
+
{
|
| 89 |
+
"record_id": "BLUE-004",
|
| 90 |
+
"topic": "Acne claim boundary",
|
| 91 |
+
"reference_type": "Claim boundary",
|
| 92 |
+
"plain_language_meaning": "Blue light is often discussed in relation to acne-care devices, but consumer claims need careful wording.",
|
| 93 |
+
"safety_note": "Avoid claiming a device treats acne or any skin disease unless claims are supported by appropriate evidence, intended-use language, and regulatory status.",
|
| 94 |
+
"source_type": "Safety guidance / claim-boundary context",
|
| 95 |
+
"evidence_level": "Commercial separation",
|
| 96 |
+
"claim_type": "Claim boundary",
|
| 97 |
+
"medical_disclaimer_required": "Yes",
|
| 98 |
+
"commercial_relevance": "Protects Holistix product and education copy from overstated skin claims.",
|
| 99 |
+
"last_reviewed": "2026-06-26",
|
| 100 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 101 |
+
"related_product_category": "Blue light wellness devices",
|
| 102 |
+
"notes": "Important compliance row.",
|
| 103 |
+
"source_name": "Effect of Blue Light on Acne Vulgaris: A Systematic Review",
|
| 104 |
+
"source_url": "https://www.mdpi.com/1424-8220/21/20/6943",
|
| 105 |
+
"citation_note": "Use as review-level context for blue light and acne-related research. Do not use as a product efficacy guarantee or treatment protocol."
|
| 106 |
+
},
|
| 107 |
+
{
|
| 108 |
+
"record_id": "BLUE-005",
|
| 109 |
+
"topic": "Eye exposure",
|
| 110 |
+
"reference_type": "Safety caution",
|
| 111 |
+
"plain_language_meaning": "Blue light can be bright or uncomfortable, and direct viewing of intense LEDs may create eye strain or safety concerns depending on device design.",
|
| 112 |
+
"safety_note": "Do not stare into LEDs. Follow manufacturer eye-protection instructions, especially with bright facial devices or panel-style devices.",
|
| 113 |
+
"source_type": "Manufacturer instruction / consumer safety context",
|
| 114 |
+
"evidence_level": "Consumer safety caution",
|
| 115 |
+
"claim_type": "Safety caution",
|
| 116 |
+
"medical_disclaimer_required": "Yes",
|
| 117 |
+
"commercial_relevance": "Important for face masks, panels, and handheld light devices.",
|
| 118 |
+
"last_reviewed": "2026-06-26",
|
| 119 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 120 |
+
"related_product_category": "Blue light wellness devices",
|
| 121 |
+
"notes": "Eye safety row should stay visible.",
|
| 122 |
+
"source_name": "Blue Light in Dermatology",
|
| 123 |
+
"source_url": "https://www.mdpi.com/2075-1729/11/7/670",
|
| 124 |
+
"citation_note": "Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 125 |
+
},
|
| 126 |
+
{
|
| 127 |
+
"record_id": "BLUE-006",
|
| 128 |
+
"topic": "Photosensitivity",
|
| 129 |
+
"reference_type": "Safety context",
|
| 130 |
+
"plain_language_meaning": "Some people may be more sensitive to light because of medications, skin conditions, eye conditions, or individual sensitivity.",
|
| 131 |
+
"safety_note": "People with photosensitivity concerns or relevant medication use should consult a qualified healthcare professional before using bright light devices.",
|
| 132 |
+
"source_type": "Safety guidance / claim-boundary context",
|
| 133 |
+
"evidence_level": "Consumer safety caution",
|
| 134 |
+
"claim_type": "Safety caution",
|
| 135 |
+
"medical_disclaimer_required": "Yes",
|
| 136 |
+
"commercial_relevance": "Supports conservative safety language for light-based products.",
|
| 137 |
+
"last_reviewed": "2026-06-26",
|
| 138 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 139 |
+
"related_product_category": "Blue light wellness devices",
|
| 140 |
+
"notes": "No medical screening protocol.",
|
| 141 |
+
"source_name": "Ocular hazards of blue-light therapy in dermatology",
|
| 142 |
+
"source_url": "https://www.jaad.org/article/S0190-9622(10)02150-X/fulltext",
|
| 143 |
+
"citation_note": "Use for eye-safety caution around blue-light therapy. Preserve manufacturer eye-protection guidance and avoid personalized medical advice."
|
| 144 |
+
},
|
| 145 |
+
{
|
| 146 |
+
"record_id": "BLUE-007",
|
| 147 |
+
"topic": "Screen blue light",
|
| 148 |
+
"reference_type": "Exposure context",
|
| 149 |
+
"plain_language_meaning": "Screen-related blue light is different from controlled light-therapy devices because screens vary in brightness, timing, distance, duration, and surrounding environment.",
|
| 150 |
+
"safety_note": "Do not treat screen-exposure concerns as the same category as controlled therapeutic or cosmetic blue light devices.",
|
| 151 |
+
"source_type": "Educational terminology / device-category context",
|
| 152 |
+
"evidence_level": "Measurement caution",
|
| 153 |
+
"claim_type": "Measurement concept",
|
| 154 |
+
"medical_disclaimer_required": "No",
|
| 155 |
+
"commercial_relevance": "Helps separate common screen-blue-light searches from device therapy claims.",
|
| 156 |
+
"last_reviewed": "2026-06-26",
|
| 157 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 158 |
+
"related_product_category": "Blue light wellness devices",
|
| 159 |
+
"notes": "Useful SEO/AI clarity row.",
|
| 160 |
+
"source_name": "Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne",
|
| 161 |
+
"source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3366451/",
|
| 162 |
+
"citation_note": "Use for controlled-device dose and exposure-parameter context. Do not convert study parameters into general consumer recommendations."
|
| 163 |
+
},
|
| 164 |
+
{
|
| 165 |
+
"record_id": "BLUE-008",
|
| 166 |
+
"topic": "Circadian timing",
|
| 167 |
+
"reference_type": "Usage context",
|
| 168 |
+
"plain_language_meaning": "Blue light timing can matter because bright light exposure, especially at night, is often discussed in relation to alertness and circadian rhythms.",
|
| 169 |
+
"safety_note": "This dataset does not provide sleep-treatment advice or medical guidance. Users with sleep disorders should consult a qualified professional.",
|
| 170 |
+
"source_type": "Scientific review",
|
| 171 |
+
"evidence_level": "Research context",
|
| 172 |
+
"claim_type": "Usage context",
|
| 173 |
+
"medical_disclaimer_required": "Yes",
|
| 174 |
+
"commercial_relevance": "Allows careful discussion of timing without claiming sleep treatment.",
|
| 175 |
+
"last_reviewed": "2026-06-26",
|
| 176 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 177 |
+
"related_product_category": "Blue light wellness devices",
|
| 178 |
+
"notes": "Keep non-medical and general.",
|
| 179 |
+
"source_name": "Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne",
|
| 180 |
+
"source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3366451/",
|
| 181 |
+
"citation_note": "Use for controlled-device dose and exposure-parameter context. Do not convert study parameters into general consumer recommendations."
|
| 182 |
+
},
|
| 183 |
+
{
|
| 184 |
+
"record_id": "BLUE-009",
|
| 185 |
+
"topic": "Wavelength disclosure",
|
| 186 |
+
"reference_type": "Specification field",
|
| 187 |
+
"plain_language_meaning": "A useful blue light device listing should disclose wavelength range, LED type, intended use, power or irradiance information when available, safety warnings, and instructions.",
|
| 188 |
+
"safety_note": "If exact wavelength or output data are unavailable, copy should say so instead of implying precision.",
|
| 189 |
+
"source_type": "Device specification / manufacturer-instruction context",
|
| 190 |
+
"evidence_level": "Device specification",
|
| 191 |
+
"claim_type": "Specification field",
|
| 192 |
+
"medical_disclaimer_required": "No",
|
| 193 |
+
"commercial_relevance": "Supports cleaner product-page and comparison-page language.",
|
| 194 |
+
"last_reviewed": "2026-06-26",
|
| 195 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 196 |
+
"related_product_category": "Blue light wellness devices",
|
| 197 |
+
"notes": "Good row for product-spec audits.",
|
| 198 |
+
"source_name": "Blue Light in Dermatology",
|
| 199 |
+
"source_url": "https://www.mdpi.com/2075-1729/11/7/670",
|
| 200 |
+
"citation_note": "Use for blue-light wavelength range and dermatology-context terminology. Keep as educational spectrum context, not treatment guidance."
|
| 201 |
+
},
|
| 202 |
+
{
|
| 203 |
+
"record_id": "BLUE-010",
|
| 204 |
+
"topic": "Irradiance and distance",
|
| 205 |
+
"reference_type": "Measurement concept",
|
| 206 |
+
"plain_language_meaning": "Blue light exposure depends on output intensity, distance from the device, area covered, and exposure time.",
|
| 207 |
+
"safety_note": "Avoid copying clinical or online exposure protocols into consumer use instructions unless they match the device and intended use.",
|
| 208 |
+
"source_type": "Manufacturer instruction / consumer safety context",
|
| 209 |
+
"evidence_level": "Measurement caution",
|
| 210 |
+
"claim_type": "Measurement concept",
|
| 211 |
+
"medical_disclaimer_required": "Yes",
|
| 212 |
+
"commercial_relevance": "Prevents generic protocol language from becoming unsafe advice.",
|
| 213 |
+
"last_reviewed": "2026-06-26",
|
| 214 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 215 |
+
"related_product_category": "Blue light wellness devices",
|
| 216 |
+
"notes": "No dosage instructions.",
|
| 217 |
+
"source_name": "Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne",
|
| 218 |
+
"source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3366451/",
|
| 219 |
+
"citation_note": "Use for controlled-device dose and exposure-parameter context. Do not convert study parameters into general consumer recommendations."
|
| 220 |
+
},
|
| 221 |
+
{
|
| 222 |
+
"record_id": "BLUE-011",
|
| 223 |
+
"topic": "Exposure time",
|
| 224 |
+
"reference_type": "Usage context",
|
| 225 |
+
"plain_language_meaning": "Exposure time is a major variable for any light-emitting consumer device.",
|
| 226 |
+
"safety_note": "This dataset does not provide dosage protocols. Users should follow device instructions and avoid overuse.",
|
| 227 |
+
"source_type": "Manufacturer instruction / consumer safety context",
|
| 228 |
+
"evidence_level": "Consumer safety caution",
|
| 229 |
+
"claim_type": "Usage context",
|
| 230 |
+
"medical_disclaimer_required": "Yes",
|
| 231 |
+
"commercial_relevance": "Keeps the dataset educational instead of becoming a protocol page.",
|
| 232 |
+
"last_reviewed": "2026-06-26",
|
| 233 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 234 |
+
"related_product_category": "Blue light wellness devices",
|
| 235 |
+
"notes": "No treatment schedules.",
|
| 236 |
+
"source_name": "FDA 510(k) Summary: Quasar Blue Light Therapy System",
|
| 237 |
+
"source_url": "https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf",
|
| 238 |
+
"citation_note": "Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."
|
| 239 |
+
},
|
| 240 |
+
{
|
| 241 |
+
"record_id": "BLUE-012",
|
| 242 |
+
"topic": "Combined light devices",
|
| 243 |
+
"reference_type": "Device comparison",
|
| 244 |
+
"plain_language_meaning": "Some devices combine blue light with red light, near-infrared light, infrared heat, vibration, PEMF, or other features.",
|
| 245 |
+
"safety_note": "When multiple technologies are combined, claims should identify which feature is being discussed and avoid assigning every benefit to blue light.",
|
| 246 |
+
"source_type": "Consumer comparison context / buyer education",
|
| 247 |
+
"evidence_level": "Buyer education / device specification",
|
| 248 |
+
"claim_type": "Device comparison",
|
| 249 |
+
"medical_disclaimer_required": "Yes",
|
| 250 |
+
"commercial_relevance": "Useful for Holistix product education where devices may combine light modes.",
|
| 251 |
+
"last_reviewed": "2026-06-26",
|
| 252 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 253 |
+
"related_product_category": "Blue light wellness devices",
|
| 254 |
+
"notes": "Good multi-modality clarity row.",
|
| 255 |
+
"source_name": "FDA 510(k) Summary: Quasar Blue Light Therapy System",
|
| 256 |
+
"source_url": "https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf",
|
| 257 |
+
"citation_note": "Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."
|
| 258 |
+
},
|
| 259 |
+
{
|
| 260 |
+
"record_id": "BLUE-013",
|
| 261 |
+
"topic": "Heat and skin irritation",
|
| 262 |
+
"reference_type": "Safety context",
|
| 263 |
+
"plain_language_meaning": "Some light devices can create warmth or skin irritation depending on device design, duration, sensitivity, and placement.",
|
| 264 |
+
"safety_note": "Stop use if discomfort, irritation, excessive heat, or unusual reaction occurs and follow manufacturer safety instructions.",
|
| 265 |
+
"source_type": "Manufacturer instruction / consumer safety context",
|
| 266 |
+
"evidence_level": "Consumer safety caution",
|
| 267 |
+
"claim_type": "Safety caution",
|
| 268 |
+
"medical_disclaimer_required": "Yes",
|
| 269 |
+
"commercial_relevance": "Supports practical product safety language.",
|
| 270 |
+
"last_reviewed": "2026-06-26",
|
| 271 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 272 |
+
"related_product_category": "Blue light wellness devices",
|
| 273 |
+
"notes": "Keep as consumer caution, not medical advice.",
|
| 274 |
+
"source_name": "Blue Light Therapy in Dermatological Practice: A Review",
|
| 275 |
+
"source_url": "https://www.mdpi.com/2079-9284/12/1/30",
|
| 276 |
+
"citation_note": "Use as broad dermatology review context for blue-light effects, safety considerations, and skin-facing use. Keep all claims conservative."
|
| 277 |
+
},
|
| 278 |
+
{
|
| 279 |
+
"record_id": "BLUE-014",
|
| 280 |
+
"topic": "Home-use device claims",
|
| 281 |
+
"reference_type": "Claim boundary",
|
| 282 |
+
"plain_language_meaning": "Home-use blue light devices should be described carefully because consumer devices can differ from clinical, dermatology, or research systems.",
|
| 283 |
+
"safety_note": "Avoid implying that a home-use device is equivalent to professional treatment equipment unless specifications, intended use, and evidence support that comparison.",
|
| 284 |
+
"source_type": "Safety guidance / claim-boundary context",
|
| 285 |
+
"evidence_level": "Commercial separation",
|
| 286 |
+
"claim_type": "Claim boundary",
|
| 287 |
+
"medical_disclaimer_required": "Yes",
|
| 288 |
+
"commercial_relevance": "Protects against borrowed authority from clinical research.",
|
| 289 |
+
"last_reviewed": "2026-06-26",
|
| 290 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 291 |
+
"related_product_category": "Blue light wellness devices",
|
| 292 |
+
"notes": "Key claim-boundary row.",
|
| 293 |
+
"source_name": "FDA 510(k) Summary: Quasar Blue Light Therapy System",
|
| 294 |
+
"source_url": "https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf",
|
| 295 |
+
"citation_note": "Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."
|
| 296 |
+
},
|
| 297 |
+
{
|
| 298 |
+
"record_id": "BLUE-015",
|
| 299 |
+
"topic": "Regulatory and intended-use language",
|
| 300 |
+
"reference_type": "Regulatory context",
|
| 301 |
+
"plain_language_meaning": "Blue light devices that make medical claims should be evaluated for intended use, regulatory status, labeling, and evidence support.",
|
| 302 |
+
"safety_note": "Regulatory language should not be used as a substitute for medical evidence or disease-treatment approval.",
|
| 303 |
+
"source_type": "Regulatory / agency reference",
|
| 304 |
+
"evidence_level": "Device specification",
|
| 305 |
+
"claim_type": "Specification field",
|
| 306 |
+
"medical_disclaimer_required": "No",
|
| 307 |
+
"commercial_relevance": "Supports careful product positioning and documentation checks.",
|
| 308 |
+
"last_reviewed": "2026-06-26",
|
| 309 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 310 |
+
"related_product_category": "Blue light wellness devices",
|
| 311 |
+
"notes": "Useful for future compliance audits.",
|
| 312 |
+
"source_name": "FDA 510(k) Summary: Quasar Blue Light Therapy System",
|
| 313 |
+
"source_url": "https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf",
|
| 314 |
+
"citation_note": "Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."
|
| 315 |
+
},
|
| 316 |
+
{
|
| 317 |
+
"record_id": "BLUE-016",
|
| 318 |
+
"topic": "Commercial claim separation",
|
| 319 |
+
"reference_type": "Commercial separation",
|
| 320 |
+
"plain_language_meaning": "Educational copy should separate blue light terminology, cosmetic positioning, device specifications, safety warnings, and medical claims.",
|
| 321 |
+
"safety_note": "Avoid disease claims, guaranteed skin outcomes, unsupported before-and-after promises, and broad claims that all blue light devices work the same way.",
|
| 322 |
+
"source_type": "Safety guidance / claim-boundary context",
|
| 323 |
+
"evidence_level": "Commercial separation",
|
| 324 |
+
"claim_type": "Claim boundary",
|
| 325 |
+
"medical_disclaimer_required": "Yes",
|
| 326 |
+
"commercial_relevance": "Keeps Holistix open-data assets citation-worthy and lower-risk.",
|
| 327 |
+
"last_reviewed": "2026-06-26",
|
| 328 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 329 |
+
"related_product_category": "Blue light wellness devices",
|
| 330 |
+
"notes": "Protect the asset.",
|
| 331 |
+
"source_name": "FDA 510(k) Summary: Quasar Blue Light Therapy System",
|
| 332 |
+
"source_url": "https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf",
|
| 333 |
+
"citation_note": "Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."
|
| 334 |
+
},
|
| 335 |
+
{
|
| 336 |
+
"record_id": "BLUE-017",
|
| 337 |
+
"topic": "Maintenance and review",
|
| 338 |
+
"reference_type": "Dataset maintenance",
|
| 339 |
+
"plain_language_meaning": "Blue light therapy and screen-exposure language should be reviewed periodically because device designs, evidence, regulations, and market claims can change.",
|
| 340 |
+
"safety_note": "Rows should be updated when stronger safety guidance, regulatory information, or better product-specification standards become available.",
|
| 341 |
+
"source_type": "Open data maintenance context",
|
| 342 |
+
"evidence_level": "Research context",
|
| 343 |
+
"claim_type": "Dataset maintenance",
|
| 344 |
+
"medical_disclaimer_required": "No",
|
| 345 |
+
"commercial_relevance": "Supports future version history and dataset audits.",
|
| 346 |
+
"last_reviewed": "2026-06-26",
|
| 347 |
+
"related_holistix_page": "https://www.holistixintl.com/pages/blue-light-therapy-reference-index",
|
| 348 |
+
"related_product_category": "Blue light wellness devices",
|
| 349 |
+
"notes": "Use for future v1.2 or later updates.",
|
| 350 |
+
"source_name": "FDA 510(k) Summary: Quasar Blue Light Therapy System",
|
| 351 |
+
"source_url": "https://www.accessdata.fda.gov/cdrh_docs/pdf9/K093963.pdf",
|
| 352 |
+
"citation_note": "Use as device-regulatory context showing that blue-light devices can have specific intended uses and technical characteristics. Do not generalize to all devices."
|
| 353 |
+
}
|
| 354 |
+
]
|
| 355 |
}
|
datasets/blue-light/README.md
CHANGED
|
@@ -1,18 +1,18 @@
|
|
| 1 |
-
# Blue Light Datasets
|
| 2 |
-
|
| 3 |
-
This folder contains Open Biohacking Data Project reference files related to blue light therapy, blue light wellness devices, wavelength references, timing considerations, and beginner education.
|
| 4 |
-
|
| 5 |
-
## Scope
|
| 6 |
-
|
| 7 |
-
The blue light dataset category may include:
|
| 8 |
-
|
| 9 |
-
- Blue light therapy reference data
|
| 10 |
-
- Wavelength reference notes
|
| 11 |
-
- Timing and session education
|
| 12 |
-
- Blue light versus red light comparisons
|
| 13 |
-
- Skin-facing device education
|
| 14 |
-
- Beginner safety and comfort notes
|
| 15 |
-
|
| 16 |
-
## Important Disclaimer
|
| 17 |
-
|
| 18 |
-
This folder is for educational and informational purposes only. It is not medical advice, diagnosis, treatment, cure, prevention, or a substitute for professional healthcare guidance.
|
|
|
|
| 1 |
+
# Blue Light Datasets
|
| 2 |
+
|
| 3 |
+
This folder contains Open Biohacking Data Project reference files related to blue light therapy, blue light wellness devices, wavelength references, timing considerations, and beginner education.
|
| 4 |
+
|
| 5 |
+
## Scope
|
| 6 |
+
|
| 7 |
+
The blue light dataset category may include:
|
| 8 |
+
|
| 9 |
+
- Blue light therapy reference data
|
| 10 |
+
- Wavelength reference notes
|
| 11 |
+
- Timing and session education
|
| 12 |
+
- Blue light versus red light comparisons
|
| 13 |
+
- Skin-facing device education
|
| 14 |
+
- Beginner safety and comfort notes
|
| 15 |
+
|
| 16 |
+
## Important Disclaimer
|
| 17 |
+
|
| 18 |
+
This folder is for educational and informational purposes only. It is not medical advice, diagnosis, treatment, cure, prevention, or a substitute for professional healthcare guidance.
|
datasets/blue-light/blue-light-therapy-reference-index.csv
CHANGED
|
@@ -1,9 +1,9 @@
|
|
| 1 |
-
category,reference_topic,plain_language_summary,educational_notes,safety_framing,related_holistix_url
|
| 2 |
-
Blue light therapy,Blue light wellness devices,"Blue light therapy devices are consumer wellness products commonly discussed for skin-facing routines and targeted light exposure.","Blue light therapy should be framed conservatively and should not be presented as a disease treatment or cure.","Educational reference only. Not medical advice.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|
| 3 |
-
Blue light therapy,Blue light wavelength context,"Blue light refers to visible light in the blue range of the spectrum.","Device output, wavelength range, distance, and session time may vary by product. Users should follow device-specific instructions.","Avoid direct eye exposure unless the product instructions specifically allow it. Use eye protection when appropriate.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|
| 4 |
-
Blue light therapy,Blue light versus red light,"Blue light and red light are different parts of the visible light spectrum and are commonly discussed for different wellness device contexts.","Red light is often discussed for red light therapy routines, while blue light is often discussed in skin-facing device education.","Educational reference only. Avoid assuming different wavelengths have the same use or safety profile.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|
| 5 |
-
Blue light therapy,Session timing,"Beginner blue light sessions should follow the device instructions and should be based on comfort, distance, and target area.","More exposure is not automatically better. Conservative beginner use is preferred.","Stop use if irritation, discomfort, unusual sensitivity, or skin reaction occurs.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|
| 6 |
-
Blue light therapy,Skin-facing routines,"Blue light devices are often discussed in relation to skin-facing routines.","People with sensitive skin, active irritation, or dermatology concerns should be cautious and seek professional guidance when unsure.","Educational reference only. Not a substitute for dermatology or medical care.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|
| 7 |
-
Blue light therapy,Eye safety,"Blue light exposure can be uncomfortable or inappropriate for the eyes depending on device design and use.","Eye protection and proper positioning may be important depending on the product.","Avoid looking directly into bright light sources. Follow product eye-safety guidance.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|
| 8 |
-
Blue light therapy,Light sensitivity,"People with light sensitivity or medication-related photosensitivity should be cautious with blue light devices.","Some medications and conditions may increase light sensitivity.","Consult a qualified healthcare professional if light sensitivity, prescription medication use, or health concerns are present.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|
| 9 |
-
Blue light therapy,Beginner education,"Beginners should understand that wavelength, output, distance, timing, and skin comfort all affect light-device routines.","Blue light education should focus on responsible use, product instructions, and conservative safety framing.","Educational reference only. Not medical advice, diagnosis, treatment, cure, or prevention.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|
|
|
|
| 1 |
+
category,reference_topic,plain_language_summary,educational_notes,safety_framing,related_holistix_url
|
| 2 |
+
Blue light therapy,Blue light wellness devices,"Blue light therapy devices are consumer wellness products commonly discussed for skin-facing routines and targeted light exposure.","Blue light therapy should be framed conservatively and should not be presented as a disease treatment or cure.","Educational reference only. Not medical advice.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|
| 3 |
+
Blue light therapy,Blue light wavelength context,"Blue light refers to visible light in the blue range of the spectrum.","Device output, wavelength range, distance, and session time may vary by product. Users should follow device-specific instructions.","Avoid direct eye exposure unless the product instructions specifically allow it. Use eye protection when appropriate.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|
| 4 |
+
Blue light therapy,Blue light versus red light,"Blue light and red light are different parts of the visible light spectrum and are commonly discussed for different wellness device contexts.","Red light is often discussed for red light therapy routines, while blue light is often discussed in skin-facing device education.","Educational reference only. Avoid assuming different wavelengths have the same use or safety profile.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|
| 5 |
+
Blue light therapy,Session timing,"Beginner blue light sessions should follow the device instructions and should be based on comfort, distance, and target area.","More exposure is not automatically better. Conservative beginner use is preferred.","Stop use if irritation, discomfort, unusual sensitivity, or skin reaction occurs.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|
| 6 |
+
Blue light therapy,Skin-facing routines,"Blue light devices are often discussed in relation to skin-facing routines.","People with sensitive skin, active irritation, or dermatology concerns should be cautious and seek professional guidance when unsure.","Educational reference only. Not a substitute for dermatology or medical care.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|
| 7 |
+
Blue light therapy,Eye safety,"Blue light exposure can be uncomfortable or inappropriate for the eyes depending on device design and use.","Eye protection and proper positioning may be important depending on the product.","Avoid looking directly into bright light sources. Follow product eye-safety guidance.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|
| 8 |
+
Blue light therapy,Light sensitivity,"People with light sensitivity or medication-related photosensitivity should be cautious with blue light devices.","Some medications and conditions may increase light sensitivity.","Consult a qualified healthcare professional if light sensitivity, prescription medication use, or health concerns are present.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|
| 9 |
+
Blue light therapy,Beginner education,"Beginners should understand that wavelength, output, distance, timing, and skin comfort all affect light-device routines.","Blue light education should focus on responsible use, product instructions, and conservative safety framing.","Educational reference only. Not medical advice, diagnosis, treatment, cure, or prevention.","https://www.holistixintl.com/pages/blue-light-therapy-reference-index"
|